0000914208-24-000276.txt : 20240501 0000914208-24-000276.hdr.sgml : 20240501 20240501130852 ACCESSION NUMBER: 0000914208-24-000276 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invesco Ltd. CENTRAL INDEX KEY: 0000914208 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] ORGANIZATION NAME: 02 Finance IRS NUMBER: 980557567 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13908 FILM NUMBER: 24901911 BUSINESS ADDRESS: STREET 1: 1331 SPRING STREET NW STREET 2: SUITE 2500 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-892-0896 MAIL ADDRESS: STREET 1: 1331 SPRING STREET NW STREET 2: SUITE 2500 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Asset Management Deutschland GMBH DATE OF NAME CHANGE: 20211102 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd. DATE OF NAME CHANGE: 20080520 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd DATE OF NAME CHANGE: 20080508 10-Q 1 ivz-20240331.htm 10-Q ivz-20240331
000091420812/312024Q1FALSE00009142082024-01-012024-03-3100009142082024-03-31xbrli:sharesiso4217:USD00009142082023-12-31iso4217:USDxbrli:shares0000914208us-gaap:InvestmentAdviceMember2024-01-012024-03-310000914208us-gaap:InvestmentAdviceMember2023-01-012023-03-310000914208us-gaap:DistributionAndShareholderServiceMember2024-01-012024-03-310000914208us-gaap:DistributionAndShareholderServiceMember2023-01-012023-03-310000914208us-gaap:InvestmentPerformanceMember2024-01-012024-03-310000914208us-gaap:InvestmentPerformanceMember2023-01-012023-03-310000914208us-gaap:FinancialServiceOtherMember2024-01-012024-03-310000914208us-gaap:FinancialServiceOtherMember2023-01-012023-03-3100009142082023-01-012023-03-310000914208us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-3100009142082022-12-3100009142082023-03-310000914208us-gaap:PreferredStockMember2023-12-310000914208us-gaap:CommonStockMember2023-12-310000914208us-gaap:AdditionalPaidInCapitalMember2023-12-310000914208us-gaap:TreasuryStockCommonMember2023-12-310000914208us-gaap:RetainedEarningsMember2023-12-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000914208us-gaap:ParentMember2023-12-310000914208us-gaap:NoncontrollingInterestMember2023-12-310000914208us-gaap:RetainedEarningsMember2024-01-012024-03-310000914208us-gaap:ParentMember2024-01-012024-03-310000914208us-gaap:NoncontrollingInterestMember2024-01-012024-03-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000914208us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000914208us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000914208us-gaap:PreferredStockMember2024-03-310000914208us-gaap:CommonStockMember2024-03-310000914208us-gaap:AdditionalPaidInCapitalMember2024-03-310000914208us-gaap:TreasuryStockCommonMember2024-03-310000914208us-gaap:RetainedEarningsMember2024-03-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000914208us-gaap:ParentMember2024-03-310000914208us-gaap:NoncontrollingInterestMember2024-03-310000914208us-gaap:PreferredStockMember2022-12-310000914208us-gaap:CommonStockMember2022-12-310000914208us-gaap:AdditionalPaidInCapitalMember2022-12-310000914208us-gaap:TreasuryStockCommonMember2022-12-310000914208us-gaap:RetainedEarningsMember2022-12-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000914208us-gaap:ParentMember2022-12-310000914208us-gaap:NoncontrollingInterestMember2022-12-310000914208us-gaap:RetainedEarningsMember2023-01-012023-03-310000914208us-gaap:ParentMember2023-01-012023-03-310000914208us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000914208us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000914208us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000914208us-gaap:PreferredStockMember2023-03-310000914208us-gaap:CommonStockMember2023-03-310000914208us-gaap:AdditionalPaidInCapitalMember2023-03-310000914208us-gaap:TreasuryStockCommonMember2023-03-310000914208us-gaap:RetainedEarningsMember2023-03-310000914208us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000914208us-gaap:ParentMember2023-03-310000914208us-gaap:NoncontrollingInterestMember2023-03-310000914208ivz:ReclassificationAdjustmentsMember2024-01-012024-03-310000914208ivz:ReclassificationAdjustmentsMember2023-01-012023-03-310000914208us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000914208us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000914208us-gaap:TotalReturnSwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000914208us-gaap:TotalReturnSwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000914208us-gaap:MoneyMarketFundsMember2024-03-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208ivz:SeedCapitalMember2024-03-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208ivz:DeferredCompensationArrangementsMember2024-03-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:LiabilityMember2024-03-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:MoneyMarketFundsMember2023-12-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208ivz:SeedCapitalMember2023-12-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208ivz:SeedCapitalMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208ivz:DeferredCompensationArrangementsMember2023-12-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208ivz:DeferredCompensationArrangementsMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:LiabilityMember2023-12-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:LiabilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:TotalReturnSwapMember2024-03-310000914208us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:TotalReturnSwapMember2023-12-310000914208us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:TotalReturnSwapMember2024-01-012024-03-310000914208us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:TotalReturnSwapMember2023-01-012023-03-310000914208ivz:SeedCapitalMember2024-03-310000914208ivz:SeedCapitalMember2023-12-310000914208ivz:DeferredCompensationArrangementsMember2024-03-310000914208ivz:DeferredCompensationArrangementsMember2023-12-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:LineOfCreditMember2024-03-310000914208us-gaap:LineOfCreditMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:LineOfCreditMember2023-12-310000914208us-gaap:LineOfCreditMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Member2024-03-31xbrli:pure0000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Member2024-03-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Member2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary152026MemberMember2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary152026MemberMember2024-03-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary152026MemberMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary152026MemberMember2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary152026MemberMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueNovember302043Member2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueNovember302043Member2024-03-310000914208us-gaap:UnsecuredDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberivz:SeniorNotesDueNovember302043Member2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberivz:SeniorNotesDueNovember302043Member2023-12-310000914208us-gaap:UnsecuredDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberivz:SeniorNotesDueNovember302043Member2023-12-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000914208us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000914208us-gaap:UnsecuredDebtMemberivz:SeniorNotesDueJanuary302024Member2024-01-300000914208us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000914208us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000914208us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000914208us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000914208us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000914208us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000914208country:BM2024-01-012024-03-310000914208country:BM2023-01-012023-03-310000914208srt:AmericasMember2024-01-012024-03-310000914208srt:AmericasMember2023-01-012023-03-310000914208srt:AsiaPacificMember2024-01-012024-03-310000914208srt:AsiaPacificMember2023-01-012023-03-310000914208us-gaap:EMEAMember2024-01-012024-03-310000914208us-gaap:EMEAMember2023-01-012023-03-310000914208ivz:TimeVestedNYSEMember2023-12-310000914208us-gaap:PerformanceSharesMember2023-12-310000914208ivz:TimeVestedNYSEMember2022-12-310000914208us-gaap:PerformanceSharesMember2022-12-310000914208ivz:TimeVestedNYSEMember2024-01-012024-03-310000914208us-gaap:PerformanceSharesMember2024-01-012024-03-310000914208ivz:TimeVestedNYSEMember2023-01-012023-03-310000914208us-gaap:PerformanceSharesMember2023-01-012023-03-310000914208ivz:TimeVestedNYSEMember2024-03-310000914208us-gaap:PerformanceSharesMember2024-03-310000914208ivz:TimeVestedNYSEMember2023-03-310000914208us-gaap:PerformanceSharesMember2023-03-310000914208ivz:EquityCommitmentMembersrt:MaximumMember2024-03-310000914208ivz:EquityCommitmentMember2024-03-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMember2024-03-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:PrivateEquityFundsMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PrivateEquityFundsMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PrivateEquityFundsMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PrivateEquityFundsMember2024-03-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:PrivateEquityFundsMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2024-03-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2024-03-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-03-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:BankLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:CorporateBondSecuritiesMember2023-12-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:EquitySecuritiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:PrivateEquityFundsMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PrivateEquityFundsMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PrivateEquityFundsMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PrivateEquityFundsMember2023-12-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:PrivateEquityFundsMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel2Member2023-12-310000914208us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2023-12-310000914208us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310000914208us-gaap:FairValueInputsLevel3Member2022-12-310000914208us-gaap:FairValueInputsLevel3Member2024-01-012024-03-310000914208us-gaap:FairValueInputsLevel3Member2023-01-012023-03-310000914208us-gaap:FairValueInputsLevel3Member2023-03-310000914208us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-03-310000914208us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310000914208ivz:MassMutualMemberivz:InvescoMemberivz:MassMutualMember2024-03-310000914208us-gaap:SubsequentEventMember2024-04-232024-04-23




                                    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
(Mark One)
☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number 001-13908
Invesco_Global_Logo_Blue_Pos_RGB.jpg
Invesco Ltd.
(Exact Name of Registrant as Specified in Its Charter)
Bermuda98-0557567
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)
1331 Spring Street,Suite 2500,Atlanta,GA30309
(Address of Principal Executive Offices)(Zip Code)
(404) 892-0896
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.20 par valueIVZNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☑Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☑
As of March 31, 2024, the most recent practicable date, the number of Common Shares outstanding was 449,831,075.




TABLE OF CONTENTS
We include cross references to captions elsewhere in this Quarterly Report on Form 10-Q, which we refer to as this “Report,” where you can find related additional information. The following table of contents tells you where to find these captions.
Page
TABLE OF CONTENTS
Glossary of Defined Terms












GLOSSARY OF DEFINED TERMS

APAC— Asia-Pacific
AUM— Assets under management
bps — Basis points
CIP— Consolidated investment products
CLOs— Collateralized loan obligations
Covenant Adjusted EBITDA— A financial measure set forth in covenants in our credit agreement, which is defined to be earnings before income tax, depreciation, amortization, interest expense, common share-based compensation expense, unrealized (gains)/losses from investments, net, and unusual or otherwise non-recurring gains and losses
EMEA— Europe, Middle East and Africa
EPS— Earnings per common share
ETFs— Exchange-traded funds
IGW or Invesco Great Wall— Invesco Great Wall Fund Management Company Limited
MassMutual— Massachusetts Mutual Life Insurance Company
NAV— Net asset value
Report— this Form 10-Q
S&P— Standard & Poor's
SEC— U.S. Securities and Exchange Commission
the company— Invesco Ltd. and its consolidated entities
the Parent— Invesco Ltd.
TRS— Total return swap
UITs— 
Unit Investment Trusts
U.K.— United Kingdom
U.S.— United States
U.S. GAAP— Accounting principles generally accepted in the United States
VIEs— Variable interest entities


i
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Invesco Ltd.
Condensed Consolidated Balance Sheets
(Unaudited)

As of
(in millions, except per share data)March 31, 2024December 31, 2023
ASSETS
Cash and cash equivalents$895.7 $1,469.2 
Accounts receivable708.3 701.5 
Investments963.5 919.1 
Assets of consolidated investment products (CIP):
Cash and cash equivalents of CIP529.8 462.4 
Accounts receivable and other assets of CIP217.3 250.1 
Investments of CIP8,902.2 8,765.9 
Assets held for policyholders— 393.9 
Other assets823.4 832.6 
Property, equipment and software, net583.6 599.5 
Intangible assets, net5,832.4 5,848.1 
Goodwill8,621.0 8,691.5 
Total assets$28,077.2 $28,933.8 
LIABILITIES
Accrued compensation and benefits$452.5 $900.4 
Accounts payable and accrued expenses1,321.2 1,294.4 
Liabilities of CIP:
Debt of CIP7,370.4 7,121.8 
Other liabilities of CIP459.1 492.1 
Policyholder payables— 393.9 
Debt1,257.5 1,489.5 
Deferred tax liabilities, net1,363.7 1,325.7 
Total liabilities12,224.4 13,017.8 
Commitments and contingencies (See Note 10)
TEMPORARY EQUITY
Redeemable noncontrolling interests in consolidated entities667.8 745.7 
PERMANENT EQUITY
Equity attributable to Invesco Ltd.:
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of March 31, 2024 and December 31, 2023)
4,010.5 4,010.5 
 Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of March 31, 2024 and December 31, 2023)
113.2 113.2 
Additional paid-in-capital7,314.6 7,451.6 
Treasury shares(2,864.4)(3,002.6)
Retained earnings6,878.0 6,826.7 
Accumulated other comprehensive income/(loss), net of tax(897.1)(801.8)
Total equity attributable to Invesco Ltd.14,554.8 14,597.6 
Equity attributable to nonredeemable noncontrolling interests in consolidated entities630.2 572.7 
Total permanent equity15,185.0 15,170.3 
Total liabilities, temporary and permanent equity$28,077.2 $28,933.8 

See accompanying notes.
1
Invesco Ltd.
Condensed Consolidated Statements of Income
(Unaudited)

Three months ended March 31,
 (in millions, except per common share data)20242023
Operating revenues:
Investment management fees$1,048.7 $1,027.9 
Service and distribution fees377.0 334.2 
Performance fees0.8 5.6 
Other48.8 50.5 
Total operating revenues1,475.3 1,418.2 
Operating expenses:
Third-party distribution, service and advisory504.0 455.1 
Employee compensation472.7 462.8 
Marketing18.1 19.6 
Property, office and technology117.6 110.5 
General and administrative138.5 105.0 
Transaction, integration and restructuring— 41.6 
Amortization of intangible assets11.3 14.1 
Total operating expenses1,262.2 1,208.7 
Operating income213.1 209.5 
Other income/(expense):
Equity in earnings of unconsolidated affiliates6.9 26.1 
Interest and dividend income12.4 8.6 
Interest expense(15.9)(18.0)
Other gains/(losses), net35.9 27.4 
Other income/(expense) of CIP, net30.5 (17.9)
Income before income taxes282.9 235.7 
Income tax provision(68.7)(69.9)
Net income214.2 165.8 
Net (income)/loss attributable to noncontrolling interests in consolidated entities(13.5)38.4 
Dividends declared on preferred shares(59.2)(59.2)
Net income attributable to Invesco Ltd.$141.5 $145.0 
Earnings per common share:
-basic$0.31 $0.32 
-diluted$0.31 $0.32 

See accompanying notes.

2
Invesco Ltd.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)

Three months ended March 31,
  (in millions)20242023
Net income$214.2 $165.8 
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries(96.3)55.1 
 Other comprehensive income/(loss), net of tax1.0 4.4 
Other comprehensive income/(loss)(95.3)59.5 
Total comprehensive income/(loss)118.9 225.3 
Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities(13.5)38.4 
Dividends declared on preferred shares(59.2)(59.2)
Comprehensive income/(loss) attributable to Invesco Ltd.$46.2 $204.5 

See accompanying notes.


3
Invesco Ltd.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

Three months ended March 31,
 (in millions)20242023
Operating activities:
Net income
$214.2 $165.8 
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Amortization and depreciation45.1 46.8 
Common share-based compensation expense21.1 37.8 
Other (gains)/losses, net(35.3)(27.4)
Other (gains)/losses of CIP, net2.4 63.2 
Equity in earnings of unconsolidated affiliates(6.9)(26.1)
Distributions from equity method investees15.9 2.7 
Changes in operating assets and liabilities:
(Purchase)/sale of investments by CIP, net(3.4)32.7 
(Purchase)/sale of investments, net16.8 2.9 
(Increase)/decrease in receivables365.1 (70.7)
Increase/(decrease) in payables(689.4)(326.6)
Net cash provided by/(used in) operating activities(54.4)(98.9)
Investing activities:
Purchase of property, equipment and software(21.0)(38.1)
Purchase of investments by CIP(472.8)(562.6)
Sale of investments by CIP237.7 669.5 
Purchase of investments(36.5)(40.7)
Sale of investments0.1 21.0 
Capital distribution from equity method investees6.9 7.0 
Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP(1.7)(10.6)
Net cash provided by/(used in) investing activities(287.3)45.5 
Financing activities:
Purchases of treasury shares(20.4)(27.7)
Dividends paid - preferred(59.2)(59.2)
Dividends paid - common(90.2)(85.7)
Third-party capital invested into CIP98.3 27.5 
Third-party capital distributed by CIP(42.6)(67.9)
Borrowings of debt of CIP274.3 39.7 
Repayments of debt of CIP(76.1)(5.2)
Borrowings of credit agreement1,030.4 — 
Repayments of credit agreement(662.8)— 
Repayment of senior notes(600.0)— 
Net cash provided by/(used in) financing activities(148.3)(178.5)
Increase/(decrease) in cash and cash equivalents(490.0)(231.9)
Foreign exchange movement on cash and cash equivalents(14.1)11.7
Foreign exchange movement on cash and cash equivalents of CIP(2.0)1.0
Cash and cash equivalents, beginning of period1,931.61,434.1
Cash and cash equivalents, end of period$1,425.5 $1,214.9 
Cash and cash equivalents$895.7 $889.0 
Cash and cash equivalents of CIP529.8325.9
Total cash and cash equivalents per condensed consolidated statement of cash flows$1,425.5 $1,214.9 

See accompanying notes.
4
Invesco Ltd.
Condensed Consolidated Statements of Changes in Equity
(Unaudited)
Three months ended March 31, 2024
Equity Attributable to Invesco Ltd.
(in millions, except per share data)Preferred SharesCommon SharesAdditional Paid-in-CapitalTreasury SharesRetained EarningsAccumulated Other Comprehensive Income/(Loss)Total Equity Attributable to Invesco Ltd.Nonredeemable Noncontrolling Interests in Consolidated EntitiesTotal Permanent EquityRedeemable Noncontrolling Interests in Consolidated Entities/ Temporary Equity
January 1, 2024$4,010.5 $113.2 $7,451.6 $(3,002.6)$6,826.7 $(801.8)$14,597.6 $572.7 $15,170.3 $745.7 
Net income— — — — 200.7 — 200.7 37.9 238.6 (24.4)
Other comprehensive income/(loss)— — — — — (95.3)(95.3)— (95.3)— 
Change in noncontrolling interests in consolidated entities, net— — — — — — — 19.6 19.6 (53.5)
Dividends declared - preferred ($14.75 per share)
— — — — (59.2)— (59.2)— (59.2)— 
Dividends declared - common ($0.20 per share)
— — — — (90.2)— (90.2)— (90.2)— 
Employee common share plans:
Common share-based compensation— — 21.1 — — — 21.1 — 21.1 — 
Vested common shares— — (158.4)158.4 — — — — — — 
Other common share awards— — 0.3 0.2 — — 0.5 — 0.5 — 
Purchase of common shares— — — (20.4)— — (20.4)— (20.4)— 
March 31, 2024$4,010.5 $113.2 $7,314.6 $(2,864.4)$6,878.0 $(897.1)$14,554.8 $630.2 $15,185.0 $667.8 
Three months ended March 31, 2023
Equity Attributable to Invesco Ltd.
(in millions, except per share data)Preferred SharesCommon SharesAdditional Paid-in-CapitalTreasury SharesRetained EarningsAccumulated Other Comprehensive Income/(Loss)Total Equity Attributable to Invesco Ltd.Nonredeemable Noncontrolling Interests in Consolidated EntitiesTotal Permanent EquityRedeemable Noncontrolling Interests in Consolidated Entities/ Temporary Equity
January 1, 2023$4,010.5 $113.2 $7,554.9 $(3,040.9)$7,518.3 $(942.4)$15,213.6 $629.9 $15,843.5 $998.7 
Net income— — — — 204.2 — 204.2 (24.8)179.4 (13.6)
Other comprehensive income/(loss)— — — — — 59.5 59.5 — 59.5 — 
Change in noncontrolling interests in consolidated entities, net— — — — — — — (17.9)(17.9)(105.5)
Dividends declared - preferred ($14.75 per share)
— — — — (59.2)— (59.2)— (59.2)— 
Dividends declared - common ($0.1875 per share)
— — — — (85.7)— (85.7)— (85.7)— 
Employee common share plans:
Common share-based compensation— — 37.8 — — — 37.8 — 37.8 — 
Vested common shares— — (180.6)180.6 — — — — — — 
Other common share awards— — 0.5 — — — 0.5 — 0.5 — 
Purchase of common shares— — — (27.7)— — (27.7)— (27.7)— 
March 31, 2023$4,010.5 $113.2 $7,412.6 $(2,888.0)$7,577.6 $(882.9)$15,343.0 $587.2 $15,930.2 $879.6 
See accompanying notes.
5
Invesco Ltd.
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
1.  ACCOUNTING POLICIES

Corporate Information

Invesco Ltd. (the Parent) and its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of investment management capabilities. The company operates globally and its sole business is investment management.

Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2023 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report.

Basis of Accounting and Consolidation

The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.

Reclassifications

In the quarter ended March 31, 2024, expenses for client-related travel and entertainment and outsourced services were reclassified to General and administrative expenses. The impact of this reclassification on the Consolidated Statements of Income is as follows:

• For the three months ended March 31, 2024: decreased Marketing and Property, office and technology expenses by $6.7 million and $23.6 million, respectively, and increased General and administrative by $30.3 million.

• For the three months ended March 31, 2023: decreased Marketing and Property, office and technology expenses by $5.4 million and $23.9 million, respectively, and increased General and administrative by $29.3 million.

The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated.

Accounting Pronouncements Recently Adopted

None.

Pending Accounting Pronouncements

Refer to the most recent Form 10-K filed with the SEC.

6
2. FAIR VALUE OF ASSETS AND LIABILITIES

The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products." See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.

March 31, 2024December 31, 2023
 (in millions)Fair ValueFair Value
Cash and cash equivalents$895.7 $1,469.2 
Equity investments297.2 272.4 
Assets held for policyholders — 393.9 
Policyholder payables (1)
— (393.9)
Total return swap related to deferred compensation plans8.1 4.9 
____________
(1)    These financial instruments are not measured at fair value on a recurring basis. Policyholder payables were indexed to the value of the assets held for policyholders and changes in fair value were recorded and offset to zero in other operating revenues. In January 2024, all funds were distributed to customers.

The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$434.7 $434.7 $— $— 
Investments: (2)
Equity investments:
Seed capital86.0 86.0 — — 
Investments related to deferred compensation plans211.2 211.2 — — 
Total return swap related to deferred compensation plans8.1 — 8.1 — 
Total$740.0 $731.9 $8.1 $— 
Liabilities:
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
7
As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$927.8 $927.8 $— $— 
Investments (2):
Equity investments:
Seed capital75.7 75.7 — — 
Investments related to deferred compensation plans196.7 196.7 — — 
Assets held for policyholders (3)
393.9 393.9 — — 
Total return swap related to deferred compensation plans4.9 — 4.9 — 
Total$1,599.0 $1,594.1 $4.9 $— 
Liabilities:    
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
____________
(1)    The balance primarily represents cash held in affiliated money market funds.
(2)    Equity method and other investments of $651.4 million and $14.9 million, respectively, are excluded from this table (December 31, 2023: $631.8 million and $14.9 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards.
(3)    The majority of Assets held for policyholders were held in affiliated funds.

Total Return Swap (TRS)

In addition to holding equity investments, the company has a TRS to hedge economically certain deferred compensation liabilities. The notional value of the TRS at March 31, 2024 was $424.4 million, and the fair value of the TRS was an asset of $8.1 million (December 31, 2023 notional value was $393.0 million and the fair value was an asset of $4.9 million). During the three months ended March 31, 2024, market valuation gains related to the TRS were $18.0 million (three months ended March 31, 2023: $13.1 million net gain).

The fair value of the TRS was determined under the market approach using quoted prices of the underlying investments and, as such, is classified as level 2 of the valuation hierarchy. The TRS is not designated for hedge accounting.

3.  INVESTMENTS

The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products."

(in millions)March 31, 2024December 31, 2023
Equity investments:
Seed capital$86.0 $75.7 
Investments related to deferred compensation plans211.2 196.7 
Equity method investments651.4 631.8 
Other14.9 14.9 
Total investments (1)
$963.5 $919.1 
_________
(1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.
8
Equity investments

The unrealized gains and losses for the three months ended March 31, 2024 that relate to equity investments still held at March 31, 2024 were a $16.2 million net gain (three months ended March 31, 2023: $6.7 million net gain).

4.  DEBT

The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products."

March 31, 2024December 31, 2023
(in millions)
Carrying Value (3)
Fair Value
Carrying Value (3)
Fair Value
$2.0 billion floating rate credit agreement expiring April 26, 2028
$367.6 $367.6 $— $— 
Unsecured Senior Notes: (1)
$600 million 4.000% - due January 30, 2024 (2)
— — 599.9 599.1 
$500 million 3.750% - due January 15, 2026
498.7 488.0 498.6 489.1 
$400 million 5.375% - due November 30, 2043
391.2 391.7 391.0 409.6 
Debt$1,257.5 $1,247.3 $1,489.5 $1,497.8 
____________
(1)    The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures.
(2)     On January 30, 2024, the outstanding balance of the $600.0 million senior notes was paid in full.
(3)    The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.

5.  SHARE CAPITAL

The number of preferred shares issued and outstanding is represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Preferred shares issued (1)
4.04.0 
Preferred shares outstanding (1)
4.04.0 
____________
(1)    Substantially all the preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024.

The number of common shares and common share equivalents issued are represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Common shares issued566.1 566.1 
Less: Treasury shares for which dividend and voting rights do not apply
(116.3)(116.6)
Common shares outstanding449.8 449.5 

9
6.  OTHER COMPREHENSIVE INCOME/(LOSS)

The components of accumulated other comprehensive income/(loss) were as follows:

Three months ended March 31, 2024Three months ended March 31, 2023
(in millions)Foreign currency translationEmployee benefit plansTotalForeign currency translationEmployee benefit plansTotal
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries
$(96.3)$— $(96.3)$55.1 $— $55.1 
Other comprehensive income/(loss), net— 1.0 1.0 — 4.4 4.4 
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Beginning balance(670.1)(131.7)(801.8)(815.0)(127.4)(942.4)
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Ending balance$(766.4)$(130.7)$(897.1)$(759.9)$(123.0)$(882.9)

7. REVENUE

The geographic disaggregation of revenue for the three months ended March 31, 2024 and 2023 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda.

Three months ended March 31,
(in millions)20242023
Americas$1,140.6 $1,083.4 
Asia-Pacific (APAC)68.769.9
Europe, Middle East and Africa (EMEA)266.0264.9
Total operating revenues$1,475.3 $1,418.2 

8.  COMMON SHARE-BASED COMPENSATION

The company recognized total compensation expense of $21.1 million and $37.8 million related to equity-settled common share-based compensation in the three months ended March 31, 2024 and 2023, respectively.

Movements on employee common share awards during the periods ended March 31 are detailed below:

Three months ended March 31, 2024 Three months ended March 31, 2023
(in millions of common shares, except fair values)Time- VestedPerformance- VestedWeighted Average Grant Date Fair ValueTime- VestedPerformance- Vested
Unvested at the beginning of period
10.4 1.6 $18.84 10.3 2.1 
Granted during the period4.9 0.9 15.13 4.3 0.7 
Forfeited during the period(0.2)(0.1)18.21 — (0.2)
Vested and distributed during the period
(4.4)(0.3)18.29 (4.5)(0.5)
Unvested at the end of the period
10.7 2.1 $17.41 10.1 2.1 

The total fair value of common shares that vested during the three months ended March 31, 2024 was $67.0 million (three months ended March 31, 2023: $87.3 million). The weighted average grant date fair value of the United States (U.S.) dollar share awards that were granted during the three months ended March 31, 2024 was $15.13 (three months ended March 31, 2023: $17.74).

At March 31, 2024, there was $182.5 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be recognized over a weighted average period of 2.94 years.

10
9.  EARNINGS PER COMMON SHARE

The calculation of earnings per common share (EPS) is as follows:

Three months ended March 31,
(in millions, except per share data)20242023
Net income attributable to Invesco Ltd.$141.5 $145.0 
Invesco Ltd:
Weighted average common shares outstanding - basic453.2 458.1 
Dilutive effect of non-participating common share-based awards0.3 0.8 
Weighted average common shares outstanding - diluted453.5 458.9 
Earnings per common share:
-basic$0.31 $0.32 
-diluted$0.31 $0.32 

See Note 8, "Common Share-Based Compensation," for a summary of common share awards outstanding under the company’s common share-based payment programs. These programs could result in the issuance of common shares that would affect the measurement of basic and diluted EPS.

10.  COMMITMENTS AND CONTINGENCIES

Commitments and contingencies may arise in the ordinary course of business.

The company has committed to co-invest in certain investment products, which may be called in future periods. At March 31, 2024, the company’s undrawn co-invest capital commitments were $664.6 million (December 31, 2023: $623.3 million).

Certain of our managed investment products have entered into revolving credit facilities with financial institutions. The company provided equity commitments and guarantees to the financial institutions for certain of these revolving credit facilities that are temporary in nature. The revolving credit facilities look first to the respective investment products for repayment and servicing. The company’s equity commitment or guarantee would only be called in the event a particular investment product is unable to meet its obligation. The company believes the likelihood of being required to fund its equity commitments or guarantees under these arrangements to be remote. To date, the company has not been required to fund any equity commitments or guarantees under these arrangements. The maximum amount of future payments under the commitments is $274.6 million and under the guarantees is $30.0 million. The fair value of the guarantee liability is not significant to the consolidated financial statements.

The company and some of its subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

Legal Contingencies

The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability.

11
The company and certain related entities have in recent years been subject to various regulatory inquiries, reviews and investigations and legal proceedings, including civil litigation, governmental investigations and enforcement actions. These actions can arise from normal business operations and/or matters that have been the subject of previous regulatory reviews. As a global company with investment products registered in numerous countries and subject to the jurisdiction of one or more regulators in each country, at any given time, our business operations may be subject to review, investigation, or disciplinary action.

In assessing the impact that a legal or regulatory matter will have on the company, management evaluates the need for an accrual on a case-by-case basis. If the likelihood of a loss is deemed probable and is reasonably estimable, the estimated loss is accrued. If the likelihood of a loss is assessed as less than probable, a loss is not accrued. If a loss is deemed probable but an amount or range of loss cannot be reasonably estimated, a loss is not accrued but the matter is disclosed.

In management’s opinion, adequate accrual has been made as of March 31, 2024 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount and are deemed probable. Management believes that the ultimate resolution of claims will not materially affect the company’s business, revenue, net income or liquidity.

The company is cooperating with requests from the SEC in connection with their investigation of investment advisers’ compliance with record retention requirements relating to certain types of electronic business communications. At this time a range of loss related to this matter cannot be reasonably estimated.

Further, the investment management industry also is generally subject to extensive levels of ongoing regulatory oversight and examination. In the U.S., United Kingdom (U.K.) and other jurisdictions in which the company operates, governmental authorities regularly make inquiries, hold investigations and administer market conduct examinations with respect to the company’s compliance with applicable laws and regulations. Additional lawsuits or regulatory enforcement actions arising out of these inquiries may in the future be filed against the company, related entities and individuals in the U.S., U.K. and other jurisdictions in which the company and its affiliates operate. Any material loss of investor and/or client confidence as a result of such inquiries and/or litigation could result in a significant decline in assets under management (AUM), which would have an adverse effect on the company’s future financial results and its ability to grow its business.

12
11.  CONSOLIDATED INVESTMENT PRODUCTS

The balances related to CIP are identified on the Consolidated Balance Sheets. At March 31, 2024, the company’s net investment in and net receivables from CIP were $521.9 million (December 31, 2023: $546.2 million). The consolidation of CIP had no impact on net income attributable to the company during the three months ended March 31, 2024.

The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2024 and December 31, 2023:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$7,133.8 $— $6,143.3 $990.5 $— 
Bonds624.5 11.9 612.3 0.3 — 
Equity securities172.9 30.1 19.4 123.4 — 
Equity and fixed income mutual funds112.9 0.2 112.7 — — 
Investments in other private equity funds412.6 — — — 412.6 
Real estate investments445.5 — — — 445.5 
Total assets at fair value$8,902.2 $42.2 $6,887.7 $1,114.2 $858.1 

As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$6,837.2 $— $6,140.1 $697.1 $— 
Bonds669.8 13.3 656.2 0.3 — 
Equity securities231.9 85.2 18.3 128.4 — 
Equity and fixed income mutual funds137.9 8.0 129.9 — — 
Investments in other private equity funds425.5 — — — 425.5 
Real estate investments463.6 — — — 463.6 
Total assets at fair value$8,765.9 $106.5 $6,944.5 $825.8 $889.1 


At March 31, 2024, CIP borrowings with a fair value of $565.0 million (December 31, 2023: $353.7 million) are classified as level 3 in the valuation hierarchy.
13

The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:
Three months ended March 31,
20242023
(in millions)Level 3 AssetsLevel 3 Assets
Beginning Balance as of January 1$825.8 $368.6 
CIP Purchases275.0 0.1 
CIP Sales(2.3)(13.4)
Deconsolidation of CIP— (0.6)
Gains and losses included in the Consolidated Statements of Income(1.9)(7.6)
Transfers from Level 3 into Levels 1 or 2(16.2)(130.2)
Transfers into Level 3 from Levels 1 or 234.0 132.2 
Foreign exchange(0.2)2.2 
Ending Balance as of March 31$1,114.2 $351.3 

Non-consolidated Variable interest entities (VIEs)

At March 31, 2024, the company's risk of loss with respect to VIEs in which the company is not the primary beneficiary included our investment carrying value of $141.4 million (December 31, 2023: $122.9 million) and unfunded capital commitments of $153.2 million (December 31, 2023: $142.5 million).

See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.

12. RELATED PARTIES

MassMutual owns approximately 18.1% in common stock of the company and owns substantially all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares as of March 31, 2024. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s Board of Directors, the company considers MassMutual a related party.

Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” The majority of the company's Operating revenues and receivables are from Invesco's managed funds. Related parties also include those defined in the company’s proxy statement.

Refer to Note 2, "Fair Value of Assets and Liabilities" and Note 3, "Investments" for more information on balances invested in Invesco affiliated funds.

13.  SUBSEQUENT EVENTS

On April 23, 2024, the company declared a first quarter 2024 dividend of $0.205 per common share, payable on June 4, 2024, to common shareholders of record at the close of business on May 14, 2024 with an ex-dividend date of May 13, 2024.

On April 23, 2024, the company declared a preferred dividend of $14.75 per preferred share to the holders of preferred shares representing the period from March 1, 2024 through May 31, 2024. The preferred dividend is payable on June 3, 2024.
14
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Condensed Consolidated Financial Statements and related Notes thereto, which appear elsewhere in this Report. Except for the historical financial information, this Report may include statements that constitute “forward-looking statements” under the United States securities laws. Forward-looking statements include information concerning future results of our operations, expenses, earnings, liquidity, cash flow, capital expenditures, and AUM which could differ materially from actual results due to known and unknown risks and other important factors, including, but not limited to, industry or market conditions, geopolitical events and pandemics or health crises and their respective potential impact on the company, acquisitions and divestitures, debt and our ability to obtain additional financing or make payments, regulatory developments, demand for and pricing of our products, the prospects for certain legal contingencies, and other aspects of our business or general economic conditions. In addition, when used in this Report or such other documents or statements, words such as “believes,” “expects,” “anticipates,” “intends,” “plans,” “estimates,” “projects,” “forecasts,” and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would” as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. None of this information should be considered in isolation from, or as a substitute for, historical financial statements.

Forward-looking statements are not guarantees, and involve risks, uncertainties and assumptions. There can be no assurance that actual results will not differ materially from our expectations. We caution investors not to rely unduly on any forward-looking statements and urge them to carefully consider the risks described in this Report and our most recent Form 10-K and Forms 10-Q filed with the SEC.

You may obtain these reports from the SEC’s website at www.sec.gov. We expressly disclaim any obligation to update the information in any public disclosure if any forward-looking statement later turns out to be inaccurate.

References

In this Report, unless otherwise specified, the terms “we,” “our,” “us,” “company,” “firm,” and “Invesco” refer to Invesco Ltd., a company incorporated in Bermuda, and its consolidated entities.

Executive Overview

The following executive overview summarizes the significant trends affecting our results of operations and financial condition for the periods presented. This overview and the remainder of this management’s discussion and analysis and supplements should be read in conjunction with the Condensed Consolidated Financial Statements of Invesco Ltd. and the notes thereto contained elsewhere in this Report.

The company is an independent investment management firm dedicated to delivering a superior investment experience. Our comprehensive range of active, passive and alternative investment capabilities has been constructed over many years to help clients achieve their investment objectives. We draw on this comprehensive range of capabilities to provide solutions designed to deliver key outcomes aligned to client needs. One of Invesco's core strengths, and a key differentiator for the company within the industry, is our diversification across investment capabilities, distribution channels and geographies. This broad diversification helps to mitigate some of the impact of different market cycles on Invesco and enables the company to take advantage of growth opportunities in various markets and channels.

Economic conditions remained relatively resilient in the first quarter, and even though this diminished expectations for central bank interest rate cuts this year, equity markets continued to rise. More modest growth was recorded in developed markets outside of the U.S. In China, markets continued to lag, but economic indicators are showing signs of bottoming and some improvement. Fixed income markets were generally weak during the quarter. While this sentiment drove organic inflows at Invesco, our asset mix profile remained constrained as did revenue growth due to investors shifting their investments into lower fee offerings. However, we are strongly positioned to capture flows with scale, performance and competitive strength in capabilities that will drive the asset management industry forward.



15
The table below summarizes returns based on price appreciation/(depreciation) of several major market indices for the three months ended March 31, 2024 and 2023:
Index expressed in currencyThree months ended March 31,
Equity Index20242023
S&P 500U.S. Dollar10.2 %7.0 %
FTSE 100British Pound2.8 %2.4 %
FTSE 100U.S. Dollar1.7 %4.5 %
S&P/TSX 60 IndexCanadian Dollar5.5 %3.2 %
S&P/TSX 60 IndexU.S. Dollar2.9 %3.3 %
MSCI Emerging MarketsU.S. Dollar1.9 %3.5 %
Bond Index
Barclays U.S. Aggregate BondU.S. Dollar(0.8)%3.0 %

We had $6.3 billion of net long-term inflows for the quarter, primarily driven by Exchange-traded funds (ETFs) and Index, Fundamental Fixed Income and Private Markets, and our ending AUM grew 12% year-over-year.

We remain highly focused on our capital priorities, investing in our key capabilities, efficiently allocating resources, and simplifying and streamlining the organization to better position the company for greater scale, performance and improved profitability. During the quarter, we redeemed our $600 million senior notes which were due on January 30, 2024 and continued to maintain our debt at lower levels consistent with our commitment to improve our leverage profile. We believe the progress we have made to build financial flexibility has Invesco well-positioned to navigate various market conditions and deliver long-term growth. We remain committed to returning capital to shareholders longer term through a combination of modestly increasing dividends and share repurchases. To this end, the Board approved an increase in our quarterly dividend from $0.20 to $0.205 per share beginning with the dividend that will be paid to holders of common shares in the second quarter of 2024.

Presentation of Management’s Discussion and Analysis of Financial Condition and Results of Operations - Impact of Consolidated Investment Products

The company provides investment management services to, and has transactions with, retail mutual funds and other investment products sponsored by the company for the investment of client assets in the normal course of business. The company serves as the investment manager, making day-to-day investment decisions concerning the assets of the products. Investment products that are consolidated are referred to in this Report as CIP. The company’s economic risk with respect to each investment in CIP is limited to its equity ownership, unfunded equity commitments and any uncollected management and performance fees. See also Note 11, "Consolidated Investment Products," for additional information regarding the impact of the consolidation of managed funds.

The majority of the company’s CIP balances are CLO-related. The collateral assets of the collateralized loan obligations (CLOs) are held solely to satisfy the obligations of the CLOs. The company has no right to the benefits from, nor does it bear the risks associated with, the collateral assets held by the CLOs, beyond the company’s direct investments in, and management and performance fees generated from, the CLOs. If the company were to liquidate, the collateral assets would not be available to the general creditors of the company, and as a result, the company does not consider them to be company assets. Likewise, the investors in the CLOs have no recourse to the general credit of the company for the notes issued by the CLOs. The company therefore does not consider this debt to be a company liability.

Due to the significant impact that CIP has on the presentation of the company’s Consolidated Financial Statements, the company has elected to deconsolidate these products in its non-GAAP disclosures (among other adjustments). See "Schedule of Non-GAAP Information" for additional information regarding these adjustments. The following discussion therefore combines the results presented under U.S. GAAP with the company’s non-GAAP presentation.
16

This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains four distinct sections, which follow the AUM discussion:

•Results of Operations (three months ended March 31, 2024 compared to three months ended March 31, 2023);
•Schedule of Non-GAAP Information;
•Balance Sheet Discussion; and
•Liquidity and Capital Resources.

Summary Operating Information

Wherever a non-GAAP measure is referenced, a disclosure will follow in the narrative or in the note referring the reader to the Schedule of Non-GAAP Information, where additional details regarding the use of the non-GAAP measure by the company are disclosed, along with reconciliations of the most directly comparable U.S. GAAP measures to the non-GAAP measures. To further enhance the readability of the Results of Operations section, separate tables for each of the revenue, expense and other income and expenses (non-operating income/expense) sections of the income statement introduce the narrative that follows, providing a section-by-section review of the company’s income statements for the periods presented.

Summary operating information is presented in the table below:

(in millions, other than per common share amounts, operating margins and AUM)Three months ended March 31,
U.S. GAAP Financial Measures Summary20242023
Operating revenues$1,475.3 $1,418.2 
Operating income$213.1 $209.5 
Operating margin14.4 %14.8 %
Net income attributable to Invesco Ltd.$141.5 $145.0 
Diluted EPS$0.31 $0.32 
Non-GAAP Financial Measures Summary(1)
Net revenues $1,053.2 $1,075.9 
Adjusted operating income $296.5 $326.9 
Adjusted operating margin 28.2 %30.4 %
Adjusted net income attributable to Invesco Ltd.$148.4 $173.4 
Adjusted diluted EPS$0.33 $0.38 
Assets Under Management
Ending AUM (billions)$1,662.7 $1,483.0 
Average AUM (billions)$1,613.0 $1,463.0 
_________
(1)Net revenues, Adjusted operating income (and by calculation, Adjusted operating margin), and Adjusted net income attributable to Invesco Ltd. (and by calculation, Adjusted diluted EPS) are non-GAAP financial measures, based on methodologies other than U.S. GAAP. See “Schedule of Non-GAAP Information” for a reconciliation of the most directly comparable U.S. GAAP measures to the non-GAAP measures.


17
Investment Capabilities Performance Overview

Invesco's first strategic objective is a commitment to deliver the excellence our clients expect, which includes strong investment performance over the long-term for our clients. The table below presents investment performance of our actively managed investment products measured by the percentage of our AUM in the first and second quartile compared to our peers and above benchmark for the investment capabilities for which peer and benchmark data are available.(1)
1st Quartile
2nd Quartile
Above Benchmark
1yr3yr5yr1yr3yr5yr1yr3yr5yr
Overall49 %39 %46 %20 %27 %23 %66 %64 %75 %
Fundamental Equities36 %28 %24 %22 %28 %28 %53 %46 %40 %
Fundamental Fixed Income55 %24 %68 %22 %44 %20 %57 %55 %92 %
Multi-Asset38 %27 %10 %10 %2 %38 %77 %44 %71 %
____________
(1)    Excludes passive products, closed-end funds, private equity limited partnerships, non-discretionary funds, unit investment trusts (UITs), fund of funds with component funds managed by Invesco, stable value building block funds and collateralized debt obligations. Certain funds and products were excluded from the analysis because of limited benchmark or peer group data. Had these been available, results may have been different. These results are preliminary and subject to revision.
AUM measured in the one, three and five year quartile rankings represents 41%, 41% and 40% of total Invesco AUM, respectively, and AUM measured versus benchmark on a one, three and five year basis represents 52%, 52%, and 48% of total Invesco AUM as of 3/31/2024. Peer group ranking are sourced from a widely-used third party ranking agency in each fund’s market (Morningstar, IA, Lipper, eVestment, Mercer, Galaxy, SITCA, Value Research) and asset-weighted in USD. Rankings are as of prior quarter-end for most institutional products and prior month-end for Australian retail funds due to their late release by third parties. Rankings are calculated against all funds in each peer group. Rankings for the primary share class of the most representative fund in each composite are applied to all products within each composite. Performance assumes the reinvestment of dividends. Past performance is not indicative of future results and may not reflect an investor’s experience.

18
Assets Under Management

The following presentation and discussion of AUM includes Passive and Active AUM. Passive AUM includes index-based ETFs, UITs, non-management fee earning AUM and other passive mandates. Active AUM is total AUM less Passive AUM.

Non-management fee earning AUM includes non-management fee earning ETFs, UITs and product leverage. The net flows in non-management fee earning AUM can be relatively short-term in nature and, due to the relatively low revenue yield, can have a significant impact on overall net revenue yield.

The AUM tables and the discussion below refer to certain AUM as long-term. Long-term inflows and the underlying reasons for the movements in this line item include investments from new clients, existing clients adding new accounts/funds or contributions/subscriptions into existing accounts/funds. Long-term outflows reflect client redemptions from accounts/funds and include the return of invested capital upon maturity. We present net flows into money market funds separately because shareholders of those funds typically use them as short-term funding vehicles and the flows are particularly sensitive to short-term interest rate movements.

Changes in AUM by investment approach were as follows:

Three months ended March 31,
20242023
 (in billions)Total AUMActivePassiveTotal AUMActivePassive
Beginning Assets (January 1)$1,585.3 $985.3 $600.0 $1,409.2 $976.2 $433.0 
Long-term inflows 80.3 42.4 37.9 79.4 46.9 32.5 
Long-term outflows(74.0)(49.5)(24.5)(76.5)(49.4)(27.1)
Net long-term flows6.3 (7.1)13.4 2.9 (2.5)5.4 
Net flows in non-management fee earning AUM9.5 — 9.5 (1.6)— (1.6)
Net flows in money market funds0.7 0.7 — 7.7 7.7 — 
Total net flows16.5 (6.4)22.9 9.0 5.2 3.8 
Reinvested distributions1.1 1.1 — 1.0 1.0 — 
Market gains and losses68.0 22.5 45.5 61.9 20.9 41.0 
Foreign currency translation(8.2)(6.8)(1.4)1.9 1.9 — 
Ending Assets (March 31)$1,662.7 $995.7 $667.0 $1,483.0 $1,005.2 $477.8 
Average AUM
Average long-term AUM$1,164.1 $787.8 $376.3 $1,083.2 $788.5 $294.7 
Average AUM$1,613.0 $980.9 $632.1 $1,463.0 $1,002.0 $461.0 
Average QQQ AUM$246.2 N/A$246.2 $156.1 N/A$156.1 

Three months ended March 31,
20242023
Revenue yield (bps) (1)
U.S. GAAP Gross revenue yield38.641.3
Net revenue yield ex performance fees ex QQQ (2)
30.732.7
Active net revenue yield ex performance fees36.837.6
Passive net revenue yield ex QQQ (2)
15.316.7
________
(1)    U.S. GAAP Gross revenue yield is not considered a meaningful effective fee rate measure. Gross revenue yield on AUM is equal to U.S. GAAP annualized total Operating revenues divided by average AUM, excluding Invesco Great Wall Fund Management Company Limited (Invesco Great Wall or IGW) AUM. The average AUM for IGW in the three months ended March 31, 2024 was $83.7 billion (three months ended March 31, 2023: $91.0 billion). It is appropriate to exclude the average AUM of IGW as the revenues resulting from these AUM are not presented in our operating revenues. This ratio is not a good measure because the numerator of the U.S. GAAP Gross revenue yield excludes the management fees earned from CIP; however, the denominator of the measure includes the AUM of these investment products. Net revenue yield metrics include the Net revenues and Average AUM of IGW and CIP. See “Schedule of Non-GAAP Information” for a reconciliation of Operating revenues to Net revenues.
(2)    Performance fees are earned when certain performance metrics are achieved and QQQ ETFs do not earn net revenues. Therefore, net revenue yield is calculated excluding performance fees and QQQ AUM. Passive net revenue yield is calculated excluding QQQ AUM.
19

Flows

There are numerous drivers of AUM inflows and outflows, including individual investor decisions to change investments, fiduciaries and other gatekeepers making broad asset allocation decisions on behalf of their clients, and reallocation of investments within portfolios. We are not a party to these asset allocation decisions, as the company does not generally have access to the underlying investor’s decision-making process, including their risk appetite or liquidity needs. Therefore, the company is not in a position to provide meaningful information regarding the drivers of inflows and outflows.

Market Returns

Market gains and losses include the net change in AUM resulting from changes in market values of the underlying securities from period to period. The table in the “Executive Overview” section of this Management’s Discussion and Analysis summarizes returns based on price appreciation/(depreciation) of several major market indices for the three months ended March 31, 2024 and 2023.

Foreign Exchange Rates

During the three months ended March 31, 2024, we experienced a decrease in AUM of $8.2 billion, due to changes in foreign exchange rates. In the three months ended March 31, 2023, AUM increased by $1.9 billion, due to foreign exchange rate changes.






































20
Total AUM by Channel (1)

Three months ended March 31,
20242023
(in billions)TotalRetailInstitutionalTotalRetailInstitutional
Beginning Assets (January 1)$1,585.3 $1,042.0 $543.3 $1,409.2 $872.3 $536.9 
Long-term inflows80.3 60.0 20.3 79.4 54.8 24.6 
Long-term outflows(74.0)(53.4)(20.6)(76.5)(58.5)(18.0)
Net long-term flows6.3 6.6 (0.3)2.9 (3.7)6.6 
Net flows in non-management fee earning AUM9.5 9.0 0.5 (1.6)(2.7)1.1 
Net flows in money market funds0.7 1.2 (0.5)7.7 1.2 6.5 
Total net flows16.5 16.8 (0.3)9.0 (5.2)14.2 
Reinvested distributions1.1 1.1 — 1.0 0.9 0.1 
Market gains and losses68.0 59.7 8.3 61.9 55.7 6.2 
Foreign currency translation(8.2)(2.7)(5.5)1.9 1.2 0.7 
Ending Assets (March 31)$1,662.7 $1,116.9 $545.8 $1,483.0 $924.9 $558.1 

Total AUM by Client Domicile (2)

Three months ended March 31,
20242023
(in billions)TotalAmericasAPACEMEATotalAmericasAPACEMEA
Beginning Assets (January 1)$1,585.3 $1,133.9 $235.5 $215.9 $1,409.2 $999.4 $223.5 $186.3 
Long-term inflows 80.3 39.4 23.0 17.9 79.4 42.1 19.1 18.2 
Long-term outflows(74.0)(37.4)(19.7)(16.9)(76.5)(41.4)(19.1)(16.0)
Net long-term flows6.3 2.0 3.3 1.0 2.9 0.7 — 2.2 
Net flows in non-management fee earning AUM9.5 10.1 (1.0)0.4 (1.6)0.5 (1.3)(0.8)
Net flows in money market funds0.7 (0.3)1.1 (0.1)7.7 6.4 1.3 — 
Total net flows16.5 11.8 3.4 1.3 9.0 7.6 — 1.4 
Reinvested distributions1.1 1.1 — — 1.0 1.0 — — 
Market gains and losses68.0 53.6 5.2 9.2 61.9 47.6 5.3 9.0 
Foreign currency translation(8.2)(0.6)(6.5)(1.1)1.9 0.1 (0.2)2.0 
Ending Assets (March 31)$1,662.7 $1,199.8 $237.6 $225.3 $1,483.0 $1,055.7 $228.6 $198.7 

________
See accompanying notes immediately following these AUM tables.
21

Total AUM by Investment Capability (3)

Three months ended March 31, 2024 and 2023:

(in billions)Total
ETFs and Index (4)
Fundamental Fixed Income (5)
Fundamental Equities (6)
Private Markets (7)
APAC Managed (8)
Multi-Asset/ Other (9)
Global Liquidity (10)
QQQ (11)
January 1, 2024$1,585.3 $362.1 $272.6 $260.5 $129.7 $108.0 $57.4 $165.0 $230.0 
Long-term inflows 80.3 33.0 15.8 9.1 3.8 16.0 2.6 — — 
Long-term outflows(74.0)(21.8)(14.7)(14.7)(2.8)(16.8)(3.2)— — 
Net long-term flows6.3 11.2 1.1 (5.6)1.0 (0.8)(0.6)— — 
Net flows in non-management fee earning AUM9.5 — — — — — 0.4 — 9.1 
Net flows in money market funds0.7 — — — — 1.1 — (0.4)— 
Total net flows16.5 11.2 1.1 (5.6)1.0 0.3 (0.2)(0.4)9.1 
Reinvested distributions1.1 — 0.5 0.3 0.2 — — 0.1 — 
Market gains and losses68.0 26.2 0.9 19.5 (3.2)0.7 3.5 0.2 20.2 
Foreign currency translation(8.2)(1.2)(2.8)(1.1)(0.6)(1.9)(0.5)(0.1)— 
March 31, 2024$1,662.7 $398.3 $272.3 $273.6 $127.1 $107.1 $60.2 $164.8 $259.3 
Average AUM$1,613.0 $377.1 $269.8 $263.4 $127.7 $107.0 $58.0 $163.8 $246.2 
January 1, 2023$1,409.2 $285.6 $261.3 $238.8 $129.9 $113.6 $57.7 $176.4 $145.9 
Long-term inflows79.4 31.0 17.3 9.7 5.0 12.0 4.4 — — 
Long-term outflows(76.5)(25.8)(15.4)(13.5)(4.6)(15.0)(2.2)— — 
Net long-term flows2.9 5.2 1.9 (3.8)0.4 (3.0)2.2 — — 
Net flows in non-management fee earning AUM(1.6)— — — — — 1.0 — (2.6)
Net flows in money market funds7.7 — — — — 1.3 — 6.4 — 
Total net flows9.0 5.2 1.9 (3.8)0.4 (1.7)3.2 6.4 (2.6)
Reinvested distributions1.0 — 0.4 0.3 0.2 — 0.1 — — 
Market gains and losses61.9 10.9 3.6 15.0 (1.0)2.2 1.8 0.1 29.3 
Foreign currency translation1.9 (0.1)0.2 0.6 0.4 0.3 0.4 0.1 — 
March 31, 2023$1,483.0 $301.6 $267.4 $250.9 $129.9 $114.4 $63.2 $183.0 $172.6 
Average AUM$1,463.0 $301.7 $264.9 $248.9 $130.7 $115.1 $61.2 $184.4 $156.1 

________
See accompanying notes immediately following these AUM tables.
22

Active AUM by Channel (1)

Three months ended March 31,
20242023
(in billions)TotalRetailInstitutionalTotalRetailInstitutional
Beginning Assets (January 1)$985.3 $501.5 $483.8 $976.2 $482.1 $494.1 
Long-term inflows42.4 24.9 17.5 46.9 26.3 20.6 
Long-term outflows(49.5)(31.9)(17.6)(49.4)(33.0)(16.4)
Net long-term flows(7.1)(7.0)(0.1)(2.5)(6.7)4.2 
Net flows in money market funds0.7 1.2 (0.5)7.7 1.2 6.5 
Total net flows(6.4)(5.8)(0.6)5.2 (5.5)10.7 
Reinvested distributions
1.1 1.1 — 1.0 0.9 0.1 
Market gains and losses22.5 20.1 2.4 20.9 17.1 3.8 
Foreign currency translation(6.8)(2.2)(4.6)1.9 1.0 0.9 
Ending Assets (March 31)$995.7 $514.7 $481.0 $1,005.2 $495.6 $509.6 

Active AUM by Client Domicile (2)

Three months ended March 31,
20242023
(in billions)TotalAmericasAPACEMEATotalAmericasAPACEMEA
Beginning Assets (January 1)$985.3 $671.4 $192.0 $121.9 $976.2 $670.8 $191.0 $114.4 
Long-term inflows 42.4 19.3 16.7 6.4 46.9 21.7 16.8 8.4 
Long-term outflows(49.5)(27.7)(14.6)(7.2)(49.4)(27.2)(15.8)(6.4)
Net long-term flows(7.1)(8.4)2.1 (0.8)(2.5)(5.5)1.0 2.0 
Net flows in money market funds0.7 (0.3)1.1 (0.1)7.7 6.4 1.3 — 
Total net flows(6.4)(8.7)3.2 (0.9)5.2 0.9 2.3 2.0 
Reinvested distributions
1.1 1.1 — — 1.0 1.0 — — 
Market gains and losses22.5 19.5 1.5 1.5 20.9 15.9 1.7 3.3 
Foreign currency translation(6.8)(0.5)(5.4)(0.9)1.9 0.1 0.1 1.7 
Ending Assets (March 31)$995.7 $682.8 $191.3 $121.6 $1,005.2 $688.7 $195.1 $121.4 

________
See accompanying notes immediately following these AUM tables.
23
Passive AUM by Channel (1)

Three months ended March 31,
20242023
(in billions)TotalRetailInstitutionalTotalRetailInstitutional
Beginning Assets (January 1)$600.0 $540.5 $59.5 $433.0 $390.2 $42.8 
Long-term inflows37.9 35.1 2.8 32.5 28.5 4.0 
Long-term outflows(24.5)(21.5)(3.0)(27.1)(25.5)(1.6)
Net long-term flows13.4 13.6 (0.2)5.4 3.0 2.4 
Net flows in non-management fee earning AUM9.5 9.0 0.5 (1.6)(2.7)1.1 
Total net flows22.9 22.6 0.3 3.8 0.3 3.5 
Market gains and losses45.5 39.6 5.9 41.0 38.6 2.4 
Foreign currency translation(1.4)(0.5)(0.9)— 0.2 (0.2)
Ending Assets (March 31)$667.0 $602.2 $64.8 $477.8 $429.3 $48.5 

Passive AUM by Client Domicile (2)

Three months ended March 31,
20242023
(in billions)TotalAmericasAPACEMEATotalAmericasAPACEMEA
Beginning Assets (January 1)$600.0 $462.5 $43.5 $94.0 $433.0 $328.6 $32.5 $71.9 
Long-term inflows 37.9 20.1 6.3 11.5 32.5 20.4 2.3 9.8 
Long-term outflows(24.5)(9.7)(5.1)(9.7)(27.1)(14.2)(3.3)(9.6)
Net long-term flows13.4 10.4 1.2 1.8 5.4 6.2 (1.0)0.2 
Net flows in non-management fee earning AUM9.5 10.1 (1.0)0.4 (1.6)0.5 (1.3)(0.8)
Total net flows22.9 20.5 0.2 2.2 3.8 6.7 (2.3)(0.6)
Market gains and losses45.5 34.1 3.7 7.7 41.0 31.7 3.6 5.7 
Foreign currency translation(1.4)(0.1)(1.1)(0.2)— — (0.3)0.3 
Ending Assets (March 31)$667.0 $517.0 $46.3 $103.7 $477.8 $367.0 $33.5 $77.3 
_________
See accompanying notes immediately following these AUM tables.

(1) Channel refers to the internal distribution channel from which the AUM originated. Retail AUM represents AUM distributed by the company’s retail sales team. Institutional AUM represents AUM distributed by our institutional sales team. This aggregation is viewed as a proxy for presenting AUM in the retail and institutional markets in which the company operates.
(2) Client domicile groups AUM by the domicile of the underlying clients.
(3) Investment capabilities are descriptive groupings of AUM by investment strategy. The company believes that presenting AUM by investment capability provides a more granular depiction of asset categorization and removed presentation of AUM by asset class in the quarter ending March 31, 2024. The comparative period reflects the current period presentation.
(4) ETFs and Index includes ETFs and Indexed Strategies; excludes Invesco QQQ Trust.
(5) Fundamental Fixed Income includes Fixed Income products; includes certain ETFs managed within this capability.
(6) Fundamental Equities includes Equity products.
(7) Private Markets includes Private Credit and Real Estate investments; comprised primarily of Real Estate, CLOs, Private Credit and listed real assets; includes certain ETFs managed within this capability.
(8) APAC Managed includes all products managed in the APAC region, including Invesco Great Wall, Japan, and greater China; includes APAC managed short term, money market, passive, and ETFs.
(9) Multi-Asset/Other includes Global Asset Allocation, Invesco Quantitative Strategies, Global Targeted Returns, Solutions, Intelliflo, and UITs; includes certain ETFs managed within this capability.
(10) Global Liquidity is comprised mainly of Money Market funds and excludes APAC Money Market funds.
(11) QQQ includes Invesco QQQ Trust.

24
Results of Operations for the three months ended March 31, 2024 compared to the three months ended March 31, 2023

The discussion below includes the use of non-GAAP financial measures. See “Schedule of Non-GAAP Information” for additional details and reconciliations of the most directly comparable U.S. GAAP measures to the non-GAAP measures.

Operating Revenues and Net Revenues

The main categories of revenues, and the dollar and percentage change between the periods, are as follows:
Three months ended
March 31,Variance
(in millions)20242023$ Change% Change
Investment management fees$1,048.7 $1,027.9 $20.8 2.0 %
Service and distribution fees377.0 334.2 42.8 12.8 %
Performance fees0.8 5.6 (4.8)(85.7)%
Other48.8 50.5 (1.7)(3.4)%
Total operating revenues$1,475.3 $1,418.2 $57.1 4.0 %
Revenue Adjustments:
Investment management fees$(192.3)$(189.8)$(2.5)1.3 %
Service and distribution fees(271.8)(225.3)(46.5)20.6 %
Other(39.9)(40.0)0.1 (0.3)%
Total Revenue Adjustments (1)
(504.0)(455.1)(48.9)10.7 %
Invesco Great Wall74.7 100.5 (25.8)(25.7)%
CIP7.2 12.3 (5.1)(41.5)%
Net revenues (2)
$1,053.2 $1,075.9 $(22.7)(2.1)%
____________
(1)    Total revenue adjustments remove pass through investment management fees, service and distribution fees, and other revenues and equal the same amount as the Third-party distribution, service and advisory expenses.
(2)    See “Schedule of Non-GAAP Information” for additional important disclosures regarding the use of net revenues.

Our revenues are directly influenced by the level and composition of our AUM. Therefore, movements in global capital market levels, net business inflows (or outflows), and changes in the mix of investment products between asset classes and geographies may materially affect our revenues from period to period. See the company’s disclosures regarding the changes in AUM during the three months ended March 31, 2024 and March 31, 2023 in the “Assets Under Management” section above for additional information.

Passive AUM generally earn a lower effective fee rate than Active AUM, and therefore, changes in the mix of AUM between Active and Passive have an impact on revenues and net revenue yield. Average AUM were $1,613.0 billion for the three months ended March 31, 2024 as compared to $1,463.0 billion for the three months ended March 31, 2023. The impact of the increase in AUM on our revenues was partially offset by the shift in AUM toward lower yield passive products, such as ETFs. As a result, net revenue yield excluding performance fees and QQQ declined from 32.7 basis points (bps) for the three months ended March 31, 2023 to 30.7 bps for the three months ended March 31, 2024.

In addition, as fee rates differ across geographic locations, changes to the mix of AUM between geographies and exchange rates have an impact on revenues and net revenue yields.
25
Investment Management Fees

Investment management fees were $1,048.7 million for three months ended March 31, 2024 as compared to $1,027.9 million for three months ended March 31, 2023, as a result of higher average AUM partially offset by the shift in AUM toward lower yield products. See discussion above on how AUM changes impact our Investment management fees.

Service and Distribution Fees

In the three months ended March 31, 2024, Service and distribution fees were $377.0 million as compared to $334.2 million for the three months ended March 31, 2023. The increase was primarily driven by higher distribution fees of $23.2 million and administrative fees of $19.3 million resulting from higher fund-related service fees and higher AUM to which the fees apply.

Performance Fees

For the three months ended March 31, 2024, Performance fees were $0.8 million as compared to $5.6 million three months ended March 31, 2023, respectively.

Other Revenues

In the three months ended March 31, 2024, Other revenues were $48.8 million as compared to $50.5 million for the three months ended March 31, 2023.

Invesco Great Wall

The company’s most significant joint venture is our 49% investment in IGW. The company reflects 100% of IGW's results in its Net revenues and Adjusted operating expenses because it is important to evaluate the contribution that IGW is making to the business. The company’s non-GAAP operating results reflect the economics of these holdings on a basis consistent with the underlying AUM and flows. Adjusted net income is reduced by the amount of earnings attributable to the 51% noncontrolling interests. See “Schedule of Non-GAAP Information” for additional disclosures regarding the use of Net revenues.

Net revenues from IGW were $74.7 million and average AUM was $83.7 billion for the three months ended March 31, 2024 (Net revenues were $100.5 million and average AUM was $91.0 billion for the three months ended March 31, 2023). The decrease in IGW revenues is primarily driven by the implementation of the regulatory mandated fee reductions in China, lower average AUM and the shift in AUM toward lower yield products.

Management, performance and other fees earned from CIP

Management believes that the consolidation of investment products may impact a reader's analysis of our underlying results of operations and could result in investor confusion or the production of information about the company by analysts or external credit rating agencies that is not reflective of the underlying results of operations and financial condition of the company. Accordingly, management believes that it is appropriate to adjust Operating revenues for the impact of CIP in calculating Net revenues. As Management and Performance fees earned by Invesco from the consolidated products are eliminated upon consolidation of the investment products, management believes that it is appropriate to add these Operating revenues back in the calculation of Net revenues. See “Schedule of Non-GAAP Information” for additional disclosures regarding the use of Net revenues.

Management and Performance fees earned from CIP were $7.2 million for the three months ended March 31, 2024 (three months ended March 31, 2023: $12.3 million).


26
Operating Expenses

The main categories of Operating expenses, and the dollar and percentage changes between periods, are as follows:

Three months ended
March 31,Variance
(in millions)20242023$ Change% Change
Third-party distribution, service and advisory$504.0 $455.1 $48.9 10.7 %
Employee compensation472.7 462.8 9.9 2.1 %
Marketing (1)
18.1 19.6 (1.5)(7.7)%
Property, office and technology (1)
117.6 110.5 7.1 6.4 %
General and administrative (1)
138.5 105.0 33.5 31.9 %
Transaction, integration and restructuring— 41.6 (41.6)N/A
Amortization of intangibles 11.3 14.1 (2.8)(19.9)%
Total operating expenses$1,262.2 $1,208.7 $53.5 4.4 %

The table below sets forth these expense categories as a percentage of total Operating expenses and Operating revenues, which we believe provides useful information as to the relative significance of each type of expense.

(in millions)Three months ended March 31, 2024% of Total Operating Expenses% of Operating RevenuesThree months ended March 31, 2023% of Total Operating Expenses% of Operating Revenues
Third-party distribution, service and advisory$504.0 39.9 %34.2 %$455.1 37.6 %32.1 %
Employee compensation472.737.5 %32.0 %462.8 38.3 %32.6 %
Marketing (1)
18.11.4 %1.2 %19.6 1.7 %1.4 %
Property, office and technology (1)
117.69.3 %8.0 %110.5 9.1 %7.8 %
General and administrative (1)
138.511.0 %9.4 %105.0 8.7 %7.4 %
Transaction, integration and restructuring—— %— %41.6 3.4 %2.9 %
Amortization of intangibles 11.30.9 %0.8 %14.1 1.2 %1.0 %
Total operating expenses$1,262.2 100.0 %85.6 %$1,208.7 100.0 %85.2 %
__________
(1)    Comparative period presented reflects reclassification of certain operating expenses to align with current period presentation. The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated. See Note 1, "Accounting Policies," for additional information.

During the three months ended March 31, 2024, Operating expenses increased $53.5 million compared to the three months ended March 31, 2023.

Third-Party Distribution, Service and Advisory

Third-party distribution, service and advisory expenses were $504.0 million for the three months ended March 31, 2024 as compared to $455.1 million for the three months ended March 31, 2023. The increase was due to an increase in pass-through Service and distribution fees resulting from higher fund costs and higher AUM to which the fees apply.

Employee Compensation

Employee compensation was $472.7 million for the three months ended March 31, 2024 as compared to $462.8 million for the three months ended March 31, 2023. This increase was primarily due to a $9.1 million increase in expense related to the mark-to-market on deferred compensation liabilities.

Headcount at March 31, 2024 was 8,527 (March 31, 2023: 8,561).

27
Marketing

Marketing expenses were $18.1 million for the three months ended March 31, 2024 as compared to $19.6 million for the three months ended March 31, 2023.

Property, Office and Technology

Property, office and technology costs were $117.6 million for the three months ended March 31, 2024 as compared to $110.5 million for the three months ended March 31, 2023. The increase was primarily driven by higher technology costs.

General and Administrative

General and administrative expenses were $138.5 million for the three months ended March 31, 2024 as compared to $105.0 million for the three months ended March 31, 2023. The increase was primarily due to $20.0 million of insurance recoveries and $9.8 million of indirect tax refunds which were received in the first quarter of 2023.

Transaction, Integration and Restructuring

Transaction, integration and restructuring charges were primarily comprised of compensation-related restructuring costs relating to our strategic evaluation which we completed in the first quarter of 2023. With the completion of strategic initiatives, any costs related to on-going projects are classified in the income statement based on the nature of the expense.

Other Income and Expenses

The main categories of Other income and expenses, and the dollar and percentage changes between periods, are as follows:

Variance
Three months ended March 31,2024 vs 2023
(in millions)20242023$ Change% Change
Equity in earnings of unconsolidated affiliates$6.9 $26.1 $(19.2)(73.6)%
Interest and dividend income12.4 8.6 3.8 44.2 %
Interest expense(15.9)(18.0)2.1 (11.7)%
Other gains/(losses), net35.9 27.4 8.5 31.0 %
Other income/(expense) of CIP, net30.5 (17.9)48.4 N/A
Total other income and expenses$69.8 $26.2 $43.6 166.4 %

Equity in earnings of unconsolidated affiliates

Equity in earnings of unconsolidated affiliates decreased to $6.9 million for the three months ended March 31, 2024 as compared to $26.1 million for the three months ended March 31, 2023. The decrease was primarily driven by losses on our real estate investments and lower earnings from our joint venture investment in IGW as discussed above, which were partially offset by higher earnings from private equity and other investments.

Interest and dividend income

Interest and dividend income was $12.4 million for the three months ended March 31, 2024 as compared to $8.6 million for the three months ended March 31, 2023. The increase was primarily due to higher interest income earned from Cash and cash equivalents.

Interest expense

Interest expense was $15.9 million for the three months ended March 31, 2024 as compared to $18.0 million for the three months ended March 31, 2023 as a result of a decrease in outstanding debt.

28
Other gains/(losses), net

Other gains/(losses), net was a gain of $35.9 million for the three months ended March 31, 2024 as compared to net gains of $27.4 million for the three months ended March 31, 2023. Included in the net gain for the first quarter of 2024 were $32.3 million of gains on investments and instruments held for our deferred compensation plans and $2.0 million of net gains related to the mark-to-market on seed capital investments. Included in the gain for the first quarter of 2023 were $22.2 million of gains on investments and instruments held for our deferred compensation plans and $5.3 million of net gains related to the mark-to-market on seed capital investments.

Other income/(expense) of CIP, net

For the three months ended March 31, 2024, Other income/(expense) of CIP, net was net income of $30.5 million (three months ended March 31, 2023: net expense of $17.9 million). Interest and dividend income of CIP decreased $59.5 million to $80.1 million (three months ended March 31, 2023: $139.6 million). Interest expense of CIP decreased $47.1 million to $47.2 million (three months ended March 31, 2023: $94.3 million). Unrealized gains/(losses) of CIP were net losses of $2.4 million (three months ended March 31, 2023: net losses of $63.2 million).

Net impact of CIP and related noncontrolling interests in consolidated entities

The consolidation of investment products did not have an impact on Net income attributable to Invesco for the three months ended March 31, 2024 and March 31, 2023. The adjustment to net income for the Net income/(loss) attributable to noncontrolling interests in consolidated entities represents the profit or loss attributable to third-party investors. The impact of any realized or unrealized gains or losses attributable to the interests of third-parties, which is reflected in Other income/(expense) of CIP, net, is offset by this adjustment to arrive at Net income attributable to Invesco. Also, the net income or loss of CIP is taxed at the investor level, not at the product level; therefore, a tax provision is not reflected in the net impact of CIP.

Income Tax Expense

The company’s subsidiaries operate in numerous taxing jurisdictions around the world, each with its own statutory tax rate. As a result, the blended statutory tax rate will vary from year to year depending on the mix of the profits and losses from each jurisdiction.

Our effective tax rate decreased to 24.3% for the three months ended March 31, 2024 (three months ended March 31, 2023: 29.7%). The decrease in the effective tax in the first quarter of 2024 is primarily due to the favorable impact of the increase in net income attributable to non-controlling interests in consolidated entities.


29
Schedule of Non-GAAP Information

We utilize the following non-GAAP performance measures: Net revenues (and by calculation, Net revenue yield on AUM), Adjusted operating income, Adjusted operating margin, Adjusted net income attributable to Invesco and Adjusted diluted EPS. The company believes the adjusted measures provide valuable insight into the company’s ongoing operational performance and assist in comparisons to its competitors. These measures also assist the company’s management with the establishment of operational budgets and forecasts. The most directly comparable U.S. GAAP measures are Operating revenues (and by calculation, Gross revenue yield on AUM), Operating income, Operating margin, Net income attributable to Invesco and diluted EPS. Each of these measures is discussed more fully below.

The following are reconciliations of the U.S. GAAP measures to the non-GAAP measures. The non-GAAP measures should not be considered as substitutes for any U.S. GAAP measures and may not be comparable to other similarly titled measures of other companies. Additional reconciling items may be added in the future to the non-GAAP measures if deemed appropriate. The tax effects related to the reconciling items have been calculated based on the tax rate attributable to the jurisdiction to which the transaction relates. Notes to the reconciliations follow the tables.

Reconciliation of Operating revenues to Net revenues:
Three months ended March 31,
(in millions)20242023
Operating revenues, U.S. GAAP basis$1,475.3 $1,418.2 
Revenue Adjustments (1)
Investment management fees(192.3)(189.8)
Service and distribution fees(271.8)(225.3)
Other(39.9)(40.0)
Total Revenue Adjustments(504.0)(455.1)
Invesco Great Wall (2)
74.7 100.5 
CIP (3)
7.2 12.3 
Net revenues$1,053.2 $1,075.9 

Reconciliation of Operating income to Adjusted operating income:
Three months ended March 31,
(in millions)20242023
Operating income, U.S. GAAP basis$213.1 $209.5 
Invesco Great Wall (2)
38.3 54.6 
CIP (3)
12.2 14.7 
Transaction, integration and restructuring (4)
— 41.6 
Amortization of intangible assets (5)
11.3 14.1 
Compensation expense related to market valuation changes in deferred compensation plans (6)
21.6 12.4 
General and administrative (7)
— (20.0)
Adjusted operating income$296.5 $326.9 
Operating margin(8)
14.4 %14.8 %
Adjusted operating margin(9)
28.2 %30.4 %
30
Reconciliation of net income attributable to Invesco to Adjusted net income attributable to Invesco
Three months ended March 31,
(in millions, except per common share data)20242023
Net income attributable to Invesco Ltd., U.S. GAAP basis$141.5 $145.0 
Adjustments (excluding tax):
Transaction, integration and restructuring (4)
— 41.6 
Amortization of intangible assets (5)
11.3 14.1 
Deferred compensation plan market valuation changes and dividend income less compensation expense (6)
(11.5)(10.4)
General and administrative (7)
— (20.0)
Total adjustments excluding tax$(0.2)$25.3 
Tax adjustment for amortization of intangible assets and goodwill (10)
$4.4 $4.2 
Other tax effects of adjustments above2.7 (1.1)
Adjusted net income attributable to Invesco Ltd. (11)
$148.4 $173.4 
Average common shares outstanding - diluted453.5 458.9 
Diluted EPS$0.31 $0.32 
Adjusted diluted EPS (12)
$0.33 $0.38 
____________
(1) Revenue adjustments: The company calculates Net revenues by reducing Operating revenues to exclude fees that are passed through to external parties who perform functions on behalf of, and distribute, the company’s managed funds. The Net revenue presentation assists in identifying the revenue contribution generated by the company, removing distortions caused by the differing distribution channel fees and allowing for a fair comparison with U.S. peer investment managers and within Invesco’s own investment units. Additionally, management evaluates Net revenue yield on AUM, which is equal to Net revenues divided by Average AUM during the reporting period, as an indicator of the Net revenues we receive for each dollar of AUM we manage.
Investment management fees are adjusted by renewal commissions and certain administrative fees. Service and distribution fees are primarily adjusted by distribution fees passed through to broker dealers for certain share classes and pass through fund-related costs. Other revenues are primarily adjusted by transaction fees passed through to third parties.
(2) Invesco Great Wall: The company reflects 100% of IGW in its Net revenues and Adjusted operating income (and by calculation, Adjusted operating margin). The company’s non-GAAP operating results reflect the economics of these holdings on a basis consistent with the underlying AUM and flows. Adjusted net income is reduced by the amount of earnings attributable to the 51% noncontrolling interests.
(3) CIP: See note 11, “Consolidated Investment Products,” for a detailed analysis of the impact to the company’s Condensed Consolidated Financial Statements from the consolidation of CIP. The company believes that the CIP may impact a reader’s analysis of our underlying results of operations and could result in investor confusion or the production of information about the company by analysts or external credit rating agencies that is not reflective of the underlying results of operations and financial condition of the company. Accordingly, the company believes that it is appropriate to adjust Operating revenues and Operating income for the impact of CIP in calculating the respective Net revenues and Adjusted operating income (and by calculation, Adjusted operating margin).
(4) Transaction, integration and restructuring: The company believes it is useful to adjust for the Transaction, integration and restructuring charges in arriving at Adjusted operating income, Adjusted operating margin, Adjusted net income, and Adjusted diluted EPS, as this will aid comparability of our results period to period, and aid comparability with peer companies that may not have similar acquisition and restructuring related charges. Transaction, integration and restructuring charges were restructuring costs relating to our strategic evaluation which we completed in the first quarter of 2023.
(5) Amortization of intangible assets: The company removes amortization expense related to acquired assets in arriving at Adjusted operating income, Adjusted operating margin, Adjusted net income, and Adjusted diluted EPS, as this will aid comparability of our results period to period, and aid comparability with peer companies that may not have similar acquisition-related charges.
(6) Market movement on deferred compensation plan liabilities: Certain deferred compensation plan awards involve a return to the employee linked to the appreciation (depreciation) of specified investments. The company hedges economically the exposure to market movements for these investments. Since these plans are hedged economically, the company believes it is useful to reflect the offset ultimately achieved from hedging the market exposure in the calculation of Adjusted operating income (and by calculation, Adjusted operating margin) and Adjusted net income (and by calculation, Adjusted diluted EPS) to produce results that will be more comparable period to period.
(7) General and administrative: The adjustment removes insurance recoveries related to fund-related losses incurred in prior periods.
(8) Operating margin is equal to Operating income divided by Operating revenues.
(9) Adjusted operating margin is equal to Adjusted operating income divided by Net revenues.
(10) Tax adjustment for amortization of intangible assets and goodwill: The company reflects the tax benefit realized on the tax amortization of goodwill and intangible assets in Adjusted net income. The company believes it is useful to include this tax benefit in arriving at the Adjusted diluted EPS measure.
(11) The effective tax rate on Adjusted net income attributable to Invesco Ltd. for the three months ended March 31, 2024 is 24.6% (for the three months ended March 31, 2023, it was 24.1%).
(12) Adjusted diluted EPS is equal to Adjusted net income attributable to Invesco Ltd. divided by the weighted average number of common and restricted common shares outstanding.
31
Balance Sheet Discussion (1)
The following table represents a reconciliation of the balance sheet information presented on a U.S. GAAP basis to the balance sheet information excluding the impact of CIP and policyholder balances for the reasons outlined in footnote 1 to the table:
As of March 31, 2024As of December 31, 2023
Balance sheet information
(in millions)		U.S. GAAPImpact of CIPAs AdjustedU.S. GAAPImpact of CIPImpact of PolicyholdersAs Adjusted
ASSETS
Cash and cash equivalents$895.7 $— $895.7 $1,469.2 $— $— $1,469.2 
Investments963.5 497.2 1,460.7 919.1 527.4 — 1,446.5 
Assets of CIP:
Investments and other assets of CIP9,119.5 (9,119.5)— 9,016.0 (9,016.0)— — 
Cash and cash equivalents of CIP529.8 (529.8)— 462.4 (462.4)— — 
Assets held for policyholders (2)
— — — 393.9 — (393.9)— 
Goodwill and intangible assets, net14,453.4 — 14,453.4 14,539.6 — — 14,539.6 
Other assets (3)
2,115.3 24.7 2,140.0 2,133.6 18.8 — 2,152.4 
Total assets$28,077.2 $(9,127.4)$18,949.8 $28,933.8 $(8,932.2)$(393.9)$19,607.7 
LIABILITIES
Liabilities of CIP:
Debt of CIP$7,370.4 $(7,370.4)$— $7,121.8 $(7,121.8)$— $— 
Other liabilities of CIP459.1 (459.1)— 492.1 (492.1)— — 
Policyholder payables (2)
— — — 393.9 — (393.9)— 
Debt1,257.5 — 1,257.5 1,489.5 — — 1,489.5 
Other liabilities (4)
3,137.4 — 3,137.4 3,520.5 — — 3,520.5 
Total liabilities$12,224.4 $(7,829.5)$4,394.9 $13,017.8 $(7,613.9)$(393.9)$5,010.0 
EQUITY
Total equity attributable to Invesco Ltd.$14,554.8 $0.1 $14,554.9 $14,597.6 $0.1 $— $14,597.7 
Noncontrolling interests (5)
1,298.0 (1,298.0)— 1,318.4 (1,318.4)— — 
Total equity15,852.8 (1,297.9)14,554.9 15,916.0 (1,318.3)— 14,597.7 
Total liabilities and equity$28,077.2 $(9,127.4)$18,949.8 $28,933.8 $(8,932.2)$(393.9)$19,607.7 
____________
(1)    This table includes non-GAAP presentations. Assets of CIP are not available for use by Invesco. Additionally, there is no recourse to Invesco for CIP debt. Policyholder assets and liabilities are equal and offsetting and have no impact on Invesco’s shareholders’ equity.
(2)    One of our subsidiaries, Invesco Pensions Limited, is an insurance company that was established to facilitate retirement savings plans in the U.K. The entity held assets that were managed for its clients on its balance sheet with an equal and offsetting liability. In January 2024, all funds were distributed to customers.
(3)    Amounts include Accounts receivable, Property, equipment and software, and Other assets.
(4)    Amounts include Accrued compensation and benefits, Accounts payable and accrued expenses, and Deferred tax liabilities.
(5)    Amounts include Redeemable noncontrolling interests in consolidated entities and Equity attributable to nonredeemable noncontrolling interests in consolidated entities.

Cash and cash equivalents

Cash and cash equivalents decreased by $573.5 million from $1,469.2 million at December 31, 2023 to $895.7 million at March 31, 2024. See “Cash Flows Discussion” below within this Management’s Discussion and Analysis for additional discussion regarding the movements in cash flows during the period.

32
Investments

Investments are comprised primarily of the equity method investment in IGW, seed capital and co-investments in affiliated funds, and investments related to the company’s deferred compensation plans.

As of March 31, 2024, and December 31, 2023 the company had $940.9 million and $956.0 million in seed capital and co-investments, respectively, including direct investments in CIP. Total seed capital and co-investments is presented as a helpful measure for investors and represents our total net investment interest including our investment in CIP. The following table reconciles the investments balance to the total seed capital and co-investment balance.
As of
(in millions)March 31, 2024December 31, 2023
Investments$963.5 $919.1 
Net investment in CIP 497.2 527.4 
Less: Investments related to deferred compensation plans, joint ventures, and other investments(519.8)(490.5)
Total seed capital and co-investments (1)
$940.9 $956.0 
____________
(1) Included in the total seed capital and co-investments balance as of March 31, 2024 is $299.7 million of seed capital and $641.2 million of co-investments (December 31, 2023: $314.1 million of seed capital and $641.9 million of co-investments).

Goodwill and intangible assets, net    

Goodwill and intangible assets, net decreased from $14,539.6 million at December 31, 2023, to $14,453.4 million at March 31, 2024. The decrease includes foreign exchange impacts of $74.9 million and amortization of $11.3 million. If our revenue and operating income continue to be adversely impacted by our AUM mix or unfavorable market conditions, including a significant decline in our stock price for an extended period of time, an impairment of goodwill and intangible assets may occur in future periods.

Liquidity and Capital Resources

Our capital structure, together with available cash balances, cash flows generated from operations, existing capacity under our credit agreement and further capital market activities, if necessary, should provide us with sufficient resources to meet present and future cash needs, including operating expenses, debt and other obligations as they come due and anticipated future capital requirements.

Sources of Liquidity by Type
As of
(in millions)March 31, 2024December 31, 2023
Cash and cash equivalents$895.7 $1,469.2 
Available revolver (1)
1,632.4 2,000.0 
Total sources of liquidity by type$2,528.1 $3,469.2 
____________
(1) As of March 31, 2024, the balance on the $2.0 billion capacity credit agreement was $367.6 million.

Capital Management

Our capital management priorities have evolved with the growth and success of our business and include, in no particular order of priority: reinvestment in the business, maintaining a strong balance sheet and returning capital to shareholders longer term through a combination of modestly increasing dividends and share repurchases.

Our capital process is executed in a manner consistent with our desire to maintain strong, investment grade credit ratings. As of the date of our filing, Invesco held credit ratings of BBB+/Stable, A3/Stable and A/Stable from Standard & Poor’s (S&P) Ratings Service, Moody’s Investor Services and Fitch Ratings, respectively.
33
Other Items

Certain of our subsidiaries are required to maintain minimum levels of regulatory capital, liquidity, and working capital. Such requirements may change from time-to-time as additional guidance is released based on a variety of factors, including balance sheet composition, assessment of risk exposures and governance, and review from regulators. These and other similar provisions of applicable laws and regulations may have the effect of limiting withdrawals of capital, repayment of intercompany loans and payment of dividends by such entities. Our financial condition or liquidity could be adversely affected if certain of our subsidiaries are unable to distribute funds to us.

We are in compliance with all regulatory minimum net capital requirements. As of March 31, 2024, the company’s minimum regulatory capital requirement was $389.1 million (December 31, 2023: $395.8 million).

We meet the regulatory liquidity and working capital requirements by holding cash and cash equivalents in the European sub-group. This retained cash can be used for general business purposes in the European sub-group in the countries where it is located. Due to the liquidity and working capital requirements, the ability to transfer cash between certain jurisdictions may be limited. In addition, transfers of cash between international jurisdictions may have adverse tax consequences.

The consolidation of $9,649.3 million and $7,370.4 million of assets and debt of CIP as of March 31, 2024, respectively, did not impact the company’s liquidity and capital resources. See Part I, Item 1, Financial Statements - Note 11, “Consolidated Investment Products,” for additional details.


34
Cash Flows Discussion

The following table represents a reconciliation of the cash flow information presented on a U.S. GAAP basis to the cash flows information excluding the impact of the cash flows of CIP for the reasons outlined in footnote 1 to the table:

Cash flows information (1)
Three months ended March 31, 2024 Three months ended March 31, 2023
(in millions)U.S. GAAPImpact of CIPAs AdjustedU.S. GAAPImpact of CIPAs Adjusted
Cash and cash equivalents, beginning of the period $1,931.6 $(462.4)$1,469.2 $1,434.1 $(199.4)$1,234.7 
Cash flows from operating activities(54.4)(52.3)(106.7)(98.9)(20.6)(119.5)
Cash flows from investing activities(287.3)236.8 (50.5)45.5 (110.8)(65.3)
Cash flows from financing activities(148.3)(253.9)(402.2)(178.5)5.9 (172.6)
Increase/(decrease) in cash and cash equivalents(490.0)(69.4)(559.4)(231.9)(125.5)(357.4)
Foreign exchange movement on cash and cash equivalents(16.1)2.0 (14.1)12.7 (1.0)11.7 
Cash and cash equivalents, end of the period$1,425.5 $(529.8)$895.7 $1,214.9 $(325.9)$889.0 
Cash and cash equivalents$895.7 $— $895.7 $889.0 $— $889.0 
Cash and cash equivalents of CIP529.8 (529.8)— 325.9 (325.9)— 
Total cash and cash equivalents per condensed consolidated statement of cash flows$1,425.5 $(529.8)$895.7 $1,214.9 $(325.9)$889.0 
____________
(1) These tables include non-GAAP presentations. Cash held by CIP is not available for use by Invesco. Additionally, there is no recourse to Invesco for CIP debt. The cash flows of CIP do not form part of the company’s cash flow management processes, nor do they form part of the company’s significant liquidity evaluations and decisions.

Operating Activities

Operating cash flows include the receipt of Investment management and Other fees generated from AUM, offset by Operating expenses and Changes in operating assets and liabilities. After allowing for the change in cash held by CIP, investment activities, non-cash activity, and seasonal payments such as bonus payments in the first quarter, our operating cash flows generally move in the same direction as our Operating income.

Cash outflows for the three months ended March 31, 2024, excluding the impact of the consolidation of CIP, was primarily driven by net outflows from changes in payables and receivables due to timing of payments and receipts, including annual compensation payments that are made in the first quarter of each year.

Investing Activities

Cash outflows for the three months ended March 31, 2024, excluding the impact of the consolidation of CIP, included Purchase of investments of $36.5 million (three months ended March 31, 2023: $55.2 million purchases), partially offset by proceeds of $7.0 million from sales and returns of capital of investments (three months ended March 31, 2023: $28.1 million proceeds). In addition, the company had capital expenditures of $21.0 million for the three months ended March 31, 2024 (three months ended March 31, 2023: $38.1 million). Our capital expenditures related principally to investments in foundational technology projects.

35
Financing Activities

Financing cash outflows during the three months ended March 31, 2024, excluding the impact of the consolidation of CIP, included $90.2 million of common dividend payments for the dividends declared in January (three months ended March 31, 2023: common dividends paid of $85.7 million), $59.2 million of preferred dividend payments for dividends declared in January (three months ended March 31, 2023: $59.2 million) and the payment of $20.4 million to meet employees’ withholding tax obligations on common share vestings (three months ended March 31, 2023: $27.7 million). The three months ended March 31, 2024 also included a $600.0 million redemption of our senior notes (three months ended March 31, 2023: none) and a net borrowing of $367.6 million on the credit agreement (three months ended March 31, 2023: none). Historically, the company has used the credit agreement to support short-term operating cash flow needs. However, due to the repayment of the senior notes and the short term operating cash flow needs in the first and second quarters, we expect to maintain a balance on the credit agreement until the second half of 2024.

Dividends

When declared, Invesco pays dividends on a quarterly basis in arrears. Holders of our preferred shares are eligible to receive dividends at an annual rate of 5.9% of the liquidation preference of $1,000 per share, or $59 per share per annum. The preferred stock dividend is payable quarterly on a non-cumulative basis when, if and as declared by our Board of Directors. However, if we have not declared and paid or set aside for payment full quarterly dividends on the preferred stock for a particular dividend period, we may not declare or pay dividends on, redeem, purchase or acquire, our common stock or other junior securities in the next succeeding dividend period. In addition, if we have not declared and paid or set aside for payment quarterly dividends on the preferred stock for six quarterly periods, whether or not consecutive, the number of directors of the company will be increased by two and the holders of the preferred shares shall have the right to elect such two additional members of the Board of Directors.

On April 23, 2024, the company declared a first quarter 2024 cash dividend of $0.205 per common share to the holders of common shares. The dividend is payable on June 4, 2024, to common shareholders of record at the close of business on May 14, 2024, with an ex-dividend date of May 13, 2024.

On April 23, 2024, the company declared a preferred dividend of $14.75 per preferred share, representing the period from March 1, 2024 through May 31, 2024. The preferred dividend is payable on June 3, 2024.

The declaration, payment and amount of any future dividends will depend upon, among other factors, our earnings, financial condition and capital requirements at the time such declaration and payment are considered. The company has a policy of managing dividends in a prudent fashion, with due consideration given to profit levels, overall debt levels and historical dividend payouts.

Debt

The carrying value of our debt at March 31, 2024 was $1,257.5 million (December 31, 2023: $1,489.5 million). See Part I, Item 1, Financial Statements - Note 4, “Debt,” for additional disclosures.

For the Three months ended March 31, 2024, the company’s weighted average cost of debt was 4.90% (Three months ended March 31, 2023: 4.28%).

Financial covenants under the credit agreement include: (i) the quarterly maintenance of an Adjusted debt/Earnings before income tax, depreciation, amortization, interest expense, common share-based compensation expense, unrealized (gains)/losses from investments, net, and unusual or otherwise non-recurring gains and losses (Covenant Adjusted EBITDA) leverage ratio, as defined in the credit agreement, of not greater than 3.25:1.00, (ii) an interest coverage ratio (Covenant Adjusted EBITDA/interest expense for the four consecutive fiscal quarters ended before the date of determination) of not less than 4.00:1.00. As of March 31, 2024, we were in compliance with our financial covenants. At March 31, 2024, our leverage ratio was 0.54:1.00 (December 31, 2023: 0.69:1.00), and our interest coverage ratio was 20.76:1.00 (December 31, 2023: 20.40:1.00).

36
The March 31, 2024 coverage ratio calculations are as follows:
(in millions)TotalQ1 2024Q4 2023Q3 2023Q2 2023
Net income/(loss) attributable to Invesco Ltd.$(337.2)$141.5 $(742.3)$131.4 $132.2 
Dividends on preferred shares236.8 59.2 59.2 59.2 59.2 
Tax expense/(benefit)(70.9)68.7 (266.4)61.3 65.5 
Amortization/depreciation/impairment1,430.0 45.1 1,295.3 42.2 47.4 
Interest expense68.4 15.9 16.8 17.3 18.4 
Common share-based compensation expense97.9 21.1 20.8 24.0 32.0 
Unrealized (gains)/losses from investments, net (1)
(5.2)(10.4)(4.5)18.3 (8.6)
Covenant Adjusted EBITDA (2)
$1,419.8 $341.1 $378.9 $353.7 $346.1 
Adjusted debt (2)
$760.1 
Leverage ratio as of March 31, 2024 (Adjusted debt/Covenant Adjusted EBITDA - maximum 3.25:1.00)
0.54 
Interest coverage ratio as of March 31, 2024 (Covenant Adjusted EBITDA/Interest expense - minimum 4.00:1.00)
20.76 
(1)    Adjustments for unrealized gains and losses from investments, as defined in our credit agreement, may also include non-cash gains and losses on investments to the extent that they do not represent anticipated future cash receipts or expenditures.
(2)    Covenant Adjusted EBITDA and Adjusted debt are non-GAAP financial measures that are used by management in connection with certain debt covenant calculations under our credit agreement. The calculation of Covenant Adjusted EBITDA above (a reconciliation from Net income attributable to Invesco Ltd.) is defined by our credit agreement, and therefore Net income attributable to Invesco Ltd. is the most appropriate GAAP measure from which to reconcile to Covenant Adjusted EBITDA. The calculation of Adjusted debt is defined in our credit agreement and equals debt of $1,257.5 million plus $2.6 million in letters of credit less $500.0 million of excess unrestricted cash (cash and cash equivalents less the minimum regulatory capital requirement, not to exceed $500 million).

Credit and Liquidity Risk

The company manages its capital by reviewing annual and projected cash flow forecasts and by monitoring credit, liquidity and market risks, such as interest rate and foreign currency risks (as discussed in Part I, Item 3, Quantitative and Qualitative Disclosures About Market Risk), through measurement and analysis.

Credit Risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to meet an obligation. The company is primarily exposed to credit risk through its cash and cash equivalent deposits, which are held by external firms. The company invests its cash balances in its own institutional money market products, as well as with external high credit-quality financial institutions. These arrangements create exposure to concentrations of credit risk. As of March 31, 2024, our maximum exposure to credit risk related to our cash and cash equivalent balances is $895.7 million, of which $434.7 million is invested in affiliated money market funds. See Part I, Item 1, Financial Statements - Note 2, "Fair Value of Assets and Liabilities," for information regarding cash and cash equivalents invested in affiliated money market funds.

Liquidity Risk

Liquidity risk is the risk that the company will encounter difficulty in meeting obligations associated with its financial liabilities as they become due. The company is exposed to liquidity risk through its $1,257.5 million in total debt. The company actively manages liquidity risk by preparing cash flow forecasts for future periods, reviewing them regularly with senior management, maintaining a committed credit agreement, scheduling significant gaps between major debt maturities and engaging external financing sources in regular dialogue.

Effects of Inflation

Inflation can impact our organization primarily in two ways. First, inflationary pressures can result in increases in our cost structure, especially to the extent that large expense components such as compensation are impacted. To the degree that these expense increases are not recoverable or cannot be counterbalanced through pricing increases due to the competitive environment, our profitability could be negatively impacted. Secondly, the value of the assets that we manage may be negatively impacted when inflationary expectations result in a rising interest rate environment. A decline in the values of AUM could lead to reduced revenues as management fees are generally calculated based upon the size of AUM.
37

Off Balance Sheet Commitments

See Part I, Item 1, Financial Statements - Note 10, “Commitments and Contingencies - Legal Contingencies,” for more information regarding undrawn capital commitments.

Critical Accounting Policies and Estimates

There have been no changes to the critical accounting policies disclosed in our most recent Form 10-K for the year ended December 31, 2023. Critical accounting policies are those that require management’s most difficult, subjective or complex judgments and would therefore be deemed the most critical to an understanding of our results of operations and financial condition.

Recent Accounting Standards

See Part I, Item 1, Financial Statements - Note 1, "Accounting Policies - Accounting Pronouncements Recently Adopted.”
38
Item 3.  Quantitative and Qualitative Disclosures About Market Risk

In the normal course of its business, the company is primarily exposed to market risk in the form of AUM market price risk, securities market risk, interest rate risk and foreign exchange rate risk. There have not been any material changes to the company’s exposures to market risks during the period ended March 31, 2024 that would require an update to the disclosures provided in the most recent Form 10-K.

AUM Market Price Risk

The company’s investment management revenues are comprised of fees based on the value of AUM. Declines in the market prices of equity and fixed income securities, commodities and derivatives, or other similar financial instruments held in client portfolios could cause revenues to decline because of lower investment management fees by:

•Causing the value of AUM to decrease.
•Causing the returns realized on AUM to decrease (impacting performance fees).
•Causing clients to withdraw funds in favor of investments in markets that they perceive to offer greater opportunity and that the company does not serve.
•Causing clients to rebalance assets away from investments that the company manages into investments that the company does not manage.
•Causing clients to reallocate assets away from products that earn higher revenues into products that earn lower revenues.

Underperformance of client accounts relative to competing products could exacerbate these factors.

Assuming the revenue yield on AUM for the year remains unchanged, a decline in the average AUM for the year would result in a corresponding decline in revenue. Certain expenses, including distribution and compensation expenses, may not vary in proportion with the changes in the market value of AUM. As such, the impact on operating margin or net income of a decline in the market values of AUM may be greater or less than the percentage decline in the market value of AUM.

Securities Market Risk

The company has investments in managed investment products that invest in a variety of asset classes. Investments are generally made to establish a track record for a new fund or investment vehicle or to hedge economically exposure to certain deferred compensation plans. The company’s exposure to market risk from financial instruments measured at fair value arises from its investments.

Interest Rate Risk

Interest rate risk relates to the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The company is exposed to interest rate risk primarily through its external debt and cash and cash equivalent investments. See Part I, Item 1, Financial Statements - Note 4, “Debt,” for details of the company’s debt arrangements. As of March 31, 2024, the interest rates on 70.8% of the company’s borrowings were fixed for a weighted average period of 9.66 years, and the company had a $367.6 million balance on its floating rate credit agreement.

Foreign Exchange Rate Risk

The company has certain investments in foreign operations, whose net assets and results of operations are exposed to foreign currency translation risk when translated into U.S. Dollars upon consolidation into Invesco.

The company is also exposed to foreign translation risk on monetary assets and liabilities that are held by subsidiaries in different functional currencies than the subsidiaries’ functional currencies. Net foreign exchange revaluation gains were $1.4 million during the three months ended March 31, 2024 (three months ended March 31, 2023: $1.1 million losses) and are included in General and administrative expenses and Other gains/ (losses), net on the Condensed Consolidated Statements of Income.
39
Item 4.  Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information the company is required to disclose in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in the reports that the company files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.

We have evaluated, with the participation of our chief executive officer and chief financial officer, the effectiveness of our disclosure controls and procedures as of March 31, 2024. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

We have evaluated any change in our internal control over financial reporting that occurred during the three months ended March 31, 2024 and have concluded that there was no change that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

40
PART II. OTHER INFORMATION
Item 1.  Legal Proceedings

See Part I, Item 1, Financial Statements - Note 10, “Commitments and Contingencies - Legal Contingencies,” for information regarding legal proceedings.

Item 1A.  Risk Factors

The company has had no significant changes in its risk factors from those previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Equity Securities

The following table sets forth information regarding purchases of our common shares by us and any affiliated purchases during the three months ended March 31, 2024:
Month
Total Number of Shares Purchased (1)
Average Price Paid Per Share
Total Number of Shares
Purchased as Part of
Publicly Announced Plans or Programs (2)
Maximum Number at end of period (or Approximate
Dollar Value) of Shares
that May Yet Be Purchased
Under the Plans
or Programs (2) (millions)
January 1-31, 2024310,285 $17.08 — $382.2 
February 1-29, 20241,054,916 $15.31 — $382.2 
March 1-31, 202432,583 $15.45 — $382.2 
Total1,397,784 — 
____________
(1)    An aggregate of 1,397,784 shares were surrendered to us by Invesco employees to satisfy tax withholding obligations in connection with the vesting of equity awards.
(2)    At March 31, 2024, a balance of $382.2 million remains available under the share repurchase authorization approved by the Board on July 22, 2016.

Item 5. Other Information

None.



41
Item 6. Exhibits
Exhibit Index
3.1
3.2
3.3
10.1
10.2
10.3
10.4
22
31.1
31.2
32.1
32.2
101
The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Changes in Equity, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
104
The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL

42
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


INVESCO LTD.
May 1, 2024/s/ ANDREW R. SCHLOSSBERG
Andrew R. Schlossberg
President and Chief Executive Officer
May 1, 2024/s/ L. ALLISON DUKES
L. Allison Dukes
Senior Managing Director and Chief Financial Officer

43
 EX-10.1 2 ivz1q2024ex101.htm EX-10.1 Document
Exhibit 10.1
Invesco Ltd.
2010 Global Equity Incentive Plan (ST)
(As amended and restated effective February 28, 2024)

1.    Purpose
The purpose of the Invesco Ltd. 2010 Global Equity Incentive Plan (ST) (the “Plan”) is to give Invesco Ltd., a company organized under the laws of Bermuda (the “Company”), a competitive advantage in attracting, retaining and motivating officers, employees, directors and/or consultants and to provide the Company and its Affiliates with a long-term incentive plan providing incentives directly linked to Shareholder value.
2.    Effective Date and Term of Plan
The Plan was initially adopted by the Board on May 18, 2010 and was most recently amended and restated effective October 10, 2017. This amendment and restatement was adopted by the Board on February 28, 2024 and is effective as of February 28, 2024 (the “Effective Date”). This amendment and restatement is effective with respect to Awards granted on and after February 28, 2024. Awards may be granted under the Plan until the date that is ten years after February 28, 2024, unless the Plan is discontinued earlier pursuant to Section 14.
3.    Types of Awards
Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Other Stock-Based Awards may be granted under the Plan.
4.    Definitions
    Except as otherwise specifically provided in an Award Agreement, each capitalized word, term or phrase used in the Plan shall have the meaning set forth in this Section 4 or, if not defined in this Section, the first place that it appears in the Plan.
    “Affiliate” means a corporation or other entity controlled by, controlling or under common control with, the Company; provided, however, that solely for purposes of determining whether a Participant has a Termination of Service that is a “separation from service” within the meaning of Section 409A of the Code, an “Affiliate” of a corporation or other entity means all other entities with which such corporation or other entity would be considered a single employer under Sections 414(b) or 414(c) of the Code.
    “Applicable Exchange” means the New York Stock Exchange or such other securities exchange as may at the applicable time be the principal market for the Shares.
    “Award” means an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit or Other Stock-Based Award granted pursuant to the terms of the Plan.
    “Award Agreement” means a written document or agreement setting forth the terms and conditions of a specific Award and any addendum thereto.


“Beneficiary” means the person(s) or trust(s) entitled by will or the laws of descent and distribution to receive any amounts payable or exercise any applicable rights under the Participant’s Awards after the Participant’s death.
    “Board” means the Board of Directors of the Company.
    “Cause” means, with respect to a Participant, (i) if such Participant is a party to an Individual Agreement at the time of the Termination of Service that defines such term (or word(s) of similar meaning), the meaning given in such Individual Agreement or (ii) if there is no such Individual Agreement or if it does not define Cause (or word(s) of similar meaning): (A) the Participant’s plea of guilty or nolo contendere to, or conviction of, (1) a felony (or its equivalent in a non-United States jurisdiction) or (2) other conduct of a criminal nature that has or is likely to have an adverse effect on the reputation or standing in the community of the Company or any of its Affiliates, as determined by the Committee in its sole discretion, or that legally prohibits the Participant from working for the Company or any of its Affiliates; (B) a breach by the Participant of a regulatory rule that adversely affects the Participant’s ability to perform the Participant’s employment duties to the Company or any of its Affiliates in any material respect; (C) the Participant’s failure, in each case in any material respect, to (1) perform the Participant’s employment duties, (2) comply with the applicable policies, codes of conduct or employee manuals of the Company or any of its Affiliates, (3) follow reasonable directions received from the Company or any of its Affiliates or (4) comply with covenants contained in any Individual Agreement or Award Agreement to which the Participant is a party; or (D) with respect to Participants employed outside of the United States, such other definition as may be codified under local laws, rules and regulations. With respect to a Participant’s termination of directorship, “Cause” shall include only an act or failure to act that constitutes cause for removal of a director under the Company’s Bye-Laws.
    “Change in Control” means any of the following events:
        (i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of twenty-five percent (25%) or more of either (A) the then outstanding shares of the Company (the “Outstanding Company Shares”) or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute a Change in Control: (1) any acquisition directly from the Company; (2) any acquisition by the Company; (3) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company; or (4) any acquisition pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (iii) below; or
        (ii)    during any period of twelve (12) consecutive months, individuals who, as of January 1, 2024, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to January 1, 2024 whose election, or nomination for election by the Company’s Shareholders, was approved by a vote of at least two-thirds (2/3) of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or
2


threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
        (iii)    consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets of another entity (each, a “Corporate Transaction”), in each case, unless, following such Corporate Transaction, (A) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Shares and Outstanding Company Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or indirectly, more than fifty percent (50%) of, respectively, the then outstanding shares and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or other entity resulting from such Corporate Transaction (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction of the Outstanding Company Shares and Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan or related trust of the Company or of such corporation resulting from such Corporate Transaction) beneficially owns, directly or indirectly, twenty-five percent (25%) or more of, respectively, the then outstanding shares of the corporation resulting from such Corporate Transaction or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Corporate Transaction and (C) at least a majority of the members of the board of directors of the corporation (or other governing board of a non-corporate entity) resulting from such Corporate Transaction were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Corporate Transaction; or
        (iv)    approval by the Shareholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, an event described above shall be a Change in Control with respect to an Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code only if such event is also a change in the ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company within the meaning of Section 409A of the Code to the extent necessary to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder.
    “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto, the Treasury Regulations thereunder and other relevant interpretive guidance issued by the Internal Revenue Service or the Treasury Department. Reference to any specific section of the Code shall be deemed to include such regulations and guidance, as well as any successor section, regulations and guidance.
    “Committee” means the Compensation Committee of the Board or such other committee or subcommittee of the Board as may be appointed by the Board to act as the Committee under the Plan. If at any time there is no such Compensation Committee or other committee or subcommittee appointed by the Board, the Board shall be the Committee. The Committee shall
3


consist of two or more directors, each of whom is intended to be, to the extent required by Rule 16b-3 of the Exchange Act, a “non-employee director” as defined in Rule 16b-3 of the Exchange Act. Any member of the Committee who does not meet the foregoing requirements shall abstain from any decision regarding an Award and shall not be considered a member of the Committee to the extent required to comply with Rule 16b-3 of the Exchange Act.
    “Disability” means, with respect to a Participant, (i) a “disability” (or words of similar meaning) as defined in any Individual Agreement to which the Participant is a party at the relevant time or (ii) if there is no such Individual Agreement or it does not define “disability” (or words of similar meaning): (A) a permanent and total disability as determined under the long-term disability plan applicable to the Participant; (B) if there is no such plan applicable to the Participant, “Disability” as determined by the Committee in its sole discretion; or (C) with respect to Participants employed outside the United States, such other definition as may be codified under local laws, rules and regulations. The Committee may require such medical or other evidence as it deems necessary to judge the nature and permanency of the Participant’s condition. Notwithstanding the foregoing, with to any Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, “Disability” shall mean a “disability” as defined under Section 409A of the Code to the extent necessary to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder.
    “Disaffiliation” means an Affiliate’s or business division’s ceasing to be an Affiliate or business division for any reason (including, without limitation, as a result of a public offering, or a spinoff or sale by the Company, of the stock of the Affiliate or a sale of a business division of the Company).
    “Eligible Individuals” means non-employee directors, officers, employees and consultants of the Company or any of its Affiliates, and prospective officers, employees and consultants who have accepted offers of employment or consultancy from the Company or any of its Affiliates.
    “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and any successor thereto. Reference to any specific section of the Exchange Act shall be deemed to include such regulations and guidance issued thereunder, as well as any successor section, regulations and guidance.
    “Fair Market Value” means, unless otherwise determined by the Committee, the closing price of a Share on the Applicable Exchange on the date of measurement or, if Shares are not traded on the Applicable Exchange on such measurement date, then on the next preceding date on which Shares are traded, all as reported by such source as the Committee may select. If the Shares are not listed on a national securities exchange, Fair Market Value shall be determined by the Committee in its good faith discretion.
    “Good Reason” means, with respect to a Participant, (i) if such Participant is a party to an Individual Agreement at the time of the Termination of Service that defines such term (or sord(s) of similar meaning), the meaning given in such Individual Agreement or (ii) if there is no such Individual Agreement or if it does not define Good Reason (or word(s) of similar meaning), during the 24-month period following a Change in Control, actions taken by the Company or any of its Affiliates resulting in a material negative change in the employment relationship of the Participant who is an officer or an employee including, without limitation:
4


        (i)    the assignment to the Participant of duties materially inconsistent with the Participant’s position (including status, titles and reporting requirements), authority, duties or responsibilities, or a material diminution in such position, authority, duties or responsibilities, in each case from those in effect immediately prior to the Change in Control;
        (ii)    a material reduction of the Participant’s aggregate annual compensation, including, without limitation, base salary and annual bonus opportunity, from that in effect immediately prior to the Change in Control;
        (iii)    a change in the Participant’s principal place of employment that increases the Participant’s commute by 40 or more miles or materially increases the time of the Participant’s commute as compared to the Participant’s commute immediately prior to the Change in Control but excluding, for the avoidance of doubt, a change that requires a Participant to forego one or more days of remote work and perform such work in person at a Company office; or
        (iv)    any other action or inaction that constitutes a material breach by the Company or an Affiliate of any Individual Agreement.
In order to invoke a Termination of Service for Good Reason, a Participant must provide written notice to the Company or Affiliate with respect to which the Participant is employed or providing services of the existence of one or more of the conditions constituting Good Reason within ninety (90) days following the Participant’s knowledge of the initial existence of such condition or conditions, specifying in reasonable detail the conditions constituting Good Reason, and the Company shall have thirty (30) days following receipt of such written notice (the “Cure Period”) during which it may remedy the condition. In the event that the Company or Affiliate fails to remedy the condition constituting Good Reason during the applicable Cure Period, the Participant’s Termination of Service must occur, if at all, within ninety (90) days following such Cure Period in order for such termination as a result of such condition to constitute a Termination of Service for Good Reason.
    “Grant Date” means (i) the date on which the Committee by resolution selects an Eligible Individual to receive a grant of an Award, establishes the number of Shares to be subject to such Award and, in the case of an Option or Stock Appreciation Right, establishes the exercise price of such Award or (ii) such later date as the Committee shall provide in such resolution.
“Individual Agreement” means a written employment, consulting or similar agreement between a Participant and the Company or one of its Affiliates.
    “Nonqualified Option” means a stock Option that is not an “Incentive Stock Option” within the meaning of Section 422 of the Code.
    “Option” means a Nonqualified Option granted under Section 8.
    “Other Stock-Based Award” means an Award of Shares or any other Award that is valued in whole or in part by reference to, or is otherwise based upon, Shares, including (without limitation) unrestricted stock, dividend equivalents and convertible debentures, granted under Section 11.
5


    “Participant” means an Eligible Individual to whom an Award is or has been granted and who has accepted the terms and conditions of the Plan as set forth in Section 5(f) hereof.
    “Performance Goals” means specified goals, other than the mere continuation of employment or the mere passage of time, the satisfaction of which is a condition for the grant, exercisability, vesting or full enjoyment of an Award. A Performance Goal and any targets with respect thereto need not be based upon an increase, a positive or improved result or avoidance of loss and may be applied, without limitation, to a Participant individually, or to a business unit or division of the Company or an Affiliate or to the Company as a whole. A Performance Goal may also be based on individual performance and/or subjective performance goals (or any combination of any of the goals described in this definition). The Committee may provide that one or more of the Performance Goals or financial measures applicable to an Award may be adjusted in a manner that the Committee determines equitable and appropriate for extraordinary, unusual, infrequently occurring or non-recurring items (for example, but without limitation, acquisitions, dispositions, material financial market movements, changes in tax laws or accounting principles, or accruals for reorganization or restructuring programs) occurring during the Performance Period that affect the applicable Performance Goal(s).
    “Performance Period” means that period established by the Committee during which any Performance Goals specified by the Committee with respect to such Award are to be measured.
    “Restricted Stock” means an Award granted under Section 9.
    “Restricted Stock Unit” means an Award granted under Section 10.
    “Restriction Period” means, with respect to Restricted Stock and Restricted Stock Units, the period commencing on the date of such Award to which vesting restrictions apply and ending upon the expiration of the applicable vesting conditions and/or the achievement of the applicable Performance Goals (it being understood that the Committee may provide that restrictions shall lapse with respect to portions of the applicable Award during the Restriction Period).
    “Retirement” means, subject to and in accordance with such rules as may be prescribed by the Committee, retirement from active employment with the Company (other than at a time when Cause exists or as a result of a termination for Cause) at or after satisfying an age and/or years of service requirement established by the Committee.

    “Share” or “Shares” means common shares, par value $0.20 each, of the Company or such other equity securities that may become subject to an Award.
    “Shareholder” has the same meaning as the term “Member” in the Companies Act 1981 of Bermuda.
    “Stock Appreciation Right” means an Award granted under Section 8(b).
    “Term” means the maximum period during which an Option, Stock Appreciation Right or, if applicable, Other Stock-Based Award may remain outstanding as specified in the applicable Award Agreement.
6


    “Termination of Service” means the termination of the Participant’s employment or consultancy with, or performance of services for, the Company and any of its Affiliates or, in the case of a director, when a director no longer holds office as a director of the Company. For Participants employed outside the United States, the date on which such Participant incurs a Termination of Service shall be the earlier of (i) the last day of the Participant’s active service with the Company and its Affiliates or (ii) the last day on which the Participant is considered an employee of the Company and its Affiliates, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws. Temporary absences from employment because of illness, vacation or approved leave of absence and transfers among the Company and its Affiliates shall not be considered Terminations of Service. With respect to any Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, “Termination of Service” shall mean a “separation from service” as defined under Section 409A of the Code to the extent required by Section 409A of the Code to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder. A Participant has a separation from service within the meaning of Section 409A of the Code if the Participant terminates employment with the Company and all Affiliates for any reason. A Participant will generally be treated as having terminated employment with the Company and all Affiliates as of a certain date if the Participant and the Company or Affiliate that employs the Participant reasonably anticipate that the Participant will perform no further services for the Company or any Affiliate after such date or that the level of bona fide services that the Participant will perform after such date (whether as an employee or an independent contractor) will permanently decrease to no more than 20 percent of the average level of bona fide services performed (whether as an employee or an independent contractor) over the immediately preceding 36-month period (or the full period of services if the Participant has been providing services for fewer than 36 months); provided, however, that the employment relationship is treated as continuing while the Participant is on military leave, sick leave or other bona fide leave of absence if the period of leave does not exceed six months or, if longer, so long as the Participant retains the right to reemployment with the Company or any Affiliate.
5.    Administration
    (a)    Committee. The Plan shall be administered by the Committee. The Committee shall, subject to Section 13, have plenary authority to grant Awards pursuant to the terms of the Plan to Eligible Individuals. Among other things, the Committee in its sole discretion shall have the authority, subject to the terms and conditions of the Plan:
        (i)    to select the Eligible Individuals to whom Awards may from time to time be granted;
        (ii)    to determine whether and to what extent Awards are to be granted hereunder;
        (iii)    to determine the number of Shares to be covered by each Award granted hereunder;
        (iv)    to determine the terms and conditions of each Award granted hereunder, including but not limited to the form of settlement of the Awards, based on such factors as the Committee shall determine, and to approve the form of Award Agreement and any related addendum;
7


        (v)    to adopt sub-plans and special provisions applicable to Awards granted to Participants employed outside of the United States, which sub-plans and special provisions may take precedence over other provisions of the Plan, and to approve the form of Award Agreement and any related addendum as may be applicable to such Awards;
        (vi)    subject to Sections 6(e), 8(e), 13 and 14, to modify, amend or adjust the terms and conditions of any Award, including adjustments to Performance Goals or financial measures applicable to an Award that may be adjusted in a manner that the Committee determines equitable and appropriate for extraordinary, unusual, infrequently occurring or non-recurring items (for example, but without limitation, acquisitions, dispositions, material financial market movements, changes in tax laws or accounting principles, or accruals for reorganization or restructuring programs) occurring during the Performance Period that affect the applicable Performance Goal(s).
        (vii)    to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it shall from time to time deem advisable;
        (viii)    to interpret the terms and provisions of the Plan and any Award issued under the Plan (and any Award Agreement relating thereto);
        (ix)    subject to Section 13, to accelerate the vesting or lapse of restrictions of any outstanding Award, based in each case on such considerations as the Committee determines;
        (x)    to decide all other matters to be determined in connection with an Award;
        (xi)    to determine whether, to what extent and under what circumstances cash, Shares and other property and other amounts payable with respect to an Award under the Plan shall be deferred either automatically or at the election of the Participant;
        (xii)    to establish any “blackout” period that the Committee deems necessary or advisable; and
        (xiii)    to otherwise administer the Plan.
    (b)    Delegation of Authority. To the extent permitted under applicable law and Section 13, the Committee may delegate any of its authority to administer the Plan to any person or persons selected by the Committee, including one or more members of the Committee, and such person or persons shall be deemed to be the Committee with respect to, and to the extent of, its or their authority.
    (c)    Procedures.
        (i)    The Committee may act by a majority of its members and, except to the extent prohibited by applicable law or the listing standards of the Applicable Exchange and subject to Section 13, through any person or persons to whom it has delegated its authority pursuant to Section 5(b).
8


        (ii)    Any authority granted to the Committee may also be exercised by the independent directors of the full Board. To the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action shall control.
    (d)    Discretion of Committee and Binding Effect. Any determination made by the Committee or an appropriately delegated person or persons with respect to the Plan or any Award shall be made in the sole discretion of the Committee or such delegate, including, without limitation, any determination involving the appropriateness or equitableness of any action, unless in contravention of any express term of the Plan. All decisions made by the Committee or any appropriately delegated person or persons shall be final and binding on all persons, including the Company, Participants and Eligible Individuals. Notwithstanding the foregoing, following a Change in Control, any determination by the Committee as to whether “Cause” or “Good Reason” exists shall be subject to de novo review.
    (e)     Cancellation or Suspension. Notwithstanding any other terms of the Plan (other than Section 8(e)), an Award Agreement or an Award, the Committee or an appropriately delegated person or persons, in its or their sole discretion, shall have full power and authority to determine whether, to what extent and under what circumstances any Award or any portion thereof shall be cancelled or suspended and may cancel or suspend any Award or any portion thereof. Without in any way limiting the generality of the preceding sentence, the following are examples, without limitation, of when all or any portion of an outstanding Award to any Participant may be canceled or suspended: (1) in the sole discretion of the Committee or any appropriately delegated person or persons, a Participant materially breaches (A) any duties of Participant’s employment (whether express or implied), including without limitation Participant’s duties of fidelity, good faith and exclusive service, (B) any general terms and conditions of Participant’s employment such as an employee handbook or guidelines, (C) any policies and procedures of the Company or any of its Affiliates applicable to the Participant, or (D) any other agreement regarding Participant’s employment with the Company or any of its Affiliates, or (2) without the prior written explicit consent of the Committee or any appropriately delegated person or persons (which consent may be granted or denied in the sole discretion of the Committee or such person or persons), a Participant, while employed by, or providing services to, the Company or any of its Affiliates, becomes associated with, employed by, renders services to, or owns any interest in (other than any nonsubstantial interest, as determined by the Committee or any appropriately delegated person or persons in its or their sole discretion), any business that is in competition with the Company or any of its Affiliates or with any business in which the Company or any of its Affiliates has a substantial interest, as determined by the Committee or any appropriately delegated person or persons in its or their sole discretion, or (3) as a result of the application to an Award of any compensation recovery or recoupment policy or policies adopted by the Company, including but not limited to the Invesco Ltd. Policy for Recoupment of Incentive Compensation.
    (f)    Award Agreements. The terms and conditions of each Award, as determined by the Committee, shall be set forth in a written (including electronic) Award Agreement, which shall be delivered to the Participant receiving such Award upon, or as promptly as is reasonably practicable following, the grant of such Award. Except (i) as otherwise specified by the Committee, in its sole discretion, (ii) as otherwise provided in the Award Agreement, or (iii) in the case of non-executive directors who may not be required to sign or accept an Award, an Award shall not be effective unless the Award Agreement is signed or otherwise accepted by the Participant receiving the Award (including by electronic signature or acceptance). The Committee, in its sole discretion, may deliver any documents related to an Award or Award
9


Agreement by electronic means. Award Agreements may be amended only in accordance with Section 14.
6.    Shares Subject to Plan
    (a)    Plan Maximums. Subject to adjustment as described in Section 6(e), the maximum number of Shares that may be issued pursuant to Awards under the Plan shall be 3,000,000.
    (b)    Source of Shares. Shares subject to Awards under the Plan may be authorized but unissued Shares, Shares held by the Company as treasury shares or, if required by local law, Shares delivered from a trust established pursuant to applicable law.
    (c)    Rules for Calculating Shares Issued; No “Share Recycling” for Options or Stock Appreciation Rights. Shares that are subject to Awards granted under the Plan shall be deemed not to have been issued for purposes of the Plan maximums set forth in Section 6(a) and 6(b)(ii) to the extent that:
        (i)    the Award is forfeited or canceled or the Award terminates, expires or lapses for any reason without Shares having been delivered;
        (ii)    the Award is settled in cash; or
        (iii)    the Shares are withheld by the Company to satisfy all or part of any tax withholding obligation related to an Award of Restricted Stock or an Award of a Restricted Stock Unit.
Shares that are tendered or withheld by the Company in payment of the exercise price of Options or Stock Appreciation Rights or to satisfy all or part of any tax withholding obligation related to such an Option or Stock Appreciation Right shall be counted as Shares that were issued. For the avoidance of doubt, Shares subject to an Option or a Stock Appreciation Right issued under the Plan that are not issued in connection with the stock settlement of that Option or Stock Appreciation Right upon its exercise shall not again become available for Awards or increase the number of Shares available for grant.
    (d)    Adjustment Provision.
(i)    In the event of a merger, consolidation, stock rights offering, liquidation, or similar event affecting the Company or any of its Affiliates (each, a “Corporate Event”) or a stock dividend, stock split, reverse stock split, separation, spinoff, Disaffiliation, reorganization, extraordinary dividend of cash or other property, share combination, or recapitalization or similar event affecting the capital structure of the Company (each, a “Share Change”), the Committee or the Board shall make such equitable and appropriate substitutions or adjustments to (A) the aggregate number and kind of Shares or other securities reserved for issuance and delivery under the Plan, (B) the various maximum limitations set forth in Sections 6(a) and 6(b) upon certain types of Awards and upon the grants to individuals of certain types of Awards, (C) the number and kind of Shares or other securities subject to outstanding Awards and (D) the exercise price of outstanding Awards.
(ii)    In the case of Corporate Events, such adjustments may include, without limitation, (A) the cancellation of outstanding Awards in exchange for payments of cash,
10


securities or other property or a combination thereof having an aggregate value equal to the value of such Awards, as determined by the Committee or the Board in its sole discretion (it being understood that in the case of a Corporate Event with respect to which Shareholders receive consideration other than publicly traded equity securities of the ultimate surviving entity, any such determination by the Committee that the value of an Option or Stock Appreciation Right shall for this purpose be deemed to equal the excess, if any, of the value of the consideration being paid for each Share pursuant to such Corporate Event over the exercise price of such Option or Stock Appreciation Right shall conclusively be deemed valid), and (B) the substitution of securities or other property (including, without limitation, cash or other securities of the Company and securities of entities other than the Company) for the Shares subject to outstanding Awards.
(iii)    In connection with any Disaffiliation, separation, spinoff, or other similar event, the Committee or the Board may arrange for the assumption of Awards, or replacement of Awards with new awards based on securities or other property (including, without limitation, other securities of the Company and securities of entities other than the Company), by the affected Affiliate or business division or by the entity that controls such Affiliate or business division following such event (as well as any corresponding adjustments to Awards that remain based upon Company securities). Such replacement with new awards may include revision of award terms reflective of circumstances associated with the Disaffiliation, separation, spinoff or other similar event.
(iv)    The Committee may, in its discretion, adjust the Performance Goals applicable to any Awards to reflect any unusual or non-recurring events and other extraordinary items, impact of charges for restructurings, discontinued operations and the cumulative effects of accounting or tax changes, each as defined by generally accepted accounting principles or as identified in the Company’s financial statements, notes to the financial statements, management’s discussion and analysis or other Company filings with the Securities and Exchange Commission. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company or the applicable Affiliate, business division or other operational unit of, or the manner in which any of the foregoing conducts its business, or other events or circumstances render the Performance Goals to be unsuitable, the Committee may modify such Performance Goals or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and equitable.
    (e)    Section 409A. Notwithstanding the foregoing: (i) any adjustments made pursuant to Section 6(e) to Awards that are considered “deferred compensation” within the meaning of Section 409A of the Code shall be made in compliance with the requirements of Section 409A of the Code; (ii) any adjustments made pursuant to Section 6(e) to Awards that are not considered “deferred compensation” subject to Section 409A of the Code shall be made in such a manner as to ensure that after such adjustment, the Awards either (A) continue not to be subject to Section 409A of the Code or (B) comply with the requirements of Section 409A of the Code; and (iii) in any event, neither the Committee nor the Board shall have the authority to make any adjustments pursuant to Section 6(e) to the extent the existence of such authority would cause an Award that is not intended to be subject to Section 409A of the Code at the Grant Date to be subject thereto.
7.    Eligibility and Participation
    Awards may be granted under the Plan to Eligible Individuals.
11


8.    Options and Stock Appreciation Rights
    (a)    Options. An Option is a right to purchase a specified number of Shares at a specified price that continues for a stated period of time. All Options granted under the Plan shall be Nonqualified Options, and the Award Agreement for an Option shall indicate the Option is intended to be a Nonqualified Option.
    (b)    Stock Appreciation Rights. A Stock Appreciation Right is a right to receive upon exercise of the Stock Appreciation Right an amount in cash, Shares or both, in value equal to the product of (i) the excess of the Fair Market Value of one Share over the exercise price per Share subject to the applicable Stock Appreciation Right, multiplied by (ii) the number of Shares in respect of which the Stock Appreciation Right has been exercised. The applicable Award Agreement shall specify whether such payment is to be made in cash or Shares or both, or shall reserve to the Committee or the Participant the right to make that determination prior to or upon the exercise of the Stock Appreciation Right.
    (c)    Award Agreement. Each grant of an Option and Stock Appreciation Right shall be evidenced by an Award Agreement that shall specify the Grant Date, the exercise price, the term, vesting schedule, and such other provisions as the Committee shall determine.
(d)    Exercise Price; Not Less Than Fair Market Value. The exercise price per Share subject to an Option or Stock Appreciation Right shall be determined by the Committee and set forth in the applicable Award Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except as provided under Section 6(e) or with respect to Options or Stock Appreciation Rights that are granted in substitution of similar types of awards of a company acquired by the Company or an Affiliate or with which the Company or an Affiliate combines (whether in connection with a corporate transaction, such as a merger, combination, consolidation or acquisition of property or stock, or otherwise) to preserve the intrinsic value of such awards.
    (e)    Prohibition on Repricing; No Cash Buyouts. Except as provided in Section 6(e) relating to adjustments due to certain corporate events, the exercise price of outstanding Options or Stock Appreciation Rights may not be amended to reduce the exercise price of such Options or Stock Appreciation Rights, nor may outstanding Options or Stock Appreciation Rights be canceled in exchange for (i) cash, (ii) Options or Stock Appreciation Rights with an exercise price that is less than the exercise price of the original outstanding Options or Stock Appreciation Rights or (iii) other Awards, unless in each case such action is approved by the Company’s Shareholders.
    (f)    Prohibition on Reloads. Options or Stock Appreciation Rights shall not be granted under the Plan that contain a reload or replenishment feature pursuant to which a new Option or Stock Appreciation Right would be granted upon receipt or delivery of Shares to the Company in payment of the exercise price or any tax withholding obligation under any other stock option, stock appreciation right or other Award.
    (g)    Term. The term of each Option or Stock Appreciation Right granted under the Plan shall be determined by the Committee, in its sole discretion, provided, however, that such term shall not exceed 10 years.
12


(h)    Accelerated Expiration Date. Unless the Committee specifies otherwise in the applicable Award Agreement, an Option or Stock Appreciation Right granted under the Plan will expire upon the earliest to occur of the following:
(i)    The original expiration date of the Option or Stock Appreciation Right;
        (ii)    Death. The one-year anniversary of the Participant’s death;
        (iii)    Disability. The one-year anniversary of the Participant’s termination of employment with the Company and all Related Companies due to Disability;    
(iv)    Termination of Employment. The date of the Participant’s termination of employment with the Company and all Related Companies for any reason other than death or Disability; provided, however, that if the Participant is terminated by the Company other than for Cause or unsatisfactory performance, then 60 days following the Participant’s termination of employment.
(i)    Vesting.
(i)Generally. Options and Stock Appreciation Rights shall have a vesting period of not less than one year from the date of grant except with respect to the death, Disability, or involuntary termination (other than for Cause or unsatisfactory performance) of a Participant, the occurrence of a Change in Control as outlined in Section 12 of this Plan, or as may be required or otherwise be deemed advisable by the Committee, whether in connection with an Award granted through the assumption of, or substitution for, outstanding awards previously granted by a company acquired by the Company or any Affiliate or with which the Company or any Affiliate combines or otherwise. The Committee shall, prior to or at the time of grant, condition the grant or vesting of an Award of Options or Stock Appreciation Rights upon such terms as outlined in the Award Agreement, which may include terms regarding Retirement.

    (j)    Method of Exercise and Payment.
(i)    Generally. Subject to the provisions of this Section 8 and the terms of the applicable Award Agreement, Options and Stock Appreciation Rights may be exercised, in whole or in part, by giving written (including electronic) notice of exercise specifying the number of Shares as to which such Options or Stock Appreciation Rights are being exercised and paying, or making arrangements satisfactory to the Company for the payment of, all applicable taxes pursuant to Section 16(d).
(ii)    In the case of the exercise of an Option, such notice shall be accompanied by payment in full of the exercise price by (A) certified or bank check; (B) delivery of unrestricted Shares of the same class as the Shares subject to the Option already owned by the Participant (based on the Fair Market Value of the Shares on the date the Option is exercised), provided that the Shares have been held by the Participant for such period as may established by the Committee to comply with applicable law, or (C) such other method as the Committee shall permit in its sole discretion (including a broker-assisted cashless exercise or netting of Shares).
    (k)    No Shareholder Rights. A Participant shall have no right to dividends or any other rights as a Shareholder with respect to Shares subject to an Option or Stock Appreciation
13


Right until such Shares are issued to the Participant pursuant to the terms of the Award Agreement.
9.    Restricted Stock
    (a)    Nature of Awards and Certificates. Shares of Restricted Stock are actual Shares that are issued to a Participant subject to forfeiture under certain circumstances and shall be evidenced in such manner as the Committee may deem appropriate, including book-entry registration.
     (b)    Award Agreement. Each grant of Restricted Stock shall be evidenced by an Award Agreement that shall specify the Grant Date, the period of restriction, the number of shares of Restricted Stock, vesting schedule, and such other provisions as the Committee shall determine. The Committee may, prior to or at the time of grant, condition the grant or vesting of an Award of Restricted Stock upon (i) the continued service of the Participant, (Bii) the attainment of Performance Goals or (iii) the attainment of Performance Goals and the continued service of the Participant. The conditions for grant or vesting and the other provisions of Restricted Stock Awards (including, without limitation, any applicable Performance Goals) need not be the same with respect to each Participant.
(c)    Vesting.
(i)    Generally. Shares of Restricted Stock shall have a vesting period of not less than one year from the date of grant except with respect to the death, Disability, or involuntary termination (other than for Cause or unsatisfactory performance) of a Participant, the occurrence of a Change in Control as outlined in Section 12 of this Plan, or as may be required or otherwise be deemed advisable by the Committee, whether in connection with an Award granted through the assumption of, or substitution for, outstanding awards previously granted by a company acquired by the Company or any Affiliate or with which the Company or any Affiliate combines or otherwise. The Committee shall, prior to or at the time of grant, condition the grant or vesting of an Award of Restricted Stock upon such terms as outlined in the Award Agreement, which may include terms regarding Retirement.
For purposes of an Award to a non-executive director that is granted as of the date of the annual general meeting of the shareholders, a vesting period shall be deemed to be one year if it runs from the date of one annual general meeting of shareholders to the next annual general meeting of shareholders provided that such next meetings are at least 50 weeks apart.
(ii)     Accelerated Vesting. Unless the Committee specifies otherwise in the applicable Award Agreement in the event of the death, Disability or involuntary termination (other than for Cause or unsatisfactory performance) of a Participant, a Change in Control as outlined in Section 12 of this Plan, or special circumstances determined by the Committee, an Award of Restricted Stock shall vest as of the termination of employment.
    (d)    Restricted Shares Non-Transferrable. Subject to the provisions of the Plan and the applicable Award Agreement, during the Restriction Period, the Participant shall not be permitted to sell, assign, transfer, pledge or otherwise encumber Shares of Restricted Stock.
    (e)    Rights of a Shareholder. Except as otherwise provided in this Section 9 or in the applicable Award Agreement, the Participant shall have, with respect to the Shares of Restricted
14


Stock, all of the rights of a Shareholder of the Company holding the class or series of Shares that is the subject of the Restricted Stock, including, if applicable, voting and dividend rights.
    (f)    Dividends. Except as otherwise provided in the applicable Award Agreement, cash dividends with respect to the Restricted Stock will be currently paid to the Participant and, subject to Section 16(e) of the Plan, dividends payable in Shares shall be paid in the form of Restricted Stock of the same class as the Shares with which such dividend was paid, held subject to the vesting of the underlying Restricted Stock; provided, however, that no dividends shall be paid with respect to Restricted Stock that is subject to one or more Performance Goals unless and until the Committee has certified that the applicable Performance Goals for such award have been met. Dividends shall accrue at the same rate as cash dividends paid on the Shares and applied to the number of Shares that vest. Such dividend equivalents shall be paid to the Participant in cash at the time the Shares are delivered. If any Shares of Restricted Stock are forfeited, the Participant shall have no right to future cash dividends with respect to such Restricted Stock, withheld stock dividends or earnings with respect to such Shares of Restricted Stock.
    (g)    Delivery of Shares. If and when any applicable Performance Goals are satisfied and/or the Restriction Period expires without a prior forfeiture of the Shares of Restricted Stock, unrestricted Shares shall be delivered to the Participant as soon as administratively practicable.
    (h)    Termination of Service. Except as otherwise provided in the applicable Award Agreement or as provided in subsection (c)(ii) above, a Participant’s Shares of Restricted Stock shall be forfeited upon his or her Termination of Service.
10.    Restricted Stock Units
    (a)    Nature of Awards. Restricted Stock Units represent a contractual obligation by the Company to deliver a number of Shares, an amount in cash or a combination of Shares and cash equal to the specified number of Shares subject to the Award, or the Fair Market Value thereof, in accordance with the terms and conditions set forth in the Plan and any applicable Award Agreement.
    (b)    Award Agreement. Each grant of Restricted Stock Units shall be evidenced by an Award Agreement that shall specify the Grant Date, the period of restriction, the number of Restricted Stock Units, vesting schedule, and such other provisions as the Committee shall determine. The Committee may, prior to or at the time of grant, condition the grant or vesting of an Award of Restricted Stock Units upon (i) the continued service of the Participant, (ii) the attainment of Performance Goals or (iii) the attainment of Performance Goals and the continued service of the Participant. The conditions for grant or vesting and the other provisions of Restricted Stock Units (including, without limitation, any applicable Performance Goals) need not be the same with respect to each Participant.
(c)    Vesting.
(i)    Generally. Restricted Stock Units shall have a vesting period of not less than one year from the date of grant except with respect to the death, Disability, involuntary termination (other than for Cause or unsatisfactory performance) of a Participant, the occurrence of a Change in Control as outlined in Section 12 of this Plan, or as may be required or otherwise be deemed advisable by the Committee, whether in connection with an Award granted through the assumption of, or substitution for, outstanding awards previously granted by a company
15


acquired by the Company or any Affiliate or with which the Company or any Affiliate combines or otherwise. The Committee shall, prior to or at the time of grant, condition the grant or vesting of an Award of Restricted Stock Units upon such terms as outlined in the Award Agreement, which may include terms regarding Retirement.
For purposes of an Award to a non-executive director that is granted as of the date of the annual general meeting of the shareholders, a vesting period shall be deemed to be one year if it runs from the date of one annual general meeting of shareholders to the next annual general meeting of shareholders provided that such next meetings are at least 50 weeks apart.
(ii)     Accelerated Vesting. Unless the Committee specifies otherwise in the applicable Award Agreement, in the event of the death, Disability or involuntary termination (other than for Cause or unsatisfactory performance) of a Participant, a Change in Control as outlined in Section 12 of this Plan, or special circumstances determined by the Committee, an Award of Restricted Stock Units shall vest as of the termination of employment.
    (d)    Dividend Equivalents. The Committee may, in its discretion, provide for current or deferred payments of cash, Shares or other property corresponding to the dividends payable on the Shares (subject to Section 16(e) below), as set forth in an applicable Award Agreement; provided, however, that no such dividend equivalents shall be paid with respect to Restricted Stock Units that are subject to one or more Performance Goals unless and until the Committee has certified that the applicable Performance Goals for such award have been met. Dividend equivalents shall accrue at the same rate as cash dividends paid on the Shares and applied to the number of Shares that vest.  Such dividend equivalents shall be paid to the Participant in cash at the time the Shares are delivered. If a Participant’s Restricted Stock Units are forfeited, the Participant shall have no right to future dividend equivalents with respect to such Restricted Stock Units, withheld stock dividends or earnings with respect to such Restricted Stock Units.
    (e)    Termination of Service. Except as otherwise provided in the applicable Award Agreement or as provided in subsection (c)(ii) above, a Participant’s Restricted Stock Units shall be forfeited upon his or her Termination of Service.
    (f)    Payment. Except as otherwise provided in the applicable Award Agreement, Shares, cash or a combination of Shares and cash, as applicable, payable in settlement of Restricted Stock Units shall be delivered to the Participant as soon as administratively practicable after the date on which payment is due under the terms of an Award Agreement.
    (g)    No Shareholder Rights. Except as otherwise provided in the applicable Award Agreement, a Participant shall have no rights as a Shareholder with respect to Shares subject to Restricted Stock Units until such Shares are issued to the Participant pursuant to the terms of the Award Agreement.
11.    Other Stock-Based Awards
Other Stock-Based Awards may be granted under the Plan; provided, that any Other Stock-Based Awards that are Awards of Shares that are unrestricted or with a minimum vesting schedule of less than one year shall only be granted in lieu of other compensation due and payable to the Participant. Notwithstanding the foregoing, no more than 5% of the Shares authorized to grant under Section 6 may be granted with a minimum vesting of less than one year.
16


12.    Change in Control Provisions
The provisions of this Section 12 shall apply in the case of a Change in Control, unless otherwise provided in the applicable Award Agreement or any other provision of the Plan.
    (a)    Awards Not Assumed, Etc. in Connection with Change in Control. Upon the occurrence of a transaction that constitutes a Change in Control, if any Awards are not assumed, converted or otherwise equitably converted or substituted in a manner approved by the Committee, then such Awards shall vest immediately at 100 percent before the Change in Control.
    (b)    Awards Assumed, Etc. in Connection with Change of Control. Upon the occurrence of a transaction that constitutes a Change in Control, with respect to any Awards that are assumed, converted or otherwise equitably converted or substituted in a manner approved by the Committee, then, in the event of a Participant’s Termination of Service during the twenty-four (24) month period following such Change in Control, (x) by the Company other than for Cause or unsatisfactory performance, or (y) by the Participant for Good Reason:
(i)    each outstanding Award shall be deemed to satisfy any applicable Performance Goals at 100 percent as set forth in the applicable Award Agreement;
(ii)    any Options and Stock Appreciation Rights outstanding which are not then exercisable and vested shall become fully exercisable and vested. Any such Option or Stock Appreciation Right held by the Participant as of the date of the Change in Control that remain outstanding as of the date of such Termination of Service may thereafter be exercised until the earlier of the third anniversary of such Change in Control and the last date on which such Option or Stock Appreciation Right would have been exercisable in the absence of this Section 12(b) (ii) (taking into account the applicable terms of any Award Agreement);
(iii)    the restrictions and deferral limitations applicable to any Shares of Restricted Stock shall lapse and such Shares of Restricted Stock shall become free of all restrictions and become fully vested and transferable;
        (iv)    all Restricted Stock Units shall be considered to be earned and payable in full, and any deferral or other restriction shall lapse, and any Restriction Period shall terminate, and such Restricted Stock Units shall be settled in cash or Shares (consistent with the terms of the Award Agreement after taking into account the effect of the Change in Control transaction on the Shares) as promptly as is practicable; and
        (v)    subject to Section 14, the Committee may also make additional adjustments and/or settlements of outstanding Awards as it deems appropriate and consistent with the Plan’s purposes.
    (c)    409A Matters. Notwithstanding the foregoing, if any Award to a Participant who is subject to U.S. income tax is considered a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, this Section 12 shall apply to such Award only to the extent that its application would not result in the imposition of any tax or interest or the inclusion of any amount in income under Section 409A of the Code.
17


    (d)    Other. In the event of a Change in Control, the Committee may in its discretion and upon at least ten (10) days’ advance notice to the affected Participants, cancel any outstanding Awards and pay to the holders thereof, in cash or Shares, or any combination thereof, the value of such Awards based upon the price per Share received or to be received by other Shareholders of the Company as a result of the Change in Control.
13.    Section 16(b); Section 409A
    (a)    Section 16(b). The provisions of the Plan are intended to ensure that transactions under the Plan are not subject to (or are exempt from) the short-swing recovery rules of Section 16(b) of the Exchange Act and shall be construed and interpreted in a manner so as to comply with such rules.
Notwithstanding any other provision of the Plan to the contrary, if for any reason the appointed Committee does not meet the requirements of Rule 16b-3 of the Exchange Act, such noncompliance with the requirements of Rule 16b-3 of the Exchange Act shall not affect the validity of Awards, grants, interpretations or other actions of the Committee.
    (b)    Section 409A. It is the intention of the Company that any Award to a Participant who is subject to U.S. income tax that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code shall comply in all respects with the requirements of Section 409A of the Code to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder, and the terms of each such Award shall be interpreted, administered and deemed amended, if applicable, in a manner consistent with this intention. Notwithstanding the foregoing, neither the Company nor any of its Affiliates nor any of its or their directors, officers, employees, agents or other service providers will be liable for any taxes, penalties or interest imposed on any Participant, Beneficiary or other person with respect to any amounts paid or payable (whether in cash, Shares or other property) under any Award, including any taxes, penalties or interest imposed under or as a result of Section 409A of the Code. Notwithstanding any other provision of the Plan to the contrary, with respect to any Award to any Participant who is subject to U.S. income tax that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code:
(i)     any payments (whether in cash, Shares or other property) to be made with respect to the Award upon the Participant’s Termination of Service that would otherwise be paid within six months after the Participant’s Termination of Service shall be accumulated (without interest, to the extent applicable) and paid on the first day of the seventh month following the Participant’s Termination of Service if the Participant is a “specified employee” within the meaning of Section 409A of the Code (as determined in accordance with the uniform policy adopted by the Committee with respect to all of the arrangements subject to Section 409A of the Code maintained by the Company and its Affiliates);
(ii)    Each payment made under the Plan shall be treated as a separate payment and the right to a series of installment payments under the Plan is to be treated as a right to a series of separate payments; and
(iii)     unless otherwise determined by the Committee, any payment to be made with respect to an Award of Restricted Stock Units shall be delivered no later than 60 days after the date on which payment is due under the Award or as otherwise permitted
18


under Treasury Regulations section 1.409A-3(g) for any portion of the payment subject to a dispute.
14.    Amendment and Discontinuance
    (a)    Amendment and Discontinuance of the Plan. The Board or the Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which would materially impair the rights of a Participant with respect to a previously granted Award without such Participant’s consent, except such an amendment made to comply with applicable law or Applicable Exchange rule or to prevent adverse tax or accounting consequences to the Company or Participants.
    (b)    Amendment of Awards. Subject to Section 8(e), the Committee may unilaterally amend the terms of any Award theretofore granted, but no such amendment shall materially impair the rights of any Participant with respect to an Award without the Participant’s consent, except such an amendment made to cause the Plan or Award to comply with applicable law, Applicable Exchange rule or to prevent adverse tax or accounting consequences for the Participant or the Company or any of its Affiliates.
15.    Unfunded Status of Plan
It is currently intended that the Plan constitute an “unfunded” plan. The Committee may authorize the creation of trusts or other arrangements to meet the obligations created under the Plan to deliver Shares or make payments; provided, however, that unless the Committee otherwise determines, the existence of such trusts or other arrangements is consistent with the “unfunded” status of the Plan.
16.    General Provisions
    (a)    Conditions for Issuance. The Committee may require each person purchasing or receiving Shares pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the Shares without a view to the distribution thereof. The certificates or book entry for such Shares may include any legend or appropriate notation that the Committee deems appropriate to reflect any restrictions on transfer, and the Committee may take such other steps as it deems necessary or desirable to restrict the transfer of Shares issuable under the Plan to comply with applicable law or Applicable Exchange rules. Notwithstanding any other provision of the Plan or agreements made pursuant thereto, the Company shall not be required to issue or deliver Shares under the Plan unless such issuance or delivery complies with all applicable laws, rules and regulations, including the requirements of any Applicable Exchange or similar entity and the Company has obtained any consent, approval or permit from any federal, state or foreign governmental authority that the Committee determines to be necessary or advisable.
    (b)    Additional Compensation Arrangements. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting other or additional compensation arrangements for its employees.
    (c)    No Contract of Employment. Neither the Plan nor any Award Agreement shall constitute a contract of employment, and neither the adoption of the Plan nor the granting of any Award shall confer upon any employee any right to continued employment. Neither the Plan nor
19


any Award Agreement shall interfere in any way with the right of the Company or any Affiliate to terminate the employment of any employee at any time.
    (d)    Required Taxes; No Tax Gross Ups. No later than the date as of which an amount first becomes includible in the gross income of a Participant for federal, state, local or foreign income or employment or other tax purposes with respect to any Award under the Plan, such Participant shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Company, withholding obligations may be settled with Shares, including Shares that are part of the Award that gives rise to the withholding requirement, having a Fair Market Value on the date of withholding equal to the rate required to be withheld for tax purposes under applicable law, all in accordance with such procedures as the Committee establishes. The obligations of the Company under the Plan shall be conditional on such payment or arrangements, and the Company and its Affiliates shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to such Participant. The Committee may establish such procedures as it deems appropriate, including making irrevocable elections, for the settlement of withholding obligations with Shares. Regardless of any arrangements made by the Company, any Affiliate or the Committee with respect to the withholding or other payment of any federal, state, local or foreign taxes of any kind, the liability for all such taxes legally due from a Participant remains the responsibility of the Participant. By accepting an Award, a Participant consents to the methods of tax withholding established by the Committee or otherwise made or arranged by the Company.
    (e)    Limitation on Dividend Reinvestment and Dividend Equivalents. Reinvestment of dividends in additional Restricted Stock at the time of any dividend payment, and the payment of Shares with respect to dividend equivalents to Participants holding Awards of Restricted Stock Units, shall only be permissible if sufficient Shares are available under Section 6 for such reinvestment or payment (taking into account then outstanding Awards). In the event that sufficient Shares are not available for such reinvestment or payment, then in the Committee’s discretion such payment shall be settled in cash.
    (f)    Rights of a Beneficiary. Any amounts payable and any rights exercisable under an Award after a Participant’s death shall be paid to and exercised by the Participant’s Beneficiary, except to the extent prohibited by applicable law, Applicable Exchange rule or the terms of an applicable Award Agreement.
    (g)    Affiliate Employees. In the case of a forfeiture or cancellation of an Award to an employee of any Affiliate, all Shares underlying such Awards shall revert to the Company.
    (h)    Governing Law and Interpretation. The Plan and all Awards made and actions taken thereunder shall be governed by and construed in accordance with the laws of the State of Georgia, without reference to principles of conflict of laws. The captions of the Plan are not part of the provisions hereof and shall have no force or effect.
    (i)    Non-Transferability. Awards under the Plan cannot be sold, assigned, transferred, pledged or otherwise encumbered other than by will or the laws of descent and distribution, except as provided in Section 6(f).
    (j)    Foreign Employees and Foreign Law Considerations. The Committee may grant Awards to Eligible Individuals who are foreign nationals, who are employed outside the United
20


States or who are not compensated from a payroll maintained in the United States, or who are otherwise subject to (or could cause the Company to be subject to) tax, legal or regulatory provisions of countries or jurisdictions outside the United States, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to foster and promote achievement of the purposes of the Plan. Notwithstanding any other provision of the Plan, Awards to Participants who are employed and/or otherwise subject to the laws of a jurisdiction outside of the United States shall be subject to such terms and conditions as the Committee shall establish and set forth in an applicable Award Agreement, including any addendum thereto and the Committee may adopt such procedures, subplans and forms of Award Agreement as it determines to be necessary or appropriate to facilitate Plan administration with respect to Participants performing services in such jurisdictions.
    (k)    Use of English Language. The Plan, each Award Agreement, and all other documents, notices and legal proceedings entered into, given or instituted pursuant to an Award shall be written in English, unless otherwise determined by the Committee. If a Participant receives an Award Agreement, a copy of the Plan or any other documents related to an Award translated into a language other than English, and if the meaning of the translated version is different from the English version, the English version shall control.
    (l)    Recovery of Amounts Paid. All Awards granted under the Plan, and any proceeds received therefrom, shall be subject to forfeiture and/or repayment to the Company under the terms of each compensation recovery or recoupment policy adopted by the Company, including but not limited to the Invesco Ltd. Policy for Recoupment of Incentive Compensation. The Committee may apply each such policy to Awards granted before such policy is adopted to the extent required by applicable law or Applicable Exchange rule or as otherwise provided by such policy.
    (m)    Notices. A notice or other communication to the Committee shall be valid only if given in the form and to the location specified by the Committee.
21

 EX-10.2 3 ivz1q2024ex102.htm EX-10.2 Document
Exhibit 10.2



Invesco Ltd. Deferred Incentive Plan
(Amended and Restated Effective February 28, 2024)
1.    Purposes
The Company has established the Plan, formerly known as the Invesco Short-Term Incentive Plan, to (i) promote the success of the Company by aligning the interests of investment professionals and other employees with the interests of the Company’s shareholders and investors, (ii) provide such employees with an incentive for outstanding performance at both the Company level and the fund level and (iii) enhance the Company’s ability to motivate, attract and retain such employees.

2.    Effective Date of Restatement
This amendment and restatement is effective with respect to Awards granted on or after February 28, 2024.
3.    Definitions
    Except as otherwise specifically provided in an Investment Fund Agreement, each capitalized word, term or phrase used in the Plan shall have the meaning set forth in this Section 3 or, if not defined in this Section, the first place that it appears in the Plan.
    “Affiliate” means a corporation or other entity controlled by, controlling or under common control with, the Company; provided, however, that solely for purposes of determining whether a Participant has a Termination of Service that is a “separation from service” within the meaning of Section 409A of the Code, an “Affiliate” of a corporation or other entity means all other entities with which such corporation or other entity would be considered a single employer under Sections 414(b) or 414(c) of the Code.
    “Applicable Exchange” means the New York Stock Exchange or such other securities exchange as may at the applicable time be the principal market for the Shares or shares or units of any Investment Choice, as applicable.
“Award” means an award granted hereunder that shall consist of an Investment Fund Award and/or an Invesco Stock Award, and administered as set forth herein.
“Award Agreement” means a written document or agreement setting forth the terms and conditions of a specific Award and any addendum thereto.
    “Beneficiary” means the person(s) or trust(s) entitled by will or the laws of descent and distribution to receive any amounts payable or exercise any applicable rights under the Participant’s Award(s) after the Participant’s death.
    “Board” means the Board of Directors of the Company.
    “Cause” means, with respect to a Participant, (i) if such Participant is a party to an Individual Agreement at the time of the Termination of Service that defines such term (or word(s) of similar meaning), the meaning given in such Individual Agreement or (ii) if there is no such Individual Agreement or if it does not define Cause (or word(s) of similar meaning): (A) the Participant’s plea of guilty or nolo contendere to, or conviction of, (1) a felony (or its equivalent in a non-United States jurisdiction) or (2) other conduct of a criminal nature that has or is likely to have an adverse effect on the reputation or standing in the community of the Company or any of its Affiliates, as determined by the Committee in its sole discretion, or that legally prohibits the Participant from working for the Company
1

or any of its Affiliates; (B) a breach by the Participant of a regulatory rule that adversely affects the Participant’s ability to perform the Participant’s employment duties to the Company or any of its Affiliates in any material respect; (C) the Participant’s failure, in each case in any material respect, to (1) perform the Participant’s employment duties, (2) comply with the applicable policies, codes of conduct or employee manuals of the Company or any of its Affiliates, (3) follow reasonable directions received from the Company or any of its Affiliates or (4) comply with covenants contained in any Individual Agreement or Investment Fund Agreement to which the Participant is a party; or (D) with respect to Participants employed outside the United States, such other definition as may be codified under local laws, rules and regulations. With respect to a Participant’s termination of directorship, “Cause” shall include only an act or failure to act that constitutes cause for removal of a director under the by-laws of the applicable Affiliate.
    “Change in Control” means any of the following events:
        (i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of twenty-five percent (25%) or more of either (A) the then outstanding shares of the Company (the “Outstanding Company Shares”) or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute a Change in Control: (1) any acquisition directly from the Company; (2) any acquisition by the Company; (3) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company; or (4) any acquisition pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (iii) below; or
        (ii)    during any period of twelve (12) consecutive months, individuals who, as of January 1, 2024, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to January 1, 2024 whose election, or nomination for election by the Company’s Shareholders, was approved by a vote of at least two-thirds (2/3) of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
        (iii)    consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets of another entity (each, a “Corporate Transaction”), in each case, unless, following such Corporate Transaction, (A) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Shares and Outstanding Company Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or indirectly, more than fifty percent (50%) of, respectively, the then outstanding shares and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or other entity resulting from such Corporate Transaction (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction of the Outstanding Company Shares and Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan or related trust of the Company or of such corporation resulting from such Corporate Transaction) beneficially owns, directly or indirectly, twenty-five (25%) or more of, respectively, the then outstanding shares of the corporation resulting from such Corporate Transaction or the combined voting power of the then outstanding voting securities of such
1

corporation except to the extent that such ownership existed prior to the Corporate Transaction and (C) at least a majority of the members of the board of directors of the corporation (or other governing board of a non-corporate entity) resulting from such Corporate Transaction were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Corporate Transaction; or
        (iv)    approval by the Shareholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, an event described above shall be a Change in Control with respect to an Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code only if such event is also a change in the ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company within the meaning of Section 409A of the Code to the extent necessary to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder.
    “Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time, and any successor thereto, the Treasury Regulations thereunder and other relevant interpretive guidance issued by the U.S. Internal Revenue Service or the U.S. Treasury Department. Reference to any specific section of the Code shall be deemed to include such regulations and guidance, as well as any successor section, regulations and guidance.
    “Committee” means the Compensation Committee of the Board or such other committee or subcommittee of the Board as may be appointed by the Board to act as the Committee under the Plan. If at any time there is no such Compensation Committee or other committee or subcommittee appointed by the Board, the Board shall be the Committee. The Committee shall consist of two or more directors, each of whom is intended to be, to the extent required by Rule 16b-3 of the Exchange Act, a “non-employee director” as defined in Rule 16b-3 of the Exchange Act. Any member of the Committee who does not meet the foregoing requirements shall abstain from any decision regarding an Award and shall not be considered a member of the Committee to the extent required to comply with Rule 16b-3 of the Exchange Act.
    “Company” means Invesco Ltd., a Bermuda exempted company.
    “Corporate Event” means a merger, consolidation, stock rights offering, liquidation, separation, spinoff, reorganization, Disaffiliation or other similar event affecting the Company or any of its Affiliates.
    “Disability” means, with respect to a Participant, (i) a “disability” (or words of similar meaning) as defined in any Individual Agreement to which the Participant is a party at the relevant time or (ii) if there is no such Individual Agreement or it does not define “disability” (or words of similar meaning), (A) a permanent and total disability as determined under the Company’s long-term disability plan applicable to the Participant, (B) if there is no such plan applicable to the Participant, “Disability” as determined by the Committee in its sole discretion, or (C) with respect to Participants employed outside the United States, such other definition as may be codified under local laws, rules and regulations. The Committee may require such medical or other evidence as it deems necessary to judge the nature and permanency of the Participant’s condition. Notwithstanding the foregoing, with respect to any Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, “Disability” shall mean a “disability” as defined under Section 409A of the Code to the extent necessary to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder.
    “Disaffiliation” means an Affiliate’s or business division’s ceasing to be an Affiliate or business division for any reason (including, without limitation, as a result of a public offering, or a spinoff or sale by the Company, of the stock of the Affiliate or a sale of a business division of the Company and its Affiliates).
2

    “Eligible Individual” means an investment professional or other individual who is employed by the Company or an Affiliate.
    “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended from time to time, and any successor thereto. Reference to any specific section of the Exchange Act shall be deemed to include such regulations and guidance issued thereunder, as well as any successor section, regulations and guidance.
    “Fair Market Value” means (i) with respect to Shares, “Fair Market Value” as defined in the GEIP, and (ii) with respect to any Investment Choice other than Shares, unless otherwise determined by the Committee, the closing price of a share or unit of such Investment Choice on the Applicable Exchange on the Valuation Date or, if shares or units of such Investment Choice are not traded on the Applicable Exchange on such Valuation Date, then on the next preceding date on which the shares or units of such Investment Choice are traded, all as reported by such source as the Committee may select; provided, however, that if the shares or units of any Investment Choice are not listed on a national securities exchange as of any Valuation Date, the Fair Market Value of such Investment Choice as of such Valuation Date shall be determined by the Committee in its good faith discretion.
    “GEIP” means the Invesco Ltd. 2016 Global Equity Incentive Plan, or such other successor, replacement or alternative plan that the Company maintains from time to time and that the Committee designates for use in connection with this Plan
    “Good Reason” means, with respect to a Participant, (i) if such Participant is a party to an Individual Agreement at the time of the Termination of Service that defines such term (or word(s) of similar meaning), the meaning given in such Individual Agreement or (ii) if there is no such Individual Agreement or if it does not define Good Reason (or word(s) of similar meaning) during the 24-month period following a Change in Control, actions taken by the Company or any of its Affiliates resulting in a material negative change in the employment relationship of the Participant who is an officer or an employee including, without limitation:
        (i)    the assignment to the Participant of duties materially inconsistent with the Participant’s position (including status, titles and reporting requirements), authority, duties or responsibilities, or a material diminution in such position, authority, duties or responsibilities, in each case from those in effect immediately prior to the Change in Control;
        (ii)    a material reduction of the Participant’s aggregate annual compensation, including, without limitation, base salary and annual bonus opportunity, from that in effect immediately prior to the Change in Control but excluding, for the avoidance of doubt, a change that requires a Participant to forego one or more days of remote work and perform such work in person at a Company office;
        (iii)    a change in the Participant’s principal place of employment that increases the Participant’s commute by 40 or more miles or materially increases the time of the Participant’s commute as compared to the Participant’s commute immediately prior to the Change in Control; or
        (iv)    any other action or inaction that constitutes a material breach by the Company or an Affiliate of any Individual Agreement.
In order to invoke a Termination of Service for Good Reason, a Participant must provide written notice to the Company or Affiliate with respect to which the Participant is employed or providing services of the existence of one or more of the conditions constituting Good Reason within ninety (90) days following the Participant’s knowledge of the initial existence of such condition or conditions, specifying in reasonable detail the conditions constituting Good Reason, and the Company shall have thirty (30) days following receipt of such written notice (the “Cure Period”) during which it may remedy the condition. In the event that the Company or Affiliate fails to remedy the condition constituting Good
3

Reason during the applicable Cure Period, the Participant’s Termination of Service must occur, if at all, within ninety (90) days following such Cure Period in order for such termination as a result of such condition to constitute a Termination of Service for Good Reason.
    “Grant Date” means, with respect to an Investment Fund Award, the date established by the Committee as of which an amount allocated to an Investment Fund Award is first credited in the form of an Investment Choice to a Participant’s Investment Funds Account and, with respect to an Invesco Stock Award, the date of grant of such award under the GEIP.
    “Individual Agreement” means a written employment, consulting or similar agreement between a Participant and the Company or one of its Affiliates.
“Invesco Stock Award” means an award of restricted stock or restricted stock units under the GEIP.
“Investment Choice” means the fund, trust, ETF, company stock or similar investment vehicle in which a Participant’s Investment Funds Account is notionally invested. The Committee shall designate the Investment Choices available with respect to each Award.

“Investment Fund Agreement” means the written document or agreement setting forth the terms and conditions of an Investment Fund Award and any addendum thereto.
“Investment Fund Award” means the right to a payment of certain amounts credited to a Participant’s Investment Funds Account, subject to the terms and conditions of the Plan, and any Investment Fund Agreement.

“Investment Funds Account” means the account maintained by the Company for each Participant, which reflects the Participant’s Investment Fund Award(s) and any adjustments thereto.

    “Participant” means an Eligible Individual who has been granted an Award and who has accepted the terms and conditions of the Plan and any applicable Investment Fund Agreement and, with regard to Awards that have been allocated to an Invesco Stock Award, who has accepted the terms and conditions of the GEIP or any related agreement, as appropriate.
    “Payment Date” means the date an Investment Fund Award is distributed and paid in accordance with the conditions established by the Committee or otherwise provided in the Investment Fund Agreement.
    “Performance Goals” means the performance goals, if any, established by the Committee in connection with the grant of an Investment Fund Award. The manner in which such Performance Goals are calculated or measured shall be determined by the Committee in its sole discretion.
“Plan” means the Invesco Ltd. Deferred Incentive Plan, formerly known as the Invesco Short-Term Incentive Plan, as set forth herein and as amended from time to time.
“Share” or “Shares” means common shares, par value $0.20 each, of the Company.
“Shareholder” has the same meaning as the term “Member” in the Companies Act 1981 of Bermuda.
    “Termination of Service” means the termination of the Participant’s employment with, or performance of services for, the Company and any of its Affiliates. For Participants employed outside the United States, the date on which such Participant incurs a Termination of Service shall be the earlier of (i) the last day of the Participant’s active service with the Company and its Affiliates or (ii) the last day on which the Participant is considered an employee of the Company and its Affiliates, as determined in each case without including any required advance notice period and irrespective of the status of the
4

termination under local labor or employment laws. Temporary absences from employment because of illness, vacation or approved leave of absence and transfers among the Company and its Affiliates shall not be considered Terminations of Service. With respect to any Award that constitutes a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, “Termination of Service” shall mean a “separation from service” as defined under Section 409A of the Code to the extent required by Section 409A of the Code to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder. A Participant has a separation from service within the meaning of Section 409A of the Code if the Participant terminates employment with the Company and all Affiliates for any reason. A Participant will generally be treated as having terminated employment with the Company and all Affiliates as of a certain date if the Participant and the Company or Affiliate that employs the Participant reasonably anticipate that the Participant will perform no further services for the Company or any Affiliate after such date or that the level of bona fide services that the Participant will perform after such date (whether as an employee or an independent contractor) will permanently decrease to no more than 20% of the average level of bona fide services performed (whether as an employee or an independent contractor) over the immediately preceding 36-month period (or the full period of service if the Participant has been providing services for fewer than 36 months); provided, however, that the employment relationship is treated as continuing while the Participant is on military leave, sick leave or other bona fide leave of absence if the period of leave does not exceed six (6) months or, if longer, so long as the Participant retains the right to reemployment with the Company or any Affiliate.
    “Valuation Date” means any date as of which an Investment Choice can be valued reliably, as determined by the Committee in its sole discretion.
    “Vesting Date” means the date an Investment Fund Award becomes vested in accordance with the vesting conditions established by the Committee or as otherwise provided in the Investment Fund Agreement.
4.    Administration
    (a)    Committee. The Plan shall be administered by the Committee, which shall have the authority set forth herein.
(b)    Authority. Among other things, the Committee in its sole discretion, acting in its dual capacity as the Committee under this Plan and the Committee under the GEIP, shall have the authority, subject to the terms and conditions of the Plan:
        (i)    to select the Eligible Individuals to whom Awards shall be made from time to time;
        (ii)    to determine the allocation of potential Awards to Investment Fund Awards and, if applicable, Invesco Stock Awards or to permit Eligible Individuals to allocate such amounts between Investment Fund Awards and, if applicable, Invesco Stock Awards, and to determine the allocation of Investment Fund Awards to Investment Choices selected by the Committee or to permit Eligible Individuals to allocate Investment Fund Awards to the Investment Choices made available by the Committee;
(iii)    to determine whether and to what extent Awards are to be granted hereunder;
(iv)     to determine the terms and conditions of Awards, including but not limited to the form of settlement of Awards, based on such factors as the Committee shall determine, and to approve the form of Award Agreement and any related addendum;
        (v)    to adopt sub-plans and special provisions applicable to Investment Fund Awards regulated by the laws of a jurisdiction outside of the United States, which sub-plans and special provisions may take precedence over other provisions of the Plan, and to approve the form of
5

Investment Fund Agreement and any related addendum as may be applicable to such Investment Fund Awards;
        (vi)    to modify, amend or adjust the terms and conditions of any Award or Investment Fund Agreement (subject to Section 10 hereof), including any Performance Goals, as set forth in the Plan;
        (vii)    to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it shall from time to time deem advisable;
        (viii)    to interpret the terms and provisions of the Plan and any Award or Investment Fund Agreement;
        (ix)    subject to Section 9, to accelerate or extend the vesting, lapse of restrictions or payment date applicable to any Investment Fund Award, based in each case on such considerations as the Committee determines;
        (x)    to determine whether, to what extent and under what circumstances cash or other property payable with respect to an Award shall be deferred either automatically or at the election of the Participant;
        (xi)    to establish any “blackout” period that the Committee deems necessary or advisable;
        (xii)    to decide all other matters to be determined in connection with any Award under the Plan; and
        (xiii)    to otherwise administer the Plan.
    (c)    Delegation of Authority. To the extent permitted under applicable law and, with respect to any Invesco Stock Award, the GEIP, the Committee may delegate its authority under the Plan to any person or persons selected by the Committee, including one or more members of the Committee, and any person or persons to whom such authority is delegated shall be deemed to be the Committee with respect to, and to the extent of, its or their authority.
    (d)    Procedures.
(i)    The Committee may act by a majority of its members then in office and through any person or persons to whom it has delegated its authority under Section 4(c), except to the extent otherwise provided in the GEIP with respect to an Invesco Stock Award.
        (ii)    Except to the extent otherwise provided in the GEIP with respect to an Invesco Stock Award, any authority granted to the Committee may also be exercised by the full Board, and to the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action shall control.
    (e)    Discretion of Committee and Binding Effect. Any determination made by the Committee or an appropriately delegated person or persons with respect to the Plan or any Award (including, without limitation, any determination involving the appropriateness or equitableness of any action) shall be made in the sole discretion of the Committee or such delegate, unless in contravention of any express term of the Plan. All decisions made by the Committee or any appropriately delegated person or persons shall be final and binding on all persons, including the Company, Eligible Individuals and Participants. Notwithstanding the foregoing, following a Change in Control, any determination by the Committee as to whether “Cause” or “Good Reason” exists shall be subject to de novo review.
6

    (f)    Cancellation or Suspension. Notwithstanding any other terms of the Plan, an Investment Fund Agreement or an Award, the Committee or an appropriately delegated person or persons in its or their sole discretion shall have the full power and authority to determine whether, to what extent and under what circumstances any outstanding Award or any portion thereof shall be cancelled or suspended and may cancel or suspend any Award or any portion thereof. Without in any way limiting the generality of the preceding sentence, the following are examples, without limitation, of when all or any portion of an outstanding Award to any Participant may be canceled or suspended: if the Participant (1) in the sole discretion of the Committee or any appropriately delegated person or persons, materially breaches (A) any duties of Participant’s employment (whether express or implied), including without limitation Participant’s duties of fidelity, good faith and exclusive service, (B) any general terms and conditions of Participant’s employment such as an employee handbook or guidelines, (C) any policies and procedures of the Company or any of its Affiliates applicable to the Participant, or (D) any other agreement regarding Participant’s employment with the Company or any of its Affiliates, or (2), without the prior written explicit consent of the Committee or any appropriately delegated person or persons (which consent may be granted or denied in the sole discretion of the Committee or such person or persons), while employed by, or providing services to, the Company or any of its Affiliates or after a Termination of Service, becomes associated with, employed by, renders services to, or owns any interest in (other than any nonsubstantial interest, as determined by the Committee or any appropriately delegated person or persons in its or their sole discretion), any business that is in competition with the Company or any of its Affiliates or with any business in which the Company or any of its Affiliates has a substantial interest, as determined by the Committee or any appropriately delegated person or persons in its or their sole discretion, or (3) as a result of the application to an Award of any compensation recovery or recoupment policy or policies adopted by the Company, including but not limited to the Invesco Ltd. Policy for Recoupment of Incentive Compensation.
(g)    Award Agreement. The terms and conditions of each Investment Fund Award under the Plan, as determined by the Committee, shall be set forth in writing (including electronically), shall be issued in the name of the Company or the Affiliate that employs the Participant and shall be delivered to a Participant receiving an Investment Fund Award upon, or as promptly as is reasonably practicable following, the grant of such Investment Fund Award. Unless otherwise specified by the Committee, in its sole discretion, or otherwise provided in an Investment Fund Award or an Investment Fund Agreement, an Investment Fund Award shall not be effective unless the related Investment Fund Agreement is signed or otherwise accepted by the Participant receiving the Investment Fund Award (including by electronic means). The Committee, in its sole discretion, may deliver any documents related to an Investment Fund Award by electronic means. Investment Fund Agreements may be amended only in accordance with Section 10. Awards that are allocated to Invesco Stock Awards shall be administered under the GEIP.
5.    Eligibility and Elections
    (a)    Eligibility. The Committee, in its sole discretion, shall determine and designate the Eligible Individuals who shall receive Awards and shall make Awards. An Eligible Individual shall become a Participant in the Plan upon the Eligible Individual’s acceptance of the terms and conditions of the Plan and an Investment Fund Agreement or, in the case of an Invesco Stock Award, an award agreement issued pursuant to the GEIP. The Committee’s decision to grant an Award to an Eligible Individual shall not guarantee or give the Eligible Individual any right to receive a grant of an Award in the future.
(b)    Elections. Unless the Committee specifies the allocation of a potential Award between Investment Choices or to an Invesco Stock Award, an Eligible Individual shall, within the time period prescribed by the Committee, elect the Investment Choices in which the Participant’s Investment Fund Award will be deemed invested (in one percent (1%) increments), if applicable.
An Eligible Individual’s election under this Section 5(b) shall be irrevocable and non-amendable, except as specifically provided by the Committee. If an Eligible Individual fails to make such allocation
7

in a timely manner, the entire amount will be allocated solely to a cash or a cash equivalent, unless the Committee specifies that the amount will be allocated in a different manner.
An Investment Fund Award shall be administered in accordance with and subject to the terms and conditions of this Plan and the applicable Investment Fund Agreement. An Invesco Stock Award shall be administered in accordance with and subject to the GEIP and the applicable stock award agreement.
6.    Investment Fund Awards
(a)    Grant of Investment Fund Awards and Credits to Investment Funds Accounts. Upon a Participant’s acceptance of the terms and conditions of the Plan and an Investment Fund Agreement, an Investment Fund Award shall be effective as of the Grant Date determined by the Committee, and the Participant’s Investment Funds Account shall be credited with the Investment Fund Award as of the Grant Date.

(b)    Investment Choice Allocation. Amounts credited to a Participant’s Investment Funds Account shall be deemed invested in one percent (1%) increments in one or more of the Investment Choices made available under the Plan. Except as otherwise permitted by the Committee in its sole discretion, a Participant may not amend, alter or otherwise reallocate the Investment Choices designated by a Participant pursuant to Section 5(b).

(c)    Investment and Valuation of Investment Funds Account. Any portion of an Investment Fund Award allocated to an Investment Choice shall be denominated in shares or units of such investment by dividing the applicable cash amount by the Fair Market Value of a share or unit in the applicable Investment Choice as of the Grant Date, and if required for record keeping purposes or otherwise applicable, rounding down to the nearest whole number of such shares or units. Unless otherwise determined by the Committee, as of the time of any payment of a cash dividend with respect to shares or units of an Investment Choice deemed held in a Participant’s Investment Fund Account, the number of shares or units deemed held shall be adjusted by crediting a number of shares or units equal to (i) the cash amount of the aggregate dividends that would be payable on the number of shares or units of the underlying Investment Choice deemed held immediately before the record date for the dividend, divided by (ii) the Fair Market Value of the shares or units of such Investment Choice on the date the dividend is paid. As of any Valuation Date, the Participant’s interest in each such investment shall be valued by multiplying the Fair Market Value of the Investment Choice as of such date by the number of shares or units deemed held in the underlying Investment Choice as of such date.
All allocations to an Investment Choice deemed credited to a Participant’s Investment Funds Account shall be wholly notional and shall be used solely to determine the amount payable to a Participant pursuant to Section 6(g). Neither the Company nor the Committee shall have any obligation to purchase shares or units in any Investment Choice unless and until payment is made to a Participant in shares or units of an Investment Choice.
(d)    Committee Discretion. The Committee shall have the sole discretion to determine the Investment Choices available to each Participant and may change, limit or eliminate an Investment Choice provided hereunder from time to time. If any Investment Choice ceases to be available under the Plan, the Committee shall have the authority to credit to any or all other then-available Investment Choices all amounts previously allocated to the terminated Investment Choice (along with deemed earnings, gains and losses and dividends relating thereto).

(e)    Investment Agreements. Unless otherwise determined by the Committee, amounts allocated to a Participant’s Investment Funds Account shall be subject to the terms and conditions provided in the Investment Fund Agreement in the form set forth and approved by the Committee from time to time.

8

(f)    Vesting and Payment. The Committee shall, prior to or at the time of grant, condition the vesting and payment of amounts credited to a Participant’s Investment Funds Account in respect of an Investment Fund Award upon (i) the continued service of the Participant, (ii) the attainment of Performance Goals or (iii) the attainment of Performance Goals and the continued service of the Participant. The conditions for vesting and the other provisions of an Investment Fund Award (including, without limitation, any applicable Performance Goals) need not be the same with respect to each Participant.

(g)    Payments. Except as otherwise provided in an Investment Fund Agreement, vested amounts from a Participant’s Investment Funds Account shall be paid by either the Company or the Affiliate that employs the Participant in a lump-sum cash payment at the time specified in the Investment Fund Agreement in an amount equal to the Fair Market Value of such vested portion on the Payment Date, or if the Payment Date is not a Valuation Date, the most recent preceding Valuation Date. Notwithstanding the foregoing, the Committee may provide in the Investment Fund Agreement that all or a portion of a Participant’s Investment Funds Account may be paid in the form of Investment Choice shares under such circumstances as the Committee shall determine in its sole discretion.

7.    Invesco Stock Awards
(a)    Invesco Stock Awards. Any amount of an Award allocated to Invesco Stock Awards pursuant to Section 5 shall be awarded in the form of restricted stock or restricted stock units, as determined by the Committee, under the GEIP. The number of Shares of restricted stock or restricted stock units granted pursuant to an Invesco Stock Award shall be determined by (i) dividing the amount allocated to the Invesco Stock Award by the Fair Market Value of the Shares on the Grant Date, and (ii) rounding down to the nearest whole number. All terms of an Invesco Stock Award, including vesting, time of payment, and the form of the grant or award agreement, shall be determined under or in accordance with the GEIP. For the avoidance of doubt, any allocations to an Invesco Stock Award shall be administered separately pursuant to the GEIP and a Participant’s Investment Funds Account shall be adjusted accordingly to reflect only allocations made to an Investment Choice.
(b)    Source of Shares. Invesco Stock Awards shall be issued under the GEIP by the Committee acting in its capacity as the Committee under the GEIP, subject to all of the terms and conditions of the GEIP and any applicable award agreement. This Plan does not constitute a separate source of Shares for the grant of the Invesco Stock Awards described herein.

8.    Change in Control Provisions
The provisions of this Section 8 shall apply in the case of a Change in Control, unless otherwise provided in the applicable Investment Fund Agreement or any other provision of the Plan.
    (a)    Investment Fund Awards Not Assumed, Etc. in Connection with Change of Control. Upon the occurrence of a transaction that constitutes a Change in Control, if any Investment Fund Award is not assumed, converted or otherwise equitably converted or substituted in a manner approved by the Committee, then such Investment Fund Award shall upon the Change in Control become fully vested and be paid or distributed, as applicable, as soon as administratively feasible.
    (b)    Investment Fund Awards Assumed, Etc. in Connection with Change of Control. Upon the occurrence of a transaction that constitutes a Change in Control, with respect to any Investment Fund Award that is assumed, converted or otherwise equitably converted or substituted in a manner approved by the Committee, then, in the event of a Participant’s Termination of Service during the 24 month period following such Change in Control, (x) by the Company other than for Cause or unsatisfactory performance, or (y) by the Participant for Good Reason each outstanding Investment Fund Award shall become fully vested and shall be paid or distributed, as applicable, as soon as administratively feasible.
    (b)    Other Corporate Events. In the case of a Corporate Event, the Committee or the Board may make such adjustments to any Investment Fund Award as the Committee or Board shall deem
9

appropriate, which may include, without limitation, (i) the cancellation of outstanding Investment Fund Awards in exchange for the payment of cash, securities or other property or a combination thereof having an aggregate value equal to the value of such Investment Fund Awards, as determined by the Committee or the Board in its sole discretion, and (ii) the substitution of securities or other property (including, without limitation, cash or other securities of the Company and securities of entities other than the Company) for any Investment Choice shares or units subject to outstanding Investment Fund Awards. In the event of any separation, spinoff, Disaffiliation or other similar event, the Committee or the Board may arrange for the assumption of Investment Fund Awards or the replacement of Investment Fund Awards with new awards based on securities or other property (including, without limitation, other securities of the Company and securities of entities other than the Company), by the affected Affiliate, or business segment or by the entity that controls such Affiliate, or business segment following such event (as well as any corresponding adjustments to Investment Fund Awards that remain based upon Company securities other than Shares).
(c)    Section 409A. Notwithstanding the foregoing, (i) if any Investment Fund Award to a Participant who is subject to U.S. income tax is considered a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, this Section 8 shall apply to such Investment Fund Award only to the extent that its application would not result in the imposition of any tax or interest or the inclusion of any amount in income under section 409A of the Code, and (ii) for any Investment Fund Award that is not considered a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code, any adjustments under Section 8(b) shall be made in such a manner as to ensure that after such adjustment, the Investment Fund Award either (A) continues not to be subject to Section 409A of the Code or (B) complies with the requirements of Section 409A of the Code; and (iii) in any event, neither the Committee nor the Board shall have the authority to make any adjustments pursuant to Section 8(b) to the extent the existence of such authority would cause an Investment Fund Award that is not intended to be subject to Section 409A of the Code at the Grant Date to be subject thereto.
9.    Section 409A
(a)    General Compliance. It is the intention of the Company that each Award made or granted under the Plan shall either be exempt from or comply in all respects with the requirements of section 409A of the Code to avoid the imposition of any tax or interest or the inclusion of any amount in income thereunder, and the terms of each such Award shall be interpreted, administered and deemed amended, if applicable, in a manner consistent with this intention. Notwithstanding the foregoing, neither the Company or any of its Affiliates, nor the Committee or any of its members, will be liable for any taxes, penalties or interest imposed on any Eligible Individual, Participant, Beneficiary or other person with respect to any amounts paid or payable (whether in cash or property) under any Award, including any taxes, penalties or interest imposed under or as a result of section 409A of the Code.
(b)    Specified Employees. Notwithstanding any other provision of the Plan, any Investment Fund Award or Investment Fund Agreement to the contrary, with respect to any Investment Fund Award that constitutes a “nonqualified deferred compensation plan” within the meaning of section 409A of the Code, any payments (whether in cash or other property) to be made with respect to the Investment Fund Award upon the Participant’s Termination of Service that would otherwise be paid within six (6) months after the Participant’s Termination of Service shall be accumulated (without interest, to the extent applicable) and paid on the first day of the seventh month following the Participant’s Termination of Service if the Participant is a “specified employee” within the meaning of section 409A of the Code (as determined in accordance with the uniform policy adopted by the Committee with respect to all of the arrangements subject to section 409A of the Code maintained by the Company and its Affiliates).
10.    Amendment and Discontinuance
    (a)    Amendment and Discontinuance of the Plan. The Board or the Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which would materially impair the rights of a Participant with respect to a previously granted Award without
10

such Participant’s consent, except such an amendment made to comply with applicable law or Applicable Exchange rule or to prevent adverse tax or accounting consequences to the Company or Participants. Notwithstanding the foregoing, no such amendment shall be made without the approval of the Company’s Shareholders to the extent such approval is required by applicable law or Applicable Exchange rule.
    (b)    Amendment of Investment Fund Awards. The Committee may unilaterally amend the terms of any Investment Fund Award theretofore granted or any related Investment Fund Agreement, but no such amendment shall materially impair the rights of any Participant with respect to such Investment Fund Award without the Participant’s consent, except such an amendment made to cause the Plan or such Investment Fund Award to comply with applicable law or an Applicable Exchange rule, to prevent adverse tax or accounting consequences for the Participant or the Company or any of its Affiliates or in accordance with Section 4(f).    
11.    Unfunded Status of Plan
It is currently intended that the Plan constitute an “unfunded” plan. The Committee may authorize the creation of trusts or other arrangements to meet the obligations created under the Plan to make payments; provided, however, that unless the Committee otherwise determines, the existence of such trusts or other arrangements is consistent with the “unfunded” status of the Plan.
12.    General Provisions
    (a)    Additional Compensation Arrangements. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting other or additional compensation arrangements for its employees.
    (b)    No Contract of Employment. Neither the Plan nor any Award shall constitute a contract of employment, and neither the adoption of the Plan nor the making or granting of any Award shall confer upon any employee any right to continued employment. Neither the Plan nor any Award shall interfere in any way with the right of the Company or any Affiliate to terminate the employment of any employee at any time.
    (c)    Required Taxes. No later than the date as of which an amount first becomes includible in the gross income of a Participant for U.S. federal, state, local or foreign income or employment or other tax purposes with respect to any Award under the Plan, such Participant shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any U.S. federal, state, local or foreign taxes of any kind required by law to be withheld with respect to such amount, unless otherwise determined by the Committee. The obligations of the Company under the Plan shall be conditional on such payment or arrangements, and the Company and its Affiliates shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to such Participant. The Committee may establish such procedures as it deems appropriate for this purpose. Regardless of any arrangements made by the Company, any Affiliate or the Committee with respect to the withholding or other payment of any U.S. federal, state, local or foreign taxes of any kind, the liability for all such taxes legally due from a Participant remains the responsibility of the Participant. By accepting an Award, a Participant consents to the methods of tax withholding established by the Committee or otherwise made or arranged by the Company.
    (d)    Rights of a Beneficiary. Any amounts payable and any rights exercisable under an Award after a Participant’s death shall be paid to and exercised by the Participant’s Beneficiary, except to the extent prohibited by applicable law, Applicable Exchange rule or the terms of an applicable Investment Fund Agreement.
    (e)    Governing Law and Interpretation. The Plan and Awards made and actions taken thereunder shall be governed by and construed in accordance with the laws of the State of Georgia,
11

without reference to principles of conflict of laws. The captions of the Plan are not part of the provisions hereof and shall have no force or effect.
    (f)    Non-Transferability. Awards cannot be sold, assigned, transferred, pledged or otherwise encumbered other than by will or the laws of descent and distribution, except as provided in Section 12(d).
    (g)    Foreign Employees and Foreign Law Considerations. The Committee may make Awards to Eligible Individuals who are foreign nationals, who are employed outside the United States or who are not compensated from a payroll maintained in the United States, or who are otherwise subject to (or could cause the Company to be subject to) tax, legal or regulatory provisions of countries or jurisdictions outside the United States, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to foster and promote achievement of the purposes of the Plan. Notwithstanding any other provision of the Plan, Awards to Participants who are employed and/or otherwise subject to the laws of a jurisdiction outside of the United States shall be subject to such terms and conditions as the Committee shall establish and set forth in an applicable Investment Fund Agreement, including any addendum thereto and the Committee may adopt such procedures and forms of Award Agreement as it determines to be necessary or appropriate to facilitate Plan administration with respect to Participants performing services in such jurisdictions.
    (h)    Use of English Language. The Plan, each Award or Investment Fund Agreement or, in the case of an Invesco Stock Award, an award agreement issued pursuant to the GEIP, and all other documents, notices and legal proceedings entered into, given or instituted pursuant to an Award shall be written in English, unless otherwise determined by the Committee. If a Participant receives a copy of the Plan, an Award or Investment Fund Agreement or, in the case of an Invesco Stock Award, an award agreement issued pursuant to the GEIP, or any other document related to an Award under the Plan that is translated into a language other than English, and if the meaning of the translated version is different from the English version, the English version shall control.
    (i)    Recovery of Amounts Paid. All Awards, including any Investment Choice shares issued under an Award, and any proceeds received therefrom, shall be subject to forfeiture and/or repayment to the Company under the terms of each compensation recovery or recoupment policy adopted by the Company, including but not limited to the Invesco Ltd. Policy for Recoupment of Incentive Compensation. The Committee may apply each such policy to Awards granted before such policy is adopted to the extent required by applicable law or Applicable Exchange rule or as otherwise provided by such policy.
    (j)    Notices. A notice or other communication to the Committee shall be valid only if given in the form and to the location specified by the Committee.

As adopted February 28, 2024


12

Appendix A
                Notwithstanding any other provision of the Plan or any Award or Investment Fund Agreement, any Awards that are regulated by the laws of a jurisdiction outside of the United States shall be subject to the terms and conditions of this Appendix A, as applicable, and any other terms and conditions established by the Committee and set forth in a Participant’s Award or Investment Fund Agreement, or, in the case of an Invesco Stock Award, an award agreement issued pursuant to the GEIP, including any addendum thereto, which may negate the provisions of Appendix A if so specifically provided therein.
                The Committee reserves the right to impose other requirements on any Award, any amounts or other property acquired pursuant to an Award and any Participant’s participation in the Plan to the extent the Committee determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the administration of the Plan.  Such requirements may include (but are not limited to) requiring a Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.



13

European Union

Compliance with Age Discrimination Rules.
    If a Participant is a local national of and employed in a country that is a member of the European Union, the grant of any Award and the terms and conditions governing each such Award are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the “Age Discrimination Rules”). To the extent a court or tribunal of competent jurisdiction determines that any provision of an Award is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Committee shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.

14
 EX-10.3 4 ivz1q2024ex103.htm EX-10.3 Document
Exhibit 10.3

image_02.jpg

INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT – PERFORMANCE VESTING
Non-transferable
Invesco Ltd. (“Company”)
hereby awards to
[Participant Name]
(“Participant” or “you”)
[Number of Shares Granted]
Restricted Stock Units (“Target Total Award”)
as of [Grant Date] (“Grant Date”)

Subject to the conditions of (i) the Invesco Ltd. 2016 Global Equity Incentive Plan as in effect from time to time (“Plan”), (ii) the Remuneration Policy of Invesco Ltd. or any of its Affiliates as in effect from time to time to the extent such policy is applicable to you (the “Remuneration Policy”), (iii) the Invesco Ltd. Policy for Recoupment of Incentive Compensation (the “Clawback Policy”) and (iv) this Award Agreement, the Company hereby grants to you the number of Restricted Stock Units (“RSUs”) set forth above, which shall become vested and non-forfeitable as follows:

On the third anniversary of the Grant Date (the “Determination Date”), the number of RSUs that shall become vested and non-forfeitable shall equal 100% of the Target Total Award multiplied by the Vesting Percentage (as defined in Exhibit 1), rounded down to the nearest full Share, all as calculated by the Committee in accordance with the Performance Vesting Formula set forth on Exhibit 1.

This Award shall be effective as of the Grant Date set forth above. By accepting this Award Agreement, you acknowledge that you have received a copy of the Plan’s prospectus, that you have read and understood the following Terms and Conditions, which are incorporated herein by reference, and that you agree to the following Terms and Conditions and the terms of the Plan, the Clawback Policy, the Remuneration Policy and this Award Agreement. If you fail to accept this Award Agreement within sixty (60) days after the Grant Date set forth above, the Company may determine that this Award has been forfeited.

ACCEPTED AND AGREED TO by the Participant as of the Grant Date set forth above.


Participant:
Signature


TERMS AND CONDITIONS – Restricted Stock Units – Performance Vesting
1. Plan Controls; Restricted Stock Units. In consideration of this Award, you hereby promise to abide by and to be bound by the Plan, the Remuneration Policy, the Clawback Policy and this Award Agreement, including the following terms and conditions, which serve as the agreed basis for your Award. The terms contained in the Plan, the Remuneration Policy, and the Clawback Policy are incorporated into and made a part of this Award Agreement, and this Award Agreement shall be governed by and construed in accordance with the Plan, the Clawback Policy and, if applicable, the Remuneration Policy. The RSUs represent a contractual obligation of the Company to deliver the number of Shares specified on page 1 hereof pursuant to the terms of Section 10 of the Plan and the additional terms and restrictions hereunder. Unless the context otherwise requires, and solely for purposes of these Terms and Conditions, the term “Company” means Invesco Ltd., its Affiliates and their respective successors and assigns, as applicable, and “Employer” means the Company or the Affiliate that employs you. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the Plan.

In the event of any conflict among the terms of the Clawback Policy, the Remuneration Policy, the Plan or this Award Agreement, the following hierarchy shall govern the resolution of such conflicts:
(a)Clawback Policy Control: To the extent of any inconsistency or conflict, the terms and conditions of the Clawback Policy shall take precedence and control over conflicting provisions in the Remuneration Policy, the Plan or this Award Agreement.
(b)In the absence of a conflict under the Clawback Policy, the terms and provisions of the Remuneration Policy shall prevail and control over conflicting provisions in the Plan or this Award Agreement.
(c)Should conflicts persist after applying the Clawback Policy and Remuneration Policy, the terms and provisions of the Plan shall, in turn, take precedence and control over conflicting provisions in this Award Agreement.
2. Restrictions and Forfeiture. The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered. Upon your Termination of Service for any reason, other than as set forth in paragraphs (b) – (e) of Paragraph 3 hereof, you shall forfeit all of your right, title and interest in and to all unvested RSUs, except as determined by the Committee pursuant to Paragraph 3.1 hereof. In addition, upon the Determination Date, you shall forfeit all of your right, title and interest in and to any RSUs which fail to vest on such date pursuant to the Performance Vesting Formula.
3. Vesting and Conversion to Shares. The Target Total Award will vest and become non-forfeitable upon the earliest to occur of the following (the “Vesting Date”):
(a)    the Determination Date, to the extent provided under the Performance Vesting Formula, if you have not experienced a Termination of Service before such date, or
(b)    as of your Termination of Service due to death or Disability, or
(c)    as of your involuntary Termination of Service, other than for Cause or unsatisfactory performance, as determined in the sole discretion by the SMD & Chief HR Officer, provided that you sign and do not revoke a severance agreement in the form stipulated by the Company, or
(d)    upon the occurrence of a Change in Control, if this Award Agreement is not assumed, converted or replaced in connection with the transaction that constitutes the Change in Control, or
(e)    your Termination of Service during the 24-month period following a Change in Control either (i) by the Company other than for Cause or unsatisfactory performance, or (ii) by
you for Good Reason, in either such case, as determined in the sole discretion by the SMD & Chief HR Officer, provided that you sign and do not revoke a severance agreement in the form stipulated by the Company.

3.1    Discretionary Vesting. If any or all of your RSUs would be forfeited upon your voluntary Termination of Service, you may appeal the forfeiture pursuant to the procedures established by the Committee, and the Committee, in its sole discretion, may vest some or all of such RSUs pursuant to the applicable guidelines adopted by the Committee.
3.2    Conversion and Payment. Unless the RSUs are forfeited on or before the Vesting Date, the RSUs will be converted into an equal number of Shares, which will be registered in your name as of the Vesting Date, and such Shares will be delivered as soon as practicable thereafter, but not later than March 15 of the year following the year in which the Vesting Date occurs if you are subject to U.S. federal income tax on such Shares. Notwithstanding anything in these Terms and Conditions or the Plan to the contrary, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares is prohibited under local law, rules and regulations, or would require the Company, the Employer and/or you to secure any legal or regulatory approvals, complete any legal or regulatory filings or is administratively burdensome.
4. No Shareholder Rights; Payment in Lieu of Dividends. You shall have none of the rights of a shareholder of the Company with respect to the RSUs.  Dividend equivalents shall accrue at the same rate as cash dividends paid on the Shares and applied to the number of Shares that vest.  Such dividend equivalents shall be paid to you in cash at the time the Shares are delivered to you, or as soon as administratively practicable thereafter, but not later than March 15 of the year following the year in which the Vesting Date occurs if you are subject to U.S. federal income tax on such dividends.  No dividends will be paid with respect to RSUs that are forfeited for any reason.
5. Notice Period Requirement. During your employment with the Employer, you and, in the absence of Cause, the Employer shall be required to give to the other advance written notice of the intent to terminate your employment relationship as set forth in (i) your Employment Agreement, or (ii) if you are based in the US or Canada your most recent time-based equity award agreement (the “Notice Period”). Your employment with the Employer shall not terminate until the expiration of the Notice Period, provided, however, that the Employer shall have the right, in its sole discretion, to relieve you of any or all of your duties and responsibilities by placing you on paid administrative leave during the Notice Period and shall not be required to provide you with work or access to the Employer's offices during such leave. You shall be entitled to continue to receive your salary and certain other employee benefits for the entire Notice Period, regardless of whether the Employer exercises its right to place you on paid administrative leave. You are prohibited from working in any capacity for yourself or any other business during the Notice Period without the prior written consent of the Company. Notwithstanding the foregoing, at any time during your employment relationship the Employer may, effective immediately and without the benefit of the Notice Period, terminate the employment relationship for Cause. The date on which your employment terminates shall be your “Termination Date” for purposes of this Award Agreement.
6. Employment Matters. You agree that this Award Agreement is entered into and is reasonably necessary to protect the Company’s investment in your advancement opportunity, training and development and to protect the goodwill and other legitimate business interests of the Company. You also agree that, in
- 2 -

consideration of the confidential information, trade secrets and training and development provided to you, you will abide by the restrictions set forth in this Paragraph 6, and you further agree and acknowledge that the restrictions set forth in this Paragraph 6 are reasonably necessary to protect the confidential and trade secret information provided to you.
6.1 Nondisclosure. You agree that, in the event of your Termination of Service for any reason, whether during or following the period when the RSUs are subject to vesting restrictions (the “Restriction Period”), you shall not directly or indirectly use for yourself or any other business or disclose to any person any Confidential Information (as defined below) without the prior written consent of the Company during the period that it remains confidential and non public or a trade secret under applicable law. “Confidential Information” means all non-public information (whether a trade secret or not and whether proprietary or not) relating to the Company’s business and its customers that the Company either treats as confidential or is of value to the Company or is important to the Company’s business and operations, including but not limited to the following specific items: trade secrets (as defined by applicable law); actual or prospective customers and customer lists; marketing strategies; sales; actual and prospective pricing; products; know-how; research and development; intellectual property; information systems and software; business plans and projections; negotiations and contracts; financial or cost data; employment, compensation and personnel information; and any other non-public business information regarding the Company and the Company’s Affiliates. In addition, trade secrets will be entitled to all of the protections and benefits available under applicable law.
6.2 Nonrecruitment; Nonsolicitation. You agree that during your employment with the Company and until six (6) months following your Termination Date, in the event of your Termination of Service for any reason, whether during or following the Restriction Period (the “Covenant Period”), you shall not directly or indirectly, individually or in concert with any other person or entity (i) recruit, induce or attempt to recruit or induce any employee of the Company with whom you worked or otherwise had Material Contact (as defined below) during your employment to leave the employ of the Company or otherwise lessen that party’s affiliation with the Company, or (ii) solicit, divert, take away or attempt to solicit, divert or take away any then-current or proposed client or customer of the Company with whom you had Material Contact during your employment for purposes of offering, providing or selling investment management products or services offered by the Company at the date of your Termination of Service that were offered, provided and/or sold by you on the Company’s behalf. For purposes of this provision, you had “Material Contact” with an employee if (i) you had a supervisory relationship with the employee or (ii) you worked or communicated with the employee on a regular basis; and you had “Material Contact” with a current or proposed client or customer if (i) you had business dealings with the current or proposed client or customer on behalf of the Company or (ii) you supervised or coordinated the dealings between the Company and the current or proposed client or customer.
6.3 Enforceability of Covenants. You acknowledge that the Company has a current and future expectation of business from the current and proposed customers of the Company. You acknowledge that the term and scope of the covenants set forth herein are reasonable, and you agree that you will not, in any proceeding, assert the unreasonableness of the premises, consideration or scope of the covenants set forth herein. You and the Company agree that if any portion of the foregoing covenants is deemed to be unenforceable because any of the restrictions contained in this Award Agreement are deemed too broad, the court shall be authorized to provide partial enforcement of such covenants, substitute an enforceable term or otherwise modify the
Award Agreement in a manner that will enable the enforcement of the covenants to the maximum extent possible under applicable law. You agree that any breach of these covenants will result in irreparable damage and injury to the Company and that the Company will be entitled to injunctive relief without the necessity of posting any bond. You also agree that you shall be responsible for all damages incurred by the Company due to any breach of the restrictive covenants contained in this Award Agreement and that the Company shall be entitled to have you pay all costs and attorneys’ fees incurred by the Company in enforcing the restrictive covenants in this Award Agreement.
7. Relationship to Other Agreements. Subject to the limitations set forth below, in the event of any actual or alleged conflict between the provisions of this Award Agreement and (i) any other agreement regarding your employment with the Employer (“Employment Agreement”), or (ii) any prior agreement or certificate governing any award of a direct or indirect equity interest in the Company (the documents described in clauses (i) and (ii) hereof being collectively referred to as the “Other Agreements”), the provisions of this Award Agreement shall control and, to the extent of any conflict, be deemed to amend such Other Agreements. Notwithstanding the foregoing, in the event that the Nondisclosure Period or Covenant Period referred to in Paragraph 6 of this Award Agreement is shorter in duration than that provided in an Employment Agreement, the Nondisclosure Period or Covenant Period (as applicable) set forth in the Employment Agreement shall apply.
8. Employee Data Privacy. Pursuant to applicable personal data protection laws, the Company hereby notifies you of the following in relation to your personal data and the collection, use, processing and transfer (collectively, the “Use”) of such data in relation to the Company’s grant of the RSUs and your participation in the Plan. The Use of your personal data is necessary for the Company’s administration of the Plan and your participation in the Plan. Your denial and/or objection to the Use of personal data may affect your participation in the Plan. As such, you voluntarily acknowledge, consent and agree (where required by applicable law) to the Use of personal data as described in this Paragraph 8.
The Company and the Employer hold certain personal information about you, which may include your name, home address and telephone number, date of birth, social security number or other employee identification number, salary, nationality, job title, any Shares held by you, details of all RSUs or any other entitlement to Shares awarded in your favor, for the purpose of managing and administering the Plan (“Data”). The Data may be provided by you or collected, where lawful, from the Company, Affiliates or third parties, and the Company or Employer will process the Data for the exclusive purpose of implementing, administering and managing your participation in the Plan. The data processing will take place through electronic and non-electronic means according to logics and procedures strictly correlated to the purposes for which Data are collected and with confidentiality and security provisions as set forth by applicable laws and regulations in your country of residence (and country of employment, if different). Data processing operations will be performed minimizing the use of personal and identification data when such data are unnecessary for the processing purposes sought. Data will be accessible within the Company’s organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and for your participation in the Plan.
The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Data to any third parties assisting the Company in the
- 3 -

implementation, administration and management of the Plan. These recipients may be located in the European Economic Area, or elsewhere throughout the world, such as the United States. You hereby authorize them to receive, possess, use, retain and transfer the Data, in electronic or other form, for purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on your behalf to a broker or other third party with whom you may elect to deposit any Shares acquired pursuant to the Plan.
You may, at any time, exercise your rights provided under applicable personal data protection laws, which may include the right to (a) obtain confirmation as to the existence of the Data, (b) verify the content, origin and accuracy of the Data, (c) request the integration, update, amendment, deletion, or blockage (for breach of applicable laws) of the Data, and (d) oppose, for legal reasons, the Use of the Data that is not necessary or required for the implementation, administration and/or operation of the Plan and your participation in the Plan. You may seek to exercise these rights by contacting your Employer’s human resources manager or Invesco, Ltd., Sr. Manager, Executive Compensation, 1331 Spring Street, NW, Atlanta, Georgia 30309.
9. Income Taxes and Social Insurance Contribution Withholding. Regardless of any action the Company or the Employer takes with respect to any or all income tax (including U.S. federal, state and local taxes and/or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and/or the Employer (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the settlement of the RSUs, the subsequent sale of any Shares acquired pursuant to the RSUs and the receipt of any dividends or dividend equivalents; and (ii) does not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.
If your country of residence (and/or the country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold a portion of the Shares otherwise issuable upon vesting of the RSUs that have an aggregate Fair Market Value on the vesting date sufficient to pay the minimum Tax-Related Items required to be withheld with respect to the Shares. For purposes of the foregoing, no fractional Shares will be withheld or issued pursuant to the grant of the RSUs and the issuance of Shares hereunder. Alternatively (or in combination), the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your regular salary or other amounts payable to you, with no withholding of Shares, or may require you to submit payment equivalent to the minimum Tax-Related Items required to be withheld with respect to the Shares by means of certified check, cashier’s check or wire transfer. By accepting the RSUs, you expressly consent to the methods of withholding as provided hereunder. All other Tax-Related Items related to the RSUs, and any Shares delivered in payment thereof shall be your sole responsibility. Further, if you become subject to taxation in more than one country between the Grant Date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that the Company may be required to withhold or account for Tax-Related Items in more than one country.
To the extent the Company or the Employer pays any Tax-Related Items that are your responsibility (“Advanced Tax Payments”), the Company or the Employer shall be entitled to recover such Advanced Tax Payments from you in any and all manner that the Company determines appropriate in its sole discretion. For
purposes of the foregoing, the manner of recovery of the Advanced Tax Payments shall include (but is not limited to) offsetting the Advanced Tax Payments against any and all amounts that may be otherwise owed to you by the Company or the Employer (including regular salary/wages, bonuses, incentive payments and Shares acquired by you pursuant to any equity compensation plan that are otherwise held by the Company for your benefit).
10. INTENTIONALLY OMITTED
11. Code Section 409A. The RSUs granted under this Award Agreement are not intended to constitute a nonqualified deferred compensation plan within the meaning of Section 409A of the Code, and the Plan and this Award Agreement shall be interpreted, administered and deemed amended, if applicable, in a manner consistent with this intention. Notwithstanding the terms of this Award Agreement, if you are subject to U.S. federal income tax on any amounts payable hereunder and if any such amounts, including amounts payable pursuant to Paragraph 5 hereof, constitute nonqualified deferred compensation under Section 409A of the Code, those amounts shall be subject to the provisions of Section 13(g) of the Plan (as if the amounts were Awards under the Plan, to the extent applicable).
12. Notice. Notices and communications under this Award Agreement must be in writing and either personally delivered or sent by registered or certified mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to Invesco Ltd., Sr. Manager, Executive Compensation, 1331 Spring Street, NW, Atlanta, Georgia 30309, or to any other address designated by the Company in a written notice to you. Notices to you will be directed to your address then currently on file with the Company, or to any other address given by you in a written notice to the Company.

13. Repatriation; Compliance with Laws. As a condition to the grant of these RSUs, you agree to repatriate all amounts attributable to the RSUs in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company, the Employer and the Company’s local Affiliates, as may be required to allow the Company, the Employer and the Company’s local Affiliates to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).

14. Discretionary Nature of Plan; No Vested Rights. You acknowledge and agree that the Plan is discretionary in nature and limited in duration, and may be amended, cancelled or terminated by the Company, in its sole discretion, at any time as provided under the Plan. The grant of the RSUs under the Plan is a one-time benefit and does not create any contractual or other right to receive RSUs or other awards or benefits in lieu of RSUs in the future. Future awards, if any, will be at the sole discretion of the Committee, including, but not limited to, the form and timing of an award, the number of Shares subject to an award and the vesting provisions.

15. Termination Indemnities. The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. As such, the RSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments to which you may be otherwise entitled.
- 4 -


16. Compliance with Age Discrimination Rules. For purposes of this Award Agreement, if you are a local national of and employed in a country that is a member of the European Union, the grant of the RSUs and the terms and conditions governing the RSUs are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the “Age Discrimination Rules”). To the extent a court or tribunal of competent jurisdiction determines that any provision of the RSUs or this Award Agreement or the Plan is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.

17. Use of English Language. You acknowledge and agree that it is your express intent that this Award Agreement, the Plan and all other documents, notices and legal proceedings entered into, given or instituted with respect to the RSUs be drawn up in English. If you have received this Award Agreement, the Plan or any other documents related to the RSUs translated into a language other than English, and if the meaning of the translated version is different from the English version, the English version shall control.

18. Addendum to Award Agreement. Notwithstanding any provisions in this Award Agreement to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different), as may be set forth in an addendum to this Award Agreement (“Addendum”). Further, if you transfer residency and/or employment to another country as may be reflected in an Addendum to this Award Agreement, the special terms and conditions for such country will apply to your RSUs to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan. Any applicable Addendum shall constitute part of this Award Agreement.

19. Additional Requirements. The Company reserves the right to impose other requirements on the Award and your participation in the Plan, to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the Award and the Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

20. Electronic Delivery. The Committee may, in its sole discretion, decide to deliver any documents related to the RSUs by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. Further, to the extent applicable, all references to signatures and delivery of documents in this Award Agreement can be satisfied by procedures that the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents, including this Award Agreement. Your electronic signature is the same as, and shall have the same force and effect as, your manual signature. Any such procedures and delivery may be effected by a third party engaged by the Company to provide administrative services related to the Plan.

2016 GEIP PSU Agreement (Feb 2024)
- 5 -

Exhibit 1
to the
Invesco Ltd. 2016 Global Equity Incentive Plan
Restricted Stock Unit Award Agreement – Performance Vesting

I.Definitions

The term “AOM Calculation” means the adjusted operating margin of the Company as set forth in the Company’s Form 10-K filed with the Securities and Exchange Commission for each fiscal year of the Grant Performance Measurement Period, which may be adjusted by the Committee in a manner that the Committee determines equitable and appropriate for extraordinary, unusual, infrequently occurring or non-recurring items (for example, but without limitation, acquisitions, dispositions, material financial market movements, changes in tax laws or accounting principles, or accruals for reorganization or restructuring programs) occurring during the Grant Performance Measurement Period.

The term “TSR Calculation” means the total shareholder return (“TSR”) of the Company and the peer group set forth in Section III below.

The term “Vesting Percentage” means the percentage by which the Target Total Award is multiplied as set forth in the chart in Section II below.

The term “Grant Performance Measurement Period” means the period commencing January 1 of the grant year and ending December 31 of the second year after the grant year.

The term “Grant Average AOM” means the sum of the AOM Calculation for each fiscal year of the Grant Performance Measurement Period divided by three.

The term “Relative TSR Ranking” means the percentile ranking of the TSR Calculation for the Grant Performance Measurement Period.

The term “Performance Vesting Formula” means the calculation described in Section II below.


II.Performance Vesting Formula

On the third anniversary of the Grant Date, the number of RSUs that shall become vested and non-forfeitable shall equal 100% of the Target Total Award multiplied by the Vesting Percentage associated with both the Grant Average AOM and Relative TSR Ranking on the chart below, rounded down to the nearest full Share, as the same shall be calculated by the Committee. The Committee’s good faith calculation of the number of RSUs that become vested and non-forfeitable pursuant to the Performance Vesting Formula shall be final and binding upon you and the Company. Vesting to range from 0% to 150%; straight line interpolation to be used for actual results of Grant Average AOM and Relative TSR Ranking.




Performance Share Vesting: 2024 to 2026 Performance Period
3 year Average AOMRelative TSR
     
Lowest40%ile55%ile75%ileHighest
≥34.0%100%116%133%142%150%
33.0%83%103%122%133%142%
31.0%67%90%111%123%133%
29.0%50%75%100%113%125%
27.0%33%58%83%100%117%
25.0%17%42%68%88%108%
≤24.0%
0%25%50%75%100%
      
Vesting percentages between the data points to be determined by straight line interpolation of 3-year Average AOM and Relative TSR.


III.Peer Group

For purposes of the TSR Calculation, the peer group shall consist of the following companies:

Alliance Bernstein
Bank of New York Mellon
BlackRock
Franklin Resources
Janus Henderson
Lazard
Northern Trust
State Street
T. Rowe Price

The Committee may, in its sole discretion, modify the peer group list to the extent it determines any companies on the list are no longer sufficiently representative for benchmarking purposes due to merger, acquisition or otherwise.




image_02.jpg

INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN

ADDENDUM TO

RESTRICTED STOCK UNIT AGREEMENT – PERFORMANCE VESTING
Non-transferable

In addition to the terms of the Invesco Ltd. 2016 Global Equity Incentive Plan (the “Plan”) and the Restricted Stock Unit Agreement – Performance Vesting (the “Agreement”), the performance-vesting RSUs are subject to the following additional terms and conditions as set forth in this addendum (the “Addendum”). All defined terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement. To the extent you relocate your residency and/or employment to another country, the additional terms and conditions as set forth in the addendum for such country (if any) also shall apply to the performance-vesting RSUs to the extent the Company determines, in its sole discretion, that the application of such addendum is necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the operation and administration of the performance-vesting RSUs and the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).

HONG KONG

1.    Settlement in Shares. Notwithstanding anything to the contrary in the Agreement, Addendum or the Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).

2.    Lapse of Restrictions. If, for any reason, Shares are issued to you within six (6) months of the Grant Date, you may not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Grant Date.

3.    Nature of the Plan. The Company specifically intends that the Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (“ORSO”). To the extent any court, tribunal or legal/regulatory body in Hong Kong determines that the Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSU shall be null and void.

4.    Wages. The RSUs and Shares subject to the RSUs do not form part of your wages for the purposes of calculating any statutory or contractual payments under Hong Kong law.

5.    IMPORTANT NOTICE. WARNING: The contents of the Agreement, the Addendum, the Plan, and all other materials pertaining to the RSUs and/or the Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.



UNITED KINGDOM

    1.    Income Tax and Social Insurance Contribution Withholding. The following provision shall replace Section 9 of the Agreement:

Regardless of any action the Company and the Employer takes with respect to any or all income tax, primary Class 1 National Insurance contributions, payroll tax or other tax-related withholding attributable to or payable in connection with or pursuant to the grant or vesting of any Restricted Shares or the release or assignment of any Restricted Shares for consideration, or the receipt of any other benefit in connection with the Restricted Shares (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility. Furthermore, the Company and the Employer: (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Restricted Shares, including the grant or vesting of the Restricted Shares, the subsequent sale of any unrestricted Shares and the receipt of any dividends or dividend equivalents; and (b) do not commit to structure the terms of the grant or any aspect of the Restricted Shares to reduce or eliminate your liability for Tax-Related Items.

As a condition of the lifting of restrictions on the Restricted Shares upon vesting of the Restricted Shares, the Company and/or the Employer shall be entitled to withhold and you agree to pay, or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy, all obligations of the Company and/or the Employer to account to HM Revenue & Customs (“HMRC”) for any Tax-Related Items. In this regard, you authorize the Company and/or the Employer to withhold all applicable Tax-Related Items legally payable by you from any salary/wages or any other cash compensation payable to you. Alternatively, or in addition, if permissible under local law, you authorize the Company and/or the Employer, at its discretion and pursuant to such procedures as it may specify from time to time, to satisfy the obligations with regard to all Tax-Related Items legally payable by you by one or a combination of the following: (a) withholding otherwise deliverable Shares; (b) arranging for the sale of Shares otherwise deliverable to you (on your behalf and at your direction pursuant to this authorization); or (c) withholding from the proceeds of the sale of Shares acquired upon the vesting of the Restricted Shares. If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, you shall be deemed to have been issued the full number of Shares subject to the Restricted Shares, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Restricted Shares. If, by the date on which the event giving rise to the Tax-Related Items occurs (the “Chargeable Event”), you have relocated to a jurisdiction other than the United Kingdom, you acknowledge that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction, including the United Kingdom. You also agree that the Company and the Employer may determine the amount of Tax-Related Items to be withheld and accounted for by reference to the maximum applicable rates, without prejudice to any right which you may have to recover any overpayment from the relevant tax authorities.

You shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to account to HMRC with respect to the Chargeable Event that cannot be satisfied by the means previously described. If payment or withholding is not made within 90 calendar days of the Chargeable Event or such other period as required under U.K. law (the “Due Date”), you agree that the amount of any uncollected Tax-Related Items shall (assuming you are not a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), constitute a loan owed by you to the Employer, effective on the Due Date. You agree that the loan will bear interest at the then-current HMRC Official Rate and it will be immediately due and repayable, and the Company and/or the Employer may recover it at any time thereafter by any of the means referred to above.


    2.    Exclusion of Claim. You acknowledge and agree that you shall have no entitlement to compensation or damages insofar as such entitlement arises or may arise from you ceasing to have rights under or to be entitled to vest in your Restricted Shares as a result of such termination (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of your Restricted Shares. Upon the grant of your Restricted Shares, you shall be deemed to have waived irrevocably any such entitlement.






 EX-10.4 5 ivz1q2024ex104.htm EX-10.4 Document
Exhibit 10.4



image_0.jpg
INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT
PERFORMANCE VESTING – UCITS STAFF – NO DEFERRAL
Non-transferable
Invesco Ltd. (“Company”)
hereby awards to
[Participant Name]
(“Participant” or “you”)
[Number of Shares Granted]
Restricted Stock Units (“Target Total Award”)
as of [Grant Date] (“Grant Date”)

Subject to the conditions of (i) the Invesco Ltd. 2016 Global Equity Incentive Plan as in effect from time to time (“Plan”), (ii) the Remuneration Policy of Invesco Ltd. or any of its Affiliates as in effect from time to time to the extent such policy is applicable to you (the “Remuneration Policy”), (iii) the Invesco Ltd. Policy for Recoupment of Incentive Compensation (the “Clawback”) and (iv) this Award Agreement, the Company hereby grants to you the number of Restricted Stock Units (“RSUs”) set forth above, which shall become vested and non-forfeitable as follows:

On the third anniversary of the Grant Date (the “Determination Date”), the number of RSUs that shall become vested and non-forfeitable shall equal 100% of the Target Total Award multiplied by the Vesting Percentage (as defined in Exhibit 1), rounded down to the nearest full Share, all as calculated by the Committee in accordance with the Performance Vesting Formula set forth on Exhibit 1.

This Award shall be effective as of the Grant Date set forth above. By accepting this Award Agreement, you acknowledge that you have received a copy of the Plan’s prospectus, that you have read and understood the following Terms and Conditions, which are incorporated herein by reference, and that you agree to the following Terms and Conditions and the terms of the Plan, the Clawback Policy, the Remuneration Policy and this Award Agreement. If you fail to accept this Award Agreement within sixty (60) days after the Grant Date set forth above, the Company may determine that this Award has been forfeited.

ACCEPTED AND AGREED TO by the Participant as of the Grant Date set forth above.

                            
Participant:
Signature
                    


TERMS AND CONDITIONS – Restricted Stock Units – Performance Vesting - UCITS Staff – No Deferral
1. Plan Controls; Restricted Stock Units. In consideration of this Award, you hereby promise to abide by and to be bound by the Plan, the Remuneration Policy, the Clawback Policy and this Award Agreement, including the following terms and conditions, which serve as the agreed basis for your Award. The terms contained in the Plan, the Remuneration Policy and the Clawback Policy are incorporated into and made a part of this Award Agreement, and this Award Agreement shall be governed by and construed in accordance with the Plan and, if applicable, the Remuneration Policy. The RSUs represent a contractual obligation of the Company to deliver the number of Shares specified on page 1 hereof pursuant to the terms of Section 10 of the Plan, subject to forfeiture as set forth below and the performance adjustment as set forth in Paragraph 18 hereof, and the additional terms and restrictions hereunder. Unless the context otherwise requires, and solely for purposes of these Terms and Conditions, the term “Company” means Invesco Ltd., its Affiliates and their respective successors and assigns, as applicable, and “Employer” means the Company or the Affiliate that employs you. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the Plan.

In the event of any conflict among the terms of the Clawback Policy, the Remuneration Policy, the Plan or this Award Agreement, the following hierarchy shall govern the resolution of such conflicts:
(a)Clawback Policy Control: To the extent of any inconsistency or conflict, the terms and conditions of the Clawback Policy shall take precedence and control over conflicting provisions in the Remuneration Policy, the Plan or this Award Agreement.
(b)In the absence of a conflict under the Clawback Policy, the terms and provisions of the Remuneration Policy shall prevail and control over conflicting provisions in the Plan or this Award Agreement.
(c)Should conflicts persist after applying the Clawback Policy and Remuneration Policy, the terms and provisions of the Plan shall, in turn, take precedence and control over conflicting provisions in this Award Agreement.
2. Restrictions and Forfeiture. The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered. Upon your Termination of Service for any reason, other than as set forth in paragraphs (b) – (e) of Paragraph 3 hereof, you shall forfeit all of your right, title and interest in and to all unvested RSUs, except as determined by the Committee pursuant to Paragraph 3.1 hereof. In addition, upon the Determination Date, you shall forfeit all of your right, title and interest in and to any RSUs which fail to vest on such date pursuant to the Performance Vesting Formula.
3. Vesting and Conversion to Shares. The Target Total Award will vest and become non-forfeitable upon the earliest to occur of the following, subject to any performance adjustment as set forth in Paragraph 18 hereof:
(a)    in the event you have not experienced a Termination of Service before the Determination Date, as of the Determination Date to the extent provided under the Performance Vesting Formula, or
(b)    in the event of your death or Disability, as of your Termination of Service, or
(c)    in the event of your involuntary Termination of Service, other than for Cause or unsatisfactory performance as determined in the sole discretion by the SMD & Chief HR Officer, as of the Determination Date, to the extent provided under the Performance Vesting Formula; provided that you sign and do not revoke a severance agreement in the form stipulated by the Company or your Employer, or
(d)    upon the occurrence of a Change in Control, if this Award Agreement is not assumed, converted or replaced in connection with the transaction that constitutes the Change in Control, or
(e)    upon your Termination of Service during the 24-month period following a Change in Control either (i) by the Company other than for Cause or unsatisfactory performance, or (ii) by you for Good Reason, as of the Determination Date, to the extent provided under the Performance Vesting Formula.

3.1    Discretionary Vesting. If any or all of your RSUs would be forfeited upon your voluntary Termination of Service, you may appeal the forfeiture pursuant to the procedures established by the Committee, and the Committee, in its sole discretion, may vest some or all of such RSUs to the extent permitted under the applicable guidelines adopted by the Committee.
3.2    Conversion and Payment. Unless the RSUs are forfeited on or before the Vesting Date, the RSUs will be converted into an equal number of Shares, which will be registered in your name as of the Determination Date, and such Shares will be delivered as soon as practicable thereafter, but not later than March 15 of the year following the year in which the Determination Date occurs if you are subject to U.S. federal income tax on such Shares. Notwithstanding anything in these Terms and Conditions or the Plan to the contrary, the Company may, in its sole discretion, settle the RSUs in the form of a cash payment to the extent settlement in Shares is prohibited under local law, rules and regulations, or would require the Company, the Employer and/or you to secure any legal or regulatory approvals, complete any legal or regulatory filings or is administratively burdensome.
4. No Shareholder Rights; Payment in Lieu of Dividends. You shall have none of the rights of a shareholder of the Company with respect to the RSUs.  Dividend equivalents shall accrue at the same rate as cash dividends paid on the Shares and applied to the number of Shares that vest.  Such dividend equivalents shall be paid to you in cash at the time the Shares are delivered to you, or as soon as administratively practicable thereafter, but not later than March 15 of the year following the year in which the Vesting Date occurs if you are subject to U.S. federal income tax on such dividends.  No dividends will be paid with respect to RSUs that are forfeited for any reason.
5. Notice Period Requirement. During your employment with the Employer, you and, in the absence of Cause, the Employer shall be required to give to the other advance written notice of the intent to terminate your employment relationship as set forth in (i) your Employment Agreement, or (ii) if you are based in the US or Canada your most recent time-based equity award agreement (the “Notice Period”). Your employment with the Employer shall not terminate until the expiration of the Notice Period, provided, however, that the Employer shall have the right, in its sole discretion, to relieve you of any or all of your duties and responsibilities by placing you on paid administrative leave during the Notice Period and shall not be required to provide you with work or access to the Employer's offices during such leave. You shall be entitled to continue to receive your salary and certain other employee benefits for the entire Notice Period, regardless of whether the Employer exercises its right to place you on paid administrative leave. You are prohibited from working in any capacity for yourself or any other business during the Notice Period without the prior written consent of the Company. Notwithstanding the foregoing, at any time during your employment relationship the Employer may, effective immediately and without the benefit of the Notice Period, terminate the employment relationship for Cause. The date on
- 2 -

which your employment terminates shall be your “Termination Date” for purposes of this Award Agreement.
6. Employment Matters. You agree that this Award Agreement is entered into and is reasonably necessary to protect the Company’s investment in your advancement opportunity, training and development and to protect the goodwill and other legitimate business interests of the Company. You also agree that, in consideration of the confidential information, trade secrets and training and development provided to you, you will abide by the restrictions set forth in this Paragraph 6, and you further agree and acknowledge that the restrictions set forth in this Paragraph 6 are reasonably necessary to protect the confidential and trade secret information provided to you.
6.1 Nondisclosure. You agree that, in the event of your Termination of Service for any reason, whether during or following the period when the RSUs are subject to vesting restrictions (the “Restriction Period”), you shall not directly or indirectly use for yourself or any other business or disclose to any person any Confidential Information (as defined below) without the prior written consent of the Company during the period that it remains confidential and non public or a trade secret under applicable law. “Confidential Information” means all non-public information (whether a trade secret or not and whether proprietary or not) relating to the Company’s business and its customers that the Company either treats as confidential or is of value to the Company or is important to the Company’s business and operations, including but not limited to the following specific items: trade secrets (as defined by applicable law); actual or prospective customers and customer lists; marketing strategies; sales; actual and prospective pricing; products; know-how; research and development; intellectual property; information systems and software; business plans and projections; negotiations and contracts; financial or cost data; employment, compensation and personnel information; and any other non-public business information regarding the Company and the Company’s Affiliates. In addition, trade secrets will be entitled to all of the protections and benefits available under applicable law.
6.2 Nonrecruitment; Nonsolicitation. You agree that during your employment with the Company and until six (6) months following your Termination Date, in the event of your Termination of Service for any reason, whether during or following the Restriction Period (the “Covenant Period”), you shall not directly or indirectly, individually or in concert with any other person or entity (i) recruit, induce or attempt to recruit or induce any employee of the Company with whom you worked or otherwise had Material Contact (as defined below) during your employment to leave the employ of the Company or otherwise lessen that party’s affiliation with the Company, or (ii) solicit, divert, take away or attempt to solicit, divert or take away any then-current or proposed client or customer of the Company with whom you had Material Contact during your employment for purposes of offering, providing or selling investment management products or services offered by the Company at the date of your Termination of Service that were offered, provided and/or sold by you on the Company’s behalf. For purposes of this provision, you had “Material Contact” with an employee if (i) you had a supervisory relationship with the employee or (ii) you worked or communicated with the employee on a regular basis; and you had “Material Contact” with a current or proposed client or customer if (i) you had business dealings with the current or proposed client or customer on behalf of the Company or (ii) you supervised or coordinated the dealings between the Company and the current or proposed client or customer.
6.3 Enforceability of Covenants. You acknowledge that the Company has a current and future expectation of business from the current and proposed customers of the Company. You acknowledge that the term and scope of the covenants set forth
herein are reasonable, and you agree that you will not, in any proceeding, assert the unreasonableness of the premises, consideration or scope of the covenants set forth herein. You and the Company agree that if any portion of the foregoing covenants is deemed to be unenforceable because any of the restrictions contained in this Award Agreement are deemed too broad, the court shall be authorized to provide partial enforcement of such covenants, substitute an enforceable term or otherwise modify the Award Agreement in a manner that will enable the enforcement of the covenants to the maximum extent possible under applicable law. You agree that any breach of these covenants will result in irreparable damage and injury to the Company and that the Company will be entitled to injunctive relief without the necessity of posting any bond. You also agree that you shall be responsible for all damages incurred by the Company due to any breach of the restrictive covenants contained in this Award Agreement and that the Company shall be entitled to have you pay all costs and attorneys’ fees incurred by the Company in enforcing the restrictive covenants in this Award Agreement.
7. Relationship to Other Agreements. Subject to the limitations set forth below, in the event of any actual or alleged conflict between the provisions of this Award Agreement and (i) any other agreement regarding your employment with the Employer (“Employment Agreement”), or (ii) any prior agreement or certificate governing any award of a direct or indirect equity interest in the Company (the documents described in clauses (i) and (ii) hereof being collectively referred to as the “Other Agreements”), the provisions of this Award Agreement shall control and, to the extent of any conflict, be deemed to amend such Other Agreements. Notwithstanding the foregoing, in the event that the Nondisclosure Period or Covenant Period referred to in Paragraph 6 of this Award Agreement is shorter in duration than that provided in an Employment Agreement, the Nondisclosure Period or Covenant Period (as applicable) set forth in the Employment Agreement shall apply.
8. Employee Data Privacy. Pursuant to applicable personal data protection laws, the Company hereby notifies you of the following in relation to your personal data and the collection, use, processing and transfer (collectively, the “Use”) of such data in relation to the Company’s grant of the RSUs and your participation in the Plan. The Use of your personal data is necessary for the Company’s administration of the Plan and your participation in the Plan. Your denial and/or objection to the Use of personal data may affect your participation in the Plan. As such, you voluntarily acknowledge, consent and agree (where required by applicable law) to the Use of personal data as described in this Paragraph 8.
The Company and the Employer hold certain personal information about you, which may include your name, home address and telephone number, date of birth, social security number or other employee identification number, salary, nationality, job title, any Shares held by you, details of all RSUs or any other entitlement to Shares awarded in your favor, for the purpose of managing and administering the Plan (“Data”). The Data may be provided by you or collected, where lawful, from the Company, Affiliates or third parties, and the Company or Employer will process the Data for the exclusive purpose of implementing, administering and managing your participation in the Plan. The data processing will take place through electronic and non-electronic means according to logics and procedures strictly correlated to the purposes for which Data are collected and with confidentiality and security provisions as set forth by applicable laws and regulations in your country of residence (and country of employment, if different). Data processing operations will be performed minimizing the use of personal and identification data when such data are unnecessary for the processing purposes sought. Data will be accessible within the Company’s organization only by those persons requiring access for purposes of the implementation,
- 3 -

administration and operation of the Plan and for your participation in the Plan.
The Company and the Employer will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Data to any third parties assisting the Company in the implementation, administration and management of the Plan. These recipients may be located in the European Economic Area, or elsewhere throughout the world, such as the United States. You hereby authorize them to receive, possess, use, retain and transfer the Data, in electronic or other form, for purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on your behalf to a broker or other third party with whom you may elect to deposit any Shares acquired pursuant to the Plan.
You may, at any time, exercise your rights provided under applicable personal data protection laws, which may include the right to (a) obtain confirmation as to the existence of the Data, (b) verify the content, origin and accuracy of the Data, (c) request the integration, update, amendment, deletion, or blockage (for breach of applicable laws) of the Data, and (d) oppose, for legal reasons, the Use of the Data that is not necessary or required for the implementation, administration and/or operation of the Plan and your participation in the Plan. You may seek to exercise these rights by contacting your Employer’s human resources manager or Invesco, Ltd., Sr. Manager, Executive Compensation, 1331 Spring Street, NW, Atlanta, Georgia 30309.
9. Income Taxes and Social Insurance Contribution Withholding. Regardless of any action the Company or the Employer takes with respect to any or all income tax (including U.S. federal, state and local taxes and/or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and/or the Employer (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the settlement of the RSUs, the subsequent sale of any Shares acquired pursuant to the RSUs and the receipt of any dividends or dividend equivalents; and (ii) does not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.
If your country of residence (and/or the country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold a portion of the Shares otherwise issuable upon vesting of the RSUs that have an aggregate Fair Market Value on the vesting date sufficient to pay the minimum Tax-Related Items required to be withheld with respect to the Shares. For purposes of the foregoing, no fractional Shares will be withheld or issued pursuant to the grant of the RSUs and the issuance of Shares hereunder. Alternatively (or in combination), the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your regular salary or other amounts payable to you, with no withholding of Shares, or may require you to submit payment equivalent to the minimum Tax-Related Items required to be withheld with respect to the Shares by means of certified check, cashier’s check or wire transfer. By accepting the RSUs, you expressly consent to the methods of withholding as provided hereunder. All other Tax-Related Items related to the RSUs and any Shares delivered in payment thereof shall be your sole responsibility. Further, if you become subject to taxation in more than one country between the Grant Date and the date of any relevant taxable or tax withholding
event, as applicable, you acknowledge that the Company may be required to withhold or account for Tax-Related Items in more than one country.
To the extent the Company or the Employer pays any Tax-Related Items that are your responsibility (“Advanced Tax Payments”), the Company or the Employer shall be entitled to recover such Advanced Tax Payments from you in any and all manner that the Company determines appropriate in its sole discretion. For purposes of the foregoing, the manner of recovery of the Advanced Tax Payments shall include (but is not limited to) offsetting the Advanced Tax Payments against any and all amounts that may be otherwise owed to you by the Company or the Employer (including regular salary/wages, bonuses, incentive payments and Shares acquired by you pursuant to any equity compensation plan that are otherwise held by the Company for your benefit).
10. INTENTIONALLY OMITTED
11. Code Section 409A. The RSUs granted under this Award Agreement are not intended to constitute a nonqualified deferred compensation plan within the meaning of Section 409A of the Code, and the Plan and this Award Agreement shall be interpreted, administered and deemed amended, if applicable, in a manner consistent with this intention. Notwithstanding the terms of this Award Agreement, if you are subject to U.S. federal income tax on any amounts payable hereunder and if any such amounts, including amounts payable pursuant to Paragraph 5 hereof, constitute nonqualified deferred compensation under Section 409A of the Code, those amounts shall be subject to the provisions of Section 13(g) of the Plan (as if the amounts were Awards under the Plan, to the extent applicable).
12. Notice. Notices and communications under this Award Agreement must be in writing and either personally delivered or sent by registered or certified mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to Invesco Ltd., Sr. Manager, Executive Compensation, 1331 Spring Street, NW, Atlanta, Georgia 30309, or to any other address designated by the Company in a written notice to you. Notices to you will be directed to your address then currently on file with the Company, or to any other address given by you in a written notice to the Company.

13. Repatriation; Compliance with Laws. As a condition to the grant of these RSUs, you agree to repatriate all amounts attributable to the RSUs in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company, the Employer and the Company’s local Affiliates, as may be required to allow the Company, the Employer and the Company’s local Affiliates to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).

14. Discretionary Nature of Plan; No Vested Rights. You acknowledge and agree that the Plan is discretionary in nature and limited in duration, and may be amended, cancelled or terminated by the Company, in its sole discretion, at any time as provided under the Plan. The grant of the RSUs under the Plan is a one-time benefit and does not create any contractual or other right to receive RSUs or other awards or benefits in lieu of RSUs in the future. Future awards, if any, will be at the sole discretion of the Committee, including, but not limited to, the form and timing of an award, the number of Shares subject to an award and the vesting provisions.
- 4 -


15. Termination Indemnities. The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. As such, the RSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments to which you may be otherwise entitled.

16. Compliance with Age Discrimination Rules. For purposes of this Award Agreement, if you are a local national of and employed in a country that is a member of the European Union, the grant of the RSUs and the terms and conditions governing the RSUs are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the “Age Discrimination Rules”). To the extent a court or tribunal of competent jurisdiction determines that any provision of the RSUs or this Award Agreement or the Plan is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.

17. Use of English Language. You acknowledge and agree that it is your express intent that this Award Agreement, the Plan and all other documents, notices and legal proceedings entered into, given or instituted with respect to the RSUs be drawn up in English. If you have received this Award Agreement, the Plan or any other documents related to the RSUs translated into a language other than English, and if the meaning of the translated version is different from the English version, the English version shall control.

18. Performance Adjustment – Malus and Claw Back. Notwithstanding any other provision of this Award Agreement or the Plan, prior to the Payment Date the Committee may determine, in good faith, whether any of the following circumstances have occurred during the time period between the Grant Date and the Payment Date:
(a) the financial performance of the Company has suffered a significant downturn or deterioration; or
(b) the investment performance of the Company has suffered a significant deterioration; or
(c) there is evidence of your fraud or willful misconduct; or
(d) there is a significant failure of risk management in relation to the Company or its investment portfolios.
If the Committee determines, in its sole discretion, that your actions were a significant contributing factor towards any of the situations set forth in (a) through (d) above, the Committee, in its sole discretion may reduce or eliminate entirely the number of Restricted Shares granted hereunder, and you will forfeit all right, title and interest in and to such Restricted Shares so reduced or eliminated (the “Forfeit Obligation”). You agree that the Company shall have the right to enforce the Forfeit Obligation by all legal means available, including without limitation, by withholding other amounts or property owed to you by the Company.
19.   Compliance with the EU Directive on Undertakings for Collective Investments in Transferable Securities. To the extent the RSUs are subject to the EU Directive on Undertakings for Collective Investments in Transferable Securities (“UCITS”), the RSUs shall be administered and settled in accordance with applicable requirements, including the timing and method of distribution.
20. Value of Benefit. The future value of the Shares subject to the RSUs is unknown and cannot be predicted with certainty. Neither the Company, the Employer nor any Affiliate shall be liable for any foreign exchange rate fluctuation, where applicable, between your local currency and the United States dollar that may affect the value of the RSUs or of any amounts due to you pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement.
21. Addendum to Award Agreement. Notwithstanding any provisions in this Award Agreement to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different), as may be set forth in an addendum to this Award Agreement (“Addendum”). Further, if you transfer residency and/or employment to another country as may be reflected in an Addendum to this Award Agreement, the special terms and conditions for such country will apply to your RSUs to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan. Any applicable Addendum shall constitute part of this Award Agreement.
22. Additional Requirements. The Company reserves the right to impose other requirements on the Award and your participation in the Plan, to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the Award and the Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

23. Insider Trading / Market Abuse Laws. Your country of residence (and country of employment, if different) may have insider trading and/or market abuse laws that may affect your ability to acquire or sell Shares under the Plan during such times you are considered to have “inside information” (as defined under local law). These laws may be the same or different from any Company insider trading policy. You acknowledge that it is your responsibility to be informed of and compliant with such regulations, and you should consult with your personal advisors for additional information.

24. Severability. The invalidity or unenforceability of any provision of the Plan or this Award Agreement shall not affect the validity or enforceability of any other provision of the Plan or this Award Agreement.

25. Electronic Delivery and Signature. The Committee may, in its sole discretion, decide to deliver any documents related to the RSUs by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. Further, to the extent applicable, all references to signatures and delivery of documents in this Award Agreement can be satisfied by procedures that the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents, including this Award Agreement. Your electronic signature is the same as, and shall have the same force and effect as, your manual signature. Any such procedures and delivery may be effected by a third party engaged by the Company to provide administrative services related to the Plan.

2016 GEIP PSU UCITS Agreement – No deferral
(Feb 2024)
- 5 -

Exhibit 1
to the
Invesco Ltd. 2016 Global Equity Incentive Plan
Restricted Stock Unit Award Agreement – Performance Vesting

I.Definitions

The term “AOM Calculation” means the adjusted operating margin of the Company as set forth in the Company’s Form 10-K filed with the Securities and Exchange Commission for each fiscal year of the Grant Performance Measurement Period, which may be adjusted by the Committee in a manner that the Committee determines equitable and appropriate for extraordinary, unusual, infrequently occurring or non-recurring items (for example, but without limitation, acquisitions, dispositions, material financial market movements, changes in tax laws or accounting principles, or accruals for reorganization or restructuring programs) occurring during the Grant Performance Measurement Period.

The term “TSR Calculation” means the total shareholder return (“TSR”) of the Company and the peer group set forth in Section III below.

The term “Vesting Percentage” means the percentage by which the Target Total Award is multiplied as set forth in the chart in Section II below.

The term “Grant Performance Measurement Period” means the period commencing January 1 of the grant year and ending December 31 of the second year after the grant year.

The term “Grant Average AOM” means the sum of the AOM Calculation for each fiscal year of the Grant Performance Measurement Period divided by three.

The term “Relative TSR Ranking” means the percentile ranking of the TSR Calculation for the Grant Performance Measurement Period.

The term “Performance Vesting Formula” means the calculation described in Section II below.


II.Performance Vesting Formula

On the third anniversary of the Grant Date, the number of RSUs that shall become vested and non-forfeitable shall equal 100% of the Target Total Award multiplied by the Vesting Percentage associated with both the Grant Average AOM and Relative TSR Ranking on the chart below, rounded down to the nearest full Share, as the same shall be calculated by the Committee. The Committee’s good faith calculation of the number of RSUs that become vested and non-forfeitable pursuant to the Performance Vesting Formula shall be final and binding upon you and the Company. Vesting to range from 0% to 150%; straight line interpolation to be used for actual results of Grant Average AOM and Relative TSR Ranking.


- 6 -

Performance Share Vesting: 2024 to 2026 Performance Period
3 year Average AOMRelative TSR
     
Lowest40%ile55%ile75%ileHighest
≥34.0%100%116%133%142%150%
33.0%83%103%122%133%142%
31.0%67%90%111%123%133%
29.0%50%75%100%113%125%
27.0%33%58%83%100%117%
25.0%17%42%68%88%108%
≤24.0%0%25%50%75%100%
      
Vesting percentages between the data points to be determined by straight line interpolation of 3-year Average AOM and Relative TSR.


III.Peer Group

For purposes of the TSR Calculation, the peer group shall consist of the following companies:

Alliance Bernstein
Bank of New York Mellon
BlackRock
Franklin Resources
Janus Henderson
Lazard
Northern Trust
State Street
T. Rowe Price

The Committee may, in its sole discretion, modify the peer group list to the extent it determines any companies on the list are no longer sufficiently representative for benchmarking purposes due to merger, acquisition or otherwise.

- 7 -

image_0.jpg

INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN

ADDENDUM TO

RESTRICTED STOCK UNIT AGREEMENT – UCITS STAFFF - PERFORMANCE VESTING
Non-transferable

In addition to the terms of the Invesco Ltd. 2016 Global Equity Incentive Plan (the “Plan”) and the Restricted Stock Unit Agreement – Performance Vesting (the “Agreement”), the performance-vesting RSUs are subject to the following additional terms and conditions as set forth in this addendum (the “Addendum”). All defined terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement. To the extent you relocate your residency and/or employment to another country, the additional terms and conditions as set forth in the addendum for such country (if any) also shall apply to the performance-vesting RSUs to the extent the Company determines, in its sole discretion, that the application of such addendum is necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the operation and administration of the performance-vesting RSUs and the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).

HONG KONG

1.    Settlement in Shares. Notwithstanding anything to the contrary in the Agreement, Addendum or the Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).

2.    Lapse of Restrictions. If, for any reason, Shares are issued to you within six (6) months of the Grant Date, you may not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Grant Date.

3.    Nature of the Plan. The Company specifically intends that the Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (“ORSO”). To the extent any court, tribunal or legal/regulatory body in Hong Kong determines that the Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSU shall be null and void.

4.    Wages. The RSUs and Shares subject to the RSUs do not form part of your wages for the purposes of calculating any statutory or contractual payments under Hong Kong law.

5.    IMPORTANT NOTICE. WARNING: The contents of the Agreement, the Addendum, the Plan, and all other materials pertaining to the RSUs and/or the Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.

- 8 -

UNITED KINGDOM

    1.    Income Tax and Social Insurance Contribution Withholding. The following provision shall replace Section 9 of the Agreement:

Regardless of any action the Company and the Employer takes with respect to any or all income tax, primary Class 1 National Insurance contributions, payroll tax or other tax-related withholding attributable to or payable in connection with or pursuant to the grant or vesting of any Restricted Shares or the release or assignment of any Restricted Shares for consideration, or the receipt of any other benefit in connection with the Restricted Shares (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility. Furthermore, the Company and the Employer: (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Restricted Shares, including the grant or vesting of the Restricted Shares, the subsequent sale of any unrestricted Shares and the receipt of any dividends or dividend equivalents; and (b) do not commit to structure the terms of the grant or any aspect of the Restricted Shares to reduce or eliminate your liability for Tax-Related Items.

As a condition of the lifting of restrictions on the Restricted Shares upon vesting of the Restricted Shares, the Company and/or the Employer shall be entitled to withhold and you agree to pay, or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy, all obligations of the Company and/or the Employer to account to HM Revenue & Customs (“HMRC”) for any Tax-Related Items. In this regard, you authorize the Company and/or the Employer to withhold all applicable Tax-Related Items legally payable by you from any salary/wages or any other cash compensation payable to you. Alternatively, or in addition, if permissible under local law, you authorize the Company and/or the Employer, at its discretion and pursuant to such procedures as it may specify from time to time, to satisfy the obligations with regard to all Tax-Related Items legally payable by you by one or a combination of the following: (a) withholding otherwise deliverable Shares; (b) arranging for the sale of Shares otherwise deliverable to you (on your behalf and at your direction pursuant to this authorization); or (c) withholding from the proceeds of the sale of Shares acquired upon the vesting of the Restricted Shares. If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, you shall be deemed to have been issued the full number of Shares subject to the Restricted Shares, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Restricted Shares. If, by the date on which the event giving rise to the Tax-Related Items occurs (the “Chargeable Event”), you have relocated to a jurisdiction other than the United Kingdom, you acknowledge that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction, including the United Kingdom. You also agree that the Company and the Employer may determine the amount of Tax-Related Items to be withheld and accounted for by reference to the maximum applicable rates, without prejudice to any right which you may have to recover any overpayment from the relevant tax authorities.

You shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to account to HMRC with respect to the Chargeable Event that cannot be satisfied by the means previously described. If payment or withholding is not made within 90 calendar days of the Chargeable Event or such other period as required under U.K. law (the “Due Date”), you agree that the amount of any uncollected Tax-Related Items shall (assuming you are not a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), constitute a loan owed by you to the Employer, effective on the Due Date. You agree that the loan will bear interest at the then-current HMRC Official Rate and it will be immediately due and repayable, and the Company and/or the Employer may recover it at any time thereafter by any of the means referred to above.
- 9 -

    2.    Exclusion of Claim. You acknowledge and agree that you shall have no entitlement to compensation or damages insofar as such entitlement arises or may arise from you ceasing to have rights under or to be entitled to vest in your Restricted Shares as a result of such termination (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of your Restricted Shares. Upon the grant of your Restricted Shares, you shall be deemed to have waived irrevocably any such entitlement.


- 10 -
 EX-31.1 6 ivz1q2024ex311.htm EX-31.1 Document
Exhibit 31.1
Certification Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Andrew R. Schlossberg, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of Invesco Ltd.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
May 1, 2024
/s/  ANDREW R. SCHLOSSBERG
  Andrew R. Schlossberg
  President and Chief Executive Officer


 EX-31.2 7 ivz1q2024ex312.htm EX-31.2 Document
Exhibit 31.2
Certification Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, L. Allison Dukes, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of Invesco Ltd.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
May 1, 2024
/s/  L. ALLISON DUKES
  L. Allison Dukes
  Senior Managing Director and Chief Financial Officer


 EX-32.1 8 ivz1q2024ex321.htm EX-32.1 Document
Exhibit 32.1
CERTIFICATION OF ANDREW R. SCHLOSSBERG
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Invesco Ltd.'s (the “Company”) Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), I, Andrew R. Schlossberg, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1.    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  
May 1, 2024
/s/  ANDREW R. SCHLOSSBERG 
  Andrew R. Schlossberg
  President and Chief Executive Officer


 EX-32.2 9 ivz1q2024ex322.htm EX-32.2 Document
Exhibit 32.2
CERTIFICATION OF L. ALLISON DUKES
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Invesco Ltd.'s (the “Company”) Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), I, L. Allison Dukes, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1.    the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2.    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  
May 1, 2024/s/  L. ALLISON DUKES
  L. Allison Dukes
  Senior Managing Director and Chief Financial Officer


 EX-101.SCH 10 ivz-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - COMMON SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - EARNINGS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - COMMON SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - EARNINGS PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - INVESTMENTS - Details of Company Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - DEBT - Schedule of Long-Term Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - REVENUE - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - COMMON SHARE-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - EARNINGS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 ivz-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 ivz-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 ivz-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Consolidated Entities [Axis] Consolidated Entities [Axis] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Net (income)/loss attributable to noncontrolling interests in consolidated entities Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Credit facility capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Related Party Transactions [Line Items] Related Party Transaction [Line Items] Liquidation preference per share (in USD per share) Preferred Stock, Liquidation Preference Per Share Net interests in consolidated investment products Net Interests In Consolidated Investment Products Net Interests In Consolidated Investment Products CIP Sales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Unvested at the beginning of period (in shares) Unvested at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number DEBT Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Equity investments: Investments, Debt and Equity Securities [Abstract] Consolidated Variable Interest Entity, Primary Beneficiary [Member] Foreign exchange movement on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred tax liabilities, net Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance- Vested Performance Shares [Member] Transfers from Level 3 into Levels 1 or 2 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Restatement Determination Date: Restatement Determination Date [Axis] Beginning Balance as of January 1 Ending Balance as of March 31 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Commitments and contingencies (See Note 10) Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] SHARE CAPITAL Equity [Text Block] Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products [Table Text Block] Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products [Table Text Block] Geographical [Axis] Geographical [Axis] Ownership [Axis] Ownership [Axis] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Geographic disaggregation of revenue Schedule of Revenue by Major Customers, by Reporting Segments [Table] Other (gains)/losses of CIP, net Gains and losses of consolidated investment products net This item represents the net total realized and unrealized gain (loss) included in earnings of the entity's consolidated investment products for the period as a result of selling or holding marketable securities. Additionally, this item would include any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments of the subject investments. Preferred stock par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of March 31, 2024 and December 31, 2023) Stock consideration Preferred Stock, Value, Issued Subsequent Event Type [Domain] Subsequent Event Type [Domain] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Dividends paid - common Payments of Ordinary Dividends, Common Stock Diluted (in USD per share) Earnings Per Share, Diluted Net gains Unrealized Gain (Loss) on Investments Schedule of Investments [Table] Schedule of Investments [Table] PEO Total Compensation Amount PEO Total Compensation Amount Other common share awards APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Treasury shares Treasury Stock, Value Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Floating rate credit facility Line of Credit [Member] Investments of CIP Total assets at fair value Investments Of Consolidated Investment Products Investment in Subsidiaries Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Interest and dividend income Investment Income, Interest and Dividend Long-term debt Long-Term Debt, Fair Value Net income attributable to Invesco Ltd. Net income attributable to Invesco Ltd. Net Income (Loss) Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Bonds Corporate Bond Securities [Member] PERMANENT EQUITY Equity, Attributable to Parent [Abstract] Change in noncontrolling interests in consolidated entities, net Temporary Equity, Other Changes (Increase)/decrease in receivables Increase (Decrease) in Receivables Cash and cash equivalents of CIP Cash and cash equivalents of CIP Cash and cash equivalents of consolidated investment products Includes currency of the entity's consolidated investment products on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts held by the entity's consolidated investment products that have the general characteristics of demand deposits in that the consolidated investment products may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Calculation of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] $500 million 3.750% - due January 15, 2026 Senior Notes - Due January 15, 2026 [Member] [Member] Senior Notes - Due January 15, 2026 [Member] [Member] Executive Category: Executive Category [Axis] Movements of Share Awards Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Quoted Prices in Active Markets for Identical Assets (Level 1) Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Carrying Value Reported Value Measurement [Member] Maximum guarantee Guarantor Obligations, Maximum Exposure, Undiscounted Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Investment Type [Axis] Investment Type [Axis] Measurement Basis [Axis] Measurement Basis [Axis] Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Investments [Domain] Investments [Domain] Accrued compensation and benefits Employee-related Liabilities OTHER COMPREHENSIVE INCOME/(LOSS) Comprehensive Income (Loss) Note [Text Block] Local Phone Number Local Phone Number Fair Value Measurement [Domain] Fair Value Measurement [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Derivative notional amount Derivative, Notional Amount Common stock dividends declared per share (in USD per share) Common stock dividends declared per share (in USD per share) Common Stock, Dividends, Per Share, Declared ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] MassMutual MassMutual [Member] MassMutual [Member] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Marketable Securities Marketable Securities [Table Text Block] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Change in noncontrolling interests in consolidated entities, net Change in Noncontrolling Interests in Consolidated Entities, Net Increase or decrease in noncontrolling interest balance from receipt of contributions or payment of dividends or other distributions to noncontrolling interest shareholders. Undrawn capital commitments Undrawn Capital Commitments The company's investment may take the form of the general partner or a limited partner, and the entities are structured such that each partner makes capital commitments that may be drawn down over the life of the partnership as investment opportunities are identified. Dilutive effect of non-participating common share-based awards (shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Repayment of senior notes Repayments of Senior Debt Fair Value by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount $400 million 5.375% - due November 30, 2043 Senior Notes - Due November 30, 2043 [Member] Senior Notes - Due November 30, 2043 [Member] Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Award Type [Axis] Award Type [Axis] Vested common shares Vested Shares Recognition of treasury shares as outstanding upon the vesting of share-based payment awards granted to employees that are in the form of restricted stock awards and restricted share units. Granted during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Borrowings of debt of CIP Proceeds from Debt, Consolidated Investment Products Proceeds from Debt, Consolidated Investment Products Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Investments related to deferred compensation plans Deferred Compensation Arrangements [Member] Deferred compensation arrangements [Member] Trading Arrangement: Trading Arrangement [Axis] RELATED PARTIES Related Party Transactions Disclosure [Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Sale of investments by CIP Proceeds from sale of investments by consolidated investment products Cash inflow associated with investments held by the entity's consolidated investment products. Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Reclassification, Type [Domain] Reclassification, Type [Domain] Amortization of intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Accounting Pronouncements Recently Adopted and Pending Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block [Table Text Block] Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Total cash and cash equivalents per condensed consolidated statement of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities Bank loan, bonds and equity securities Collateralized Loan Obligation, Collateral Assets Collateralized Loan Obligation, Collateral Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] (Purchase)/sale of investments by CIP, net (Purchase)/sale of investments by CIP, net Cash inflow (outflow) associated with investments held by the entity's consolidated investment products - operating activities Common stock issued (in shares) Common shares issued Common Stock, Shares, Issued Vested and distributed during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Bermuda BERMUDA Security Exchange Name Security Exchange Name Total Assets, Fair Value Disclosure Debt Long-Term Debt Accumulated other comprehensive income/(loss), net of tax Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Foreign currency translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Purchase of investments by CIP Purchase of investments by consolidated investment products Cash outflow associated with investments held by the entity's consolidated investment products. Weighted average non-vested shares compensation cost expected to recognize Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive income/(loss) attributable to Invesco Ltd. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Unrecognized compensation cost related to non-vested shares Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Europe, Middle East and Africa (EMEA) EMEA [Member] Entity Address, Address Line One Entity Address, Address Line One Purchase of common shares Treasury Stock, Value, Acquired, Cost Method Entity Address, Address Line Two Entity Address, Address Line Two Carrying value and maximum risk of loss with respect to VIEs in which the Company is not primary beneficiary Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount Subsequent Event [Table] Subsequent Event [Table] Assets of consolidated investment products (CIP): Consolidated Investment Products (CIP) Assets [Abstract] Consolidated Investment Products (CIP) Assets COMMON SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Increase/(decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Other (gains)/losses, net Other Noncash Income (Expense) Seed capital Seed Capital [Member] Seed Capital Dividends paid - preferred Payments of Ordinary Dividends, Preferred Stock and Preference Stock Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Subsequent Event Subsequent Event [Member] Income Statement [Abstract] Income Statement [Abstract] Segment Reporting, Other Significant Reconciling Items [Line Items] Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items] Schedule of Investments [Line Items] Schedule of Investments [Line Items] Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Total return swap related to deferred compensation plans Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Approximate stake help in common stock of combined firm (percent) Subsidiary, Ownership Percentage, Noncontrolling Owner Unvested at the beginning of period (in USD per share) Unvested at the end of the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Assets held for policyholders Separate Account Asset Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Dividends declared on preferred shares Dividends declared on preferred shares Dividends, Preferred Stock Other Commitments [Domain] Other Commitments [Domain] Equity method investments Equity Method Investments Accounts receivable and other assets of CIP Accounts receivable and other assets of consolidated investment products Amount due from customers or clients of the entity's consolidated investment products within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the net realizable fair value by an allowance established by the consolidated investment product entity of the amount it deems uncertain of collection. Third-party capital distributed by CIP Capital distributed by consolidated investment products The cash outflow from any dividend or other distribution in cash with respect to any shares of, or other ownership interest in, an entity, except a dividend consisting of distribution of earnings or stock dividend or pro rata stock split. Statistical Measurement [Axis] Statistical Measurement [Axis] Time- Vested Time Vested N y s e [Member] Time Vested N Y S E [Member] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Market valuation gain recognized Increase (Decrease) in Derivative Assets and Liabilities Total Shareholder Return Amount Total Shareholder Return Amount Purchases of treasury shares Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] $600 million 4.000% - due January 30, 2024 Senior Notes - Due January 30, 2024 [Member] Senior Notes - Due January 30, 2024 [Member] Total Equity Attributable to Invesco Ltd. Parent [Member] De-consolidated Variable Interest Entity, Not Primary Beneficiary [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Transfers into Level 3 from Levels 1 or 2 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Debt instrument, face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Bank loans Bank Loan Obligations [Member] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Other liabilities of CIP Other liabilities of consolidated investment products Aggregate carrying amount as of the balance sheet date of current obligations of the entity's consolidated investment products not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer). Total return swaps related to deferred compensation plans Total Return Swap [Member] Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Common shares outstanding Common Stock, Shares, Outstanding Other investments Other Other Investments Earnings per common share: Earnings Per Share, Basic [Abstract] PEO PEO [Member] Reclassification Adjustments [Member] Reclassification Adjustments [Member] Reclassification Adjustments Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Asset Class [Domain] Asset Class [Domain] Consolidated Investment Products [Abstract] Consolidated Investment Products [Abstract] Consolidated Investment Products Transaction, integration and restructuring Total Transaction And Integration Charges Total Transaction And Integration Charges Other Financial Service, Other [Member] Common stock par value (in USD per share) Common Stock, Par or Stated Value Per Share Marketing Marketing expense Marketing Expense Net cash provided by/(used in) investing activities Net Cash Provided by (Used in) Investing Activities Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Credit Facility [Axis] Credit Facility [Axis] Third-party capital invested into CIP Capital invested into consolidated investment products The cash inflow from the capital received in cash from a partner in a partnership during the period. Total liabilities Liabilities Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accumulated Other Comprehensive Income/(Loss) Total AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Preferred stock dividend declared (in USD per share) Preferred Stock, Dividends Per Share, Declared Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Employee benefit plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings per common share: Earnings Per Share [Abstract] Earnings Per Share [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Reclassification, Type [Axis] Reclassification, Type [Axis] Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of March 31, 2024 and December 31, 2023) Common Stock, Value, Issued General and administrative General and administrative expense General and Administrative Expense Investments Measured at NAV as a practical expedient Fair Value Measured at Net Asset Value Per Share [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Preferred Shares Preferred Stock [Member] CONSOLIDATED INVESTMENT PRODUCTS Consolidated Investment Products Disclosure [Text Block] This item represents the disclosure of the company's consolidated investment products, including: (1) investment products that are variable interest entities and the company is the primary beneficiary; (2) other partnership entities in which the company is the general partner and is considered to have control, in the absence of simple majority kick-out rights to remove the general partner, simple majority liquidation rights to dissolve the partnership, or any substantive participating rights of the other limited partners; and (3) investment products in which the company has a controlling financial interest. Tri-Level Hierarchy, Carrying Value Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Equity securities, Equity and fixed income mutual funds Equity Securities [Member] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Accounts receivable Accounts Receivable, after Allowance for Credit Loss All Individuals All Individuals [Member] Supplemental Cash Flow Information [Abstract] Supplemental Cash Flow Information [Abstract] Other gains/(losses), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Redeemable noncontrolling interests in consolidated entities Beginning balance Ending balance Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Current Fiscal Year End Date Current Fiscal Year End Date Movements in Shares Issued and Outstanding Schedule of Stock and Treasury Stock [Table Text Block] Schedule of Stock and Treasury Stock [Table Text Block] PEO Name PEO Name Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Asia-Pacific (APAC) Asia Pacific [Member] Accumulated Other Comprehensive Income/(Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock authorized (in shares) Preferred Stock, Shares Authorized Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Segment, Reconciliation of Other Items from Segments to Consolidated [Table] Investments Total investments Investments Weighted average fair value of shares granted (in USD per share) Granted during the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Preferred shares outstanding (in shares) Preferred shares outstanding (in shares) Preferred Stock, Shares Outstanding Net cash provided by/(used in) operating activities Net Cash Provided by (Used in) Operating Activities Debt of CIP Long Term Debt Of Consolidated Investment Products Sum of the carrying values as of the balance sheet date of all long-term debt of the entity's consolidated investment products, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premium, if any. Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Purchase of investments Payments to Acquire Other Investments Amortization and depreciation Depreciation, Depletion and Amortization Other comprehensive income/(loss), net of tax Other comprehensive income/(loss), net Other Comprehensive Income, Other, Net of Tax Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Lock up, term Lock Up, Term Lock Up, Term Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total equity attributable to Invesco Ltd. Equity, Attributable to Parent Net income Temporary Equity, Net Income Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP Proceeds From (Payments To) Consolidation And Deconsolidation Of Subsidiaries Proceeds From (Payments To) Consolidation And Deconsolidation Of Subsidiaries Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Currency translation differences on investments in foreign subsidiaries Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Subsequent Events [Abstract] Subsequent Events [Abstract] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Investment management fees Investment Advice [Member] (Purchase)/sale of investments, net Payments for (Proceeds from) Short-Term Investments Foreign exchange Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Foreign Exchange Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Foreign Exchange Preferred shares issued (in shares) Preferred shares issued (in shares) Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Significant Other Observable Inputs (Level 2) Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] TEMPORARY EQUITY Temporary Equity [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Third-party distribution, service and advisory Third party distribution service and advisory Includes: (1) renewal commissions paid to independent financial advisors for as long as the clients' assets are invested and are payments for the servicing of the client accounts, (2) the amortization of upfront commissions paid to brokers/dealers for sales of fund shares with a contingent deferred sales charge and (3) sub-transfer agency fees that are paid to a third party for transferring shares of a mutual fund or units of a unit trust into the investor's name. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title Common share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common Shares Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code EARNINGS PER COMMON SHARE Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total permanent equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Investments Investments [Abstract] Property, equipment and software, net Property, Plant and Equipment, Net Real estate investments Real Estate Investments, Net Contingent consideration liability Liability [Member] Distributions from equity method investees Proceeds from Equity Method Investment, Distribution Exercise Price Award Exercise Price Other comprehensive income/(loss) Other comprehensive income/(loss) Other comprehensive income/(loss), net of tax Other Comprehensive Income (Loss), Net of Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Dividends declared - common Dividends, Common Stock, Cash ASSETS Assets: Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Total Liabilities, Fair Value Disclosure LIABILITIES Liabilities: Liabilities [Abstract] Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash provided by/(used in) financing activities Net Cash Provided by (Used in) Financing Activities COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Retained Earnings Retained Earnings [Member] Other income/(expense) of CIP, net Other Nonoperating Income (Expense), Consolidated Investment Products Other Nonoperating Income (Expense), Consolidated Investment Products Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities, temporary and permanent equity Liabilities and Equity Other income/(expense): Nonoperating Income (Expense) [Abstract] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Ownership [Domain] Ownership [Domain] Basic (in USD per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Investments in other private equity funds Private Equity Funds [Member] Basis of Accounting and Consolidation Consolidation, Policy [Policy Text Block] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Unsecured Senior Notes Unsecured Debt [Member] Termination Date Trading Arrangement Termination Date Increase/(decrease) in payables Increase (Decrease) in Accounts Payable Common stock authorized (in shares) Common Stock, Shares Authorized Americas Americas [Member] Repayments of credit agreement Repayments of Lines of Credit Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Geographic Disaggregation of Revenue Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Foreign exchange movement on cash and cash equivalents of CIP Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, CIP Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, CIP Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net income to net cash provided by/(used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Liability Class [Axis] Liability Class [Axis] Related Party Transactions [Abstract] Related Party Transactions [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] INVESTMENTS Investment [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Fair value of vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Other Commitments [Axis] Other Commitments [Axis] Policyholder payables Policyholder payables Separate Account, Liability Reclassification [Table] Reclassification [Table] Variable interest entity, unfunded capital commitments Variable Interest Entity, Reporting Entity Involvement, Unfunded Capital Commitments, Amount Variable Interest Entity, Reporting Entity Involvement, Unfunded Capital Commitments, Amount Performance fees Investment Performance [Member] Net income Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Total return swap related to deferred compensation plans Derivative asset Derivative Asset Forfeited during the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Equity attributable to Invesco Ltd.: Stockholders Equity Attributable to Parent Abstract Stockholders Equity Attributable to Parent Abstract. Forfeited during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Equity and fixed income mutual funds, and investments in other private equity funds Private Equity Fund Assets Private Equity Fund Assets Insider Trading Arrangements [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Capital distribution from equity method investees Proceeds from Equity Method Investment, Distribution, Return of Capital Other assets Other Assets Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Equity attributable to nonredeemable noncontrolling interests in consolidated entities Equity, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Borrowings of credit agreement Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Treasury Shares Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Gains and losses included in the Consolidated Statements of Income Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income tax provision Income Tax Expense (Benefit) Designated as Hedging Instrument Designated as Hedging Instrument [Member] FAIR VALUE OF ASSETS AND LIABILITIES Fair Value Disclosures [Text Block] Dividends declared - preferred Dividends, Preferred Stock, Cash Name Trading Arrangement, Individual Name Cash equivalents: Cash and Cash Equivalents [Abstract] Equity [Abstract] Equity [Abstract] Total operating revenues Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Money market funds Money Market Funds [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total comprehensive income/(loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Credit Facility [Domain] Credit Facility [Domain] Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Contingent consideration liability Obligations, Fair Value Disclosure Sale of investments Proceeds from Sale of Other Investments Repayments of debt of CIP Repayments of consolidated investment products Repayments of consolidated investment products. Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Equity Commitment Equity Commitment [Member] Equity Commitment Weighted average common shares outstanding - diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Commitments Other Commitment Operating expenses: Operating Expenses [Abstract] REVENUE Revenue from Contract with Customer [Text Block] Purchase of property, equipment and software Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in-capital Additional Paid in Capital, Common Stock Additional Paid-in-Capital Additional Paid-in Capital [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Equity in earnings of unconsolidated affiliates Equity in earnings of unconsolidated affiliates Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Common share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Employee compensation Labor and Related Expense Vested and distributed during the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Equity investments Equity investments Short-Term Investments CIP Purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Total operating expenses Operating Expenses Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Deconsolidation of CIP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Deconsolidation of CIP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Deconsolidation of CIP Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Property, office and technology Property, office, and technology expense Communications, Information Technology and Occupancy Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted average common shares outstanding - basic (shares) Weighted Average Number of Shares Outstanding, Basic Debt Instrument [Line Items] Debt Instrument [Line Items] Less: Treasury shares for which dividend and voting rights do not apply Treasury Stock, Shares For Which Dividend and Voting Rights Do Not Apply Treasury stock, shares for which dividend and voting rights do not apply. Entity Current Reporting Status Entity Current Reporting Status Operating income Operating Income (Loss) Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Operating revenues: Revenues [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Service and distribution fees Distribution and Shareholder Service [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Fair Value Estimate of Fair Value Measurement [Member] Other comprehensive income/(loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Line of credit facility, amount outstanding Long-Term Line of Credit Invesco Invesco [Member] Invesco Nonredeemable Noncontrolling Interests in Consolidated Entities Noncontrolling Interest [Member] EX-101.PRE 14 ivz-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 image_0.jpg begin 644 image_0.jpg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image_02.jpg begin 644 image_02.jpg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ivz-20240331_g1.jpg begin 644 ivz-20240331_g1.jpg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end XML 19 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover Page
 3 Months Ended
Mar. 31, 2024
shares
Cover [Abstract]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2024
Document Transition Report false
Entity File Number 001-13908
Entity Registrant Name Invesco Ltd.
Entity Incorporation, State or Country Code D0
Entity Tax Identification Number 98-0557567
Entity Address, Address Line One 1331 Spring Street,
Entity Address, Address Line Two Suite 2500,
Entity Address, City or Town Atlanta,
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30309
City Area Code 404
Local Phone Number 892-0896
Title of 12(b) Security Common stock, $0.20 par value
Trading Symbol IVZ
Security Exchange Name NYSE
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 449,831,075
Entity Central Index Key 0000914208
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2024
Document Fiscal Period Focus Q1
Amendment Flag false
XML 20 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Cash and cash equivalents $ 895.7 $ 1,469.2
Accounts receivable 708.3 701.5
Investments 963.5 919.1
Assets of consolidated investment products (CIP):    
Cash and cash equivalents of CIP 529.8 462.4
Accounts receivable and other assets of CIP 217.3 250.1
Investments of CIP 8,902.2 8,765.9
Assets held for policyholders 0.0 393.9
Other assets 823.4 832.6
Property, equipment and software, net 583.6 599.5
Intangible assets, net 5,832.4 5,848.1
Goodwill 8,621.0 8,691.5
Total assets 28,077.2 28,933.8
LIABILITIES    
Accrued compensation and benefits 452.5 900.4
Accounts payable and accrued expenses 1,321.2 1,294.4
Debt of CIP 7,370.4 7,121.8
Other liabilities of CIP 459.1 492.1
Policyholder payables 0.0 393.9
Debt 1,257.5 1,489.5
Deferred tax liabilities, net 1,363.7 1,325.7
Total liabilities 12,224.4 13,017.8
Commitments and contingencies (See Note 10)
TEMPORARY EQUITY    
Redeemable noncontrolling interests in consolidated entities 667.8 745.7
Equity attributable to Invesco Ltd.:    
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of March 31, 2024 and December 31, 2023) 4,010.5 4,010.5
Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of March 31, 2024 and December 31, 2023) 113.2 113.2
Additional paid-in-capital 7,314.6 7,451.6
Treasury shares (2,864.4) (3,002.6)
Retained earnings 6,878.0 6,826.7
Accumulated other comprehensive income/(loss), net of tax (897.1) (801.8)
Total equity attributable to Invesco Ltd. 14,554.8 14,597.6
Equity attributable to nonredeemable noncontrolling interests in consolidated entities 630.2 572.7
Total permanent equity 15,185.0 15,170.3
Total liabilities, temporary and permanent equity $ 28,077.2 $ 28,933.8
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
shares in Millions
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock par value (in USD per share) $ 0.20 $ 0.20
Liquidation preference per share (in USD per share) $ 1,000 $ 1,000
Preferred stock authorized (in shares) 4.0 4.0
Preferred shares issued (in shares) 4.0 4.0
Preferred shares outstanding (in shares) 4.0 4.0
Common stock par value (in USD per share) $ 0.20 $ 0.20
Common stock authorized (in shares) 1,050.0 1,050.0
Common stock issued (in shares) 566.1 566.1
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating revenues:    
Total operating revenues $ 1,475.3 $ 1,418.2
Operating expenses:    
Third-party distribution, service and advisory 504.0 455.1
Employee compensation 472.7 462.8
Marketing 18.1 19.6
Property, office and technology 117.6 110.5
General and administrative 138.5 105.0
Transaction, integration and restructuring 0.0 41.6
Amortization of intangible assets 11.3 14.1
Total operating expenses 1,262.2 1,208.7
Operating income 213.1 209.5
Other income/(expense):    
Equity in earnings of unconsolidated affiliates 6.9 26.1
Interest and dividend income 12.4 8.6
Interest expense (15.9) (18.0)
Other gains/(losses), net 35.9 27.4
Other income/(expense) of CIP, net 30.5 (17.9)
Income before income taxes 282.9 235.7
Income tax provision (68.7) (69.9)
Net income 214.2 165.8
Net (income)/loss attributable to noncontrolling interests in consolidated entities (13.5) 38.4
Dividends declared on preferred shares (59.2) (59.2)
Net income attributable to Invesco Ltd. $ 141.5 $ 145.0
Earnings per common share:    
Basic (in USD per share) $ 0.31 $ 0.32
Diluted (in USD per share) $ 0.31 $ 0.32
Investment management fees    
Operating revenues:    
Total operating revenues $ 1,048.7 $ 1,027.9
Service and distribution fees    
Operating revenues:    
Total operating revenues 377.0 334.2
Performance fees    
Operating revenues:    
Total operating revenues 0.8 5.6
Other    
Operating revenues:    
Total operating revenues $ 48.8 $ 50.5
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 214.2 $ 165.8
Other comprehensive income/(loss), net of tax:    
Currency translation differences on investments in foreign subsidiaries (96.3) 55.1
Other comprehensive income/(loss), net of tax 1.0 4.4
Other comprehensive income/(loss) (95.3) 59.5
Total comprehensive income/(loss) 118.9 225.3
Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities (13.5) 38.4
Dividends declared on preferred shares (59.2) (59.2)
Comprehensive income/(loss) attributable to Invesco Ltd. $ 46.2 $ 204.5
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net income $ 214.2 $ 165.8
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Amortization and depreciation 45.1 46.8
Common share-based compensation expense 21.1 37.8
Other (gains)/losses, net (35.3) (27.4)
Other (gains)/losses of CIP, net 2.4 63.2
Equity in earnings of unconsolidated affiliates (6.9) (26.1)
Distributions from equity method investees 15.9 2.7
Changes in operating assets and liabilities:    
(Purchase)/sale of investments by CIP, net (3.4) 32.7
(Purchase)/sale of investments, net 16.8 2.9
(Increase)/decrease in receivables 365.1 (70.7)
Increase/(decrease) in payables (689.4) (326.6)
Net cash provided by/(used in) operating activities (54.4) (98.9)
Investing activities:    
Purchase of property, equipment and software (21.0) (38.1)
Purchase of investments by CIP (472.8) (562.6)
Sale of investments by CIP 237.7 669.5
Purchase of investments (36.5) (40.7)
Sale of investments 0.1 21.0
Capital distribution from equity method investees 6.9 7.0
Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP (1.7) (10.6)
Net cash provided by/(used in) investing activities (287.3) 45.5
Financing activities:    
Purchases of treasury shares (20.4) (27.7)
Dividends paid - preferred (59.2) (59.2)
Dividends paid - common (90.2) (85.7)
Third-party capital invested into CIP 98.3 27.5
Third-party capital distributed by CIP (42.6) (67.9)
Borrowings of debt of CIP 274.3 39.7
Repayments of debt of CIP (76.1) (5.2)
Borrowings of credit agreement 1,030.4 0.0
Repayments of credit agreement (662.8) 0.0
Repayment of senior notes (600.0) 0.0
Net cash provided by/(used in) financing activities (148.3) (178.5)
Increase/(decrease) in cash and cash equivalents (490.0) (231.9)
Supplemental Cash Flow Information [Abstract]    
Foreign exchange movement on cash and cash equivalents (14.1) 11.7
Foreign exchange movement on cash and cash equivalents of CIP (2.0) 1.0
Cash and cash equivalents, beginning of period 1,931.6 1,434.1
Cash and cash equivalents, end of period 1,425.5 1,214.9
Cash and cash equivalents 895.7 889.0
Cash and cash equivalents of CIP 529.8 325.9
Total cash and cash equivalents per condensed consolidated statement of cash flows $ 1,425.5 $ 1,214.9
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Millions
Total
Total Equity Attributable to Invesco Ltd.
Preferred Shares
Common Shares
Additional Paid-in-Capital
Treasury Shares
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Nonredeemable Noncontrolling Interests in Consolidated Entities
Beginning balance at Dec. 31, 2022 $ 15,843.5 $ 15,213.6 $ 4,010.5 $ 113.2 $ 7,554.9 $ (3,040.9) $ 7,518.3 $ (942.4) $ 629.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 179.4 204.2         204.2   (24.8)
Other comprehensive income/(loss) 59.5 59.5           59.5  
Change in noncontrolling interests in consolidated entities, net (17.9)               (17.9)
Dividends declared - preferred (59.2) (59.2)         (59.2)    
Dividends declared - common (85.7) (85.7)         (85.7)    
Common share-based compensation 37.8 37.8     37.8        
Vested common shares 0.0 0.0     (180.6) 180.6      
Other common share awards 0.5 0.5     0.5 0.0      
Purchase of common shares (27.7) (27.7)       (27.7)      
Ending balance at Mar. 31, 2023 15,930.2 15,343.0 4,010.5 113.2 7,412.6 (2,888.0) 7,577.6 (882.9) 587.2
Beginning balance at Dec. 31, 2022 998.7                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (13.6)                
Change in noncontrolling interests in consolidated entities, net (105.5)                
Ending balance at Mar. 31, 2023 879.6                
Beginning balance at Dec. 31, 2023 15,170.3 14,597.6 4,010.5 113.2 7,451.6 (3,002.6) 6,826.7 (801.8) 572.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 238.6 200.7         200.7   37.9
Other comprehensive income/(loss) (95.3) (95.3)           (95.3)  
Change in noncontrolling interests in consolidated entities, net 19.6               19.6
Dividends declared - preferred (59.2) (59.2)         (59.2)    
Dividends declared - common (90.2) (90.2)         (90.2)    
Common share-based compensation 21.1 21.1     21.1        
Vested common shares 0.0 0.0     (158.4) 158.4      
Other common share awards 0.5 0.5     0.3 0.2      
Purchase of common shares (20.4) (20.4)       (20.4)      
Ending balance at Mar. 31, 2024 15,185.0 $ 14,554.8 $ 4,010.5 $ 113.2 $ 7,314.6 $ (2,864.4) $ 6,878.0 $ (897.1) $ 630.2
Beginning balance at Dec. 31, 2023 745.7                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (24.4)                
Change in noncontrolling interests in consolidated entities, net (53.5)                
Ending balance at Mar. 31, 2024 $ 667.8                
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Preferred stock dividend declared (in USD per share) $ 14.75 $ 14.75
Common stock dividends declared per share (in USD per share) $ 0.20 $ 0.1875
XML 27 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
ACCOUNTING POLICIES
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
ACCOUNTING POLICIES ACCOUNTING POLICIES
Corporate Information

Invesco Ltd. (the Parent) and its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of investment management capabilities. The company operates globally and its sole business is investment management.

Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2023 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report.

Basis of Accounting and Consolidation

The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.

Reclassifications

In the quarter ended March 31, 2024, expenses for client-related travel and entertainment and outsourced services were reclassified to General and administrative expenses. The impact of this reclassification on the Consolidated Statements of Income is as follows:

• For the three months ended March 31, 2024: decreased Marketing and Property, office and technology expenses by $6.7 million and $23.6 million, respectively, and increased General and administrative by $30.3 million.

• For the three months ended March 31, 2023: decreased Marketing and Property, office and technology expenses by $5.4 million and $23.9 million, respectively, and increased General and administrative by $29.3 million.

The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated.

Accounting Pronouncements Recently Adopted

None.

Pending Accounting Pronouncements

Refer to the most recent Form 10-K filed with the SEC.
XML 28 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE OF ASSETS AND LIABILITIES
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE OF ASSETS AND LIABILITIES FAIR VALUE OF ASSETS AND LIABILITIES
The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products." See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.

March 31, 2024December 31, 2023
 (in millions)Fair ValueFair Value
Cash and cash equivalents$895.7 $1,469.2 
Equity investments297.2 272.4 
Assets held for policyholders — 393.9 
Policyholder payables (1)
— (393.9)
Total return swap related to deferred compensation plans8.1 4.9 
____________
(1)    These financial instruments are not measured at fair value on a recurring basis. Policyholder payables were indexed to the value of the assets held for policyholders and changes in fair value were recorded and offset to zero in other operating revenues. In January 2024, all funds were distributed to customers.

The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$434.7 $434.7 $— $— 
Investments: (2)
Equity investments:
Seed capital86.0 86.0 — — 
Investments related to deferred compensation plans211.2 211.2 — — 
Total return swap related to deferred compensation plans8.1 — 8.1 — 
Total$740.0 $731.9 $8.1 $— 
Liabilities:
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$927.8 $927.8 $— $— 
Investments (2):
Equity investments:
Seed capital75.7 75.7 — — 
Investments related to deferred compensation plans196.7 196.7 — — 
Assets held for policyholders (3)
393.9 393.9 — — 
Total return swap related to deferred compensation plans4.9 — 4.9 — 
Total$1,599.0 $1,594.1 $4.9 $— 
Liabilities:    
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
____________
(1)    The balance primarily represents cash held in affiliated money market funds.
(2)    Equity method and other investments of $651.4 million and $14.9 million, respectively, are excluded from this table (December 31, 2023: $631.8 million and $14.9 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards.
(3)    The majority of Assets held for policyholders were held in affiliated funds.

Total Return Swap (TRS)

In addition to holding equity investments, the company has a TRS to hedge economically certain deferred compensation liabilities. The notional value of the TRS at March 31, 2024 was $424.4 million, and the fair value of the TRS was an asset of $8.1 million (December 31, 2023 notional value was $393.0 million and the fair value was an asset of $4.9 million). During the three months ended March 31, 2024, market valuation gains related to the TRS were $18.0 million (three months ended March 31, 2023: $13.1 million net gain).

The fair value of the TRS was determined under the market approach using quoted prices of the underlying investments and, as such, is classified as level 2 of the valuation hierarchy. The TRS is not designated for hedge accounting.
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS
 3 Months Ended
Mar. 31, 2024
Investments [Abstract]  
INVESTMENTS INVESTMENTS
The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products."

(in millions)March 31, 2024December 31, 2023
Equity investments:
Seed capital$86.0 $75.7 
Investments related to deferred compensation plans211.2 196.7 
Equity method investments651.4 631.8 
Other14.9 14.9 
Total investments (1)
$963.5 $919.1 
_________
(1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.
Equity investments

The unrealized gains and losses for the three months ended March 31, 2024 that relate to equity investments still held at March 31, 2024 were a $16.2 million net gain (three months ended March 31, 2023: $6.7 million net gain).
XML 30 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
DEBT
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products."

March 31, 2024December 31, 2023
(in millions)
Carrying Value (3)
Fair Value
Carrying Value (3)
Fair Value
$2.0 billion floating rate credit agreement expiring April 26, 2028
$367.6 $367.6 $— $— 
Unsecured Senior Notes: (1)
$600 million 4.000% - due January 30, 2024 (2)
— — 599.9 599.1 
$500 million 3.750% - due January 15, 2026
498.7 488.0 498.6 489.1 
$400 million 5.375% - due November 30, 2043
391.2 391.7 391.0 409.6 
Debt$1,257.5 $1,247.3 $1,489.5 $1,497.8 
____________
(1)    The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures.
(2)     On January 30, 2024, the outstanding balance of the $600.0 million senior notes was paid in full.
(3)    The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE CAPITAL
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SHARE CAPITAL SHARE CAPITAL
The number of preferred shares issued and outstanding is represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Preferred shares issued (1)
4.04.0 
Preferred shares outstanding (1)
4.04.0 
____________
(1)    Substantially all the preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024.

The number of common shares and common share equivalents issued are represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Common shares issued566.1 566.1 
Less: Treasury shares for which dividend and voting rights do not apply
(116.3)(116.6)
Common shares outstanding449.8 449.5 
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER COMPREHENSIVE INCOME/(LOSS)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
OTHER COMPREHENSIVE INCOME/(LOSS) OTHER COMPREHENSIVE INCOME/(LOSS)
The components of accumulated other comprehensive income/(loss) were as follows:

Three months ended March 31, 2024Three months ended March 31, 2023
(in millions)Foreign currency translationEmployee benefit plansTotalForeign currency translationEmployee benefit plansTotal
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries
$(96.3)$— $(96.3)$55.1 $— $55.1 
Other comprehensive income/(loss), net— 1.0 1.0 — 4.4 4.4 
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Beginning balance(670.1)(131.7)(801.8)(815.0)(127.4)(942.4)
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Ending balance$(766.4)$(130.7)$(897.1)$(759.9)$(123.0)$(882.9)
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
REVENUE
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
The geographic disaggregation of revenue for the three months ended March 31, 2024 and 2023 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda.

Three months ended March 31,
(in millions)20242023
Americas$1,140.6 $1,083.4 
Asia-Pacific (APAC)68.769.9
Europe, Middle East and Africa (EMEA)266.0264.9
Total operating revenues$1,475.3 $1,418.2 
XML 34 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMON SHARE-BASED COMPENSATION
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
COMMON SHARE-BASED COMPENSATION COMMON SHARE-BASED COMPENSATION
The company recognized total compensation expense of $21.1 million and $37.8 million related to equity-settled common share-based compensation in the three months ended March 31, 2024 and 2023, respectively.

Movements on employee common share awards during the periods ended March 31 are detailed below:

Three months ended March 31, 2024 Three months ended March 31, 2023
(in millions of common shares, except fair values)Time- VestedPerformance- VestedWeighted Average Grant Date Fair ValueTime- VestedPerformance- Vested
Unvested at the beginning of period
10.4 1.6 $18.84 10.3 2.1 
Granted during the period4.9 0.9 15.13 4.3 0.7 
Forfeited during the period(0.2)(0.1)18.21 — (0.2)
Vested and distributed during the period
(4.4)(0.3)18.29 (4.5)(0.5)
Unvested at the end of the period
10.7 2.1 $17.41 10.1 2.1 

The total fair value of common shares that vested during the three months ended March 31, 2024 was $67.0 million (three months ended March 31, 2023: $87.3 million). The weighted average grant date fair value of the United States (U.S.) dollar share awards that were granted during the three months ended March 31, 2024 was $15.13 (three months ended March 31, 2023: $17.74).
At March 31, 2024, there was $182.5 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be recognized over a weighted average period of 2.94 years.
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EARNINGS PER COMMON SHARE
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The calculation of earnings per common share (EPS) is as follows:

Three months ended March 31,
(in millions, except per share data)20242023
Net income attributable to Invesco Ltd.$141.5 $145.0 
Invesco Ltd:
Weighted average common shares outstanding - basic453.2 458.1 
Dilutive effect of non-participating common share-based awards0.3 0.8 
Weighted average common shares outstanding - diluted453.5 458.9 
Earnings per common share:
-basic$0.31 $0.32 
-diluted$0.31 $0.32 

See Note 8, "Common Share-Based Compensation," for a summary of common share awards outstanding under the company’s common share-based payment programs. These programs could result in the issuance of common shares that would affect the measurement of basic and diluted EPS.
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Commitments and contingencies may arise in the ordinary course of business.

The company has committed to co-invest in certain investment products, which may be called in future periods. At March 31, 2024, the company’s undrawn co-invest capital commitments were $664.6 million (December 31, 2023: $623.3 million).

Certain of our managed investment products have entered into revolving credit facilities with financial institutions. The company provided equity commitments and guarantees to the financial institutions for certain of these revolving credit facilities that are temporary in nature. The revolving credit facilities look first to the respective investment products for repayment and servicing. The company’s equity commitment or guarantee would only be called in the event a particular investment product is unable to meet its obligation. The company believes the likelihood of being required to fund its equity commitments or guarantees under these arrangements to be remote. To date, the company has not been required to fund any equity commitments or guarantees under these arrangements. The maximum amount of future payments under the commitments is $274.6 million and under the guarantees is $30.0 million. The fair value of the guarantee liability is not significant to the consolidated financial statements.

The company and some of its subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

Legal Contingencies

The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability.
The company and certain related entities have in recent years been subject to various regulatory inquiries, reviews and investigations and legal proceedings, including civil litigation, governmental investigations and enforcement actions. These actions can arise from normal business operations and/or matters that have been the subject of previous regulatory reviews. As a global company with investment products registered in numerous countries and subject to the jurisdiction of one or more regulators in each country, at any given time, our business operations may be subject to review, investigation, or disciplinary action.

In assessing the impact that a legal or regulatory matter will have on the company, management evaluates the need for an accrual on a case-by-case basis. If the likelihood of a loss is deemed probable and is reasonably estimable, the estimated loss is accrued. If the likelihood of a loss is assessed as less than probable, a loss is not accrued. If a loss is deemed probable but an amount or range of loss cannot be reasonably estimated, a loss is not accrued but the matter is disclosed.

In management’s opinion, adequate accrual has been made as of March 31, 2024 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount and are deemed probable. Management believes that the ultimate resolution of claims will not materially affect the company’s business, revenue, net income or liquidity.

The company is cooperating with requests from the SEC in connection with their investigation of investment advisers’ compliance with record retention requirements relating to certain types of electronic business communications. At this time a range of loss related to this matter cannot be reasonably estimated.
Further, the investment management industry also is generally subject to extensive levels of ongoing regulatory oversight and examination. In the U.S., United Kingdom (U.K.) and other jurisdictions in which the company operates, governmental authorities regularly make inquiries, hold investigations and administer market conduct examinations with respect to the company’s compliance with applicable laws and regulations. Additional lawsuits or regulatory enforcement actions arising out of these inquiries may in the future be filed against the company, related entities and individuals in the U.S., U.K. and other jurisdictions in which the company and its affiliates operate. Any material loss of investor and/or client confidence as a result of such inquiries and/or litigation could result in a significant decline in assets under management (AUM), which would have an adverse effect on the company’s future financial results and its ability to grow its business.
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED INVESTMENT PRODUCTS
 3 Months Ended
Mar. 31, 2024
Consolidated Investment Products [Abstract]  
CONSOLIDATED INVESTMENT PRODUCTS CONSOLIDATED INVESTMENT PRODUCTS
The balances related to CIP are identified on the Consolidated Balance Sheets. At March 31, 2024, the company’s net investment in and net receivables from CIP were $521.9 million (December 31, 2023: $546.2 million). The consolidation of CIP had no impact on net income attributable to the company during the three months ended March 31, 2024.

The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2024 and December 31, 2023:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$7,133.8 $— $6,143.3 $990.5 $— 
Bonds624.5 11.9 612.3 0.3 — 
Equity securities172.9 30.1 19.4 123.4 — 
Equity and fixed income mutual funds112.9 0.2 112.7 — — 
Investments in other private equity funds412.6 — — — 412.6 
Real estate investments445.5 — — — 445.5 
Total assets at fair value$8,902.2 $42.2 $6,887.7 $1,114.2 $858.1 

As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$6,837.2 $— $6,140.1 $697.1 $— 
Bonds669.8 13.3 656.2 0.3 — 
Equity securities231.9 85.2 18.3 128.4 — 
Equity and fixed income mutual funds137.9 8.0 129.9 — — 
Investments in other private equity funds425.5 — — — 425.5 
Real estate investments463.6 — — — 463.6 
Total assets at fair value$8,765.9 $106.5 $6,944.5 $825.8 $889.1 


At March 31, 2024, CIP borrowings with a fair value of $565.0 million (December 31, 2023: $353.7 million) are classified as level 3 in the valuation hierarchy.
The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:
Three months ended March 31,
20242023
(in millions)Level 3 AssetsLevel 3 Assets
Beginning Balance as of January 1$825.8 $368.6 
CIP Purchases275.0 0.1 
CIP Sales(2.3)(13.4)
Deconsolidation of CIP— (0.6)
Gains and losses included in the Consolidated Statements of Income(1.9)(7.6)
Transfers from Level 3 into Levels 1 or 2(16.2)(130.2)
Transfers into Level 3 from Levels 1 or 234.0 132.2 
Foreign exchange(0.2)2.2 
Ending Balance as of March 31$1,114.2 $351.3 

Non-consolidated Variable interest entities (VIEs)

At March 31, 2024, the company's risk of loss with respect to VIEs in which the company is not the primary beneficiary included our investment carrying value of $141.4 million (December 31, 2023: $122.9 million) and unfunded capital commitments of $153.2 million (December 31, 2023: $142.5 million).

See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.
XML 38 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RELATED PARTIES
 3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTIES RELATED PARTIES
MassMutual owns approximately 18.1% in common stock of the company and owns substantially all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares as of March 31, 2024. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s Board of Directors, the company considers MassMutual a related party.

Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” The majority of the company's Operating revenues and receivables are from Invesco's managed funds. Related parties also include those defined in the company’s proxy statement.

Refer to Note 2, "Fair Value of Assets and Liabilities" and Note 3, "Investments" for more information on balances invested in Invesco affiliated funds.
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUBSEQUENT EVENTS
 3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
On April 23, 2024, the company declared a first quarter 2024 dividend of $0.205 per common share, payable on June 4, 2024, to common shareholders of record at the close of business on May 14, 2024 with an ex-dividend date of May 13, 2024.

On April 23, 2024, the company declared a preferred dividend of $14.75 per preferred share to the holders of preferred shares representing the period from March 1, 2024 through May 31, 2024. The preferred dividend is payable on June 3, 2024.
XML 40 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net income attributable to Invesco Ltd. $ 141.5 $ 145.0
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
ACCOUNTING POLICIES (Policies)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Accounting and Consolidation
Basis of Accounting and Consolidation
The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.
Reclassifications
Reclassifications

In the quarter ended March 31, 2024, expenses for client-related travel and entertainment and outsourced services were reclassified to General and administrative expenses. The impact of this reclassification on the Consolidated Statements of Income is as follows:

• For the three months ended March 31, 2024: decreased Marketing and Property, office and technology expenses by $6.7 million and $23.6 million, respectively, and increased General and administrative by $30.3 million.

• For the three months ended March 31, 2023: decreased Marketing and Property, office and technology expenses by $5.4 million and $23.9 million, respectively, and increased General and administrative by $29.3 million.

The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated.
Accounting Pronouncements Recently Adopted and Pending Accounting Pronouncements
Accounting Pronouncements Recently Adopted

None.

Pending Accounting Pronouncements

Refer to the most recent Form 10-K filed with the SEC.
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE OF ASSETS AND LIABILITIES (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value by Balance Sheet Grouping
The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products." See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.

March 31, 2024December 31, 2023
 (in millions)Fair ValueFair Value
Cash and cash equivalents$895.7 $1,469.2 
Equity investments297.2 272.4 
Assets held for policyholders — 393.9 
Policyholder payables (1)
— (393.9)
Total return swap related to deferred compensation plans8.1 4.9 
____________
(1)    These financial instruments are not measured at fair value on a recurring basis. Policyholder payables were indexed to the value of the assets held for policyholders and changes in fair value were recorded and offset to zero in other operating revenues. In January 2024, all funds were distributed to customers.
Tri-Level Hierarchy, Carrying Value
The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$434.7 $434.7 $— $— 
Investments: (2)
Equity investments:
Seed capital86.0 86.0 — — 
Investments related to deferred compensation plans211.2 211.2 — — 
Total return swap related to deferred compensation plans8.1 — 8.1 — 
Total$740.0 $731.9 $8.1 $— 
Liabilities:
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds (1)
$927.8 $927.8 $— $— 
Investments (2):
Equity investments:
Seed capital75.7 75.7 — — 
Investments related to deferred compensation plans196.7 196.7 — — 
Assets held for policyholders (3)
393.9 393.9 — — 
Total return swap related to deferred compensation plans4.9 — 4.9 — 
Total$1,599.0 $1,594.1 $4.9 $— 
Liabilities:    
Contingent consideration liability$(1.3)$— $— $(1.3)
Total$(1.3)$— $— $(1.3)
____________
(1)    The balance primarily represents cash held in affiliated money market funds.
(2)    Equity method and other investments of $651.4 million and $14.9 million, respectively, are excluded from this table (December 31, 2023: $631.8 million and $14.9 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards.
(3)    The majority of Assets held for policyholders were held in affiliated funds.
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS (Tables)
 3 Months Ended
Mar. 31, 2024
Investments [Abstract]  
Marketable Securities
The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products."

(in millions)March 31, 2024December 31, 2023
Equity investments:
Seed capital$86.0 $75.7 
Investments related to deferred compensation plans211.2 196.7 
Equity method investments651.4 631.8 
Other14.9 14.9 
Total investments (1)
$963.5 $919.1 
_________
(1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
DEBT (Tables)
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt Instruments
The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products."

March 31, 2024December 31, 2023
(in millions)
Carrying Value (3)
Fair Value
Carrying Value (3)
Fair Value
$2.0 billion floating rate credit agreement expiring April 26, 2028
$367.6 $367.6 $— $— 
Unsecured Senior Notes: (1)
$600 million 4.000% - due January 30, 2024 (2)
— — 599.9 599.1 
$500 million 3.750% - due January 15, 2026
498.7 488.0 498.6 489.1 
$400 million 5.375% - due November 30, 2043
391.2 391.7 391.0 409.6 
Debt$1,257.5 $1,247.3 $1,489.5 $1,497.8 
____________
(1)    The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures.
(2)     On January 30, 2024, the outstanding balance of the $600.0 million senior notes was paid in full.
(3)    The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE CAPITAL (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Movements in Shares Issued and Outstanding
The number of preferred shares issued and outstanding is represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Preferred shares issued (1)
4.04.0 
Preferred shares outstanding (1)
4.04.0 
____________
(1)    Substantially all the preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024.

The number of common shares and common share equivalents issued are represented in the table below:

As of
(in millions)March 31, 2024December 31, 2023
Common shares issued566.1 566.1 
Less: Treasury shares for which dividend and voting rights do not apply
(116.3)(116.6)
Common shares outstanding449.8 449.5 
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER COMPREHENSIVE INCOME/(LOSS) (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Income/(Loss)
The components of accumulated other comprehensive income/(loss) were as follows:

Three months ended March 31, 2024Three months ended March 31, 2023
(in millions)Foreign currency translationEmployee benefit plansTotalForeign currency translationEmployee benefit plansTotal
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries
$(96.3)$— $(96.3)$55.1 $— $55.1 
Other comprehensive income/(loss), net— 1.0 1.0 — 4.4 4.4 
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Beginning balance(670.1)(131.7)(801.8)(815.0)(127.4)(942.4)
Other comprehensive income/(loss), net of tax(96.3)1.0 (95.3)55.1 4.4 59.5 
Ending balance$(766.4)$(130.7)$(897.1)$(759.9)$(123.0)$(882.9)
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
REVENUE (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Geographic Disaggregation of Revenue
The geographic disaggregation of revenue for the three months ended March 31, 2024 and 2023 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda.

Three months ended March 31,
(in millions)20242023
Americas$1,140.6 $1,083.4 
Asia-Pacific (APAC)68.769.9
Europe, Middle East and Africa (EMEA)266.0264.9
Total operating revenues$1,475.3 $1,418.2 
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMON SHARE-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Movements of Share Awards
Movements on employee common share awards during the periods ended March 31 are detailed below:

Three months ended March 31, 2024 Three months ended March 31, 2023
(in millions of common shares, except fair values)Time- VestedPerformance- VestedWeighted Average Grant Date Fair ValueTime- VestedPerformance- Vested
Unvested at the beginning of period
10.4 1.6 $18.84 10.3 2.1 
Granted during the period4.9 0.9 15.13 4.3 0.7 
Forfeited during the period(0.2)(0.1)18.21 — (0.2)
Vested and distributed during the period
(4.4)(0.3)18.29 (4.5)(0.5)
Unvested at the end of the period
10.7 2.1 $17.41 10.1 2.1 
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EARNINGS PER COMMON SHARE (Tables)
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Calculation of Earnings Per Share
The calculation of earnings per common share (EPS) is as follows:

Three months ended March 31,
(in millions, except per share data)20242023
Net income attributable to Invesco Ltd.$141.5 $145.0 
Invesco Ltd:
Weighted average common shares outstanding - basic453.2 458.1 
Dilutive effect of non-participating common share-based awards0.3 0.8 
Weighted average common shares outstanding - diluted453.5 458.9 
Earnings per common share:
-basic$0.31 $0.32 
-diluted$0.31 $0.32 
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED INVESTMENT PRODUCTS (Tables)
 3 Months Ended
Mar. 31, 2024
Consolidated Investment Products [Abstract]  
Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products
The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2024 and December 31, 2023:

As of March 31, 2024
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$7,133.8 $— $6,143.3 $990.5 $— 
Bonds624.5 11.9 612.3 0.3 — 
Equity securities172.9 30.1 19.4 123.4 — 
Equity and fixed income mutual funds112.9 0.2 112.7 — — 
Investments in other private equity funds412.6 — — — 412.6 
Real estate investments445.5 — — — 445.5 
Total assets at fair value$8,902.2 $42.2 $6,887.7 $1,114.2 $858.1 

As of December 31, 2023
(in millions)Fair Value MeasurementsQuoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)		Investments Measured at NAV as a practical expedient
Assets:
Bank loans$6,837.2 $— $6,140.1 $697.1 $— 
Bonds669.8 13.3 656.2 0.3 — 
Equity securities231.9 85.2 18.3 128.4 — 
Equity and fixed income mutual funds137.9 8.0 129.9 — — 
Investments in other private equity funds425.5 — — — 425.5 
Real estate investments463.6 — — — 463.6 
Total assets at fair value$8,765.9 $106.5 $6,944.5 $825.8 $889.1 
Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block
The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:
Three months ended March 31,
20242023
(in millions)Level 3 AssetsLevel 3 Assets
Beginning Balance as of January 1$825.8 $368.6 
CIP Purchases275.0 0.1 
CIP Sales(2.3)(13.4)
Deconsolidation of CIP— (0.6)
Gains and losses included in the Consolidated Statements of Income(1.9)(7.6)
Transfers from Level 3 into Levels 1 or 2(16.2)(130.2)
Transfers into Level 3 from Levels 1 or 234.0 132.2 
Foreign exchange(0.2)2.2 
Ending Balance as of March 31$1,114.2 $351.3 
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue from External Customer [Line Items]    
Marketing expense $ (18.1) $ (19.6)
Property, office, and technology expense (117.6) (110.5)
General and administrative expense 138.5 105.0
Reclassification Adjustments [Member]    
Revenue from External Customer [Line Items]    
Marketing expense 6.7 5.4
Property, office, and technology expense 23.6 23.9
General and administrative expense $ 30.3 $ 29.3
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash and cash equivalents $ 895.7 $ 1,469.2 $ 889.0
Assets held for policyholders 0.0 393.9  
Policyholder payables 0.0 (393.9)  
Fair Value      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash and cash equivalents 895.7 1,469.2  
Equity investments 297.2 272.4  
Assets held for policyholders 0.0 393.9  
Policyholder payables 0.0 (393.9)  
Fair Value | Total return swaps related to deferred compensation plans      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Total return swap related to deferred compensation plans $ 8.1 $ 4.9  
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Equity investments:    
Assets held for policyholders $ 0.0 $ 393.9
Total return swap related to deferred compensation plans 8.1 4.9
Total 740.0 1,599.0
Liabilities:    
Total (1.3) (1.3)
Equity method investments 651.4 631.8
Other investments 14.9 14.9
Contingent consideration liability    
Liabilities:    
Contingent consideration liability (1.3) (1.3)
Money market funds    
Cash equivalents:    
Money market funds 434.7 927.8
Seed capital    
Equity investments:    
Equity investments 86.0 75.7
Investments related to deferred compensation plans    
Equity investments:    
Equity investments 211.2 196.7
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Equity investments:    
Assets held for policyholders   393.9
Total return swap related to deferred compensation plans 0.0 0.0
Total 731.9 1,594.1
Liabilities:    
Total 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent consideration liability    
Liabilities:    
Contingent consideration liability 0.0 0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds    
Cash equivalents:    
Money market funds 434.7 927.8
Quoted Prices in Active Markets for Identical Assets (Level 1) | Seed capital    
Equity investments:    
Equity investments 86.0 75.7
Quoted Prices in Active Markets for Identical Assets (Level 1) | Investments related to deferred compensation plans    
Equity investments:    
Equity investments 211.2 196.7
Significant Other Observable Inputs (Level 2)    
Equity investments:    
Assets held for policyholders   0.0
Total return swap related to deferred compensation plans 8.1 4.9
Total 8.1 4.9
Liabilities:    
Total 0.0 0.0
Significant Other Observable Inputs (Level 2) | Contingent consideration liability    
Liabilities:    
Contingent consideration liability 0.0 0.0
Significant Other Observable Inputs (Level 2) | Money market funds    
Cash equivalents:    
Money market funds 0.0 0.0
Significant Other Observable Inputs (Level 2) | Seed capital    
Equity investments:    
Equity investments 0.0 0.0
Significant Other Observable Inputs (Level 2) | Investments related to deferred compensation plans    
Equity investments:    
Equity investments 0.0 0.0
Significant Unobservable Inputs (Level 3)    
Equity investments:    
Assets held for policyholders   0.0
Total return swap related to deferred compensation plans 0.0 0.0
Total 0.0 0.0
Liabilities:    
Total (1.3) (1.3)
Significant Unobservable Inputs (Level 3) | Contingent consideration liability    
Liabilities:    
Contingent consideration liability (1.3) (1.3)
Significant Unobservable Inputs (Level 3) | Money market funds    
Cash equivalents:    
Money market funds 0.0 0.0
Significant Unobservable Inputs (Level 3) | Seed capital    
Equity investments:    
Equity investments 0.0 0.0
Significant Unobservable Inputs (Level 3) | Investments related to deferred compensation plans    
Equity investments:    
Equity investments $ 0.0 $ 0.0
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative asset $ 8.1   $ 4.9
Total return swaps related to deferred compensation plans | Designated as Hedging Instrument      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative notional amount 424.4   393.0
Derivative asset 8.1   $ 4.9
Market valuation gain recognized $ 18.0 $ 13.1  
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS - Details of Company Investments (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Schedule of Investments [Line Items]    
Equity method investments $ 651.4 $ 631.8
Other 14.9 14.9
Total investments 963.5 919.1
Seed capital    
Schedule of Investments [Line Items]    
Equity investments 86.0 75.7
Investments related to deferred compensation plans    
Schedule of Investments [Line Items]    
Equity investments $ 211.2 $ 196.7
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Investments [Abstract]    
Net gains $ 16.2 $ 6.7
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
DEBT - Schedule of Long-Term Debt Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Jan. 30, 2024
Dec. 31, 2023
Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 600.0 $ 600.0  
Debt instrument, interest rate, stated percentage 4.00%    
Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 500.0    
Debt instrument, interest rate, stated percentage 3.75%    
Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 400.0    
Debt instrument, interest rate, stated percentage 5.375%    
Carrying Value      
Debt Instrument [Line Items]      
Long-term debt $ 1,257.5   $ 1,489.5
Carrying Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024      
Debt Instrument [Line Items]      
Long-term debt 0.0   599.9
Carrying Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026      
Debt Instrument [Line Items]      
Long-term debt 498.7   498.6
Carrying Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043      
Debt Instrument [Line Items]      
Long-term debt 391.2   391.0
Carrying Value | Floating rate credit facility      
Debt Instrument [Line Items]      
Credit facility capacity 2,000.0    
Line of credit facility, amount outstanding 367.6   0.0
Fair Value      
Debt Instrument [Line Items]      
Long-term debt 1,247.3   1,497.8
Fair Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024      
Debt Instrument [Line Items]      
Long-term debt 0.0   599.1
Fair Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026      
Debt Instrument [Line Items]      
Long-term debt 488.0   489.1
Fair Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043      
Debt Instrument [Line Items]      
Long-term debt 391.7   409.6
Fair Value | Floating rate credit facility      
Debt Instrument [Line Items]      
Line of credit facility, amount outstanding $ 367.6   $ 0.0
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details) - shares
shares in Millions
 3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Equity [Abstract]    
Preferred shares issued (in shares) 4.0 4.0
Preferred shares outstanding (in shares) 4.0 4.0
Lock up, term 5 years  
Common shares issued 566.1 566.1
Less: Treasury shares for which dividend and voting rights do not apply (116.3) (116.6)
Common shares outstanding 449.8 449.5
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Currency translation differences on investments in foreign subsidiaries $ (96.3) $ 55.1
Other comprehensive income/(loss), net 1.0 4.4
Other comprehensive income/(loss) (95.3) 59.5
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance 15,170.3 15,843.5
Other comprehensive income/(loss), net of tax (95.3) 59.5
Ending balance 15,185.0 15,930.2
Foreign currency translation    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Currency translation differences on investments in foreign subsidiaries (96.3) 55.1
Other comprehensive income/(loss), net 0.0 0.0
Other comprehensive income/(loss) (96.3) 55.1
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (670.1) (815.0)
Other comprehensive income/(loss), net of tax (96.3) 55.1
Ending balance (766.4) (759.9)
Employee benefit plans    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Currency translation differences on investments in foreign subsidiaries 0.0 0.0
Other comprehensive income/(loss), net 1.0 4.4
Other comprehensive income/(loss) 1.0 4.4
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (131.7) (127.4)
Other comprehensive income/(loss), net of tax 1.0 4.4
Ending balance (130.7) (123.0)
Total    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income/(loss) (95.3) 59.5
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (801.8) (942.4)
Other comprehensive income/(loss), net of tax (95.3) 59.5
Ending balance $ (897.1) $ (882.9)
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
REVENUE - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue, Major Customer [Line Items]    
Total operating revenues $ 1,475.3 $ 1,418.2
Bermuda    
Revenue, Major Customer [Line Items]    
Total operating revenues 0.0 0.0
Americas    
Revenue, Major Customer [Line Items]    
Total operating revenues 1,140.6 1,083.4
Asia-Pacific (APAC)    
Revenue, Major Customer [Line Items]    
Total operating revenues 68.7 69.9
Europe, Middle East and Africa (EMEA)    
Revenue, Major Customer [Line Items]    
Total operating revenues $ 266.0 $ 264.9
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMON SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Common share-based compensation expense $ 21.1 $ 37.8
Fair value of vested shares $ 67.0 $ 87.3
Weighted average fair value of shares granted (in USD per share) $ 15.13 $ 17.74
Unrecognized compensation cost related to non-vested shares $ 182.5  
Weighted average non-vested shares compensation cost expected to recognize 2 years 11 months 8 days  
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details) - $ / shares
shares in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Weighted Average Grant Date Fair Value    
Unvested at the beginning of period (in USD per share) $ 18.84  
Granted during the period (in USD per share) 15.13 $ 17.74
Forfeited during the period (in USD per share) 18.21  
Vested and distributed during the period (in USD per share) 18.29  
Unvested at the end of the period (in USD per share) $ 17.41  
Time- Vested    
Number of Shares    
Unvested at the beginning of period (in shares) 10.4 10.3
Granted during the period (in shares) 4.9 4.3
Forfeited during the period (in shares) (0.2) 0.0
Vested and distributed during the period (in shares) (4.4) (4.5)
Unvested at the end of the period (in shares) 10.7 10.1
Performance- Vested    
Number of Shares    
Unvested at the beginning of period (in shares) 1.6 2.1
Granted during the period (in shares) 0.9 0.7
Forfeited during the period (in shares) (0.1) (0.2)
Vested and distributed during the period (in shares) (0.3) (0.5)
Unvested at the end of the period (in shares) 2.1 2.1
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net income attributable to Invesco Ltd. $ 141.5 $ 145.0
Weighted average common shares outstanding - basic (shares) 453.2 458.1
Dilutive effect of non-participating common share-based awards (shares) 0.3 0.8
Weighted average common shares outstanding - diluted (shares) 453.5 458.9
Earnings per common share:    
Basic (in USD per share) $ 0.31 $ 0.32
Diluted (in USD per share) $ 0.31 $ 0.32
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Loss Contingencies [Line Items]    
Undrawn capital commitments $ 664.6 $ 623.3
Equity Commitment    
Loss Contingencies [Line Items]    
Maximum guarantee 30.0  
Equity Commitment | Maximum    
Loss Contingencies [Line Items]    
Commitments $ 274.6  
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Variable Interest Entity [Line Items]    
Net interests in consolidated investment products $ 521.9 $ 546.2
Debt of CIP 7,370.4 7,121.8
Variable interest entity, unfunded capital commitments 153.2 142.5
Fair Value, Inputs, Level 3 [Member]    
Variable Interest Entity [Line Items]    
Debt of CIP 565.0 353.7
De-consolidated    
Variable Interest Entity [Line Items]    
Carrying value and maximum risk of loss with respect to VIEs in which the Company is not primary beneficiary $ 141.4 $ 122.9
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Total assets at fair value $ 8,902.2 $ 8,765.9
Consolidated    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Real estate investments 445.5 463.6
Total assets at fair value 8,902.2 8,765.9
Consolidated | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Real estate investments 0.0 0.0
Total assets at fair value 42.2 106.5
Consolidated | Significant Other Observable Inputs (Level 2)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Real estate investments 0.0 0.0
Total assets at fair value 6,887.7 6,944.5
Consolidated | Significant Unobservable Inputs (Level 3)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Real estate investments 0.0 0.0
Total assets at fair value 1,114.2 825.8
Consolidated | Investments Measured at NAV as a practical expedient    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Real estate investments 445.5 463.6
Total assets at fair value 858.1 889.1
Consolidated | Bank loans    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 7,133.8 6,837.2
Consolidated | Bank loans | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 0.0 0.0
Consolidated | Bank loans | Significant Other Observable Inputs (Level 2)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 6,143.3 6,140.1
Consolidated | Bank loans | Significant Unobservable Inputs (Level 3)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 990.5 697.1
Consolidated | Bank loans | Investments Measured at NAV as a practical expedient    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 0.0 0.0
Consolidated | Bonds    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 624.5 669.8
Consolidated | Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 11.9 13.3
Consolidated | Bonds | Significant Other Observable Inputs (Level 2)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 612.3 656.2
Consolidated | Bonds | Significant Unobservable Inputs (Level 3)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 0.3 0.3
Consolidated | Bonds | Investments Measured at NAV as a practical expedient    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 0.0 0.0
Consolidated | Equity securities, Equity and fixed income mutual funds    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 172.9 231.9
Equity and fixed income mutual funds, and investments in other private equity funds 112.9 137.9
Consolidated | Equity securities, Equity and fixed income mutual funds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 30.1 85.2
Equity and fixed income mutual funds, and investments in other private equity funds 0.2 8.0
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Other Observable Inputs (Level 2)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 19.4 18.3
Equity and fixed income mutual funds, and investments in other private equity funds 112.7 129.9
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Unobservable Inputs (Level 3)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 123.4 128.4
Equity and fixed income mutual funds, and investments in other private equity funds 0.0 0.0
Consolidated | Equity securities, Equity and fixed income mutual funds | Investments Measured at NAV as a practical expedient    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Bank loan, bonds and equity securities 0.0 0.0
Equity and fixed income mutual funds, and investments in other private equity funds 0.0 0.0
Consolidated | Investments in other private equity funds    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Equity and fixed income mutual funds, and investments in other private equity funds 412.6 425.5
Consolidated | Investments in other private equity funds | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Equity and fixed income mutual funds, and investments in other private equity funds 0.0 0.0
Consolidated | Investments in other private equity funds | Significant Other Observable Inputs (Level 2)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Equity and fixed income mutual funds, and investments in other private equity funds 0.0 0.0
Consolidated | Investments in other private equity funds | Significant Unobservable Inputs (Level 3)    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Equity and fixed income mutual funds, and investments in other private equity funds 0.0 0.0
Consolidated | Investments in other private equity funds | Investments Measured at NAV as a practical expedient    
Segment Reporting, Other Significant Reconciling Items [Line Items]    
Equity and fixed income mutual funds, and investments in other private equity funds $ 412.6 $ 425.5
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details) - Significant Unobservable Inputs (Level 3) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning Balance as of January 1 $ 825.8 $ 368.6
CIP Purchases 275.0 0.1
CIP Sales (2.3) (13.4)
Deconsolidation of CIP 0.0 (0.6)
Gains and losses included in the Consolidated Statements of Income (1.9) (7.6)
Transfers from Level 3 into Levels 1 or 2 (16.2) (130.2)
Transfers into Level 3 from Levels 1 or 2 34.0 132.2
Foreign exchange (0.2) 2.2
Ending Balance as of March 31 $ 1,114.2 $ 351.3
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RELATED PARTIES (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Related Party Transactions [Line Items]    
Stock consideration $ 4,010.5 $ 4,010.5
MassMutual | Invesco | MassMutual    
Related Party Transactions [Line Items]    
Approximate stake help in common stock of combined firm (percent) 18.10%  
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUBSEQUENT EVENTS (Details) - $ / shares
 3 Months Ended
Apr. 23, 2024
Mar. 31, 2024
Mar. 31, 2023
Subsequent Event [Line Items]      
Common stock dividends declared per share (in USD per share)   $ 0.20 $ 0.1875
Preferred stock dividend declared (in USD per share)   $ 14.75 $ 14.75
Subsequent Event      
Subsequent Event [Line Items]      
Common stock dividends declared per share (in USD per share) $ 0.205    
Preferred stock dividend declared (in USD per share) $ 14.75    
EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 224 226 1 false 52 0 false 4 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.invesco.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited Condensed Consolidated Statements of Income (Unaudited) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) Sheet http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited Condensed Consolidated Statements of Changes in Equity (Unaudited) Statements 7 false false R8.htm 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) Sheet http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) Statements 8 false false R9.htm 0000009 - Disclosure - ACCOUNTING POLICIES Sheet http://www.invesco.com/role/ACCOUNTINGPOLICIES ACCOUNTING POLICIES Notes 9 false false R10.htm 0000010 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES Sheet http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIES FAIR VALUE OF ASSETS AND LIABILITIES Notes 10 false false R11.htm 0000011 - Disclosure - INVESTMENTS Sheet http://www.invesco.com/role/INVESTMENTS INVESTMENTS Notes 11 false false R12.htm 0000012 - Disclosure - DEBT Sheet http://www.invesco.com/role/DEBT DEBT Notes 12 false false R13.htm 0000013 - Disclosure - SHARE CAPITAL Sheet http://www.invesco.com/role/SHARECAPITAL SHARE CAPITAL Notes 13 false false R14.htm 0000014 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) Sheet http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSS OTHER COMPREHENSIVE INCOME/(LOSS) Notes 14 false false R15.htm 0000015 - Disclosure - REVENUE Sheet http://www.invesco.com/role/REVENUE REVENUE Notes 15 false false R16.htm 0000016 - Disclosure - COMMON SHARE-BASED COMPENSATION Sheet http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATION COMMON SHARE-BASED COMPENSATION Notes 16 false false R17.htm 0000017 - Disclosure - EARNINGS PER COMMON SHARE Sheet http://www.invesco.com/role/EARNINGSPERCOMMONSHARE EARNINGS PER COMMON SHARE Notes 17 false false R18.htm 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 0000019 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS Sheet http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTS CONSOLIDATED INVESTMENT PRODUCTS Notes 19 false false R20.htm 0000020 - Disclosure - RELATED PARTIES Sheet http://www.invesco.com/role/RELATEDPARTIES RELATED PARTIES Notes 20 false false R21.htm 0000021 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.invesco.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - ACCOUNTING POLICIES (Policies) Sheet http://www.invesco.com/role/ACCOUNTINGPOLICIESPolicies ACCOUNTING POLICIES (Policies) Policies 24 false false R25.htm 9954472 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables) Sheet http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTables FAIR VALUE OF ASSETS AND LIABILITIES (Tables) Tables http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIES 25 false false R26.htm 9954473 - Disclosure - INVESTMENTS (Tables) Sheet http://www.invesco.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.invesco.com/role/INVESTMENTS 26 false false R27.htm 9954474 - Disclosure - DEBT (Tables) Sheet http://www.invesco.com/role/DEBTTables DEBT (Tables) Tables http://www.invesco.com/role/DEBT 27 false false R28.htm 9954475 - Disclosure - SHARE CAPITAL (Tables) Sheet http://www.invesco.com/role/SHARECAPITALTables SHARE CAPITAL (Tables) Tables http://www.invesco.com/role/SHARECAPITAL 28 false false R29.htm 9954476 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) (Tables) Sheet http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables OTHER COMPREHENSIVE INCOME/(LOSS) (Tables) Tables http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSS 29 false false R30.htm 9954477 - Disclosure - REVENUE (Tables) Sheet http://www.invesco.com/role/REVENUETables REVENUE (Tables) Tables http://www.invesco.com/role/REVENUE 30 false false R31.htm 9954478 - Disclosure - COMMON SHARE-BASED COMPENSATION (Tables) Sheet http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONTables COMMON SHARE-BASED COMPENSATION (Tables) Tables http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATION 31 false false R32.htm 9954479 - Disclosure - EARNINGS PER COMMON SHARE (Tables) Sheet http://www.invesco.com/role/EARNINGSPERCOMMONSHARETables EARNINGS PER COMMON SHARE (Tables) Tables http://www.invesco.com/role/EARNINGSPERCOMMONSHARE 32 false false R33.htm 9954480 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS (Tables) Sheet http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSTables CONSOLIDATED INVESTMENT PRODUCTS (Tables) Tables http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTS 33 false false R34.htm 9954481 - Disclosure - Accounting Policies (Details) Sheet http://www.invesco.com/role/AccountingPoliciesDetails Accounting Policies (Details) Details 34 false false R35.htm 9954482 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details) Sheet http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details) Details 35 false false R36.htm 9954483 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details) Sheet http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details) Details 36 false false R37.htm 9954484 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details) Sheet http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details) Details 37 false false R38.htm 9954485 - Disclosure - INVESTMENTS - Details of Company Investments (Details) Sheet http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails INVESTMENTS - Details of Company Investments (Details) Details 38 false false R39.htm 9954486 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.invesco.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 39 false false R40.htm 9954487 - Disclosure - DEBT - Schedule of Long-Term Debt Instruments (Details) Sheet http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails DEBT - Schedule of Long-Term Debt Instruments (Details) Details 40 false false R41.htm 9954488 - Disclosure - SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details) Sheet http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details) Details 41 false false R42.htm 9954489 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details) Sheet http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details) Details 42 false false R43.htm 9954490 - Disclosure - REVENUE - Disaggregation of Revenue (Details) Sheet http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails REVENUE - Disaggregation of Revenue (Details) Details 43 false false R44.htm 9954491 - Disclosure - COMMON SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails COMMON SHARE-BASED COMPENSATION - Narrative (Details) Details 44 false false R45.htm 9954492 - Disclosure - COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details) Sheet http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details) Details 45 false false R46.htm 9954493 - Disclosure - EARNINGS PER COMMON SHARE (Details) Sheet http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails EARNINGS PER COMMON SHARE (Details) Details http://www.invesco.com/role/EARNINGSPERCOMMONSHARETables 46 false false R47.htm 9954494 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIES 47 false false R48.htm 9954495 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details) Sheet http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details) Details 48 false false R49.htm 9954496 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details) Notes http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details) Details 49 false false R50.htm 9954497 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details) Sheet http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details) Details 50 false false R51.htm 9954498 - Disclosure - RELATED PARTIES (Details) Sheet http://www.invesco.com/role/RELATEDPARTIESDetails RELATED PARTIES (Details) Details http://www.invesco.com/role/RELATEDPARTIES 51 false false R52.htm 9954499 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.invesco.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.invesco.com/role/SUBSEQUENTEVENTS 52 false false All Reports Book All Reports ivz-20240331.htm ivz-20240331.xsd ivz-20240331_cal.xml ivz-20240331_def.xml ivz-20240331_lab.xml ivz-20240331_pre.xml ivz-20240331_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 77 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ivz-20240331.htm": { "nsprefix": "ivz", "nsuri": "http://www.invesco.com/20240331", "dts": { "inline": { "local": [ "ivz-20240331.htm" ] }, "schema": { "local": [ "ivz-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "ivz-20240331_cal.xml" ] }, "definitionLink": { "local": [ "ivz-20240331_def.xml" ] }, "labelLink": { "local": [ "ivz-20240331_lab.xml" ] }, "presentationLink": { "local": [ "ivz-20240331_pre.xml" ] } }, "keyStandard": 193, "keyCustom": 33, "axisStandard": 23, "axisCustom": 0, "memberStandard": 39, "memberCustom": 10, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 224, "entityCount": 1, "segmentCount": 52, "elementCount": 479, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 564, "http://xbrl.sec.gov/dei/2023": 30, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.invesco.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AccountsReceivableNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R3": { "role": "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "longName": "0000004 - Statement - Condensed Consolidated Statements of Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ivz:ThirdPartyDistributionServiceAndAdvisory", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R5": { "role": "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R6": { "role": "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R7": { "role": "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "longName": "0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-15", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R8": { "role": "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical", "longName": "0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PreferredStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://www.invesco.com/role/ACCOUNTINGPOLICIES", "longName": "0000009 - Disclosure - ACCOUNTING POLICIES", "shortName": "ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIES", "longName": "0000010 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.invesco.com/role/INVESTMENTS", "longName": "0000011 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.invesco.com/role/DEBT", "longName": "0000012 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.invesco.com/role/SHARECAPITAL", "longName": "0000013 - Disclosure - SHARE CAPITAL", "shortName": "SHARE CAPITAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSS", "longName": "0000014 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS)", "shortName": "OTHER COMPREHENSIVE INCOME/(LOSS)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.invesco.com/role/REVENUE", "longName": "0000015 - Disclosure - REVENUE", "shortName": "REVENUE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATION", "longName": "0000016 - Disclosure - COMMON SHARE-BASED COMPENSATION", "shortName": "COMMON SHARE-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.invesco.com/role/EARNINGSPERCOMMONSHARE", "longName": "0000017 - Disclosure - EARNINGS PER COMMON SHARE", "shortName": "EARNINGS PER COMMON SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIES", "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTS", "longName": "0000019 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS", "shortName": "CONSOLIDATED INVESTMENT PRODUCTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "ivz:ConsolidatedInvestmentProductsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ivz:ConsolidatedInvestmentProductsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.invesco.com/role/RELATEDPARTIES", "longName": "0000020 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.invesco.com/role/SUBSEQUENTEVENTS", "longName": "0000021 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.invesco.com/role/ACCOUNTINGPOLICIESPolicies", "longName": "9954471 - Disclosure - ACCOUNTING POLICIES (Policies)", "shortName": "ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTables", "longName": "9954472 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables)", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.invesco.com/role/INVESTMENTSTables", "longName": "9954473 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.invesco.com/role/DEBTTables", "longName": "9954474 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.invesco.com/role/SHARECAPITALTables", "longName": "9954475 - Disclosure - SHARE CAPITAL (Tables)", "shortName": "SHARE CAPITAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "ivz:ScheduleOfStockAndTreasuryStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ivz:ScheduleOfStockAndTreasuryStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables", "longName": "9954476 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) (Tables)", "shortName": "OTHER COMPREHENSIVE INCOME/(LOSS) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.invesco.com/role/REVENUETables", "longName": "9954477 - Disclosure - REVENUE (Tables)", "shortName": "REVENUE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONTables", "longName": "9954478 - Disclosure - COMMON SHARE-BASED COMPENSATION (Tables)", "shortName": "COMMON SHARE-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.invesco.com/role/EARNINGSPERCOMMONSHARETables", "longName": "9954479 - Disclosure - EARNINGS PER COMMON SHARE (Tables)", "shortName": "EARNINGS PER COMMON SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSTables", "longName": "9954480 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS (Tables)", "shortName": "CONSOLIDATED INVESTMENT PRODUCTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "ivz:FairValueHierarchyLevelsOfInvestmentsHeldAndNotesIssuedByConsolidatedInvestmentProductsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ivz:FairValueHierarchyLevelsOfInvestmentsHeldAndNotesIssuedByConsolidatedInvestmentProductsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.invesco.com/role/AccountingPoliciesDetails", "longName": "9954481 - Disclosure - Accounting Policies (Details)", "shortName": "Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MarketingExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-61", "name": "us-gaap:MarketingExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R35": { "role": "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "longName": "9954482 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details)", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-63", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R36": { "role": "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "longName": "9954483 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details)", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:SeparateAccountAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R37": { "role": "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails", "longName": "9954484 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details)", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-105", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R38": { "role": "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails", "longName": "9954485 - Disclosure - INVESTMENTS - Details of Company Investments (Details)", "shortName": "INVESTMENTS - Details of Company Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-109", "name": "us-gaap:ShortTermInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:MarketableSecuritiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R39": { "role": "http://www.invesco.com/role/INVESTMENTSNarrativeDetails", "longName": "9954486 - Disclosure - INVESTMENTS - Narrative (Details)", "shortName": "INVESTMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails", "longName": "9954487 - Disclosure - DEBT - Schedule of Long-Term Debt Instruments (Details)", "shortName": "DEBT - Schedule of Long-Term Debt Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-117", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-117", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails", "longName": "9954488 - Disclosure - SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details)", "shortName": "SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:PreferredStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "us-gaap:PreferredStockSharesOutstanding", "us-gaap:PreferredStockSharesOutstanding", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ivz:LockUpTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "ivz:ScheduleOfStockAndTreasuryStockTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R42": { "role": "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails", "longName": "9954489 - Disclosure - OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details)", "shortName": "OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R43": { "role": "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails", "longName": "9954490 - Disclosure - REVENUE - Disaggregation of Revenue (Details)", "shortName": "REVENUE - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-145", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R44": { "role": "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails", "longName": "9954491 - Disclosure - COMMON SHARE-BASED COMPENSATION - Narrative (Details)", "shortName": "COMMON SHARE-BASED COMPENSATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R45": { "role": "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "longName": "9954492 - Disclosure - COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details)", "shortName": "COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails", "longName": "9954493 - Disclosure - EARNINGS PER COMMON SHARE (Details)", "shortName": "EARNINGS PER COMMON SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R47": { "role": "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails", "longName": "9954494 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-2", "name": "ivz:UndrawnCapitalCommitments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ivz:UndrawnCapitalCommitments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails", "longName": "9954495 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details)", "shortName": "CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-2", "name": "ivz:NetInterestsInConsolidatedInvestmentProducts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ivz:NetInterestsInConsolidatedInvestmentProducts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "longName": "9954496 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details)", "shortName": "CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-2", "name": "ivz:InvestmentsOfConsolidatedInvestmentProducts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-187", "name": "us-gaap:RealEstateInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ivz:FairValueHierarchyLevelsOfInvestmentsHeldAndNotesIssuedByConsolidatedInvestmentProductsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R50": { "role": "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails", "longName": "9954497 - Disclosure - CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details)", "shortName": "CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-100", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ivz:BeginningAndEndingFairValueMeasurementsForLevelThreeAssetsAndLiabilitiesTableTextBlockTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-100", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ivz:BeginningAndEndingFairValueMeasurementsForLevelThreeAssetsAndLiabilitiesTableTextBlockTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.invesco.com/role/RELATEDPARTIESDetails", "longName": "9954498 - Disclosure - RELATED PARTIES (Details)", "shortName": "RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:PreferredStockValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-223", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } }, "R52": { "role": "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails", "longName": "9954499 - Disclosure - SUBSEQUENT EVENTS (Details)", "shortName": "SUBSEQUENT EVENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-224", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ivz-20240331.htm", "unique": true } } }, "tag": { "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses", "label": "Accounts Payable and Accrued Liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r76" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r560", "r687", "r737", "r899" ] }, "ivz_Accountsreceivableandotherassetsofconsolidatedinvestmentproducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "Accountsreceivableandotherassetsofconsolidatedinvestmentproducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable and other assets of CIP", "label": "Accounts receivable and other assets of consolidated investment products", "documentation": "Amount due from customers or clients of the entity's consolidated investment products within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the net realizable fair value by an allowance established by the consolidated investment product entity of the amount it deems uncertain of collection." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefit plans", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r5", "r12", "r30", "r841", "r842", "r843" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r153", "r154", "r416", "r418", "r419", "r420", "r421", "r422" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income/(loss), net of tax", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r29", "r30", "r91", "r145", "r489", "r516", "r517" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r153", "r154", "r416", "r418", "r419", "r420", "r421", "r422" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "verboseLabel": "Total", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r12", "r30", "r394", "r397", "r426", "r512", "r513", "r841", "r842", "r843", "r854", "r855", "r856" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r12", "r30", "r154", "r155", "r418", "r419", "r420", "r421", "r422", "r841" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r787" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Additional paid-in-capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r85" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in-Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r376", "r377", "r378", "r529", "r854", "r855", "r856", "r885", "r905" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r793" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r793" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r793" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r793" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other common share awards", "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Common share-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r50", "r51", "r343" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by/(used in) operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r758", "r769", "r779", "r804" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r761", "r772", "r782", "r807" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r793" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r800" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r765", "r773", "r783", "r800", "r808", "r812", "r820" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r818" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas [Member]" } } }, "auth_ref": [ "r907", "r909", "r910", "r911" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r40", "r42" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia-Pacific (APAC)", "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r907", "r909", "r910", "r911" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r122", "r144", "r167", "r197", "r207", "r211", "r248", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r386", "r390", "r414", "r483", "r565", "r729", "r749", "r874", "r875", "r889" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "ASSETS", "terseLabel": "Assets:", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r65" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r811" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r811" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r811" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r811" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r811" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r811" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r814" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r813" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r812" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r812" ] }, "country_BM": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BM", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bermuda", "label": "BERMUDA" } } }, "auth_ref": [] }, "us-gaap_BankLoanObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankLoanObligationsMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Bank loans", "label": "Bank Loan Obligations [Member]", "documentation": "Investments in debentures, bonds and other debt securities issued by a bank holding company, its subsidiaries, or affiliates." } } }, "auth_ref": [] }, "ivz_BeginningAndEndingFairValueMeasurementsForLevelThreeAssetsAndLiabilitiesTableTextBlockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "BeginningAndEndingFairValueMeasurementsForLevelThreeAssetsAndLiabilitiesTableTextBlockTableTextBlock", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block", "label": "Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block [Table Text Block]", "documentation": "Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block" } } }, "auth_ref": [] }, "ivz_CapitalDistributedByConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "CapitalDistributedByConsolidatedInvestmentProducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Third-party capital distributed by CIP", "label": "Capital distributed by consolidated investment products", "documentation": "The cash outflow from any dividend or other distribution in cash with respect to any shares of, or other ownership interest in, an entity, except a dividend consisting of distribution of earnings or stock dividend or pro rata stock split." } } }, "auth_ref": [] }, "ivz_CapitalInvestedIntoConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "CapitalInvestedIntoConsolidatedInvestmentProducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Third-party capital invested into CIP", "label": "Capital invested into consolidated investment products", "documentation": "The cash inflow from the capital received in cash from a partner in a partnership during the period." } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Carrying Value", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r68", "r69" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents:", "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r35", "r141", "r703" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "ivz_CashAndCashEquivalentsOfConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "CashAndCashEquivalentsOfConsolidatedInvestmentProducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 }, "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents of CIP", "terseLabel": "Cash and cash equivalents of CIP", "label": "Cash and cash equivalents of consolidated investment products", "documentation": "Includes currency of the entity's consolidated investment products on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts held by the entity's consolidated investment products that have the general characteristics of demand deposits in that the consolidated investment products may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "totalLabel": "Total cash and cash equivalents per condensed consolidated statement of cash flows", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r35", "r101", "r164" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Increase/(decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r101" ] }, "ivz_ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in noncontrolling interests in consolidated entities, net", "label": "Change in Noncontrolling Interests in Consolidated Entities, Net", "documentation": "Increase or decrease in noncontrolling interest balance from receipt of contributions or payment of dividends or other distributions to noncontrolling interest shareholders." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r791" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r792" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r792" ] }, "ivz_CollateralizedLoanObligationCollateralAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "CollateralizedLoanObligationCollateralAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails": { "parentTag": "ivz_InvestmentsOfConsolidatedInvestmentProducts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Bank loan, bonds and equity securities", "label": "Collateralized Loan Obligation, Collateral Assets", "documentation": "Collateralized Loan Obligation, Collateral Assets" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (See Note 10)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r24", "r78", "r486", "r551" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "verboseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r108", "r260", "r261", "r688", "r868" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical", "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock dividends declared per share (in USD per share)", "verboseLabel": "Common stock dividends declared per share (in USD per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r113" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common Shares", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r734", "r735", "r736", "r738", "r739", "r740", "r743", "r854", "r855", "r885", "r901", "r905" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock par value (in USD per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r84" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r84", "r552" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "calculation": { "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails": { "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued (in shares)", "verboseLabel": "Common shares issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r84" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "calculation": { "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Common shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r84", "r552", "r571", "r905", "r906" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of March 31, 2024 and December 31, 2023)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r84", "r488", "r729" ] }, "us-gaap_CommunicationsInformationTechnologyAndOccupancy": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommunicationsInformationTechnologyAndOccupancy", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, office and technology", "negatedTerseLabel": "Property, office, and technology expense", "label": "Communications, Information Technology and Occupancy", "documentation": "The aggregate amount of communications, data processing and occupancy expenses." } } }, "auth_ref": [ "r96", "r132" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r797" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r796" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r798" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r795" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income/(loss) attributable to Invesco Ltd.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r31", "r150", "r152", "r159", "r475", "r502" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income/(loss)", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r60", "r115", "r150", "r152", "r158", "r474", "r501" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER COMPREHENSIVE INCOME/(LOSS)", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r90", "r157", "r473", "r499" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r170", "r386", "r387", "r390", "r391", "r433", "r698", "r873", "r876", "r877" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r170", "r386", "r387", "r390", "r391", "r433", "r698", "r873", "r876", "r877" ] }, "ivz_ConsolidatedInvestmentProductsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ConsolidatedInvestmentProductsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Consolidated Investment Products [Abstract]", "label": "Consolidated Investment Products [Abstract]", "documentation": "Consolidated Investment Products" } } }, "auth_ref": [] }, "ivz_ConsolidatedInvestmentProductsCIPAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ConsolidatedInvestmentProductsCIPAssetsAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Assets of consolidated investment products (CIP):", "label": "Consolidated Investment Products (CIP) Assets [Abstract]", "documentation": "Consolidated Investment Products (CIP) Assets" } } }, "auth_ref": [] }, "ivz_ConsolidatedInvestmentProductsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ConsolidatedInvestmentProductsDisclosureTextBlock", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTS" ], "lang": { "en-us": { "role": { "verboseLabel": "CONSOLIDATED INVESTMENT PRODUCTS", "label": "Consolidated Investment Products Disclosure [Text Block]", "documentation": "This item represents the disclosure of the company's consolidated investment products, including: (1) investment products that are variable interest entities and the company is the primary beneficiary; (2) other partnership entities in which the company is the general partner and is considered to have control, in the absence of simple majority kick-out rights to remove the general partner, simple majority liquidation rights to dissolve the partnership, or any substantive participating rights of the other limited partners; and (3) investment products in which the company has a controlling financial interest." } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.invesco.com/role/ACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Basis of Accounting and Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r54", "r707" ] }, "us-gaap_CorporateBondSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateBondSecuritiesMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bonds", "label": "Corporate Bond Securities [Member]", "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)." } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r168", "r169", "r282", "r309", "r431", "r704", "r706" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.invesco.com/role/DEBT" ], "lang": { "en-us": { "role": { "verboseLabel": "DEBT", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r109", "r165", "r278", "r284", "r285", "r286", "r287", "r288", "r289", "r294", "r301", "r302", "r304" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r18", "r81", "r82", "r123", "r124", "r170", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r299", "r300", "r425", "r714", "r715", "r716", "r717", "r718", "r851" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r71", "r73", "r279", "r425", "r715", "r716" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt instrument, interest rate, stated percentage", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r22", "r280" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r170", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r425", "r714", "r715", "r716", "r717", "r718", "r851" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r23", "r170", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r299", "r300", "r425", "r714", "r715", "r716", "r717", "r718", "r851" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r23", "r44", "r46", "r70", "r71", "r73", "r79", "r111", "r112", "r170", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r425", "r714", "r715", "r716", "r717", "r718", "r851" ] }, "ivz_DeferredCompensationArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "DeferredCompensationArrangementsMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments related to deferred compensation plans", "label": "Deferred Compensation Arrangements [Member]", "documentation": "Deferred compensation arrangements [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities, net", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r379", "r380", "r484" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization and depreciation", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r201" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total return swap related to deferred compensation plans", "verboseLabel": "Derivative asset", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r146", "r147", "r413", "r531", "r532", "r533", "r535", "r536", "r538", "r539", "r540", "r542", "r543", "r558", "r559", "r651", "r654", "r655", "r656", "r657", "r658", "r706", "r736", "r902" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r540", "r543", "r557", "r558", "r559", "r561", "r562", "r563", "r564", "r566", "r567", "r568", "r569", "r584", "r585", "r586", "r587", "r590", "r591", "r592", "r593", "r651", "r652", "r655", "r657", "r734", "r736" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r61", "r62", "r63", "r64", "r540", "r543", "r557", "r558", "r559", "r561", "r562", "r563", "r564", "r566", "r567", "r568", "r569", "r584", "r585", "r586", "r587", "r590", "r591", "r592", "r593", "r651", "r652", "r655", "r657", "r706", "r734", "r736" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Total return swap related to deferred compensation plans", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r146", "r147", "r413", "r531", "r532", "r533", "r535", "r538", "r539", "r540", "r542", "r543", "r566", "r568", "r569", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r706", "r902" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r883", "r884" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r14" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "verboseLabel": "COMMON SHARE-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r341", "r345", "r372", "r373", "r375", "r726" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Movements of Share Awards", "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r11", "r49" ] }, "us-gaap_DistributionAndShareholderServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DistributionAndShareholderServiceMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Service and distribution fees", "label": "Distribution and Shareholder Service [Member]", "documentation": "Distribution and shareholder assistance. Distribution assistance includes, but is not limited to, marketing and selling fund shares, advertising, printing and mailing of prospectus and sale literature to investor. Shareholder assistance includes, but is not limited to, answering shareholder inquiry and providing shareholder with investment information." } } }, "auth_ref": [ "r881" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends declared - common", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r113" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStock", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends declared on preferred shares", "negatedLabel": "Dividends declared on preferred shares", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r113" ] }, "us-gaap_DividendsPreferredStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStockCash", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends declared - preferred", "label": "Dividends, Preferred Stock, Cash", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r6", "r113" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r753" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r786" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe, Middle East and Africa (EMEA)", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r907", "r909", "r910", "r911" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings per common share:", "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in USD per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r160", "r176", "r177", "r178", "r179", "r180", "r185", "r187", "r189", "r190", "r191", "r195", "r402", "r403", "r476", "r503", "r708" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings per common share:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in USD per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r160", "r176", "r177", "r178", "r179", "r180", "r187", "r189", "r190", "r191", "r195", "r402", "r403", "r476", "r503", "r708" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHARE" ], "lang": { "en-us": { "role": { "terseLabel": "EARNINGS PER COMMON SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r184", "r192", "r193", "r194" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange movement on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r415" ] }, "ivz_EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange movement on cash and cash equivalents of CIP", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, CIP", "documentation": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, CIP" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Employee-related Liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r77", "r897" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost related to non-vested shares", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r374" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average non-vested shares compensation cost expected to recognize", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r374" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r751" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r751" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r751" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r825" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r751" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r751" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r751" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r751" ] }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customer [Line Items]", "label": "Revenue from External Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EntityWideRevenueMajorCustomerLineItems", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Major Customer [Line Items]", "label": "Revenue, Major Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "ivz_EquityCommitmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "EquityCommitmentMember", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Commitment", "label": "Equity Commitment [Member]", "documentation": "Equity Commitment" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r137", "r153", "r154", "r155", "r171", "r172", "r173", "r175", "r181", "r183", "r196", "r249", "r250", "r321", "r376", "r377", "r378", "r382", "r383", "r393", "r394", "r395", "r396", "r397", "r398", "r401", "r416", "r418", "r419", "r420", "r421", "r422", "r426", "r512", "r513", "r514", "r529", "r596" ] }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDividendsOrDistributions", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Distributions from equity method investees", "label": "Proceeds from Equity Method Investment, Distribution", "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities." } } }, "auth_ref": [ "r7", "r9", "r93", "r494" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r204", "r247", "r838", "r863" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity securities, Equity and fixed income mutual funds", "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r38", "r744", "r745", "r746", "r908" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r794" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r758", "r769", "r779", "r804" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r755", "r766", "r776", "r801" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair Value", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r292", "r413", "r715", "r716" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r800" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r406", "r407", "r410" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r406", "r407", "r410" ] }, "ivz_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r15" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r65", "r67" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r65", "r68", "r69" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Balance Sheet Grouping", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r65", "r68" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r292", "r334", "r335", "r336", "r337", "r338", "r339", "r407", "r440", "r441", "r442", "r715", "r716", "r722", "r723", "r724" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r67", "r119" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r16", "r65", "r292", "r715", "r716" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r292", "r715", "r716" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIES" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE OF ASSETS AND LIABILITIES", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r405" ] }, "ivz_FairValueHierarchyLevelsOfInvestmentsHeldAndNotesIssuedByConsolidatedInvestmentProductsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "FairValueHierarchyLevelsOfInvestmentsHeldAndNotesIssuedByConsolidatedInvestmentProductsTableTextBlock", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products", "label": "Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products [Table Text Block]", "documentation": "Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)", "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r292", "r334", "r339", "r407", "r440", "r722", "r723", "r724" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Significant Other Observable Inputs (Level 2)", "terseLabel": "Significant Other Observable Inputs (Level 2)", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r292", "r334", "r339", "r407", "r441", "r715", "r716", "r722", "r723", "r724" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Significant Unobservable Inputs (Level 3)", "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r292", "r334", "r335", "r336", "r337", "r338", "r339", "r407", "r442", "r715", "r716", "r722", "r723", "r724" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations", "crdr": "credit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Contingent consideration liability", "label": "Obligations, Fair Value Disclosure", "documentation": "Fair value of obligations measured on a recurring basis." } } }, "auth_ref": [ "r65", "r120" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Tri-Level Hierarchy, Carrying Value", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r65", "r120" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r15" ] }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments Measured at NAV as a practical expedient", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "documentation": "Fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r334", "r404", "r411" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gains and losses included in the Consolidated Statements of Income", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CIP Purchases", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r66" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "CIP Sales", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r66" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers into Level 3 from Levels 1 or 2", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3", "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r409" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Transfers from Level 3 into Levels 1 or 2", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r409" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning Balance as of January 1", "periodEndLabel": "Ending Balance as of March 31", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r15" ] }, "ivz_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisDeconsolidationOfCIP": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisDeconsolidationOfCIP", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deconsolidation of CIP", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Deconsolidation of CIP", "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Deconsolidation of CIP" } } }, "auth_ref": [] }, "ivz_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisForeignExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisForeignExchange", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Foreign Exchange", "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Foreign Exchange" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r292", "r334", "r335", "r336", "r337", "r338", "r339", "r440", "r441", "r442", "r715", "r716", "r722", "r723", "r724" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r303", "r319", "r399", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r500", "r712", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r859", "r860", "r861", "r862" ] }, "us-gaap_FinancialServiceOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialServiceOtherMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Financial Service, Other [Member]", "documentation": "Financial assistance, including, but not limited to, management and maintenance of depositor account, credit card, merchant discount, trust, investment and insurance, classified as other." } } }, "auth_ref": [ "r881" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r762", "r773", "r783", "r808" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r762", "r773", "r783", "r808" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r762", "r773", "r783", "r808" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r762", "r773", "r783", "r808" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r762", "r773", "r783", "r808" ] }, "ivz_GainsAndLossesOfConsolidatedInvestmentProductsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "GainsAndLossesOfConsolidatedInvestmentProductsNet", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other (gains)/losses of CIP, net", "label": "Gains and losses of consolidated investment products net", "documentation": "This item represents the net total realized and unrealized gain (loss) included in earnings of the entity's consolidated investment products for the period as a result of selling or holding marketable securities. Additionally, this item would include any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments of the subject investments." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "General and administrative", "terseLabel": "General and administrative expense", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r95", "r575" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r142", "r259", "r472", "r713", "r729", "r865", "r866" ] }, "us-gaap_GuaranteeObligationsMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsMaximumExposure", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum guarantee", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions." } } }, "auth_ref": [ "r268" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r14", "r392" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r92", "r130", "r197", "r206", "r210", "r212", "r477", "r495", "r710" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in earnings of unconsolidated affiliates", "negatedLabel": "Equity in earnings of unconsolidated affiliates", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r9", "r93", "r129", "r202", "r247", "r494" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r134", "r135", "r182", "r183", "r203", "r381", "r384", "r504" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase/(decrease) in payables", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDerivativeAssetsAndLiabilities", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market valuation gain recognized", "label": "Increase (Decrease) in Derivative Assets and Liabilities", "documentation": "The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)." } } }, "auth_ref": [ "r848" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "(Increase)/decrease in receivables", "label": "Increase (Decrease) in Receivables", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r765", "r773", "r783", "r800", "r808", "r812", "r820" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r818" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r754", "r824" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r754", "r824" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r754", "r824" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r72", "r133", "r156", "r200", "r424", "r581", "r747", "r904" ] }, "ivz_InvescoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "InvescoMember", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco", "label": "Invesco [Member]", "documentation": "Invesco" } } }, "auth_ref": [] }, "us-gaap_InvestmentAdviceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentAdviceMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Investment management fees", "label": "Investment Advice [Member]", "documentation": "Investment recommendation and research provided to customer." } } }, "auth_ref": [ "r881" ] }, "us-gaap_InvestmentIncomeInterestAndDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterestAndDividend", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest and dividend income", "label": "Investment Income, Interest and Dividend", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r97" ] }, "us-gaap_InvestmentPerformanceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPerformanceMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Performance fees", "label": "Investment Performance [Member]", "documentation": "Result achieved from investment. Excludes non-performance related result from asset under management." } } }, "auth_ref": [ "r881" ] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://www.invesco.com/role/INVESTMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS", "label": "Investment [Text Block]", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r828", "r829", "r858" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type [Axis]", "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r532", "r534", "r535", "r538", "r541", "r603", "r612", "r626", "r634", "r647", "r659", "r660", "r676", "r680", "r681", "r682", "r683", "r736" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments [Domain]", "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r532", "r534", "r535", "r538", "r541", "r603", "r612", "r626", "r634", "r647", "r659", "r660", "r676", "r680", "r681", "r682", "r683", "r736" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 }, "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "totalLabel": "Total investments", "label": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r480" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments:", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "ivz_InvestmentsOfConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "InvestmentsOfConsolidatedInvestmentProducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments of CIP", "totalLabel": "Total assets at fair value", "label": "Investments Of Consolidated Investment Products", "documentation": "Investment in Subsidiaries" } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee compensation", "label": "Labor and Related Expense", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r844" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r21", "r167", "r248", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r387", "r390", "r391", "r414", "r550", "r709", "r749", "r874", "r889", "r890" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "LIABILITIES", "terseLabel": "Liabilities:", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities, temporary and permanent equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r89", "r126", "r492", "r729", "r852", "r864", "r886" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r65" ] }, "us-gaap_LiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liability", "label": "Liability [Member]", "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, amount outstanding", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r18", "r124", "r898" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r20" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Floating rate credit facility", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ivz_LockUpTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "LockUpTerm", "presentation": [ "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lock up, term", "label": "Lock Up, Term", "documentation": "Lock Up, Term" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r18", "r124", "r291", "r305", "r715", "r716", "r898" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "ivz_LongTermDebtOfConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "LongTermDebtOfConsolidatedInvestmentProducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails", "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Debt of CIP", "label": "Long Term Debt Of Consolidated Investment Products", "documentation": "Sum of the carrying values as of the balance sheet date of all long-term debt of the entity's consolidated investment products, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premium, if any." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r23" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r23", "r43" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r262", "r263", "r264", "r267", "r869", "r870" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r262", "r263", "r264", "r267", "r869", "r870" ] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.invesco.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities [Table Text Block]", "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets." } } }, "auth_ref": [] }, "us-gaap_MarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingExpense", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Marketing", "negatedTerseLabel": "Marketing expense", "label": "Marketing Expense", "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs." } } }, "auth_ref": [ "r95" ] }, "ivz_MassMutualMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "MassMutualMember", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MassMutual", "label": "MassMutual [Member]", "documentation": "MassMutual [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r263", "r264", "r265", "r266", "r340", "r470", "r511", "r542", "r543", "r606", "r625", "r630", "r631", "r670", "r699", "r700", "r711", "r719", "r725", "r731", "r878", "r891", "r892", "r893", "r894", "r895", "r896" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r792" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r792" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity attributable to nonredeemable noncontrolling interests in consolidated entities", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r28", "r125", "r167", "r248", "r269", "r271", "r272", "r273", "r276", "r277", "r414", "r491", "r554" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Approximate stake help in common stock of combined firm (percent)", "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r811" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r882" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r819" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r793" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by/(used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r163" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by/(used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r163" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by/(used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r101", "r102", "r103" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Invesco Ltd.", "terseLabel": "Net income attributable to Invesco Ltd.", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r94", "r103", "r131", "r140", "r148", "r151", "r155", "r167", "r174", "r176", "r177", "r178", "r179", "r182", "r183", "r188", "r197", "r206", "r210", "r212", "r248", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r403", "r414", "r498", "r573", "r594", "r595", "r710", "r747", "r874" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net (income)/loss attributable to noncontrolling interests in consolidated entities", "negatedLabel": "Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r59", "r116", "r148", "r151", "r182", "r183", "r497", "r843" ] }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity." } } }, "auth_ref": [ "r19", "r116", "r117" ] }, "ivz_NetInterestsInConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "NetInterestsInConsolidatedInvestmentProducts", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net interests in consolidated investment products", "label": "Net Interests In Consolidated Investment Products", "documentation": "Net Interests In Consolidated Investment Products" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.invesco.com/role/ACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Pronouncements Recently Adopted and Pending Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r792" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r762", "r773", "r783", "r800", "r808" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r790" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r789" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r800" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r819" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r819" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Nonredeemable Noncontrolling Interests in Consolidated Entities", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r52", "r321", "r854", "r855", "r856", "r905" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Other income/(expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r197", "r206", "r210", "r212", "r710" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.invesco.com/role/ACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "ACCOUNTING POLICIES", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r80", "r104", "r105", "r114" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r121", "r143", "r481", "r749" ] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitment", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments", "label": "Other Commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitments [Axis]", "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitments [Domain]", "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation differences on investments in foreign subsidiaries", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income/(loss)", "verboseLabel": "Other comprehensive income/(loss)", "terseLabel": "Other comprehensive income/(loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r13", "r17", "r149", "r152", "r157", "r416", "r417", "r422", "r473", "r499", "r841", "r842" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income/(loss), net of tax:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeOtherNetOfTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other comprehensive income/(loss), net of tax", "terseLabel": "Other comprehensive income/(loss), net", "label": "Other Comprehensive Income, Other, Net of Tax", "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other investments", "verboseLabel": "Other", "label": "Other Investments", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r839" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other (gains)/losses, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r103" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other gains/(losses), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r98" ] }, "ivz_OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other income/(expense) of CIP, net", "label": "Other Nonoperating Income (Expense), Consolidated Investment Products", "documentation": "Other Nonoperating Income (Expense), Consolidated Investment Products" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r792" ] }, "ivz_Otherliabilitiesofconsolidatedinvestmentproducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "Otherliabilitiesofconsolidatedinvestmentproducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Other liabilities of CIP", "label": "Other liabilities of consolidated investment products", "documentation": "Aggregate carrying amount as of the balance sheet date of current obligations of the entity's consolidated investment products not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer)." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r760", "r771", "r781", "r806" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r763", "r774", "r784", "r809" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r763", "r774", "r784", "r809" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Axis]", "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Domain]", "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Total Equity Attributable to Invesco Ltd.", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r788" ] }, "us-gaap_PaymentsForProceedsFromShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromShortTermInvestments", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Purchase)/sale of investments, net", "label": "Payments for (Proceeds from) Short-Term Investments", "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r845", "r847", "r849" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of treasury shares", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid - common", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid - preferred", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r99" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, equipment and software", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r100" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r791" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r791" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r790" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r800" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r793" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r789" ] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance- Vested", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r412" ] }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsPerShareDeclared", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical", "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock dividend declared (in USD per share)", "label": "Preferred Stock, Dividends Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Liquidation preference per share (in USD per share)", "label": "Preferred Stock, Liquidation Preference Per Share", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r44", "r45", "r83", "r850", "r879" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Shares", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r734", "r735", "r738", "r739", "r740", "r743", "r901", "r905" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock par value (in USD per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r83", "r307" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r83", "r552" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued (in shares)", "verboseLabel": "Preferred shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r83", "r307" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical", "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares outstanding (in shares)", "verboseLabel": "Preferred shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r83", "r552", "r571", "r905", "r906" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of March 31, 2024 and December 31, 2023)", "verboseLabel": "Stock consideration", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r83", "r487", "r729" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.invesco.com/role/ACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r837" ] }, "ivz_PrivateEquityFundAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "PrivateEquityFundAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails": { "parentTag": "ivz_InvestmentsOfConsolidatedInvestmentProducts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity and fixed income mutual funds, and investments in other private equity funds", "label": "Private Equity Fund Assets", "documentation": "Private Equity Fund Assets" } } }, "auth_ref": [] }, "us-gaap_PrivateEquityFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivateEquityFundsMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments in other private equity funds", "label": "Private Equity Funds [Member]", "documentation": "Investments held in private equity funds." } } }, "auth_ref": [ "r882" ] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Capital distribution from equity method investees", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r162", "r846" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings of credit agreement", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r32", "r851" ] }, "ivz_ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP", "label": "Proceeds From (Payments To) Consolidation And Deconsolidation Of Subsidiaries", "documentation": "Proceeds From (Payments To) Consolidation And Deconsolidation Of Subsidiaries" } } }, "auth_ref": [] }, "ivz_ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Sale of investments by CIP", "label": "Proceeds from sale of investments by consolidated investment products", "documentation": "Cash inflow associated with investments held by the entity's consolidated investment products." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherInvestments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Sale of investments", "label": "Proceeds from Sale of Other Investments", "documentation": "Amount of cash inflow from the sale of investments classified as other." } } }, "auth_ref": [ "r826" ] }, "ivz_ProceedsfromDebtConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ProceedsfromDebtConsolidatedInvestmentProducts", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings of debt of CIP", "label": "Proceeds from Debt, Consolidated Investment Products", "documentation": "Proceeds from Debt, Consolidated Investment Products" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r213", "r471", "r505", "r506", "r507", "r508", "r509", "r510", "r701", "r720", "r730", "r827", "r871", "r872", "r880", "r900" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r213", "r471", "r505", "r506", "r507", "r508", "r509", "r510", "r701", "r720", "r730", "r827", "r871", "r872", "r880", "r900" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "verboseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r140", "r148", "r151", "r161", "r167", "r174", "r182", "r183", "r197", "r206", "r210", "r212", "r248", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r385", "r388", "r389", "r403", "r414", "r477", "r496", "r528", "r573", "r594", "r595", "r710", "r727", "r728", "r748", "r843", "r874" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, equipment and software, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r478", "r493", "r729" ] }, "ivz_PurchaseOfInvestmentsByConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "PurchaseOfInvestmentsByConsolidatedInvestmentProducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments by CIP", "label": "Purchase of investments by consolidated investment products", "documentation": "Cash outflow associated with investments held by the entity's consolidated investment products." } } }, "auth_ref": [] }, "ivz_PurchasesaleofinvestmentsbyCIPnet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "PurchasesaleofinvestmentsbyCIPnet", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Purchase)/sale of investments by CIP, net", "label": "(Purchase)/sale of investments by CIP, net", "documentation": "Cash inflow (outflow) associated with investments held by the entity's consolidated investment products - operating activities" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r788" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r788" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r263", "r264", "r265", "r266", "r333", "r340", "r368", "r369", "r370", "r443", "r470", "r511", "r542", "r543", "r606", "r625", "r630", "r631", "r670", "r699", "r700", "r711", "r719", "r725", "r731", "r736", "r867", "r878", "r892", "r893", "r894", "r895", "r896" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r263", "r264", "r265", "r266", "r333", "r340", "r368", "r369", "r370", "r443", "r470", "r511", "r542", "r543", "r606", "r625", "r630", "r631", "r670", "r699", "r700", "r711", "r719", "r725", "r731", "r736", "r867", "r878", "r892", "r893", "r894", "r895", "r896" ] }, "us-gaap_RealEstateInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails": { "parentTag": "ivz_InvestmentsOfConsolidatedInvestmentProducts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate investments", "label": "Real Estate Investments, Net", "documentation": "Amount of real estate investments, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; (7) other real estate investments; (8) real estate joint ventures; and (9) unconsolidated real estate and other joint ventures not separately presented." } } }, "auth_ref": [ "r479", "r903" ] }, "ivz_ReclassificationAdjustmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ReclassificationAdjustmentsMember", "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification Adjustments [Member]", "label": "Reclassification Adjustments [Member]", "documentation": "Reclassification Adjustments" } } }, "auth_ref": [] }, "us-gaap_ReclassificationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationTable", "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification [Table]", "label": "Reclassification [Table]", "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ReclassificationTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationTypeAxis", "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification, Type [Axis]", "label": "Reclassification, Type [Axis]", "documentation": "Information by type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r837" ] }, "us-gaap_ReclassificationTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationTypeDomain", "presentation": [ "http://www.invesco.com/role/AccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification, Type [Domain]", "label": "Reclassification, Type [Domain]", "documentation": "Type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r837" ] }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSBeginningandEndingFairValueMeasurementsforLevel3AssetsandLiabilitiesDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails", "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]", "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Table]", "documentation": "Disclosure of information about reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets." } } }, "auth_ref": [ "r36", "r37" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r755", "r766", "r776", "r801" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r576", "r577", "r580" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIES" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTIES", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r432", "r524", "r525", "r526", "r578", "r579", "r580", "r600", "r602" ] }, "ivz_RepaymentsOfConsolidatedInvestmentProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "RepaymentsOfConsolidatedInvestmentProducts", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments of debt of CIP", "label": "Repayments of consolidated investment products", "documentation": "Repayments of consolidated investment products." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of credit agreement", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r34", "r851" ] }, "us-gaap_RepaymentsOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSeniorDebt", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayment of senior notes", "label": "Repayments of Senior Debt", "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period." } } }, "auth_ref": [ "r34" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r168", "r169", "r282", "r309", "r431", "r705", "r706" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r756", "r767", "r777", "r802" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r757", "r768", "r778", "r803" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r764", "r775", "r785", "r810" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r86", "r113", "r490", "r515", "r517", "r523", "r553", "r729" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r137", "r171", "r172", "r173", "r175", "r181", "r183", "r249", "r250", "r376", "r377", "r378", "r382", "r383", "r393", "r395", "r396", "r398", "r401", "r512", "r514", "r529", "r905" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total operating revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r198", "r199", "r205", "r208", "r209", "r213", "r214", "r216", "r330", "r331", "r471" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.invesco.com/role/REVENUE" ], "lang": { "en-us": { "role": { "terseLabel": "REVENUE", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r136", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r332" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating revenues:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r819" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r819" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r30", "r887", "r888" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.invesco.com/role/DEBTTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt Instruments", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r23", "r44", "r46", "r70", "r71", "r73", "r79", "r111", "r112", "r715", "r717", "r853" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Calculation of Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r857" ] }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic disaggregation of revenue", "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers." } } }, "auth_ref": [ "r106" ] }, "us-gaap_ScheduleOfInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsLineItems", "presentation": [ "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments [Line Items]", "label": "Schedule of Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ] }, "us-gaap_ScheduleOfInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsTable", "presentation": [ "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments [Table]", "label": "Schedule of Investments [Table]", "documentation": "Disclosure of information about investments owned by investment company." } } }, "auth_ref": [ "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r661", "r662", "r663", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.invesco.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r74", "r75", "r576", "r577", "r580" ] }, "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "presentation": [ "http://www.invesco.com/role/REVENUETables" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Disaggregation of Revenue", "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]", "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r342", "r344", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371" ] }, "ivz_ScheduleOfStockAndTreasuryStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ScheduleOfStockAndTreasuryStockTableTextBlock", "presentation": [ "http://www.invesco.com/role/SHARECAPITALTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Movements in Shares Issued and Outstanding", "label": "Schedule of Stock and Treasury Stock [Table Text Block]", "documentation": "Schedule of Stock and Treasury Stock [Table Text Block]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r750" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r752" ] }, "ivz_SeedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "SeedCapitalMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Seed capital", "label": "Seed Capital [Member]", "documentation": "Seed Capital" } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r214", "r215", "r533", "r537", "r539", "r612", "r626", "r647", "r676", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r702", "r721", "r736", "r880", "r900" ] }, "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, Other Significant Reconciling Items [Line Items]", "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ivz_SeniorNotesDueJanuary152026MemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "SeniorNotesDueJanuary152026MemberMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$500 million 3.750% - due January 15, 2026", "label": "Senior Notes - Due January 15, 2026 [Member] [Member]", "documentation": "Senior Notes - Due January 15, 2026 [Member] [Member]" } } }, "auth_ref": [] }, "ivz_SeniorNotesDueJanuary302024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "SeniorNotesDueJanuary302024Member", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$600 million 4.000%\u00a0- due January 30, 2024", "label": "Senior Notes - Due January 30, 2024 [Member]", "documentation": "Senior Notes - Due January 30, 2024 [Member]" } } }, "auth_ref": [] }, "ivz_SeniorNotesDueNovember302043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "SeniorNotesDueNovember302043Member", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$400 million 5.375%\u00a0- due November 30, 2043", "label": "Senior Notes - Due November 30, 2043 [Member]", "documentation": "Senior Notes - Due November 30, 2043 [Member]" } } }, "auth_ref": [] }, "us-gaap_SeparateAccountAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeparateAccountAssets", "crdr": "debit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 }, "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets held for policyholders", "label": "Separate Account Asset", "documentation": "Amount of asset at fair value held for benefit of separate account policyholder." } } }, "auth_ref": [ "r482", "r518", "r519", "r732" ] }, "us-gaap_SeparateAccountsLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeparateAccountsLiability", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Policyholder payables", "negatedLabel": "Policyholder payables", "label": "Separate Account, Liability", "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account." } } }, "auth_ref": [ "r485", "r518", "r520", "r521", "r733" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Common share-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited during the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r362" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited during the period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r362" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted during the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average fair value of shares granted (in USD per share)", "terseLabel": "Granted during the period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unvested at the beginning of period (in shares)", "periodEndLabel": "Unvested at the end of the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r357", "r358" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unvested at the beginning of period (in USD per share)", "periodEndLabel": "Unvested at the end of the period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r357", "r358" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested and distributed during the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r361" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of vested shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and distributed during the period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r361" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r342", "r344", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 }, "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESTriLevelHierarchyCarryingValueDetails", "http://www.invesco.com/role/INVESTMENTSDetailsofCompanyInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments", "verboseLabel": "Equity investments", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r127", "r128", "r840" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r13", "r27", "r137", "r153", "r154", "r155", "r171", "r172", "r173", "r175", "r181", "r183", "r196", "r249", "r250", "r321", "r376", "r377", "r378", "r382", "r383", "r393", "r394", "r395", "r396", "r397", "r398", "r401", "r416", "r418", "r419", "r420", "r421", "r422", "r426", "r512", "r513", "r514", "r529", "r596" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.invesco.com/role/REVENUEDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r214", "r215", "r533", "r537", "r539", "r612", "r626", "r647", "r676", "r686", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r702", "r721", "r736", "r880", "r900" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r171", "r172", "r173", "r196", "r471", "r522", "r530", "r544", "r545", "r546", "r547", "r548", "r549", "r552", "r555", "r556", "r557", "r558", "r559", "r561", "r562", "r563", "r564", "r566", "r567", "r568", "r569", "r570", "r572", "r574", "r575", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r596", "r737" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r171", "r172", "r173", "r196", "r471", "r522", "r530", "r544", "r545", "r546", "r547", "r548", "r549", "r552", "r555", "r556", "r557", "r558", "r559", "r561", "r562", "r563", "r564", "r566", "r567", "r568", "r569", "r570", "r572", "r574", "r575", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r596", "r737" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r759", "r770", "r780", "r805" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity attributable to Invesco Ltd.", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r84", "r87", "r88", "r107", "r554", "r571", "r597", "r598", "r729", "r749", "r852", "r864", "r886", "r905" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "PERMANENT EQUITY", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "ivz_StockholdersEquityAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "StockholdersEquityAttributableToParentAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity attributable to Invesco Ltd.:", "label": "Stockholders Equity Attributable to Parent Abstract", "documentation": "Stockholders Equity Attributable to Parent Abstract." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited", "http://www.invesco.com/role/OTHERCOMPREHENSIVEINCOMELOSSAccumulatedOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total permanent equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r52", "r53", "r58", "r137", "r138", "r154", "r171", "r172", "r173", "r175", "r181", "r249", "r250", "r321", "r376", "r377", "r378", "r382", "r383", "r393", "r394", "r395", "r396", "r397", "r398", "r401", "r416", "r418", "r422", "r426", "r513", "r514", "r527", "r554", "r571", "r597", "r598", "r684", "r748", "r852", "r864", "r886", "r905" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.invesco.com/role/SHARECAPITAL" ], "lang": { "en-us": { "role": { "verboseLabel": "SHARE CAPITAL", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r110", "r166", "r306", "r308", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r400", "r599", "r601", "r685" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r423", "r435" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r423", "r435" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r423", "r435" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r423", "r435" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r423", "r435" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.invesco.com/role/SUBSEQUENTEVENTS" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r434", "r436" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental Cash Flow Information [Abstract]", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r799" ] }, "us-gaap_TemporaryEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAbstract", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "TEMPORARY EQUITY", "label": "Temporary Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited", "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable noncontrolling interests in consolidated entities", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests", "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r25", "r167", "r248", "r414" ] }, "us-gaap_TemporaryEquityNetIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityNetIncome", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income", "label": "Temporary Equity, Net Income", "documentation": "The portion of net income or loss attributable to temporary equity interest." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityOtherChanges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityOtherChanges", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Change in noncontrolling interests in consolidated entities, net", "label": "Temporary Equity, Other Changes", "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other." } } }, "auth_ref": [] }, "ivz_ThirdPartyDistributionServiceAndAdvisory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "ThirdPartyDistributionServiceAndAdvisory", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Third-party distribution, service and advisory", "label": "Third party distribution service and advisory", "documentation": "Includes: (1) renewal commissions paid to independent financial advisors for as long as the clients' assets are invested and are payments for the servicing of the client accounts, (2) the amortization of upfront commissions paid to brokers/dealers for sales of fund shares with a contingent deferred sales charge and (3) sub-transfer agency fees that are paid to a third party for transferring shares of a mutual fund or units of a unit trust into the investor's name." } } }, "auth_ref": [] }, "ivz_TimeVestedNYSEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "TimeVestedNYSEMember", "presentation": [ "http://www.invesco.com/role/COMMONSHAREBASEDCOMPENSATIONMovementsonShareAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Time- Vested", "label": "Time Vested N y s e [Member]", "documentation": "Time Vested N Y S E [Member]" } } }, "auth_ref": [] }, "us-gaap_TotalReturnSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TotalReturnSwapMember", "presentation": [ "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESFairValueofFinancialInstrumentsHeldbyConsolidatedInvestmentsDetails", "http://www.invesco.com/role/FAIRVALUEOFASSETSANDLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total return swaps related to deferred compensation plans", "label": "Total Return Swap [Member]", "documentation": "Contracts in which one party makes payments at a fixed or variable rate while the counterparty makes payments based on an asset, including the income and capital gains derived therefrom." } } }, "auth_ref": [ "r118", "r741", "r742" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r791" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r798" ] }, "ivz_TotalTransactionAndIntegrationCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "TotalTransactionAndIntegrationCharges", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction, integration and restructuring", "label": "Total Transaction And Integration Charges", "documentation": "Total Transaction And Integration Charges" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r818" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r820" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.invesco.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r303", "r319", "r399", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r500", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r859", "r860", "r861", "r862" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r821" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r822" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r820" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r820" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r823" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r821" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Treasury Shares", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r47" ] }, "ivz_TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply": { "xbrltype": "sharesItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply", "calculation": { "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails": { "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/SHARECAPITALMovementsInSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Treasury shares for which dividend and voting rights do not apply", "label": "Treasury Stock, Shares For Which Dividend and Voting Rights Do Not Apply", "documentation": "Treasury stock, shares for which dividend and voting rights do not apply." } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury shares", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r26", "r47", "r48" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of common shares", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r13", "r47", "r113" ] }, "ivz_UndrawnCapitalCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "UndrawnCapitalCommitments", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Undrawn capital commitments", "label": "Undrawn Capital Commitments", "documentation": "The company's investment may take the form of the general partner or a limited partner, and the entities are structured such that each partner makes capital commitments that may be drawn down over the life of the partnership as investment opportunities are identified." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r817" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net gains", "label": "Unrealized Gain (Loss) on Investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r9" ] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebtMember", "presentation": [ "http://www.invesco.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Senior Notes", "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value and maximum risk of loss with respect to VIEs in which the Company is not primary beneficiary", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity [Line Items]", "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r386", "r387", "r390", "r391", "r451", "r452", "r453" ] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "De-consolidated", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSFairValueHierarchyLevelsofInvestmentsHeldandNotesIssuedbyConsolidatedInvestmentProductsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r55", "r386", "r387", "r390", "r391" ] }, "ivz_VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount", "crdr": "credit", "presentation": [ "http://www.invesco.com/role/CONSOLIDATEDINVESTMENTPRODUCTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable interest entity, unfunded capital commitments", "label": "Variable Interest Entity, Reporting Entity Involvement, Unfunded Capital Commitments, Amount", "documentation": "Variable Interest Entity, Reporting Entity Involvement, Unfunded Capital Commitments, Amount" } } }, "auth_ref": [] }, "ivz_VestedShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.invesco.com/20240331", "localname": "VestedShares", "crdr": "debit", "presentation": [ "http://www.invesco.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested common shares", "label": "Vested Shares", "documentation": "Recognition of treasury shares as outstanding upon the vesting of share-based payment awards granted to employees that are in the form of restricted stock awards and restricted share units." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of non-participating common share-based awards (shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r857" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted average common shares outstanding - diluted (shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r186", "r191" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.invesco.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding - basic (shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r185", "r191" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(3)", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.27(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "b", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "83", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.14)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480141/944-80-45-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480078/944-80-55-17" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480078/944-80-55-18" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 78 0000914208-24-000276-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000914208-24-000276-xbrl.zip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�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

[S (?^-*6IJWT*2]0)8/4Q3@*SWXEO-PW(&OQ1K1"/"5 WS"+@GN".Z4 MJ.YN?XJ[317W3SG&Q]"8@Y! MUB1O(,KQQ'J5X([@CN!.E;B3JUAR4T:N3S#R0S)A+AC;]M SP04CU%7S@V\X M&'I6FL]%-T7)HHZR!' 1PBRX([C#09?-[52M)LM"U98$+D*8>>9.D1TWMY5E M1].,@%KKZN>R M4MR:10%,/])2AY!S(><%R+EZ&#E?%F6MUE44K;!Z,B'(0I!/6I U+@VV7NNV MSS5%;[2$G LY%W)>P+*4OJ%APY$EOEGKJN>=EKY3JD8(NQ#VB@I[+EG?<'S@ MD42\5>NVSCOM3F/Y4&)AU(6<"SG/;]27%D#W;-27A;I=ZW:,=DJ#3F&UA32? MO#3G$N8VEU:[4^LJ^GFSJ3"OKN@=XZ5/#? ]>*VXPM!%D(\BD+ M\H$6P?(9;$6F757/E4Y3Q-E"SH6<[U_.^W@T]@@BDTC(KQ A$R!";P1T#;81 M^91FR9JB@.UNMQ@F_<]TI-$[890.&OOX,OGPT;+]L8,FE[;+ MN,AN^CA"Y,5VD^'3AG3O7LF&%/W\\:=M!<-+PVBT.QIE?5SG%[\X^E5I "HN MEK]7E4;'T%)_DAM*ZO>K'J4W6GHGUY-6?Z_I:H7'9+3S4?Q4Z<3?F-J-9KO% MV9B:#4,W.!L3GW3JZ'G?O>\Q*7*CI:Y_5&KI=DN>.HQK2K1-3"WN8=P217[G ME[13_9+^D& LC>"ZH2]AU\*6M%"XK2T8^DUEZZOL^+PI3S_UW,CWD",3MY.) MMI%_)LV[8%+@2;?N*_9-3_H:6(V5+1L*(:IX1B'/V(!Z+O9D9$/DF>U*\%0' M_'C_7,)O)H;9CS&)VQ9;*$!+ZVC;DJ\4(OI \ 3 EKO:7T+E2/@KQ0$O(H: MT CJ;46]63LMB?;3JD.(&7?4$J3,2\0!@B\MZ081%T8M*)A; MF$TS'(4.HL=D1F<"T&9X! ^QZ]NO&/P^TQOAB[.OGN\79F5/AKI]#[2B5(Q+ MG9%XI:+/G>>"&X/QB-%D,=$K33.]$CB 5^#\41PPH-ZX 5B@3/JRBE2+4/6 M"3P(!A?CZT2)\;@#?BZDZ;)$&A%/H"WC?R,WI+-/RYNL6R")9WJ2JW_YYEZ9 M!3YMPQ$>1UK)+V[;>BZ^[G.M?DUW$R&00B 3@=0W-%'<6XF<4M3^.R>C&)LO2UZYU#5TM MHLFL$#L^$'B28I=+ZKAL,:)TV-XG5=%V;QPF))(K< J)W"21&PY#V)_YH[N* M54-D:(3$G9;$*5S:0#7:_]O1-;%L*"122.3!=^JJ"H2#1J?1YE[Z-A0!)1MO M80IXM;"*J\159;U*"("XZJ2O.H%CC^YP(-FLTG^KX[A3)ESEX[32^7N,UCV" M.X([@CN".X([Y>).KISUAI:W8+NC37ITB][&^'RVW2IS[EI5Z?&@>F$=,06Z MA.R?,'=RR?Z&+KC[EWU-R'ZIT)6O+&AI2]>*LJ#]XTP'G*5U3\]]0H) &$?Z M2]G0%73_N&K6NDK;2"D[$_J+2W3ETE_+\%JAO]ZM:4UAEX:8%B FK33JX)KH M!+:?1QU'S(6.(W;<<<19VW%D'?A3Z% .\&_GN*>S_1AE!H([@CN".X([@CN" M.X([QPBXFAMZ0C"':Z'#VRS^ J_X?M!';VE.<;O6;1J%U4H*R' $F4TYQFTA MTQ&0*1-DA W@F3M%)MVV%6A#"'29('-4@2ZH9BXBM,QW$NMJB-P7FK>2W,4& ME/9\ TISO@$ECAM0GDLN#D3)G4B_"^X([@CN".X([@CN".X([@CN".X[%GV*Z%W>"R#E\<1T->VZ\V#,'RJ>IS$#VWLRZ-IV=XGOUUG09] MP(2=#;A>DZKO]>?TB%#67VDZ@N1IU_% IKI4GNE2>KB#WF@OZ]+9F:LSK0K4 M%\698K5+<$=P1W!'<$=PY]CIG0V;Q6>>P(*#<(7\85I[DD^$-!9DY9;@I9+@D*!$RS#-W"LF3;RG#+2'#)4%)%:HNJYY[,[W1 M".2WB,2;_EZPK]BS\V?=VK6NW% Z>TN[E79]2=0>".X([@CN".X([G#K[F=. MN\VY!ZM\_4ZMVVFF'(P@2E]X@X@08)ZYLY^<6P8!-H0 EP0B0H!YYLY^$FZ; M!5B7A0"7!")'%> 3Z,]W,QH[W@3C)&7&TE#2V($G7J[ M;1,_P%P\ZQ&;WHO+GO('8J; BEP25 A$H7W!'<.5Y2;EFG#CPR0@'\\A9<#NPW;-5_8>*EZ=K6%"!" MVY8#,4*>>>9.47UNMY7GMI#GDB&F"IOYRY$:FQX$/JLR1C\1L;;+CXE.4HSV>7G9S ^(;09Q0Y_O, A_XU):FK?0H0U!=CYL48"/0_ 5M69; M%/BRN[!&82ZL *:P68([@CL\<^> M T3Q;T!]!Y-;UW1"2HD'C]#']X* V,]A@)X=W/?N/)>^@'@.C.OE%EY%L!\L MUJ"XX:AN>4$]?F^:$6C6NOJYK!2W:%$ TX^TUB'D7,AY 7*N'T;.ET6Y5>LJ MBI9RN*$09"'(0I!S"W*32X/=KG7;Y[JB[KYU7,BYD/.*RGF^=:G6AGX.1Y;X M3JVKGG="S@LQZDLK MH'LVZDM"W:*GGW74AB&LMI!F(AY M!1ULYG&2YRVUUFUVVB)Y+@19"'(16_66_C MT=@CB$PB*;]"A$R "KT1$#;81N;3NBFW= BUVT;9LV>LTNZ"S;Y@OBOR)L:K ME/%/&$O(I$>8(I=R27*] /N-*?DL^[7["?Y)QA7?K'4:*FV+-_9\MC'ZDF ' M!?8K_OC3MH)A@JJY&V/*RK-;T#,0,@Q6WS)'1A-3+!0M&QEIU%RDQOR_=+04 MD;9BJ&:GTU8[+66@8UE!1[28#TBG1W]-K)54&@[U1)<(XJ &0=,9-$"E,Z%4P M)L3-6*0AH4KK+YOYTZYU^U0,Z<;E*ZKOW,#_=(&Z:;P_*D;;J1B]=5^Q;WK2 MU\!:+;R\#/:.ZA@I\*1@B"FQ+>S2@Y3A$U.MB)[T\L5VD6O:R)&> OAB%/%C MQ<1&B+R D,0ZQECT/HXZU;/O+@)[!S/ZL#SZC)JC79N[Z3C34!J168V-:V1R M[\(1/,U\[QZ\]P?NR0MR[5],-&:;*?!>X]A4P/<\Q;4&?%XY2F=4Z3P@ D/Z("'7DNS IS"9J1[X!3P4>/T9 M#-#!)O5KG,DYTU:QIR1Y1(J?^D$:$^_5MK!$<(!L)WJFZ\,SPJ@;C60Z-L6R M]-,.AO"S!!XQFE!#8]-'L/8U$DP2G 'V$;")GFV'C:$A]>??.L:4+[[TXGC/ MR'$FTPG Z+'T'/HP=]^7;#_]T]CN MF?9''\@#8N@ 9P#0@032^ 7P+"ER_7]H'H'=,L&( ,OI0ZZQB4?/F$1:+MD< M(IV]>PJ9/0401##UF>'': ,6-6O/>#8P>">0RJ8FR!Y)S\AGO$D=[)\A(G 9 M<#5ZDY\,V*?O^KMT]LB^_K"(B2%B\(UM* S.&]D!A3&\PL?SU&+W@3_D$4S! M# .)'BCY0R]T+#IL<$49+>&!_P[=*!9DJ-U(W#S0RF4^%DP&4_:3%%7?2E'U MK6557PK]^YF!!-3#S,@Q.5^@Q#N_])VY*I=DK[29E(-="O8P\:+RN(L@&J^@ M%#%V047C,2*1GJ#A+K'@:APKY!F5QP3DUAX[5,-B%W0M4[&FB&]'NO]_"!J91$T@?3 =DS(\K8R%Y*0OH2^B?!+Z'#?F4\9V^@ MCWS"9D@B.T0ONWDSA\A]H?[R:&3[/GW:V=/-563#YNP7>\+L[?Z,'/'3(]O' M;H/Y,3,464"6=X&9^>&S;ULV(LS^W$:S]L:V2]\)E\_LR7E>#QYF.Z 6E;T9 MS9JWG;,9V#[C KS"I12CJ@5H0!C^39. LH$+?PYM5%7:4U[ I:$3D2:RK8P-R>/&K/^;GSP1@_?0@W'[,SB MB@,"0A"EH6"@8* IR. 3P:\8%%/$2/Q&>]#1/V *V+$ANF?D"L>>.\='>$:D MYR/H3F>3RMD45$]AF5@F?][% ",U0C_@_4#Q$<,Q@X/OAZ-Q1(-@B(!+@P%E M%J5%I.5AG(CE\:(;%DWQ2N0!V3_'U=%V=GKS9&F4)HL$&$AC3RMV^Q;V NOG,PFE>B#RW>LLOTF=*@(V)?+Q M65J!>J2C1)UZ8>![(3&I#HTZ2(+/#QX7U6,Q;2,'\??(N$1"9X$& ,U'6/YT M^O)(^&U0+"" 3(O9_MQSS%@AN(D&GNG=IP6-?^N"=L(T(D!T0H[C_?0OBV7M M@B.EM8[F1E#'5&U]E.!_7V(-'@P)QM((;AWZJ=R^I$L9M)M"],L///6V'@BU M" '$?=X Z(W9EP$VARY,YV4R0\GS1/IKKHJ'I0,45M0I3L=S$[TJ]]IGI]9M MI71[B,(;8("3F,']C)]Z*O"@6)W,Y1+Z4RKV7.O>-$, BSG)/3VCUE6UE2M M\?RH]?7'LR ^BLX3EJ\1Q-W9NDB-^%4PX]["B[9D;ENN=36YH:V?_>I<\"JA MK:ZL:\>0]4T'QQ8EZVT(E)H-O7!9SSK^/SU#9$&$.'6.P T*R2Q N8\".1#M).XZG_O.9O[0.8PO MF'X&!4+#-Q;+T7PM7,P81(.I$>NTA.E;HLAS+HJR?9838RW%\?MUMY24S)X# M%B#YW+((\5SX:$:>8)0W6Y4]:^ME#%CFLF.+DY4@E('_.A.I9WDT= MYV+>T_8Y&?< QIER;24#.9_N6GX!^&A2(U[<'GD^71J@<)Q?>K!IFFV:5W^Z MN=J@.Y:2(3MK]_EZDI,HXFD54<2CRZ*(IT)%/,>II5 ;DI3/L']!-F%='F?5 M$"GE#NV4KKI/TF]NVOIZVWO\^W7V_[M MS9-4? %$-)24 :JUG'[.E!R?)Y^C'/O3$./@=^*%8S F*91)61UL;U@=Y,.: M])-%C5> 0TP7A MB71U^\ 6*A:>3NNW) 6BZMI"XO%V5G( ]MP*SL]?@/D9V>K%D $T/&5I8_0"<4XI&B!^Q!JQ1ZH!&FS."%Q2C=3\Q=L[, M,JM/IM4J:.SCR^3#1QCAV$&32]ME-& W?5PLEJ.VZ%UY,AM*]'-LI@RCH;/\ M>=(5-'YQ;,0:0-.+Y>];G8;>[*3^)#>4_[-Z4T,R;% )..WN52]4M$:[J6YZ M8<;OFUHSUQUK![7^41OZK:[M?KN6:FL>EK)-(_+/#K,MH;/)5"YW:=57'B&4 MFU2E(D)2E93>K38C=HZZ*R?;/*-DUAG8ESBAY2]U3=@:]2MW<*1LXN ;#=3Y MD9CW4YPX5)XZI3YX;;-/PZ9^A?QA5 M$/]":#_ X%K(IN81H$VDR8^;(.P(S M4B_[EL#<\S_2QK^,$\^U[+&AH36%8,^UZ']N9OCK!L;$+=WC.;* MI>J]\>9(1Q<(V1*RM21;&YI(9Y2MG N+G5I7.==;QNZ;XP\A>AO,>#97\/A7 ME?IXC8S0C_9^S^U"V=(-,;.<\I)"GV.?\G($Z_LT]$C0QV0TR\.E[9QOT[(I MH[B^-QSTM1 @R6Q&,H*D(].3HM25!46B.8__@#W9,!*&$[W?!\G MZR T[S]FM3-Q_R)IC\:,PR/+CF',HDTO.*X1B;BQZ-X.[#=LU7]AXJ4I,&5Z MAEI!GBT'<:/ 3W8[EXZ?99RHM:YFK*XLK?K1>P>H@DAG]L.(KXYC$GPO]I1EX1)'K.@ M%6861/AS( SE:@*?TR[,@V@9+/HJVY"[G?O!S4()/>Z^%[ MPD%(X-T_T5B: M;KKT@*<#3.@&_FG!/44":%-WGXFE$_&EEHX]6[')Y_K_9^]=F]O6D;71OX+R MGGV.4R4S(G5W5KG*<9P9[S>),[&SYKR?IB@2LKA"D1I>[&C_^M,-@!(E4A(I M41))8=6,8TN\ (VGKVATPUA>F6J,V,:BJ495Y^*FKZ@E,:FDX5TH6+*VSLH, MEN[%3;LJ]O?I8R\Y(C117=$MY?).=XCSW['_,A^>6CJ!JO8CWA*IDU?XR?J* M,CSK-R476#MZW5U>'E!]%R^L%__YS,HWI6?G1D6GQ.$TD^C!4E:O0_18[116 M=$HAZ1X7JT^ Q/O-%2UFQCLCH+E8,O4]-SD\3Q-34 M5\%7C\Z/B(M84:[DT8)^+RE.^KW*'"U@]4 0Y3R?7&3Y8_&B&1E;P *>,9X1 M&W"%I9=8QKS(-U@6$HG2<%QH((?9"[(V1%D\O'VB_P7"Q.=%KF8DF$TI$R^4 M;QRSZD)T&$17L+L7I9_6"[ZTT:PI4"4.CQ!V>H351X'9L)3CI0* ;3:8]-J MRR?."ZJK6MC^08SKRF#8_:9_3 M#9I:S9S]VX4L23^^4)^T_;P)^W5,-B?"8,B:Z)2)!F>3M/_/T$5U_-UC!=, M3K=,GXH:/;P,VP.J3APO$1OS3'5>?D'+A*B%X>YL:!XKI4X>F'"FX0J)-4GB?4C\TW$WDK?UKL;G5=:I2.3CZRRPVBO9>!O>=HH#R\&59G % M94SP2'VS-$RSX9!7[&S7;NR392]9WG_\^X\M]C=%U4\$\*^N0V=DPBP_$;"L M44[0WGN'I1-(N<]VU?7X5F^7XULIA7W2=DC[%S?M5KNPXY$EV%"7C%!;1N@? MD!$&DA$D(U2%$0:%,4+F]-9!LX:G'B2+U)5%>LT3L$CI#@:=X,A'JM=WDE2$ MYKP_(S^+>EU%=T_+?@2D.L&(<[^_H& ,5TB#DFND9+F&O0+SIXX@R_L/&"1O M-16M4W(\/U$\*J)/L2;]6B#7\[A4+@-L2\^BC-4B!MK%3;^K-.61NCIB9$NO MFZP8:4F,U!6IW5K#9Z>B1=GATRD;?(KT+:I@CL76;=]#O?($ M9B]Q7'O%;6"B[.YJFQ1;A1:0 MVG1#K.JVM RG.L4FAW;HH&QQUV(B(]O>BJKM*R**7:L3 MI8Y)/I5\>LPL@FU\FMWX+3P;3S*R9&3)R%GS&(ICY,++!TE&EHQ<;T;.YW9O M2:;(;SIWJF\Z,\?\/6O*NZZK?;*C>*PVLUB.-M9V2M8E%DU9N="-W25FVES< MH@]A4F&P_I9$$[T3-:3NK111COT<>]%@IOH+O1IZ5/]UI8]@K->Z_:;/?"1X M;$H3R[F*TV]UZFLG.!H=;((<.B8VGV>+?0UHI1ZO(/V'7IJQD+&'3/U?ECK0 MC'Z_I_6[ZJA-FZK>[/6,SH V1UVUUQWH_^Y=W#RS?H;N"/MJ![SWJ7Z3MHSK MNM9WL&O]NF]9'_4M;;1EI^Q2=("68\HV)MDI.[U3]B=JT,F0>E&S[)9LEAV7 M:#7HABN;9?,LY.#*-SC9+%LVRZ[)_;)9MFR67=N] MANKEZ>7:+]A2G'R/'L%MM7MQ,]!Z2E\FK$I&*#TC'*YK?%OM24:0C% 51BBN M:WSVM) ZMB>0+%);%CE^/_FV6KH#<[)9=KR75@6]O45L_!3$NTYW-2L="#GW M^V6C[MTW!4X=O9;W'S! 7X7.D+)1=R;C;[ E5SY;.[^VUKRXZ7647DFJ2Q>I M.21&!H4TUC@1)C4&R4S?W['JW6[8P MOX1/H? Y:)_WME9XG?,#FVVG+X9'V\;4-MFQMZEK M6\9L[-HF]2JY-]Y:DPDM(U!S4V9; (I.=4\/Z*UA &V"M0U:M?[%36O0VK]] MF Q3EA D@RW9A)E1,I HJ3%*MB34K4%)9K>H55SQ;(F?$N('[C@P@$K7:+[0 M5*NTXZ/Q C]7@Q1CZ>1EJ(E'@]"#=[_I4[E%(9O+ MPYYU(>-JURDNT-C,V/+9"2=7ILNJI^*CT@1 ]^)&;70& Z59;+WQ2I<3ETQV M%DRVS68OCLMZG,O:BBJY3'+9F7'9%O=F Y)$654UUI*[*)'.5CF'0,%A9JDI24E)24+!,E9<)E M11(N3X$7[.,#8Z5.@+:2;P$3\(UL6ZC-V3XI!S4UG"MD'N=JZZ8VMU04**Z= M>KM94,.W"CB9DB/*-+=\#+&E?,+.#)'9G6R7+B=,: M)))CJL0Q.:VN+64C"K2Z6B6QNNH5>"PB064Y#K%#_^*Z;UH43Z :R9 M2C=W M/^YV>U]!4?ARE;2^NF18R;#%)\UL8]CLQG#AN:F2HR5'2X[.G:!3'$<77KM) MH[KEN2/Y_'E QU M6W<,2J8>\(H'+R<>G7K49V5E#>S*RVKV6 [11R/@&':&>I)H9JJ4>YFR4>I2 M6TLJT.;/GC6([E%" M?QMV: (X1YX[(<'8\@D3<^3R$S7H9$@]OI(MM4&TIM:ZSC?E+6&:@A:KTX3% M:JDIC2!W7ZPM(]]WL3IJKL5ZIQ 0.SY=XAQ86WVN7[^:/H8=& MT!IDG-1^8$^\QMXZEK$Y-UI;%#CYP0NT)+@ 3:(%+$"?(TS311JL!XIVRXBVZ,R-C'00(@\8 6U@'B*57?;$7C@"33"B'X'.@+9,]R%KX,GP\"*6ONF>,E_1(F[S!^W,) M9+6YI8[XXD#[-S&8VPE*N-RB&>NM:.T-JK_!U E.<"%NXU/&N0$0=&3DW/9- MCGFF'=S/,+_6Q4T_Y4CA7%>N4?VK:[S#"FXI\EW8"K9Y5;ODX>0E>V!E ?=< MMF"X4X,;^?7!6B73KF+&00VZ2X2GU_B847&:B M4UZC5VUNV>PX^,0QZM+:Q.(.+#HN];L<'F@V:R!I)Y9#33YOE-8F#:@W@9M, M6%FPL]B7@CG 9O9X?=+%KIC@J[PB1\: M8[#'?6+8(%ZLD87&ND]L"K8]T:*'++AP;%$/83CCRA5'"3>CK6]2WWIQN,4' MMB%7W M3/HL!N'D9$4*6.M",?K^G];OJJ$V;JM[L]8S.@#9'7;77'>C_QKR: M56OIB.?! M^ R?08'3IFCX>2$%P^O;G_=/SU_OOST_18PFWIXDZWJ:YQKV5X9(=-^>, F* M"8>4"0Q6A_K'"@X64\5WI$Q6NRBAI8NL8,ZCS3X94MM] WYC$0QD8=VRYQPI M[%RV<=3[X,?94B'Q)E#,EQK.R-W#=^91\^< ?QW7-) LFCC?>X!IVOK4 MI]?1+Q^B U:6PP;+;OJPK"%3ZJ6SH?"O/[Q99C"^'@R4MMK!#5J10BA>S+]5 M%9C\^^3GW;X"O)SZ55-14S]?]RBP)GH=+=>CUG_>:76*&]3F1VU)NRQ%=F4_ MTZGN2^!\8;WYB=VS?%,S ./4*]/DF,U-(KZN2:M)H=M>EY=:V4H/$B9[I\LF8=)9EQ%;RK9J%13<%0RO MLIQEZ3X5EY^?9+ONFJQNZ3=5'QZY3P0DX=$K%3Q.T%_]E&TMXXE9%6R=KJYI MG;YMM>19X.,1J#[";HLNW"+G^A"]*+A_HI.1ZCM"CIR[F6UDJP4;C\XN9K@'5M8,8\VFF])VTZD*G+FCMTE&*6YN$4? M D^$P?I;$MEK)\K#[J\0*_9S["TVPE_HU="C^J\K?01CO=;M-WWF([/&F0(X M(DZ_U:FOG>!H=+ )$.9H7_H9=F+&3LH1KXK^V'-<#K?&;I MRL!7V/Z Q^KUF[1E7']08.5(P-*IWX.>"91%CET[W/[' 1L)$--YGB M>!X*,MOU?7@-'@+*?N /+M.#F,Q,'A*&^5FVS67HNI.[>!)0SWDD;K.I\G,^ MP[_#!+_ U!Z=/8HK]+#70C]N$G;A]]ZW.]PY\,& MIS\?UM[C?-@G.@P6A:V21ZQZ6O+85$]+GA'[=/_QF1SK=-B3,:9F:-/'$0[_ MP?%A# Q/*>-O93TBQF95F1.>.Q\/,X%B"D&Z,2WY\!T/7,Z/@K%35^+DT]$. M&:VE]\6QCQ^!/:8TN4V6Y_Q1IZMTV\6 M=!H4<4HK=5]J4,W#/L6>>*HH$?8Z\52*G??#G-W+$RK+L_MVM$!"-K+1+P:C+N^/]9/%K!UPE>\\:EK!9]U@O5^_ZK^M23CY MZ'J>^P:TN=.G\$TPRQ:1&2S\Z_;%C996>6HH(C(CV]59[4T/0W$&&P317SQ* MF2])?T\M5LSK=NI9-M&ZS#Y:#;SGJYU]?IO'N>=?G[WA5?2GE')?H#\MI-BY MN&EU>TJWV)8+5>^H('GHK'AH2Y_";3S4E3PD>>C<>6A+-=ME'LK<%*C7.U!3 M(,E=Y0"9Y*Y,W+6EZO"NW-6O%'>=S4&&GXZ/=3^I29ZH8[D>VY7TK^MTG*&P MTZ3R_N/?7_ICGF6]Z@0AO-1$OJ[2ZYPB@6.7\-YR=?EN6@K/(@?FLV[0W9H) M] 87-]WFAB+R:T<-SQY2;\O 4QH%Q,?]@#%HZ@<_]( ^!9AR\IUZ&)G67Q;] M]O"TCAAMOXF)3\V4\?XW5]Q7Q PI^1_="75O1EI-D=1700VB;=,@\LBJJFYK MN^PZ+UCI!T$W[^B8PU#LJT4;BB7PM"2 8@#:UN5W7P!I$D"U!I"VK:5L.H"2 M0&E=W'0&@](K7#;/KN'M;Q>53;4K5M>^19A4X/G*Y!?_]*F+(H M6REALFT;."M,^@"3?EI#.@F3.L!DVTYG5I@,N#39.VU PJ24,-FV99<1)@., M]/6+*^!1DLKU9V7I'BF$/5 !*H5:NH<,80\TL,N55B]9/6HIA/W-?16'AU@, MN]V2T>"M>-LM&IS$4PO[*\O^ '6%R6XQWR1,VAPF96D0(&%2*$Q:!45V!QT. MD[W=(@F34L*DH,CNH(M&S*"P;.JJ179/L="X)BT3D^6II6E:24['XZ=N[OMK.3DYC[CYG9/:4ENEMPLN?EPRODH M[#Q =L:0ME3.DITE.Q]..>^VGYV+FSO-)N/F0:^P'F0EJC"_I49CM_C]IVZ^ M*O39"]%_6-H\4_LKY3RO\).3%:N/%W"-_WQ.J>#I\Q-Q#M;IY(-G54 1^ECH MUX"%Q7]Q)\JS& Y] HPRH=X+]>!7#R\5A3WQ2X5\I#/7,;%L1 ZUNLEEN^'#%"&ZXM780%@]N)] M.CKLO$;[%RZ!3XCWIXX-P?ZZA.D>7@+V2UN&2WL!,+7.QCS3QSF9%9 M'>[KM0)QS;Q+7Q1[,%#::B=O3>QN7VEWBJGUK&(ZN%98L>=\9:,W#FKSH\ZP MVO,MZCM9W#C.F#4HQYF[AK>L9EI8]>_Z%#7]OD;%5O!$_EXU778H%%31D!Q? MYYP=5^+3LH^9:WD[Z\ MU2O-5<'*._L?T"V)GHG[;^>F;/;>4I"J:%E6/2[ E":PN@7JHX+.F16T]E); M94- KQ"553C?EJC3=(%;?.7=55B_I_<4#A$_@:7;]HS #[&AL**U<.N-=2<= MSLA7W?=U8QSZ- A\\C4,0MTF7ZP1)0^.'WIL:^".;Q.22[R87_*.A2_Q07XX M_(OM+KA$)QC)O0JG9 HSW].<=-\:;L)J&1':#O(TM8PQS=\?6T(*IL9T2W9[OG"6H(H@A2! "%6WX M8$9P%PZ#$PHI "M;0K);'E26D+;A3B:X?2?@Y)A+G["6N*] :K:'*X+='BTF MNKT+=6586X:URQK!DV'M.L9E95C[=&'MTL=#2C_ PC<&3N&MW2W9*-P,6O2904%HEJ\/V%\PY3L&",/%7JU>6]'O%^GY@NYCL2?3JU9YF+UE20 M@RZ+$=,87UE*ON,,]-GU_H64_B0(#73^DY'Y!Z/R)_>;&]PBB=-X3+VX4=5N MRKG!A*F?CN2"A'%&F7L&:[]&?!YB[36^]LDZ$H=:^_.S6&-;BP68K85HX:[' M53I9-VO$6K9Q3R"9@"&"WGRA8W<) C47M^A#H$48K+\E$:L[T2;08,72COW, M?D*GJ\Y/Z(R]A7GP0J^&8*3\NM)',,%KW7[39SZN;'R18(7B1%^EUVFHLBWQ M9S0ZV,LY@X!0<#T&\6M@2^KQY)X_]-*,A8P]E&#_M1T_TF#7@G.]_5W>-\%VZE>W1,'1]DQ(-CN!.*![R2QZ"PY^_JL2ZUDSS6 M]?C\C_L?Y.[QZ_?@&?]^_O_SR^/3T[N!'O>9'U^;'O6X- M(YR$-I:I?<3CO2F3_N+Z_IH#8-B/-=L!,$:/$W)^=(3:==A6-V!67\Q@FH]JO8AK+,YAX ME(#_&8Q]0L'R,TGN'(BS)$PK V%* %:9;51BC'UV/?C3(4;H83F1&0D\>)C- M;&69>Y23F/>3J>W.*&:E.G1D!038Q?&/1,;3*Z^Z+^^S&^CVOLHH V&J195# M21 I/O87'WO3L%H$S,J@9165,F]SY^@J6__';6&S!G%HP$[QZ+^OLS#67EE= MVYANI\W0B@SN]("O(-'R#ZZ\(ROUX*J.XE(IBOTK,JP8SN*T7H=UDBQ+PNE= MBGD;*\/)BME:SBOU@PD5!6A'PC+VPZ%OF9;N6=1/3SC-0]N:E@JO4+'O]]=]I MV3N]BYM!GN3;,KL_+\-0&LU"W&RJ@:V M,FFE,V>"HR?';>(&%<1N1XK=>B/N:%EEFY!6[.Z\A%M=X+9'.M8FN+4*\4C/ M"6VUA]H>B4J;D-8&P59 +>1Q^['L&;=SM+&7T>]E/0O&K@VT\N__$UK!#)2V'2)UOKL>RQT. L\:AJQV M\;/[S77P59YKPQ!?'K""$?6#-+7>N;CI]IHI#DMVUUBVF:L;+/LGAV7WXD9M MJ4KOC&!9)CTFV24[NV@)A^OHW-*[N.DWU92>2O7E%HG*;4)\<')8]@&6:B=E M%TK"\FQAV6Z>')8#L"VT7DK45,+R7&'93NS"'QN5P!M[-5=BR=0N>5HSEWMK*;^X?8/>QDLLE MEQ^$RT^>Z=?N8UYLL\"\V.IR>2E-+"E]I/0YC/1)^O='%SZ#BYO^H%?@69'J M"I^])B@YO"#JU(B]U7;6#=.#\7>G"2Y$9Z ,#LS?]69NR=]2@Z]C\9-G&7=4 MS'UO%7@D0ZKPW/5%:L[?64E3(\[NG/S ;$<#V[ROG5!WRWV:8O=IWC,(P+^F M]7K#5A618#DA:Q5V$ZWSMW " #=N_F"7\94>>O@0L>KL<_C!D&*I \WH]WM: MOZN.VK2IZLU>S^@,:'/457O=@?[O;N\B=M.A>:^WRGL:\EXO&OR1&9^]7"$D M>OT2A9.Y/DGSUW1N(S_#!%-A["H\.O) >7/RE+\&/^S_OO_V\GY-B%6TK"$G#7"[J/1EC M:H8V?1P).GZ4S)"W5?/'TZ!M*!>-!?7CSZP@?OCHC':81M$D@ M%P=CCU(R@0>/?4)A^";YJGO&F&^XM]0&T9I:F^B.B;^TB.Y1,@5- M.$2X?4 M=M\4 F^%C_&K?$;MEF2E+7QQ_UOHOUO?I_ _,TO_A^9BL3MYTTNWI,D<>+C= MBQO'3>CHQ ?1"OM$%_8 K%/@LL7&Y'3=F;&N%[T//OP=PCAGB O3G5B&9=,& M^4B]26CJ2E(-;$3Z.MTA;IKHWHOE,.7?8?_?(CT MF^4PK+.;/HAG"3.CDVRLQD;(O_[P9IG!^'HP4-IJ!Y-<1!*#>#'_5E6 =]XG M/^_VE7:GG_I54U%3/U_W*+6E]#I:KD>M_[S3ZA0WJ,V/VI+XL7%W99"X+,6E M,5"2>,60^"I-D@6/^$.Y)ES'I>^ MW/! ?7AP2FS9K3P/,K?VX[8*IJ#=,HM7]P]V;K_>4:7*!X7SV:.)$H %VZ-. M.+DRW>!*O"0M=@0NO]I0VTVE6U!KHYJ$?B4GGA4G)H*XQ^=$3.]J-/NMPIJ, M'903*VTZ9U7FOJ5??=<-:V09Y/+V^^W=7A;TAJE7G7T2]>8*8)\DAPPN;L"A M3^8_%K$HN]KK]5W43J):VR$6M=N$14W+.SD[U^$^]-PI;9"OEFG:E-SK?L"B MMKTDD\RZG622V=WCUZ^/W\C3/VY_W%]]O'VZ_T3@H^_WWYYN MGQ_@BV0"V,JZ;,P#2TN^XJ-(&9M6UI0LD7@#%J?AOCAP,Z;DH#%JQ!:(T-_X M.\5TG+\5:%\L%CL.A]SRI0N.CIIR@B_*#V#1AGSCWB(U"QIX[^*FU4OI<#(? MN,A(=9^<3,_30&<1U!,_0J8)LJ5^S;JY,IA*T4P-7]B*!JL<RW,C 9UV1/ZD/1F4AL]ZVN5,/LGVG'K/L'4-2+S_U_L7^ /%S"X/27RCY M.YCV ?D$G@WYC&SX)[+AOK*Z=F23O'I$7JU&[=&8-R<><8777[>5>0L2X>!= ML8].%)_^Z;PRNA,]8,[K<-Y<'=0Q]V27'4[99'U#4)\;+LDD@D1IG2PAJEA8 M95U4)3K"[P=>R.(4K&+R\UAW'J?X"/^;*];W6S@94B\ML(7=*)O5R/T0CDE;'M-[**EJ_;W/K'TKH=2YNFA)ZU8?>!M]1/9'ON R^G1S(+ACB M'44MZB2"Q&?I1..6\]RG%(T]U,H2>G6%7G?+J?-30J^/6CE9?J!,T#OI!FU5 MG+7/KC>B5G'N6@HU*L*=ZRN=E\Y?FR_:)@X=((L?C?62#O9.Y: M%N3UFXB\ KIC2>1)9RT!O1 88A=/K<^W^K2BHL\2G&4SET_GJ:5(Q2VET&/2 M4L/L^[ZF:A\D,BN"S-P*^W2>7":%W2JUJ5B-&D#K$FW5#G<"HP\9"? TY7+R M[4D.ES(P_RD2;QT3.VS,NRRL=P?SY]]6-V13(:>0K^,F-F>;>,E4I^QL+B.% MI87=R3S"[;!C&WC)*+6$7>E@5R5WX1RKWEJN SOU@\F4NX72RR MS;N.%(LUA-WIW+WML&,;=Z6%G3Q4>=G+O?>Q:]+)W0)_"*!OU,]O., ?] \P#F$ZN+^Q%@O74[,KN<^BR!0 M187 A@"!5L6#H0/<+>XI;2DCI&X\@&XL<2&. 3]:*H$O@7\ X)>XE,?@$(=3 M2X7[/8(KR?+UN8K5BT>7HYHRUC#G!MCU%XO'?4Z%S?]7LI. M:42]=PI![+Y%Q1%U41SQA15'-+$XXC*B$; _'9;=_Q3 USZY_*D\*>] %MFV M[BV7#F> ?Z.>>-YA8%^V7<3]3P .UIX + CL:TEV*L>J )KUF'?52\E%459B MTHE&*=72-1NZ?H"=?1ND<5$#.0[8,+<.V2(%[T7C@"?JO5H&30?(W$YB6/"9 M1(M_CQU7OKG!_Z7PTJC]1VY!A^V=^UK*+M1<3Z#P8BHZ=&)M1I;:51@PDGBW M"WC.E=#7*9T1/G#YQFZR?-:=Q! W#FF\E8D+."9Z4LCR'1,<6+Z^%0>C.F>_ MSZXG/L+KU*6E - :UR#$9U3W%L0?H)D[:*\:<02O\I4DQR4[>FQFL2U\*=BC MS7(B79\-^YHMH_5*16L'X5S$[A)V='-QBSX$DSD,UM^2*#E[(A&@-E=$6NQG MCD9.W7DCI[&WV'Q\H5=#C^J_KO01S/!:M]_TF8]6>XP0$\NYBE-]E6"G(/AH=[.7]W#8L!^9 LEVOATF\U$$RWX+-G@Z_[VQ[>' M;W]_(M_O?Y!XMZ_B6WOQ]^=L<_1DC*D9VO1QM#IG4!J6<>N8GRP4>R9;\!0Z M)&9_J@V+.DH7 M>\[T4UO>GF:Y^S:5"]XS6]D5>=H.%V'3OF;.J5 M<[#N =6^JIX-@^;]@5!U<9UEZH%^1BV",O;-DNU&YN1J20E1J:N.G6!\BKW< M;S0@E@.V-R5ZP(^!,O,X<,D#1J<,EWP)3&7'C=!SSPVK=>I7SLU,0-H# ]H7 MU_>3\>%N$U-0VFI*?+@RA:)E6PW)0ONQT);-G*T\U$(>ZJ3LQ5>&ATZO]N55 M*P;0RB:.VF8QMB)/$&:X/P;%E+RJ?9]>BM&=?L'E5?6T_=-=TIB!?YW%D]\I M@;8\]Y\>5/*J4]5I.H7A-V]G'"63+*>:NF'@![J#TR%79(C[?+)5RL8\\LVV M\4I*&L_X?ARQ753_<4%LMJ.:9CMCH:1.*Z4BFBP,4@_\;'&N]@90!P'4W_\P M00EK+]FILL55L/'.VB&7<#4@^!U"\U MD$ZO%^15TD]:G.OV\13/_3CR3E[ .FF7)N/ZW)'<>R,S[WI5P,L\=^SM MYH+F =^ .Z%%E3>5.X!G?54A.X %A?D/M -8IM&=?L'E5?4T/=-W ._7'<#9 M;3^PH,WT(]U_>HC)JPJ.A'*CL5D:KDLW&J]2-_OV#D.5;IZY4_YJDM6W6[F3 MU).?%XDR&EV5-5ILU:BCG41^[9&_N6I-9NBK#/I[[]#+\/&97%60#5\1LV)- M;'COS(_2S32[>$V;8@W%:R[I*J*):?)5*\:T*$\&E,1^[;&?S[38 /Y6,<:% MS-XZDZNREC>;+7$;E1W-+ZKS8I?L8*C6.I/=V:L,W;O@Y^6%S;E12O)U'-?/'WB ML^JH/IW_#?>$MDD\ZH/Z&Z'WJL8";> MPN(UHE,1J]4,>P MJ/_)\@W;15(G:UJI[61M+[6=K.V%Y;P>GK_>?WM^(K??/I&[QV_/#]_^?O_M M[N'^Z0#UO?@84D:FE;'J5HSX#,!&G/QDHL^([EG /H)17 \X$MD6N,CS&;\, M0Q^>ZOM*#M*5B0RJ%A4?X\*%C'4N6*Q E (U7!@@5N)$*AB@D'7XEW\2B1HS M- *_0=[&EC%F5!NR8F8V/ "N'84!0%@4"P6)M*'":T+$@?#S]#__?Z)W_E'7]/#"$Y2[IVU<[%3;?;5KH;2G]_H@;%+(:] M2GVWCC&9+DQ&:VVNQ%U1'N"B0" ;>!J8&U#LZ"\,OPF@ XM@PC:6T&$7 (]X M]-6U7UFN-GQF!62D&Y9M!2A%WJQ@3$8@-T"H &XMQP^L(&15HWGM\HCSX/FO M%M;,HJS:]!+"43B]A#HK0HYZV67!61T>^Y6/<=+?MNK]@*!XPIQ@7F Y82ACSVM/HA^/S:&2JX-1\5@@8'K]$ MD;D42! $)/&"',) <1U[1?"P_HZO[!V$9]2'6.$].20LI1@Z4667"<6J+S!. M=PA>!]-NRPLUI+8%S_79"VSK%_PY=GD=Y"%%&GDX8(^+SQ&(,/:TE%6-S\)? M&'JP6OJB)KD_K\<\ 2L31N*RLO9+\I));<<-X#KJ)%^/5^S\>C[WB?[;FH03 MHD_ FV-F7R36^3+ZRW;J_!U6WIX/W<[F)#!6>7TAR'++L=[%C=9+$\I2 M&5&YF%&,3/DGU-T\H;]'SWZ6#%VZ-P"-WYKP.LV5I;ZSD^$(@^=A;@>.GREHASO9, M4&$I** 3,K0?#GW+M,!"I&DZ07_QJ&#@#2H R;@@^%QJ+Z# %!)B?CZ.^'N7 M!1,7A$Q6+"0 V%V(GB7^CN,Y+B?1 11#,.E(!Q]QY0V1G!GKX&N"/0>CLG5K MPF0)N"H^/' *IG&X (C/(!(@ KD:XV7FN? $X_H7OA1O719SQ198/S:8TOW$ M+_0%5G_)Q:NTR10'!@B(D>=.2 O8"N/_X*F!:N!*^,IY>$,UV.-4T Z./ % MFA NMXD:@0N<+/UGO?B$?SETPAE1NM3"DL: '?"'J*!0(,--HO M&&% 3<0LN 7:*UHT(ND=E@ MZDX@$$S99_P^%IVG(\K!6)"CV'"$]D4^\IGH:&#Y.3M$RC50]R(!41C %ZZ# M%"$3UYM+;EX+&N.JO*&UYQJ4,JI;C-&9&:)[8">!>'[!UC?X !@F?+)8E'&CA D_&&, M6"@48" ^I;^XE01F5"3<@"P.F?>R<&&1Q?OY_:#\0+3B\OA,HCKN*[6)S1AJ M(8'XHR94QZ#V*(PNF(\%S=4/L."^@1TM%M(,J.$%?-Q"T>%(;!K0#Z+O",X^ MKOQ&3)RAF+3\*79<8(!;7,M'PH"#+L#896XQC_%9#C/( '% DB"F9;/$S/82 M@^?79T)=WV="MHR0+2-V;QFQ/ORII88_6V4,?ZY:MY'M%W40@M%Q%Y\I./8% MLC-OB\-]33!&_V+[ BXX$6 0ACY<]()=#%P614 [%)[0P B"1=^X"<@]\+F% MBQ]Q2;W06''-1PSKU;)C^KM!7E" .Z@BF3V=>!QUP.8U^!8%]WWF6R'B3V8# M\.@N,UP<]+#LN3%!7+";%P]\CXJ2Z2"AP1E%& 50/454 .!,<:(K9!!S5\@M M/(R\V.Z0!S"YT8[.05J8!!Y@^9%#01P,T>-S#73 F<_!')(%_7$@?X4P([1@ MA,T3-Q+F V**B^K&6#QK!J9%P'32"^@!A]EN#18%2Z.&B._&7LRGUUA>AP:^ M%U6M-;6YU<8)7W'+/IV1'AQAM$6] 87MR -K MPLZC7'A+!HUMF/#1&!9)"@ MZ)^S7H5XA4/1T\9M1'BK87@A/AM^!43[H,=F5_@OVY4#Q#V,4J)4.G>XP-8Q MT45EEO*023[&G;XP5N&3&<$5G7 3C_F)/K=:S/DCV!"HN?55G$!XD-<'@O@^ M-_FB-S=B5Z(!%CV51RP>-HUY& :,%"(R!53&V-7(&X>>35G5H.8V;=I/]!",X1A[8SDW\3^ K7%.B=UOZ2 M.54LL"TPBP$,$#TB6L X9+'1QD1Q)&CQ>KZGM.0OB1WLQ%K&0( P9DT'EJ&B MP CG3!6+X@J/;&Z1@Y>!]JV0H<*_8)S*/348G:7;\.K8IOAJS#H2G4SS43 & M&L"X\VKB&"ZQ0#>:2;._'G!:B0T8KM @(!^9PL,(%2Q<%#6 JY_N[]@.H^LX ME.LO=B%\97G+JH4Y_@N%J9NO !W/%Z3GOIO%$AK$J\ J1,2@0<M,&9L):489PNW:J$:V;,&!F,\(MWB^*<0R';7#%YN)'7,'VZ!9A_$1NT1(3Z5/X MTV#Z%F-@['6"W/K^^B9 V^8\#L3]2>)C+ HAB9DPH-L1*+ M_0P^&']!';%IA%L;GONV'*25S50+#W)I1313[7=D,U49&:MR,U55W2$-$Y.D M[F);V ]S*^.[B,-LS,('K\\?+I]OO]$'K[]>?_$4C+)]Q^/ MGW[>/3^10V1B#E(S,0?ES,1$?V&HVVAP+%G-=P_?F2>'VC)@.T^16HJO&OG( M;R5/8TJ#G#F&W"V;&Y<63_[ 3S'<:;TB\(6?@J/!9,,TT;+VK$-9!-Y!7UY4 M]B7KX8)!3_ -'YS-G)DW+49K7MQT-'5M]:>C964>=)(J3++=75NH.YFM62H0 M/R^E% EG']D.,TX<-PJLPN?.^MYL<9/=!*M>!&6#->U)EX5$$>&8S*KGLVYY M?V+RU3\L<"-@++,OS$%]'"V0X/^#VN:M8^(A$__!]T&8?YQM!LV:1MB:5HU& MV/,\!A)PX2OV_;DCN$A8&T=$B[GU40P',3-7*-S98;D8_.R*B3L>L2>MCU^B M+E@C#RK:#XLNG:1L?M4\_ M;JV7N*X2;75O%V*-1!)MZ:AN/=M/[]5GNEFUWLEH0Q!F1)"OBY.9ZYL#Y*3! MK@VH*T?'?X8NNI+?P63C>=&W_ C+5Q9*Y]N1#\P-A?&26QY>O63V&E$+@]S9 MD/LI%K9FASK(XQ#/ 3%CZ,&9A@!A-)@$A35)X7TH_--Q5ZE+XN1M2?+F)6_, M0XL$+W,KOMW^R7=UILSS1F&!9QY,W/G)HWQKT>"&B\F]&B@6@KHC%#:6@SO7 MP6UAY-,78SF'JPJM9J+%=UPAY]Y5:%W<]!IJJ[5_=RI9_D[RR>'YI'\(/AE9OZEY M];_4<]-8I'UQP_:4M0^2122+E)]%!B=2)5@6J:&VTVH)23XI#98DGP@^Z36+ MXI,D*W0O;@:#9F&]\"0C2$8X(".LZ0UY2)NJ5S:;JM!6/%6(,KB.[#.^D2LV M)#/NJQ[Z6'.QO;]Z*$\S&XF<&'(V9(CNBYP!2X??N\VI!$XI@=,^&'!:31 Y MH)?V=LTD$J7/;8+SG%8-] M:H3\1/I.;D!6O[_J'%+8QER2$UI@S/6TPIK6ER!*))$30TYA6U5)Y+19'>@: M=2R3P(D!I[ -G"1P.B!R!DI; J>.P.D?;D>CU<5Z%"V)G)HBY_A; *VJ;0&< M/A/R'*Z2BU""J\YM,TQXQ'@DG,FLJ/[ ) RP)";VVI%[93LZR=\]ZQ54!"?Q M9Z#->ANCCYL;!?C#,M982I!L\(=S@&2 X>B]VQ5+B)02(AL\W^P0:3>Y'.E) MD-01))N\W+4@R>R6M-6R;4](^!S-U2T /E7;W3J]LW$.5YW;%F/\"#VV/>1= MLSAW11U+=_>JSB4HMR$#,8JLCF??)'QB M\-F0N6R<*3'58*KSFT+ZP?% MA0%([GG5'$!K]KSR M6CH=K5R6CO2T2G"57(027%70!F.I7=QGEW72Y?7YE]K\Y(WPB"K HKM."R2/ MZ8980#V:Q-HRP>=0YZ@HZM1(@:X+%6"@,J8R'T?%]GSKM"YN^HU!4]L_X;'8 MM2UI$3+)UY*O"XGMY.;K).NVP526?"OY5O+M$4-JA];'K,1MO]_;/[=<\K7D M:\G762.=A^9K/-W>4-6VU->2KR5?'R\ 78"=W0,7N=,OK!;."1E7!E)+<)5< MA!)<)1>A!%?)12C!56P1W@?8W17^-:W7FS_@1W0UTRV6@[V+KP=@O7%+X(;U M?YTKOM2;N.[AO5?A-O:"N6[D&L[ VCY3GUY'OWR(!FQ__^@/OW#[H*]U^&VT( 2_QXLVMX%M]I=TIK*M\WD=M:'7?3G_) M#H/J-ELE&]1 Z:GMDHVIE(3"0:F;'[5%H&Y.8NDEKDOQGGG.6EP-KW'_QFZX/F2[YYE4'9T^A:N1!]3WK/TX/Q)# M1*MW5;9ZSTON)QB -8+!. %Y9(?4'X?PI%=F#CTXTQ @C,:4H+ F*;P/A7\Z M[BIU29R\+4G>O.2-%UH0@M?$W*AOMW\2W2SFX6@Y.AFM*<-6YU?GYJ#N_B.W"$_9JIEG/?<#:;N85 MUADQYRY]GV7?M'J%[=)78*M=\DF9YI:/3UI'+ZK?*>XLL601R2*'9Y'".E[F M4R5=;(?94-NUZJ$D^:2^?'*X_IY=%5AAT).,(!FA"HQP_(:EW>)*.A?$(N=6 MV^JC*_NO;.:*PS4I[;9 /70'2K\D)1^*C,%*Y*B#PS4I[;8O;M26[!Q>4^ < MKDEI%T_9=;JRR4\MD:,U#]>EM-O%YE!2XM03-\?O4=HMKD?I<2I>U6Z#471F M]*D1>E9@4=DP9!.'%+8QE^2$_L6-UE+W[\U8GBB11$X,.85M5261,\ #FG7: MLI7 B0&GL VCIP)PM+[2ELBI)7*.OP70J]H6 MP.DS(<_A*KD();CJW#;#A$>L.R9A,HM8CN%.*)F$0:C;>W35/)\/RUAC*4&RP1_. 9(VN+Y*4T*DEA#9I7-F$B(=]%4&4H[4%"0'[8_9 M*ZX_IH1/*>&S2W_,[/"IVN[6Z9V-<[CJW+88XT?H+8>XK S$E',7H=S;VMVK M.I>@W(8,Q!S6$';2U KH+R4CMZ4$R89DPP+461W/ODGXQ."S(>5P?_CTB^NB M*>%31OBH&_(."X!/<3TT)7Q*"9\-Z8?9+9R^5BX+1WI<);CJW+:PL-TLH:S? M+'A<<^]+[EIMD#YK=JWR=O#MMT#^=%M*MR01'QDP+!8F:_:MBNH4WF^7+60H M 50L@-;L:A4&H(X$4+T!M&;'JS R3VOF@-HS9Y7;DNG5RY+1WI:);A*+D() MKBIH@['4+NZS&X"/J_/Z_'I 1M@?X17[(YRJFV ]ZQS)7HN90P4'[J':[U_< M]!N];J>P,Z*RAZKD:\G76V,[^_=0[0\N;M1FM[!-"-F#3$7P+@:,&Y_4%@Q M[1,RK@R5EN JN0@EN$HN0@FNDHM0@JO8(KP/L'\K_&M:KS>1GOL63D!Q&S=_ ML ^YDL/.KG.%QS[/]N41;0<-;0=";@-LL&R,N9(63]36 ML9GWAS?+#,:1X1J[2YAYS<4M^A"H$P;K;TDT)SZ^_Z_:;/O-1M,3F-+&C@[V<6^T M>]=C4+L&1X%Z>!401"_-6,C80_[_+TL=:$:_W]/Z7774IDU5;_9Z1F= FZ.N MVNL.]'_W+FZ>61-PD)]W*#I8]K=^DX:A.#!T[P6PL?"&^& L&($37 ^FP<5Z M[;+"K9'$4 =7VMQ[%$IL59K%I=='"B-P0!O<.N:]@P[69] &?Z(R$.VWF>OX MV?582_-G( GEAT'@AB^6/K1L5L:83?\97O+1=HU?RW\MQ!D(3@I";HJ,[H7T M8B=J')M1GD%\CES;9DJ3,&.!^&/W#;N1>X ;QP :\$6 Y4=A.XR(RJI:44;6 MN):=Q"B+&F$NK$5^1>CC#;ZUZ#0?QCO-6ZS3_'7"VEA+2""<&'8DEYF3;6 ! MP:E/KZ-?/D3VD>4P,K";/BP_#@78BH_-EHE_+63;8*"TU0Z*-V'ABA<+R:< M6=\G/^_VE7:GG_I54U%3/U_W*!5T9D?+]:CUGW=:G>(&M?E16[R"C;F6@\1E M*?$_KE2/$^KJK[!7+SVS"$4*F,W1S)X%\U&W=,2@&&,#6_1\=O ]O1M1]SA[4 M;9LR;8KUV6M<&PJ+CK.DN8__LH+QSY@'\\ L6E$U0G@-3DF'JRC":NJ:2V#$9IG=QTP+O6AX=.Q.K0PY0#O#4 ZS% ML3?<,/T>>L98]V6KOHU:;DTIQ -HN?EZI&DZ;.O76[\O+&N651ME:RHF'AME M VS+6U1.I+2FY !ED(FIVB=@M',KFW995CW+%B,I_7K-)NC8E#:6B3V'"L1= M)+9.HUW78@M;7;92.ET>'5SGX-U\PF42Z8HB?06DL'1S\HM?3*4JACU6UN1Q M!"N2O9Q8KUFZSI[2!3J.E#XT!)-0:Z$7E(PI9Q?5QW& :F$=_UVW')^E$]HN M*%#L[&+8H!RQ)6JE,5$7Y'=7 MT4YO+DF#O+)ADZQ8ZV$4I5D&L)V#;;X0V0LI#2)[(;_W$MG5M8-*+[$?8+G6 M,U'_XJ;5EMW.:PJW$PCMS7##FI4M+45FES)'KQ:V]F?7@S\=0G\;8]UYV2U$ MW]Y;#TH#.#!%> M>&#E<%%T"#BOXMM88NY,2R<629KZ2)MUQ8L.=S(C5_6?GJJ!2=A0U79A1F$1 M "CI"2G)]I+M,QH9VLF/,/;4%A;V4E.RZ*K%V 44T(OF=L+R/^R)UU8 LS,V MGZ=7-0#;-]>Y,N+;[7_JGB4J\P34HWY 8,BL+!*Y_//A/E:-8772V>L];;WI MB"S'*FFLJS&(R0B&.X$1S?Y?GWB6_PNM.C(,BS\?9[\X(9>K.,R,73/FZ$IN5LU0TW; M8A%$"_T@UOD>EWG&?W[5?UN3<(+;JO>_IRX*CML)L&J06^WC3G];34F"/$1M M0TW;THGY.'/NP)PU;6VKI46A0\>$Z8Q"5B?(T*?(M(B:B17,\UWRS7^]PYD^ M\Q]TZH(T=%[XGP_.JVN_,AWQ4XSKC@_K;C&J'8F"6X:=UEKKKU@@M$I,"-S/ M:FMK^WY$Z% 2(K-"\O2)TK@(9$F$,>KC)M>_4G5%$*R%4=U4<=_U[U@QB+Y''G^ISFE$W4.>Q@J%32D MYFT@/L-G+U<__''_Y?;Y_A/Y?OOC^>'^*6$Z94=S>C5(_M(28OVK[OM?PR $ MQ+IOF-0B-0$- M43'(R*1!KF.3]<.A'^BP6+H-DX4?T94N>!3P!8N%[:'#^JL$^.[1$?4\:C[A MN'*$(@;S:8/+=).V%TJ&0@?!Y*?4FU)$:LSBZCW1)QX,:1Y5B! -7MTQWI=YH- M@BN@-3\(<4R8/"8+(>PK[ +U \%RK1/]+[[FRSP(_L@CH%1'HP7>^DI!/O.D M:M2O%G/L^>A9[H98>[AK:7H*^1$;,$X%^,Z-0 3O?'Y_N M__GS_MLSN?\3?A[ &*O+:$4?03)-O4LFR^ UDH)GJ!*MW54FCI8_1XX ?\) M0=X 6^&E8.F_@IYQS*T.+U@Y3ZCYDF93>Z/9=,=L&68R?!+O\J-G?1)#FUL* MS<7B:VQGOIGTU=! F%M(^)0&"- 9+YOND/\)'ZRL.T8:@=JNR74_ MWWT65BE\Z[GARQAA0A:FZO.8IM'.\M-QG8XLV79C23.U5ZBSTC@AHX[MS76L M[-4A>W4Y,RWF&C^;#E@PUO@*=^A^QZ(:PX\O;TX[LBT_4']T.:[&\*#=1T_ MZ31FE(]8Q/?D3LAGUWO3/?/JB^O^0@V\.+-<9=-KN5E,(6Q TA??'[NA;6)T M!72:R:./SE^APXTU9NR*<^% $HRI+9T07[PK=E:<1T)X; .]=F5^6'[@>9@Z "Q.],.; -^)W MDXD^W]E=A$9P#&#G8UPML *P8:)(T$C@QQ;X6=P118(6$::?8+I&Q^*!QA3)C[^) M([8-8EO_"2U88 R@Z?Z8C NC?EN)KL#OL6H5H.#Y.=7L0 &6W/3&F%X!>OLZQ M!?QHTHEE^'C?F.HV8-2 T8@@' S&\J+\ !8W=E$[,\R TV($45A8^#! ' ,( MR6U<_@B0!Y3AA-'.I,. SQ,6A4>99D@2=\B"EK%],X%.6%$VHU\437B&@ 8, MZ 4#V:Z'3M,KM=VI^ +FPK;2< L.9P= 9T_@()B*GG\-D<7@LFGQ?D]1V-2F M+VS[FOD@% 80K3A?&%W<(IZX<&\](+$#& /JPLWNA$=M!/T5\K"8&W(N!=_- MCV*1"W:#I_@A8(J_RW2-4.R@>S$&@/O!T_;YE;H?,=^0VA;0PF]$O"8^1^SB MG%<^QMT.PYHB]ZU^A2DSX &N?CRU00@GG@Y+.TE["%#WK[3W JTI<%CL"[9@ MG&EQ'2*B 25?J3=,S//-LNW5AX*86OV(L>7JAUQ +[TY>BI^,?_<)V_4MO%? M],OY:LP7@$L_AQJP[CJX](A!% \LQB$FPCFLP0+7G)P\\([N*,8MR7I1J8"< M=R@/DUO^DI1;Z)=H3X-#R (EPJ] H=- ,N+0^;86E]#PD$:Z[(^]NBPYGN%A1=(C2ME+UR@&%!Z<,W7Q_'_APT.QR8(B$Z0^S[ART0*8H>X,X1]F M@6P"$%IG1,ZH/ 'R:%422E8]D.L2P'_!;_ M\O'/?XHDB+F)\W1_5VDT_5\W9+:/4$LP)1]-"J2+J (A9CDW(M_H$+0>Q0#H MZ9RD39&!M[*&@=@(!4%H@/$)W^5$[&E\ M-+:-1W%[K9,TBR"69H#?>-'V:;21^24P%= CB_Q8![ANBHS'1>E'&')H MZD+5@-A8RD^.]MPK@;G[W^">,?/_$4RR5XN^51E[R_$ .I^;*^8&9M,$/"AX M(G.VEYJ^!AXS]'30Z0;;I$ %&7VL T.$*)@Y>P6/#$? MMQ,/5S"/2F?Y%VM#%75,R7]>SJ#747]Q=P$U4BQ/?K&FN+4\ ;/,!,AQ[Q[^ ML &A'FM?C,N)T%G*LD=3TK-0+2CD,61[NH K<#-]1+:'QVIQG73FQ.,FK\^^ M8%"Q0;@Z/"ML*6]_.D\"(6-P)X:4.CSFXX$/C0EAK\RNA8G-J ZV*HQS3.TI M,< /96:H,4:'5,008H]VAW_Q: *W>DU/?^-A!,M?-_"ET<"+P+O$K3W"]M 8 MNX$9"WRZ1"[RB\Y0T6.I1'C^8@W%&\C0 M 9CEW"' @]$.%JW!H;Q0]\73IV/4'EQD##U7-Q-OP,5@Q)K (U_0E/*!$%'^ M512^&2TF-8\;S0R;)RO/DW98SVR>BQ6?,&[I8F1&-U]UEK6)SWOQW#<0(^X4 MF1IWJ"V6"D1>0::ZH2_>PN<232PEVZH&S'^?C 0):4Y%5!>6#(Q@T 6AZ1 MSU)R"0<@1A0PD0WWO!FGF-;$@T#0AH.Q\ M_@#DV@:A_PDQ!!"Z""9QN#2 MB^ZP\6&8V$>?3W!*@\KS@4H_UW' M132CK,>(MB)&O(@!^&-K%"5$+ E24=P*A@"R;D21V".F)("=_@$?OB)VWBBG M7>"YS@O,-TI $))0G[)X%9\'4_\LS:.!Y@GSN=CI?^148'F*-NOK0C8R\V%) M,F,DA(4^3,_BHC\BQD*]S2/5PE,[BMX_Q$WGEPK269\*(K,Z9%9'(5D=Y5#= M:+>S,]1@]X)LC/N$X,ZP$-(P.A:!NTR4'9BA!C]V_O[2I(N_WK'C$BB.026S M//C(TF(*COIS0S( XJ*N=<#N)'S3(*JY(M+>4!2SDX0I'C@?[US,L /F0"]; MG_KT.OKE0]3(R'+8K-E-'Y93:9 ?5\Z7LU7A7R]856ER=A6U<,2;Q=<*?/4^ M^7FKH_3:6NI7345-_7SMHWI*L],KY%$J?-%JYWK4^L\[K?27[#2HK?-+J>)1 MFNY8*YI2:S)^3G_$QCI<%T)H\X&G2WU'L&*W"- M)*JRHJJ"FG!#*=L*Z(+/ST_W1-U1#59[ZA\QS=T?D^\XI3.K;JXI_1-4;"ZO MW)$UR>/8:$ML5%LG5=L_V4LG57OJ!;EF%90ZJM([02^7\DH=V;QH0:^VTI'8 MJ+9&JK:K(.*%[Y^?_C_2;6:/_M>,#'>ZHYL6O'-Z8Z."&JK:CD-A&JK:9#A?_TE3!M)&EO[3&NW4DMBHMG:JMN/P]>GN M@=Q/**:V8N$G=O[C#!VH?=53=0UD-;=ZJK>!+)VGN'J2CG7%U5.9^NIF2\W\ MZ#IF<6[2MHS6BM]?0416VU#XJ'L&3-_GQW5O7UX\RLZ-(VJEW71&=M-E4^F_ MDWI1VDP)FREO5FF]L5$2#;7<[;<>M3/^1!9YNSAMC7=X_?_9Y$U-F MES7(9_AY^@U8B99A\?Z:NFV[1M0@S(?KC:B IV]-IK8UFLTK@ 0>U2CCU>8L'P_=\[(>+J\*);J^L@HC?#;L&YN=3G^A4<$2 M5IA)5!2.BB6_X-%5G-=8?\5R*B:K4S(,+3M>Z&QDT]^6J.N,9:.B$D)84/=J MN?B(H[_RND3+E8'BU7)8 6E1S6G!]KQ2"ANC !^?F:B6Q0_HLY:# GWPX5*_ M(GP45O/#AT6-9%@EOZ'EB#9F(U'RQF:5_0 7/CXPZB@C"JNQOC8>G0(F8:ZL M'I/+2\; -;QR(>].R+II(G)8 3#V.!JA7T"&%<,4_6I8A=&_8<\F'#K[I<-Z MZO W#NF+Y; )S@NVS6]=E& 98L5LBU$DUG,GWK[)C^H-^5ARQYQWLX++TALN M[2:PLG9 :)V^ \+WI5Z3HX-V"[@B#_,:7$M5]A9-]D#=\(KE5:^W& E94;?- M7U/YSL?2AP8K\<8E/$J0(-;BEP$>Z[^#\+/)A/?R%!TN%\7S%\^.*KX3[$+J MNQYO5;HJ]GG!MD5]NE%4(4[G/1$%ESBH"["48^@M-S?C?:>B)^(D>$/5E>?R MB7I8_HI5IC7UV57@7IFLQ\+\*FS5Y;.YQIH:S LI^5%%K6AF2APN\^GRDM0> M72XZRJ65:([%:DPM%WSVR=W#]Z7)S%$_K\F%1:.YV!%= ?!!5&RQ,K7@%6;LJJ#,;2P"O\Q%3VB M*(&Q:3?K_LF:5JIJ@UQLXZ[&Q6K3[GC!80R">&:T"HNZ>1Q%T9,CI;'4EK3J M;+NF:>L<%;C(\VZ?B*Z[+X]7HEU)A".;E5W&EKM+^%U\ 6,R02/##!?UG\$N MAT>A70X/'5,;J[O96"H/-3EKP^.@S;-7C#4BY\@M1IL4$*V8)#:,!S9NZ\$?(RW4S6 MJ7BEE!N7>%OP+2K7L?:I;.2+*3\L-[=F!B66AV.=3>".=2-GK0]8I7EL"_P* M@I75$1*$BKI:@,T"W.%Z_@H61'E,GW541C6WTM,0B8K/CE>>GXC2V_,^W&P@ M"OEB_:)8_;D1DYSX1B%_<9K<^,35I$(.IXYSM=-W).6YQ6WY?DB75FL9,*QF M+3:J2!T^UEY$BUOT49[?95N10U!'1^]3."=UO""R$(=,WZ T0%X3CM5TQ99* M%2#;J@LOHPF?3H4B8'5>8^I-%.F?JT#LBQ'XK._YWV]OO\8$Y[H:( M2JM1;>EYE6C10HG%IMFPYB[ *FWG,X\OQ'ILGE\UPZZL9GBPE\MJA@>3^&N# M[,>S#$$%'M(S%K7B,:[+*F=CL-! [] 0WH?DOH?N2].GL:4!C%Y MS!O;K*6\I'-..G^)NH4RNMZ)788?T>[4>B-[Z6G%1X_Z0N/:D)UWG+,Y_%4;+QB8C.H6#LRM@@3RJQ;H,HE9FUO+"3Q6O\J-YK8Z!;YZ- M0H\YY=09B]Z*G!Y1JUCQOC7]E[F!V(!?\/V!*.'-\P-8C%K<+EHNS%L!+VT> MS/?ZHS[!Y!+'ZLZ!S2]Y+[Y^-[=+YZU5^",6C> !%,%ZLNGO2 M7]B)(C?5J,#>4Y5.M[ *Y5UU4+:RZ9K2&VQ]>7FSN=;G&U!>MR7O"C1NN)3-0Y:62%]'IA*T]B-K,=%G&E MKY%Y(31!3*S ;':+U^-_^IZ074[9OBX$EC:YVQ5W61!VA3+ MS>Z:VE+4$QR2RZ&4-IQ?E%BK%-::@Y,4L:B3[JB+K\1C9F=6?DYMY^X:4.\: M8[+^W!(X\K8;J3#JGMQ4Z.@ZBI9A?"EG@W%W\DI3^LFK'6:)<(2*C*97V K(RSGA[66UCU)([PZ:9%JNR I6H1GY"2T2*:LBZS6 M8OE80K O9/R(F)YNY\[7J#8X*RNF:6/M.P;DYTBXK(0NJ[?Y) M$D2E#W"&6.NURH6U"NJ6FO@ Y@Y).C(^7$*>;BJMO*>/Y5:$A-J.4,M[6N$\ M]B'R).EDW* _R66E(>C1$FA.D#MSRUM:_&0U\AB@Z5_EY-UTTAWM=,(]KLH30>,?T?_ M[=HWY3BS62VYFCZ9V"F0H[]]F2H]I:,A%>)'!QID?2[H)=:B'F*;>ML(;=%X M86W2SSO>%3/O9O.6M\2V%7ACU'D+A47[]:B90H/@V1L3>S%.:#!V32#QBP6D MC)7BGI=1YET/6:^5YH=M_2;89>H'W@%QI1]$H>T@?I6T6[%:E:-$_# M_7]]T D>"&$_P#XX+Y9!W.%?V$GFE74M8EV+19]UWDG7MEYYBZ#-[-"$<<,+7*8F%TWH8R1UHX=B!Z$K$!(3IC=B MS^4M<6/-6*).+?[:9X[8_3J;#*B7J.5Z_/*H";!0)O->S_ 0_H0YVKRVZ[8@V@WC3E%)/M*1=NY2#F4A>[F&T%T[J3OBTEI3O-AI.^!9BJ MQ^VK,^@IS5XW;UL=;: TM6(ZV'25?C]?]YPR/FG]Y^VF5OG9K7M21]&T3LGH MU%%:O7QC.@K%!YNY)6/#FM1MT4R-@;95?SB:69YM;UNM7M4'/SC(F+/1B_Q3 MJ._,A2?.#E):]2#EF&<&J?*U+[ME-N_'R&Q=BCGO([0S-)DJ2X>IC!)[YNW3 ME:M:DVV=TV0[F28KT5[;R4JT2[2?#P#.&NV53IO.VD<$TY!L>Y_V(=E6OR(' MU=L[5O/(S +5/L!^;G!H23A(.,2D0U?"X;3MB&H%)VW'Y+TS@=/9P2'O^1,) MAUK#H>C^U_6"@U0V^2C9E;:+E"XQ..Q8LD;"H99PZ.U8,;?&<$@O0]'=OPK% M=IJ5_@&5&:B<:S@()6-A(.$@U0V!Z%D1VZ:2.DB$S8D'-+A M(!,NUD2YLVN=]#*$E8D%?K9^4Y,\L)H\9]:AJY-WCZ>.+9CJN;2Y0S9R::NR MM-U3= JH PJJA&6/U(:NZ>=7GI4$F&.'-0['F M38*BCJ!0]]MS.0-0'&^/7X+J;$!UAJ#8+\]08J*.F)!VJM0^Q1^6E':NE#1[ M[]A(4-0?%#U5@F)-W'!MD[X*M.3+UY5/?(+9@V5OTL?1FOQY_UMT_9GJOH^M MA*)&.PUBV*Y/S2OJF&0$0(9/II[UJ@>44#QV.R.V-;&P>]U4]P*'>O[8FL)% MV/;-M'S#HU@*7O=FT=VA8P7Q+CJ!%_J!3RY_/CS[[QKL*FSAPZXF;U8P9DUZ M7 >OY1]&?8&&LZC)7@,HR3K)O.IV2,DPM&Q< C*T7>.7N L[\AC842; BIA M-9.8=!@0=PCLPYID^0JY Y[2+2=VR[SCT!OU6 LEI!.0PG,GK!\0C,6>^99/ MAM300Y^U'XHHLF@ Y/+60@2%P92U U+(/W03G^!CER'J+%H#-8A'_=#&)D?Z MC(SU5W&!:8U&, 8G8)V5X+;H,FPL-/4HOI41FC4Z"EE7*.QKY-%7RX?I)?ON MK>7(T^ 3.S;-^SJ)UDVP[@WXQ:.436N$V)Q1W5NT9P!9XM;7F#<,Z0CU8TQ0S1V>%1['Q!8WB\:D,NOKN<@[0+=:Y"' MVP;Y8DVG%'ZG?PKV;)"OV%D+/OJ[;NN_@4Q/#\]W<.6?C--^P%1USQB_XSVS MO;5A9RCN&1?2RJ+\R MP*A%)TQ ?]%Q-$2WHZ=&U%PP<^SNJ$48#'."?.B/V?-L(,M2_\PY1%AS#"[Q MH@>#].#$FDYMBW;L &$'1=7P03;@HV/">, .&(A<&# *)OP0H^.;!0T0'_^$M>;PPP[ MRWD6-IQ;+WNV*<\+VRT+/M_ROZ?!UWP M]/Z?;.?>)S]Q?N0KLPQ1S%6TU2>;$O;-'(&EZKZA'E_H"C0_'.P6[1NA[XNN MS+S-I;#>OPOKG9DRO"1M 5VJY?FVF3YS M^FZ@XX+<<1\#R(35^E\H;YV*O<5' )F=6Q9% /(,&0FCBZ:I_ICUPMX8U:\ M76<*'%[6B%E&\>NQ0:OHETYF%K7A0GPH('"LT9@$<"[KZ0I\RCY B&M8FS'V]F"&,4>N"XQA-,HC/EY1UR%?)DWQ[4< MOI31T[@\GN'Z@:+UP?F"&,D8.%-(G#%_&>?^P,.S%TT MW@7K_;?ELZ;U48M?;E2QBW3#<$/X[#TW:.&=!E"$=:Y'%_@].([@M%M3]A>\ M!^8W?]SRO?'IN6' YQ>9@_S-\*=))^)9W&]9?KW.3%\^)PY(P"F3:WR&()H, M?6JA' FGV/(><6P%,X7\BT:2<8E18+C@']!9Y.+PU_@4^]0'B//(36?&^=BU M36SXRZQSUZ?B\F VQ< :7(U7PK@FN*XQCL++D""O=&P9<9"(14:'')T+="0\ M9$;JH('YRAAOB3/A'XHN 3HH\X6O-/OQL'MCC+H]@IJJCKHM@MJ/MMIM>28,KRAK1;5 MS+C.="IV3(.#-0YN)2II9MI\*7='JV<6AF0!,9]0!P/37S$<1UIJH[#NG6JG M;HW ,,Q:2-NS\Z%7:QTSY&/7M2L M=ZUB7#G*\5B')%M.LHDHD&P[>@A&+*Z6>"5HMC\+GAG!TIBO7H?\TN?]D8+' MSX.E?+O@\G]T)\0]6C6A[C.F;FT7Q:DI;,4HHM)I@B$?-E[ZP50GMQM">%S@/! E@"N,H [C:;2M$%.R6 )8"/:$2T MFP.EZ/8'$L(2PL'T@N:.D7M%-*T7MF,>)OV)![ET+Z]T=:&E9"4?L@EZ>< MRR,YI[1+,\I=B5*;:[9VU6];*[0TJ;7-#R+JB6?S=7CT?HK3V1@';19>SS;]7UZ;O49NOU=HQ@5 M\VDKN#9:_BHML12R71B[-^6U'E,3,3&_[>N^8 M5JSGZU?=,\:D5=^6KQEQ5[]605EE8:/;U7*?^JE(!J($\7F >##H2 A+"%<9 MPMUNKZ[)_1+"YP%AM='NE[/QH 2Q!'%F$#>;M3V1(T%\'B!N]WIU/G]4$M"E M!UAN83#Z"]U8.S7#E&/KT )*FVXXM&EB(5(C@_M&%N7HY.CJ,;HSRR^/1,^B M04N*$-H[BZQTT\ZMYBNDR=6&VFWG/A)8GOQ%B;8JH:W7W]ENE%B36,O9Y#Q_ MLRR)-8FU'8,Z_=:N01V)-HFVG%JT7^&36A)K5<*:-FCONO-=DF!>U9SK/"YU MUCR\TDTV.\ND3;'<+*,VNFK^;:&LV-8FV$JU(G='6[IZL8-V9[EC_\Y__E'O5E8]% MM;L5CK'OP6WE7I9O[V]W2D23,6+)ER7@2XFU*F%-[70KG*TD=8#D2\F7LM*> MO$I6VCNCJ^2"UNPJN: UNTHN:,VND@M:LZOD@M;L*KF@-;N*+>C[0!_:%/XU MK=>;/^!'='6\;>5@&@@W_>:/H8>W"H\YN@E>B8^9N\[\5"J,P=:G/KV.?OD0 M#<%RF$?.;OHPT;T7R[GB#O)U)]DADPV%?_WAS3*#\?5@H P&&KCQ$2#%B_FW MJ@(>_OODY[V6,FBF?]54U-3/USU*A2]:[5R/6O]YIU7@H+K;'E5>+*X7+AMC MDX/$92G!-0-P3+WCA*#ZF>HB/(\]2LD$KAO[A *CF20J/MG($)L\/IUC<=%U M-3$V!8'+MP):4VMGB0)OG>W9D*MU,& >$>2%EZUE"K#0!1ED6I ?])4Z(24S MB]HFN1Q._7Q3[-+S2#XCYJY:BIFCUH>Y3 M? (6;'^W;%'LLB6S/Y<>:F-L[Y%5D*.J?;3II_*DD+_?WGXG?_=G-'V M*6)4J3W25E_I%C'9?6OC5()8;561RG&-/-N@9$3A9? 99F8>1,EVE54=FS;2]3IVLXK5"E"Q ME6+(5E/I%9WB45]B:9F(54'IM<$04;OIELBJ1"K+2C$Y=6L@SQ,GB[@Z'TNE MJ_2EI9*YSE FLZZ"O'X>ELIWW??7B@!IG52#"0%36=P%:9TP8G6K9)U$.VK% MLE\FT?!O\5]B?RX:Q_)66PL>*CX1!60_+ N^_C(R_@K]P!K-E@4A7I0=%[>> MI=L9H]#I<[Q4W_&TW>3/@PB^U5!L^J@V1HR(Y1/'#0!!CF^9U*,FTA3:!!B21VIHXM@2"PO]W%[@+8 M741,V]E=&(B[@:)7]O>"^B0)R?K]- C@,QBY!Y\G\.UO8!:"*@[N\EYB AS! MQ7[39$GH.HM/'Q80UU\(_,F'X('%;@BO9S0A?U+?)S^!%B$?:0"MYX \>1?. M@:0Q^79D:0Z9<-^'I8;T=CRYBQ7VFF]GXI'MV5@7Y-AK)6GT[=C0]!S9 M"U+GM48^)$+"Z/U]%-Z#U@*A!#E+)81)ABWR6HB-/D](0;B(2+@EK4)P8"#BTS#7))3.>KZ4[#7?1*("AR;&_^_#IALS"1W@ZZLO6 MH/_#.0^*[\H'Q(-"KQE]TLESH202^0H@K+=P$YC@=O!MSI*(NW'>D>RGT IP M 65TNP, ^!A&JI'/H!%$[4Q3O_GLSIBW\)EH\VL87$E:? BDJRQL5=G,N)'Z MB,(;0$V[W.?R._',#@4*G% GI,G@B=R0P,*4T2=T:#NZ*)!8]/X0&7TXAG^C\$2RHB=Z#: MOS)V+]X^IU]%[Y,HI+ \BS+8!%RWT$WMG_4+X(\)FU%_FAES/"*NS].WB)Y! MP:T?@R:%89!'GLR$=1!&R30$TQZ6M#_9R@BFY)Y&R5),(342]X^BGYO8;N9] M>B%+3>([%H"9YOM+,@/#' P.E\5QUB5)Q7694C$EG2RL[MS$J[ZO,D* 62H> M+5(^G6W$XZ_"'V )^+O"M?7YWPON<1AYP)BWN4P7QY@9[4 F&FVR(F1P9N$ M'UX,!?"U60H$O:-1_OXBL^QBE/VK\K9$J"])%54+>-9?@6%^9\DB"CJL8S(Z MW($EGG*'#PX?V_2BA+VW4A12[SQQ4M,OQ4.@&F1_#]073D_FXQ5D*6;N(@)V MAB_EHZ!/>.A)UI:_I3&?]&I %N7)?++W_\"C,N3U&W#U V>/N1<6BU!8JD$2 MX?>N(TXKB?V1Q^XB%C*;NH$!]9 M/(B[E*\W/8^M_WHM7A@+YQ;4ZYS^#\0[F[U0NZZ8(7ST7)R*K$)48E BNE-% M)IO'B567?U"+,$[R_I^,^WZ'-:C#LOHC2$ZFVLM%/OOD$7SN?X1D,7#I1 P9 MEBY8=>.5) ,+?SO2S#Q^UB?>@JT- RG2TPP&EL,@PLVP='VH$(2U^IF]DKY= MQI&_-;3QUGMWOBP?S;9TO'#%"+_$+_%+_+*BB]RYJ)2I8U0*HU(GC4J=TYS< MNFF4AE/DWK8P0\#X> <61<#\DY]\JC3&NF>AGEZ&>ED)GOWNM:T[5>]>6XXV M#KK)O74W.5, 3;Z> M7/H^_2&4,P8MO-6]_Q*\,6KA=*TZW'#1?*WEIM;C01Z!B5_OA;1U:0FD)8AI M'$K3ZW>64(X$*T^P#T&<\&0A3/E2C-8MZJ#XH?A=2/S.?4'LJ),OE^+EWPS< MM+*P,52YH@YS:=K5"Y%RE0.PDYPYL"S4N\FWC^-;HV_JX M;I$SY%PU0.PDYXX<$S4N\FWC^'9@#;6Q:GS;EKR=Y2#X)0SNKA(6S?,;$GNC M;&8U$NR4.N4X<*175ISJ%(1O-S1#_5+UTQ&:EXH!H]2H"HTSUFR$1DEH!K8V M0FB4A,:TM>%EH#G2?ESCK,W\#FXM<[-L=6CE^*SGV)I>>1-2 4^\Y; ,+,U& M6)2#!>S,(<*B'"S.4!L@+,K!,A@A+ K"8HPNL.1W*X@I\@KZ*]/RX##FWMAR MJ9T%Y3AP6#=84YH.#?!)6X=I37\5,546TYZN6>47"L13=3S-RGN;B*GJF/8L MS4$9;0^>:JZCW0H*"^L]3<[( Q+(I)+%E.HRM[.\S?''QVY%B\?:H-[A&'3J M3XY,S8/YB,R)D=%19A1%IF=@,%]!5,PJ!BVBV+!)O5.? JH1H@*O:/E"K7GE 4%4'M=HY!<13 M=3QK;V8@ILIBVAMH)LIH>_ T[*,GICD&J-T*%__.TD*8S",>CY.(3V2&S8[% MB:OO3: /C\AT&QE9AM.\07241,? 1".*(J/7/4*-R)P50J>XX(#)X5+W;R%SLHEH':J>^#SQ> M*)SZD4;NC%BUZZ:F4[FV@-A>N)CX+"W1@G5[#J2,TO)I](=#LV[4Y1CDN5"T M!F4"96*_3!C&H;6N4"90)MHD$P-[<.#M()0(E(@V2831MT?6@;=Q4"90)MHD M$V/31KL))0(EHG"D850W/=BE)$)&SMXD%%X%_WK\X>WW\D^5QDI?TQG'.7 ]GR41]UJ$-M M4&NL-_=AS,4F\'7$Q&[P [L14%Y9LK^GV-"8B0[$=MWK/<3?BXP$;?)>>!W*D\J&;.8WN>)!SX(Z!2:9*O[YYY%XRNQZ/M/%P!%#D ML=?LQ>FWA@8HO=G^W-(UT[!W?J5KQL[/]W4UU!QS5*FG_9\/K&H]X9A4&9.A MV2;R$X[)>:&G%W:)GMVOLP=K4>]F,49MLIF[:^X]SV2V4IM@-1:3D?9;H[);YU]+J=PV,NW7\7#$FV1;)/M^^0 M7*7)]?[C^]L2Y.H645!-H9I"-:42N;;45 <.WOV;W?$@*)Z]^P\-%C1:DMJ' M[VKF/FO+#D")Z2L=YC?Z@]&@[I5?U5/Y(0MW@X4-RSIP]Q996 DHN\K"IC5H M:UYR9.!.,+ Q0 W#S6;.1;Y-N&\:UI M6D>W=I%OD6]/;BF,AD>/E&%QA$H0_!(&=U<)B^:$!VE-W6[E(AKIE3D0$T:< M!QJKNC&&T)PKO(:Y]Q6%QG P-Y&BT#BHT%2%QC:Q"(^BT!ACA$95:$:7RK;6 MK>H3:RS$1;E8($5LT(F7X3E7+ , MM3'"HAPLSK!*AF6$Y4RPV :N+0K"(KPQA$4]6(87,)"[M5/V*TN(OW+$ZGMA M&1%:5NF^^D9N53HT((+3,DS-NIL\B*FRF%HHIZW#M'8A=,1464S-NKNXB*FR MF-:N@(*8*HOIO[X9F89Y@[BV#%>S[L[F23'MUK:G\+C3,ZD\($$87$&']([- M12[7*6.$T2A-O?#'QV[MAX[KGO;'0-RI37&];HYGA.;D,5(\0Z >*GK="W>( MS.GE98CRHAHJ.B[]BB(#\F*AO"B'BJZ-<&/T?&[:/ S8DLQI]%5\"E,\:).T M>?QVL2K'>%C]94U003\C*N?:N\++'6HB _)2X:07HG(>5!Q<7Q1%9HB7.Q5% MQL 4#XHB<]#N*6ZF52%U6A QR'VU0S;,6K;5:PS;FBJVRZ :!Q:I1U#5 ]4Z M>G9&Q/32F%8WSA!3U3$=5SZ0C)BJCJFC#1'3EF%:S_U"7%7'U5#23NK6KNCO MC )Q&?+!)12;9;VZ&XO8/((#(-"HHB.HA.@]&I?146D4%D.HH, M:C1$![=(@=0?TU.K=Y0',:&!1_PPCEG'[<% MNG5I5,,(C*F5"I5+<$43D3*@;>FE8/E>J1)D3F/,A4SY>( MR)QMU4=;3#E4:M?D4.0H@!I^F+.3MN\#,5)R&\N)CX;'62_K#K!JJYK]]>D#Y*RZK1'P[-ROE:CDZD"P7[44I02LI) MB3$>'WA9'Z4$I:3=4F):AU[ 11E!&6FYC)BU#T=T6T;VSZ[KTE&6,DK+A=&W M1]:!*3D.(@_*!,J$?B]_I*.?1*))-I/-+TN0]C;BU*]+4%,0]*_LO_IC.!*\ MV,TC]Y)9QE_%IS).T=>/T GPQ2+9_TB! M*UP6)"PZMI08>BDZFL8F+8H_Q7"Y]\,K;HQ-=S1RS-'0F-I,-ZCN..Y@S/3I MT'"&8_J780Q>Y4_-HGP.]_2.74TB1K]>T2E,\9KZCW09"U8O4&+.@ZLBV9]2 M[#)T(3E9]KQ\.CW9RU.-X3$WC.0YTFO04"P2K8 @5)FQD%G$IC^\^N9E[G!> MO?TBY(Z$4_(.7@C\'G__AK[=Q7E/183#^X)$*(57QU&$58DC>[SF"ON.WM,)]WFR?(FSZ@UXJ UJC7B'EA,KVY4E^WNZ M5-&8I7S8*]3C.>Y"=6I\@&N9*'65S&+"@+D\DA\6Z!-3-VV9/0!^L:ZK3E"N M+>LE05H),%&?WL?L.O_E)C\OSP,Y./G0S9Q&=Z &LW5D!^6E+*1?9PIR/-8& M0T/HR.QD1_;B3'UJH,3>;']N.AI81#N_TC5CY^?[NAIJ(-Z5>MK_N6G91QJ3 MK5>;W>G'Y&ACL^J[3S\F?6 J-J:!9AF6?_EIS1MT@>PB/XYC84ZT,P28]EGCYK:Z%E[U'YBCR*ZA4N*X+11 MX86 9_(3_X<)F-UPSIJ(\P!Q+H7S^[\70%[HNH$8#Q'CO1A_BO@#31A)$]XU M$EX'X=U%41EVO/UT^PZP#>@=:.E+86O6QW:$V.X5W8\+/^%7\HK*&_);,F-1 M$Z5WC CO1?AG/YS VOL+A\77.UFH][3X&CH"O!?@__[WOXW$U#@ TP[<'OP/ M#18T6I)L"^!DI7=*GR6!KIIUD.08Y\\O-FFC/Q@=>OS\F*?+!2'.>D *.;>A MG&L-S/;;B72 M_R4,[JX2%LT)#Z9^^+@^V7*^]/D7X]^17GGWX:#4H!4Y]*(96R\76Z^>=P5! M.;F%,JB<;A!!.34HX_,F D=,RF@OE!/E,#&&N*(H!TKUC4C$Y-28_.N;D6F8 M-X@+XG(D7(YTB+%QSG2X2*0W780#S4],\0%<<'M9X'3KRPA M_LIKKN\R9T0X[$")6BP\K+LW??FC%4>*TK4)3T9=E@$N1^]B'[UFTZKV$,6YD+O[-P5K\9@' J#&Y>E8#1%)-)"N$.A!)=9&L?01!732[=3[A=\:# M!Q8GS",>CY.(3Q:BA'67#B;@)H5ZF#0W^-IN7*H7V$1,U/-R$)/38U(SCPMB M@FL*XH*X*("+CG:QW:T$V* MY34,%'-8]Q0!@G+"=7:,F"B&B8$Y0=0#!=.:JX5']1M]B,FI,;%0;RF'2?5@ M(&)R M=8HA(!ZGE(\QXJ$0'KHV0#R4P@/7#X7PZ/Q1(35\9&??^2!W1BRC3TS=M$]V M>6HGF^ZBQ<6X]-O3S5U=T33ZPZ%9=_-4W9MSR+FMYUQK/&KEG7KDVW;SK>F8 MR+?(MPWD6TL;(M\BWS:,;PW3:5]F".3;]O.MCGR+?-L\OAW6/LZ(;*L&@IUD M6V-H:R/D6^3;AO&M.1BW+YQPI%.*:FR[[,;M%L9"[]BN^N8OS;* FP7(>.%B MXK/6RVSUR:LKM$9_:%B5+Z57IL EMK&1>=O.O)93W3%%UD7656#6YG!J'49"_D+_**S!G6/F@'C(8,EAY!K,'C33!NI5Z_IV&N=+AXNDOC/= MS/*P/6=8I;J("I&>E@-B#JJ4"T- 3@Z(,=!L!$0E0"Q464H!8EF:("^*"N\\"IU]90OR5UWSP_O-A28+58F&S\N&)JD10 M/4K7)C0'1[AN?UDT2PT$H7[UUFB\X"+49TJ2M/BH&;/P-TQE?!H;I 9<4%<$!?$!7%!7!"7Z@'^JM=)$!.4 ME6[BTC.;YK-T[P#&RM.>AP%;DCF-OHI/88J=2@: MVF5PZ2Y%Y\0%\0%<4%< M$!>5<:F>Y1@Q05GI)B[5LP4B)B@KN)\MYK'[)GW::S&N.Z@=3+ MG],X4C2O36A6O^*@&IJG.6350JBK7W% J!L*=;4K#@AS0V&N?L4!H6XHU#U# M985Z"N7<@!H6X:U+7.4R@#<\/# XH1YQ.-Q$O')(N%A MT*53%IC<7SU,FAM%;C5!3&C@$3^,8]:EV@O#VANR33HLT3!0#!U!40Z4QA9M M;S$F1O6B>0C*&7:),?._0GA4SUB'F)Q^,V.$F"B&2?4 !V)R!V' ]K\.6V$K]5HA:V.KEK;JUI&BG\((_@R(NX@B%KA+DD30 MF4_%N:).'2NJ67,#MT].%T$ 4[QR*GW$ X])= J3JN%HQ 2/W741$SQVIQXF M*"?J88+'NU3#I//'B-3PGYU]9X?<&;&,/C%UTSK9Q:J=;+J+%A?CTF]/-W=U M1=/HVR.KE4EHD'/;S;F6;M0]R81\JP:$G>1;<^@T_K(Z\FT'^790^S0O\JT: M$':2;PUSC'R+?-L\OC5LM!.0;QO'M\/FI]U"MNT>VQH8!D.^;2+?.F;[PF!' M.L&HQK;+;MQN82STCNTJX/[2+ NX68",%RXF/FN]S%:?O,)"V[>'U9>;RA2X MQ#8V,F_;F5=LO-0L%(FLJPJ(W61=YX865<5$+O)ND.C[FTWY%Q5,.PFYQJCZCO?R+K(N@K,VA@, M6V@O8*X4;-725I*UWR049 W^]?C#V^_ECU1V)Y%HDLGQYI@D*@@1A IWS^9QYG";,7Y)IZ/OAH_@N MF;%8[FX22=Q8VYI#/OKL'=80!G$?QEPD;KF.F,C@\L!N'KF7S#+M6GPJW;N] MUM>/T$D<^HMD_R,%;>FR(&'1L=<(0R]%1]/L:M)Q.C7*SJ%*5Y3_Y$N M8\'J!4K,>7!5)/M3BEV&+B0GRYZ73ZWFZDGK,#2.9..@:5D46B59 $*K, M6,@L8M,?7GWS,G'C^A M,4M9K%=($U02$JE5U\I0VHXP;9_>Q^PZ_^4F7^YX($]G\^L 8XIA)OL U'L3&I2*?CCFGT;$\O.&+/II6P"IY?JBXR!;!Y]N^Y M,W2IU72>4W2C4LD+OL""R,@\_-%C0:$DJ9!,^V?6N2UZ:N>0-KTO.>SP:U*T?Z(8V0 9&!FXJ XLLB35+G;66@;O,O0UBW;$S/'I&#N1;Y-O3JURS;B5# MY%LU(.PFWXYM]?BV6S7!?@F#NZN$17/"@ZD?/L;G+P1V40XTSUN8HKIZ?.:0 M?+NA,6M?0$=H3@R-X50.42 T9U)H0Y0:1:$QA^1SR5QU-'^6P5GF85'Q_Q5![/H>8@GNW!TSY"MK_C8XJ9HUK6JEN1 M?>&"2<>+\$#<,F=+,J?15_$I3+%C8?[J29PQ&G.FDPMUS_/# XH1YQ.-Q$O&)S&:UMNC3!-R=B!P;=>_# MHE>/R'04F7]],S(-\P;141(=0],1&261T2O?%$5DSH7,A=8:/(32LE;=VA+X MF)XXN:,\B D-/.*'<L<^T]A!'\&Q%U$$0O<)4DBZ,R7Y46[=8B]-ZQR MZ@1#0V>[7&@B*LJA8F.B&O50,3# K2PRN"FD)C(7VQ0Z4J1:#=MR=[6R]X$8 MZ:I465Y^M^YYLW0JUQ80VPL7HL9Y/H.N%M(Y/GV4EM7Q>'#@&;S#1ME!&4$9>09PMBCZO8XR@C*2)=DQ.CK^J%7?5!*4$K:+24V>"0U M"RF@C*",=$)&!OJXF3*"._LM:R4!?9-0X*#\EIW\D3+E)!)-,@;=_/)H$F/H MNGWX)'^=WFPIA^;NF:85@[OX)O=GZ^KZNAYMB[O]G7T_[/!]88Q]3( M,1F:;3J*C4E%.K5_3,-G>WK!>GEVI]<>K%V"#1/L^?P 1=O*A06*1>>Q0T>E M=B._S"+&1*K69!83%GC,(_F.9'_#,#V$@&9TJ:6F6\F&URY:N$CJ5S%O;++!GCVN4FX5 M"1831 =A40X6 [,,JPB+@QFY%40%EA8;85$.%A.E1458C $6>U 0EN$% M=%BW=LE^90GQ5VY8?1]L,T-3S0.:ZC&@H]5.3ZYLHK8NXSFJHE 03]7Q-.O6 MWT-,E<6TIUIA6OR!X#DPQ@2ZV MPI*])PGAI ><>2#R&;(EF=/HJ_@4IMBQ+76]\G$G#.:>S:^S,,2N&BI&Y0@* M(G,V>:F>8PE1.3$J#JXOBB)3_7H (G.N-:9FPC!$YL3(_.N;D6F8-XVN>-T0 M+TWFS81"1'50Y-(Y+J(FD=6.<3T50)3? C MQRB7;4#RT/J[B*9*:.IU[TPCF@JB:=;-Z(%H*HGFL??/5;D97-I%]OA#WG?6 MQ95H?VT,"JXV#SP6)-=70-7+ /4[X\$#BQ/F$8_'2<0G"U%J=.U>R\*@W=CZ MQ*T<1 :1:5 %-%!=!J,3NW,K(@,(M-19%"C(3JX'0JD_IB>4+VC/(@)#3SB MAW',#MH6;1Z_F:8VP QP2D)CC!$:5:%!9! 91*;:2E-[MPFA.;70#! :5:'! MW,F*(F-=JH "WF'%5BK<8;W\ +%5.UIUZ[+T3V$$?P;$7401"]PE22+HS*?B MU$"W;DKWAICR4D%4=,P(KR J TRFK" JE4ZV(RKG/TK(Z'@_J!NR/1Z(+A?M11E!&2F7)&9EUJTZBC*", M=$)&C''UC$4H(R@CG9(1T]"&*",H(R@C^V6DK^N'YNQ *4$I:;>4#$&4G^2(5E M$HDFF>!L?EE"DF\C3OVZ\FN8(+]_9?_5'\.1M(DIM,EGQ@AUW7 .KUZ*726:;.BD]EBDE?/T(GH(,6R?Y'"NK'94'"HF,K94,O14?3 M>I**J_!3#)=[/[SBQMAT1R/'' V-J7!7)_I1BEZ$+R MGBY-'G/#2!Y[OH8%D46B%1"$*C,6,HO8](=7W[S,'[..^$^D1V>,T3D#KWA=,/#G# )QK'(/12;4R6Y-V,!@'S7^*+>F,< M:*-!K6'N4%+""+JR-$-T^-2FH3%+^:A7.,51[>D% MW^?9\X96(:"PX< ]GWGU9LLT.H\7.RIU)NX+K'I,5'%,9C%AL!AZ)#\7U]]P M:P^AG#%X2KF7$]:J3393-^V]U[>,40NG:]7AAHO&M\I-K<<#,N&^+[+X;IT$ MW15+; >BLCS04::[6U>VC5Z_LX1R)%AY@GT(XH0G,CMV*4;K%G50_%#\+B1^ MYT[L?X&+'O]FX)X'Q;L>_Z'!@D9+4KW";5=W\RI/7^G-NJ&NU\U1K,1^]3/W MX9"!N\# UNOG.P0&1@96)EY#ZHGN&T[_W:9>1O$N;9E'=UV0+Y%OCWUI*VQ M7ODR /*M4A!VDF_MZC>&3\ZVW2J6\4L8W%TE+)H3'DS]\+%C93(L!S-DJPI- M[7L)",V)H:F=YP&1.;708-D?5:$Q1PB-HM#8=6MRG]W6;'2"[+6M&2Z2^L9F M8Q/^]4P;,S"K"(N!L"@(BZ7IB(IRJ)B.5OUD!<)R BJ>J#V=,VLFYX<\50/ MSP$JWM9A6OUP$&*J.J:FDG+:K<"PL.&EY4YX0((PN((.Z1V;LP ^9XPP&J57 M//[XV*V(<>V#M.C9GQR9FN=$$9D3(U/[\@0BT\9H&*+R8NA8 MC/M(HZ_@/M]1'L2$!A[QPSAF';NJ80]P%T%1:*QQ9=\7H3G7F:>J029$YDSZ MS,#]:D6AL4:HSQ2%IOK9,-R$PU:X"?=3&,&? 7$74<0"=TF2"#KS91FN;N47 MZAF:7?E4?\/B@PU$1:]R61)1.1LJ8T1%-53^]SJ%OLX0F'V5J>7/09]E);3X= Y,.7W$4AT MH>@-R@C*2+F2.N:!Z<511E!&6BXC]H&IS%%$4$3:+2*VXZ",H(R@C#PG(^:X M\H%CE!&4D4[)2/5,ZDJ(B(S.O4DHO!#^]?C#V^_ECW0.DT@TR>:S^>7QZ2L[ MO.8)#-%](>CF ,4_T3CF#TPD8"&3)7GG&C/1@[@(_WH/_?>"([%<<5W*.S!Q MG]['[#K_Y28_#, #.53YT,V<1G<\R%EQQ\ D7Z5?WSQR+YE=CT?:>#@"./(0 M;_;B]%M# ]EXL_VYI6NF8>_\2M>,G9_OZVJH.>:H4D_[/Q]8U7K",:DR)D.S M3>0G')/S0D\O;$8]NR5H#]8FY,::_?SEJ^)B[,(2Q:+SV"VC4EM77V818V0. M[68Q88''/))O7_4W+)E#*&<:3RGW\ITUM3;FI M]7A )MSWP3:+MS9L=WF/[4!4YB0YRG1W2GSKZ'4[A\=!G&N;56O.55I^LBWR+>G2&ICULYJ@WRK!H0=Y=NC6[K(MLBV MIYZT8]3-O'>QO,8M2WGTRZH$.0_24H;=2G1D.74+C& FBA-#8^J5:TDA-&?: MVJA;7 "1.3$RAE&W4@!"HYZ-CM"<;:FI64T;H3DU-+C4*(K,N&Z]*$6RA37. M0PL72?WBD(U-9MTS[2I93S''^)E@&6/Y9051&6C5CQLB*B@K743%=%!8%(3% ML*MDH$58S@2+I5F(BG*HC+7AV5'IU@[9KRPA_LH'J^^ 940X[&2F<@QH6'4C M9TH<43Q2\*9MH-8.AR*HZH):M^0"8JHPIC5#L(BILI@.4/>V#M,AZM[68=HS M-+URH1S$4UD\:Y>D.GWNU<[L=0I?.SV%R@,2A,$5=$COV%QD;9TR1AB-TA0+ M?WSLUB;HN.[Q?HS G=Y7KGI*%:%1<85&5,ZUSEZH.#DB\[*\G'\S 5%Y45YP MZ5<3&9 7W!)5#Q5=&ZFV)9I74@"7ANT'$5MAJY=:=6OO7:9V)4$>%3C)OGL# M59QIUKVT>OG;_J<./C81SNHF'L*I+IS'#R0CFI>\?X9HM@=-Z^@')A#-2VZK M.XAF:]#LF57"*8BDPDCJ50+))T<2@S/82LW@3*,/:WRDT5>6D#O*@YC0P"-^ M&,>L8[?3[0%NSR@*C67CR0Q5H:ELN",RYT'&06041<8VZF941VA.K/L#=L7:2 J>I6T8HC*V60%45$/%;U*KC=$Y3RH_.N; MD6F8-YAW&]%!=*IKM.JG6!"5DY_)O5 5@2,="5##'W-VTO9]X,F<#'',DICT M/M+(G1&K>F;=[ !0.I5K"XCMA8N)SU:Y-+"H];'HH[2L#H?.@;6#CT"B"X7\ M44901DIMGA@H(R@C*"//'IBH7J40101%I$LB8NBU3^*AC*",=$)&;,>I?&D0 M901EI$LR8J'+CC*",O*\C%AU;PJAB*"(=$)$P-)JI,)!1>"/]Z_.'M M]_)'21+>1ISZ=0EGF$"XO_+_5G3+!Y&_?DZC.Q[(^0-US@ZO*>#]S!BAKAO. MX=5+L644A ETSN=SYG&:,'])IJ'OAX_BNV3&8B82?1-)UUC;.[4,O2LAYM?& M:#6[M]]/(@%.*8K<;/62XL\#CP7)]56AWS-3K6>\)H2\F]$@8#Z)V)1%,4E" M02#"@X1% ?6)Q^,DXI.%. -)W*SM- KGY''&W9EL+&@9 B?S &CM:>1WEE#N MRX\C=A\!N8,DEG^N>F,>F2SEPQEJ\NR!(SQ=Z^S'A,Z-U=Q.[DR4X"?SYP]@C/4OB"W$?A/X)?(I*]@Z=Y MX47F>#'@;(#B7O+F2^;RVK+,,+^F338]$MZS"*CS#+>I($@]4[*$ST5>?"^< M#JA.*\3ZE= ;:ZJMP*O\&O*Q\N/4^%Q<,2M/@0/+ XD74"7'I/ M)]SG"8=WT BHP&(WXO<)?\AH!/.(!4DR2O'UL\"?@/[=4K#?FBDF#(CU(#AS M1I.G[+;9P>KE2\&@#]P38R#S,!*OIL'"IQ&,YYZ[DJ5A#%3LFL-C\%:0S?^7 MLKI@VHC-PP=@]NQU-'\@>V?VG __YAS_]X)&H X(2_?C\WWX/C%UTR[,"*8H M2 &J4[R[XKO5EPB;,$%[[_\E&8B^ !L^0_0Q?47 H'- MSX&HGU.<@4-N"/LG:R5YR W)?__[7_(E6L2)XE,>B"G_!#)-!>N!9ON)B[E] M" !EMI[\QJ? E-X"T+Y9?^^"54.!A221TGH;'GGDR4RR%6C=-4\K3I#A4X*\ M_WN1JH$U)XA/EBLRM$#].6+2GR+^ Q-/J[6MFR^^1?O(C"Q$BD#OS-!F3@1 M'Z\U%W"$4 X1CZ7.X3!_&*M0.(7V??+NE]_B_JY>?5C;F= FT%CJIA.SF,*( MC 0BMY]NWP$T*H\5PK_0RD3_$QZ#TWP$M:8'DLK?\#?$LC!(BZM?V82T*V#(S@OKD'K""Q2#M M2\#3 OJ/!?T_+OR$7\DS:6]^ _)&:]+\[(<38:#*%?06_ U7+G#]]0*PH+"^ M)^DRN5XJ^OF37X 23' [6-"+*( O/H>^-"]CT0DX,CZ?^F%*U#\^?&FGMC5T M0>>,)+]P4*R>4*UB"BM%,H>IIEKDHV2[+&70%'1TNB"O%M]47K8:J4X#Z9L) M@V$%<'4K(@M:#,LZKMD0K*&0PC#F@O&N(^9+?KUYY%XRR^(IQ:>RM^CK1^@D M%FR[_Y%" ,1EPM,\-I4-O12937N3%L6?8KC<^^$5-\:F.QHYYFAH3&VF&U1W M''(%,"4 M#I]XEM *"4&7&0F;@X?SP MZIN7&<1Y]?:+"#4)=?4.7BBLHN_?T+>[F.\,@&\=MI: _\YB6-FD^_J;C%6( M54>&080-D.PNP-P!/QH\^O!QK;-E;"26P(NB@S_?WGXB4["G I>+@!&C M\0(\88V( *:(@)GZS6=WQKQ%RBR_YL]\" "(N<1$-C-N)#+"4LJ"3YZ,2L69 MA^^&\ :?9R!F09IY&"6+!@*05%NX8D#W,;O.?[G)[*7(]Z5?9ROKV-$< M:R06U^SV3/;B;-W5@&YOMC\?6)IN[/Y*UXR=G^_K:JR-C-U/[.MI_^<#V\$Q MG7E,PY=ZVK&K??E4'MBJ':U>N/?W_ U,8WW,8F-?^_F\V-M*^SQ[^Z-2MP2_ M;-F8>W.UJ(2CJJT.X:_Q4_9Z.>>ZVKRUVNHJP5(O3[D;-/N_-.+@X#"4PM-+ MX47/I)5CAQYX']"K+SS1K9O;M<2H$5(@PB&G4QIM))=5@ER'$J5Q=/E6GL^Z M*Z-,2TVZ,X3[KCSA+J_ML54[6C4Z)\O+(44I6(4#<>DNL_QURK;KL[PTZP,* M4RE'E;HG[U^:_(5.U9>7%!,Q!;M;U5%Z)^,BM!6^J5EHUJC#"JH2HV [UR M?E+$YEQFAE'%RD!8S@6+=>[ZRVC\8:NVM^I"#/!+*/+3A:NT!M'3+ :'GBSI M^CFQAAT5,_JV,S@P^773T[\C$S>?B8U1Y2,%R,3(Q I-?.!H1CLYN$HH_C!N M5@]5^^A'=P\&%5TY;-7V5IDKEW^=4'B*VP51=;=2&PG*7#);?>_Q9998_K$B9_/4<2GU?E^4&[NY2.\NZ:H=I2K9XQ-S6KBB1GDLV;Q MV6A+K6LZXJ(<+GKE,^L(S;E$1C_W1A1:@-BJ[:W.?91K54_\W&*5 M7A3><:IK5>']J*,::H,2P[JY#V-9T?XZ8CY-^ .[$8>OKRQM1VGO"8V9Z$#L MEJX5H21HG9AFVVXF]0:Z7<6FPLMFZD-J#P::@9"V"M)1%8<4$54>44,_>D6T M@U%%RQU;M;U5%U([RF/%;DA^CAA-R)_4]SL6OW7LRLH5 U)G6_@PT:.RX/3, M03//$W< ES-GX$1C$%NUO547;N2^^_"I8V/CT4=M9<4HZ\/K+I%IH]$(D4OV->?'4I(50(I+R3.0!N? M6TA03E!.&B4G/=.L$8-OO(!4V5DYL;"HR!-58B:79PGT[+%5VUM)S_Y-0D&B MQK'))F!KKR;$;XW)V*? MQ,]E*NG+CT-Q774=\! ?L;\7\'[XG,1T#@_/02@\\#J,E8?_14 1[.BH^-KZ8 OAM4633B &9(N8F_A(D8.HO M6. RCTR6DDX^M/,E([KA/(^C"$#N_' " M8+CTG@LA!.;\"L26_8' ",)/%C&,+8[E:\/'F/0 QW"1R#]>IT+ESFAPQV2' M8CAS_H]X>4%2[Z/06[CPR@E+'AD+0+IBZ-OUQ;^I%-ZQ\"ZB]S,.?\_I$OY/ M@'#4APG3Z11F+B>SHL@T"N?D'EJ$'DG"[#>-"+X40Q!TH,%2\)[AW,3/\%AA M[$ IXBVB_!O0.-#;')":Q80!/WCD(XW<62H!EM$GIF[:.NP5+&L"4'<-(&?G6Z \-2]/)A/N^7'P MS0K\M"L&O]=7.!=$L!I*D8J8%+>3[!.4' K0UQX6Z*LDO:J!;EV2GG)Q6#'\ M5(Z:!V[$:,QRK2A6DZ+V?01^$#91JI_#Z51H\VPQBF=\FN0/)N$CZ-I,B*7$ M2&M.B%J^)H EM7!GPMYZ_^6G& 0*1 W>%"_\I+\M<&!AN?Y":F_0^5(OPDHH M#3PIH?_][W^)QUPQ32]=)"Q3<\B$QAR&''*Q[O4F]_'KB@@)KK=TT=-]7%&B M-=)&I4W QELM4GT!7ZZ9Q6H+ZAJ6,#<*P7!8K>PN\($KE[%XK9Z!KGO4<]$B MD';Z/^DSV4NJJNIG3$=%*+IW?%DS&SA9;(9N[Y0^GWA&HRC"2(GF]$*9INJG^/55F+ 14[/2' M5]]P8VRZHY%CCH;&U&:Z077'<0=CID^'AC,R>U%D5CND" M#**5[P>_S,)'^?#*@\E6.+# ]I/OV%:&LG)13$?\8S'(UWS1J&!4]LFS:9DS M8;(:-KB_]Y='#JPH*SV?"DY3TP7FITIN6)]\>NHPID*B:Z.] M(C+0AJOORBX=P*#W:; *V*JIOE]%MI)90/,\4(UFJHI:^+?-_:24H\" >8:E M=&U06^EV1$L]DZ&@@2SU9<>&Q#R,$Q*#E\VGW!6[8/\3L2D";)0L@(5X+,T] M>_Q=<1L%C,H//_^9+KU9A\!Z4Y^)K17ARXK5$EK\GSA;)67TFR=B)LEF>"1- MU09L%MXSL=S"N.)&,=ZHPZXESU0?Y%&W\40@O6JGLP *7BW M>&1.O\I-E#2TD^\@;8Q[18@@WS)<#R0?>S8UV0GXAD$XYVZ+/0%]P; M"Y.99A$^: 7_"-^///(D7>139W(I>A8&@)B]W+S2UD00P2*P9<*YI#Q(ZJ*P MNY9M",-[Q9:$?"--THE+?S.;YL#X3DQ&$B4$Z8;7<1$_ ? R6_^P#=,7MTE_ M+;5-JO:R\ZP<;3"Q-/X$OZ4J5Z3TV+0EB_LRH(._'5DB>EMO3Z:W\>K,4=6+ MBGSG*\=&W6T@ZW4J+1Y;!^+%9%=CX+OM[20-Y?O2+Z3Y-K#X%%AF =:Q.*0 M0'C23I816\'L,B8KWO%NQ@/:S_S5XGRRS;4*WFU#.;#B2K4.S?0W-B369TVD MI2DT1[XA4;QQW<#5K!",FC"? T/&J?+/E@1Y'''%>KL. 8CM_2RF(6(L%-3S M_Q&K$O670H=GYQ8*:CM?$,0WZ2HAV#4][[ ILOB-&*MDZ\#28.!3!42M]?]HO1GTT4TD4;?-HH M! 4AE^HP.U1%?BLLL;D:SZ__'QQ#_/?XJ5T9W*+GZH3P\LLB!WT$#O' M^9&!%0G2UV]2X84%/=7FQU[5MY5J,Q7'PUKN;D. M,+T^B^WTPD.=W/$;XHX?[OB=?L?O\J:DLSN&MEJ-WF>>>).UO?!>YE0:$@F[ M"R.>QO)_VPHWK [N$0_<9AK)/Z&5T$7"^\AWP?)C(>E13_$8+ _BV D\!=[\ M]7$4\-OO4Z=^I4[E51M7C.P^9M?Y+S?YK0(>R*G+AVXVSW;ON+FC M\5@;FV.ADK)D ]F+,VVE 2G?;'\^L#7=&.[\2M>,G9_OZVJL#1RS4D_[/Q]8 MN]^!8SK=F$8O]:3D)1Q56[V0]N/Y"Y#&^@;DQA6^YV__WVS97^>YG#=ZHL:W M%J6TP,>6"7VRRWJ'T'[\E/0O9UU0F^[23R'@HI0@]\M3[@;-_B\%'Q_K/;(1YEN4!P&:V#A$6-/X9$JCEX#U9@QJAMC:I@3WD1LQMH0L5$3 MF][9R[0A+&5@<:H4;<#J>=ULU9EJ<)\B<3$Q6?9%4JM\:SQA[BR =PM.V>G M-=?=- RGLC& L8"S@:-K P1'37"&=0]&8K@G!H[OD3P,'73JR1=E"4@"V0*LR1:N(DL/]:QXUXR%ZAY@TZWFO#8!@82 M5<6F)\"I7&%:)5P.4_+J(?+KFUNT!!H4N+D$C]S.0QC,_RLD24UH<,JV/1,;83'B=2#Q1AK8SQ/I(HQH6JK3H0[0E%1 M?KN\2%5G93.7G@7BX84+D:)3YD JEQVI;;>^CTD:M?6,T3>'IF;6BS\<@SX7 M\H\/FAH*QI&HH[QLZ*.Z%V6/1"(4C\OS 8K'[HQ.U;>&6R$;54+>IY03]3C" MKGM\\%(,@;Y=\UI)W^Z-+ BPHQC!9HD X*2\:(!@'?'G1DU.8Y2+5%:_X$I\ M4JZ$S/:;U"D,D=98F# _?"0Q2V09JK1:8\QR1[%8.$)68R_4A!#%H*1[N5U. M0NZF;Q=VZF=5GQ]97B)*U(]ZX!X\L8C9=.%OU@2+\[*.^?G%0K%.EZ7%($41 MZ>5]^D?Z]OVE@\JB<010SU[ 0A]850M8F(ZF.]7*)NSKRK T9URM%L9SE1F< MHPQJI-FC:CUU+.I;A; Z2),U-7[/;)F.4N,ER3EB>8%&T04EIY[D'.FD41KZT'"-SFRS=*S25NOV742-+0S$5,W.?8G*5RJH M-62.E\VAKD;ID#=>5!Q8,T]=<*KG#$7![0IO.)U5ZD?:>FEJ.HC#B],U='LC MJSZ'\8Z&U.Q305<@?R!_(']@4YHVJV^;(&UWA#2P_ MJS V>.L*>6,O;W3US$ 7TDZ=I:RKF )6Z&M]A;[3%7=FF#"WOU;_5:CQNSDE9VM"HRK3N8TX M]?=,8OS2'&0%Y]Y)KKN5>[?Q.I6@[9_OPOD]S>[CW4/?H4?N(Q:+TG3B!.O4 M9VX2PR^N3^-8%G+.-[)=X'W*@QU!+5$$6@H$>>3)C+B+*(+^GG0O^]'(%UDL M^DGO,^J1("0;Q.$\\\C7QFC/P:)HP8??+J MUG5!Y\AW?@+%X7(8QRM1DIL(OA/SH!O5L2M4N2Y7U5J-PN3D1WF^65;]3O;4 MFDQ9+2_5VM]5?QR@B@ )>.+; 6B:O)*MI#^-X..LL'BI5U@:V:):*9)NJ(R3 MTE3V>,T3D!.W!)73NH.?9-W!'S?J#GXNU!V\?5IWL!S+-(+/JE5>7#/6(P/A M_E96Y%LQE1#2\OPJRMH7V?!;66VH1&=I-SO94^J]G.?)([S!6S"I-X/UQZ!< M[T$O7D'/X>)NM@%UD01DRIC0T?'"ET(UC<(YF0'M6$2F8!;!Z&-0XN*Q[-/; M/SZ*EZ4*3PQ>]D#O[_WE#M%I!O=4E*A5(9!WNPJ!-&OJY29:K'@B6>Y;60[D M*2.GK%J>FW?(A\A[?YA\@+3'F_)Q'W%8)X$\*TDAWXX+8EB4FDSXB;S;OUX[ MX/FO8.Q?S67F9['B>VS*(C'L#=KXG$ZX#TLXBQLK#<^RQ/_'J">-%T*3G1I/ M$'S4'Y@.Z>V YUI\-S1>;ULTI6B0#<4&WA->QG8FAD?N);/,JRD^F!E(^OH1 M.@&?;9'L?V2KW/*%*&XZF^0H_IQ%:_/CCEU-@(V_7M$I#/::^H]T&8L00=%< M!%OQ"0V?3O]"IN +'LYT>K*7IZZ=Q]PPO8!W#B]*D'=]39<9"0 =.?WCU M#3?&ICL:.>9H:$QMIAM4=QQW,&;Z=&@XPS']RP&+1SCOPM-Z!R\$YHV_?T/? M[F*C)ABPJVS[;=2GZU("3\Q.D;7^6%:G2,M6R];Y47];YT?] MLLJ/VD;>>RDE;&K[9^PHC1]%TKW:#+GE_Q3LNPB,@(!,EKFW\G0V^R,I M[>+F8NJLVXW46?4,+S48]IF$8$^UI\@]=31V%;E53L*NJ3ORK:D7^I<7?>)% M)$.,$9@"#T LEOK@X+:,-AMZ')HD)*'_B) KF MQYII+.L!W#*CC"<]&^NH\ MBA/R]X)&8"**#N00&ZK;JL;!B@D7/CQ)N/#[SH0+S:)'^=D_FVZ"N#,:W>62 MM&96(1(1%V%6$<$O.+U7N:_\I!NY>J2>F0CRAC(4+P66W7&7L ?J+[*(0L:Q MLEN?)2\Q+/E3; Z([[,',G%8=PZJ(>%2,\1]&< OC":5:ACW72@&=A^%_Y,[ M%2#O)-]-6(\@W0B KN%!&=F?R%!SF'X;T$3N $SE7YD2:JSGOU>BG)T\]5LB MEM@/*8$$'[U_>C2Y@6O,%QGM ?!=P4JA5+T ;SI7OIYKON#T4ZL)GO)"WZ>1 M_!/,*A$S )]<2%,@I&G"DD<&MDFZE24> [Z!U6 *3X6/\74UFKW]7N[/KL,; M2!G*A^ZV=PTVG'K52*1?IW%!\8C;6@,1(@@ M.VV?O3B+'FA N3?;GP\,S1@/=WZE:\;.S_=U!1:CI3N5NMK_^<#>_9*+#LH: MF^H-ZIB4,EY\^8Z3,#D#!V' L!6VPE;G:O7"W:IG3Z)5;K9YWFKS1%7Q4-5Y MNGFVV;CRVW:)RC%ACP=Y MY#9^78(+VR5^QYIP.?NO'40KHZLZ1Y=OR3L94$.&JDBX[\H3[O)J'UMAJRZV M.G=IKS-OL$A%]/[O!4^6\JPMC0(8M=Q?600N&$9"OQ M'[C' B\[7;A7.;6SOHEA7J3X305;HKNU9T98,DI5:*S*=1P0FC-!8]MULXZA M+8VML!6VPOVD.K9T=B.GEOWJ M0M,S#,TYK\B@T8RML!6VZEH .KW.?D=Y$+_I^6$D&AI^+B:'>]+(8]&N9 M>_?#I_HF=7.C.)9>V3; "-O9(FP.;A8HB(L]JNSJ*(C-89I=/51^?7.+YB6V MPE:*MNI"H/9+F%"?A/NRCYZOKF6I&R_*D>^,%9RW"*3VXC8CP272@ MB$*"0E+Z#N_9"PBCD*"0-$I(;*ON-9'&"TF5K:03"XQZ?&$,AW4W<"_(&+B/ MA:VP%;;:"C2\D<4SRACV$O5N7HL+S4ORG8-M?&Q2HR) M9$$'51C+1[:W(%YZR$_4+1)EF*"M3Y@L:@2S?X#?1&VCM,B8'SZR:$T061)< M//._D <)@>YDR:/U4X)\'W[^4\P)!,==Q((^=!(^L'ZQ%IFHO\ZI#X,*I].8 M)84J?9OO@M$_B'&Q%!PQI#S^M1IHS?K!R@I=J80 QU$\:DC>4S4)P-70J>?H=C6=RJJ[X17#V _4E([>N5M@+>#^] MI=? 5>/I7#)^'1QO.1!WQVHRK.B+BE)\"S\1BQE=+PUNS=[@^^\MW21JHX_=.2BI[*K\1 'YK'4_MB][E&T7'X!,X M=0T@L%H^!*Z_\-9E3/.^5QWMJJQJ9]63+5.SBF6<$%6ZX"?)Q$B_3O&?,] MV;OP%3PV99&85K%0+ &G.L@*&9N;%8_74R^4:$UD*<[HZU427HE_H0VTCIGH MEMX+_MQP";;F_.)\K6R^IJF9)Y[O8).BQYAO-PS'"N=K&ZAF?LJX<]?RNCN:%ZR TYH@.S1HG[S,'E)ABW\SMTPJ;;U0';Y73J=>RTYRDU_T(@[3 MYKV\ULBS+FTZH$( Z=O!N# &Z:3JA1A0Z4%]:UCCM7=;'$9AJ$]>;3N%-XE7 MPP=FC5>/[;56@S?_$8BP$D#J/5DX\R%(;2NHF >CIF(AL.LA4>AC:*V'__K( M>E%9L^M7P=)@/+A)3MZTE'NZG 2A"&(F40A$ 5\OCTW$8FWUQ0)B$S^B#.T:WH%Y!?UPJ")DG$)XNTP#9(QP?1 MD1M6-NZ"9P)*U/O?(AM<9OAE+\]?LAY/*D6OMX95&6'@C7MH(8T7\0J@RI3# MY",I2EO])S,>>5O2.@_(NR=9/-*Z45\]L#\ON2Y[*N,%]-O;L1',+\P8GUP*J / M\?T#CP4/0Z?BN8WIKX91%/R:P7!5+;X/*8F_ #'>-S]8F.HF@"M8_NN;D6DX M-S&)%Y.8>YQ&0BK#>Q:EVS D -<"##[)3$*F_[>(>.QQ5Z@T8&)I"TH6> PC MW^L31L7F"D] 3(0(/8K)T60!C+>4O"3ZU4YCLYE'"1N=E/*WZT!H*K\@V5); M;Q,)B.C[Y('"1S)O0?-],ZCG9@42F M"%]CX_S/.V?@^K+I%-234*@K:FYLDYI@)'Y7=?$L;0F:8\WY[O63/=!,46Z. M+/MP=]R#[]C6D:WI0QC))6&M<9/BAI"0VOV+"*S15]46Z;-X]1C%WX[BC_=' M\<5PN??#JY=#NX9EO<+8/\;^CQ7[/S7@6Z5")>"?W1GS%ND@?P4-]O/M[2>P MAT&%S^7,FVR._?-\ MDJGKX3&P@_Q%NN8%L2"=6+;2Y?"I(1L&=Z$TC-+!AP'U-^@GAD7CF,M#$=E> M!X^%,0L="KM)ALMAY 4H5NG421M8+OFQ( V/9_)C MX-_BR"8+[XYEQIIPN5P:)YE'.P_A)1Z'SQ(P -*!2A+\H0$-)5^LQQ4Q\ML* MK>>9XN=(>(E[V.*W+6[X;8L)2L0ETG!C ?+WPOA,#94B/7GQ?-82(\A\[%6OL2N ML%'1L1*?I:$B^5@$[$+3+])1 !E^#9,UH$\Y(.6/[)WPCI@A#]\E5#$F>].O,!A[;FCX:"C,XN^^=O3BSD#68SIOM MSX_^:E]7^S\?.$,5!S5^Z0DE#^2XHC5Y2%6D:@CWA&&(9_1)7ETJFC5$ M(M>12V'10\6ZVRS M,][*Y;3K1N.^NW+/)<)0CP5%G.Z0V18G_%+ZH@JW"Y4GFM4,^52U52=R&&Z9 M??V"?P)V.2^?:.:EFL&MOOI?;?)J7TDV^K8ST*PCE[!7(6%=[<%WG7V;Q\'& MJ'("EZ:5L5=IL51N>;[\ +&5VDG]+K&MJJ?1MW13X'9U-BT^S7&9H38H,: = MV_Q"]UU9VHX G0C5IKNP/>/UD[W+9URS6JEUVO/\Y86K >+\3%YC*5@J6UH? MUD>."YN34[:=IW-%BG;FL^X98U.S,-&X@L",QMJHT<"HI-T:H$^?J>VCO#[] MS*('GATC 4*D&\'R-FQ=E=K>P/=KB+) M5 M2SOM0\?6G.9716PG-O"S#65>55+*#5@&FKK7+G*T-%#O6X?H_>9&5)VZ1;=4 M,C#;"8UA5CX1JB V*NG@!FC]!IYH+UY9K'GRLT;QJ0X=#CZ8.HKKN;X^L X\ M.GPHB=0^'8_BT6WQ< ;:N(OBH>22?B$C8F])M+(9#UJ8."%+UI*$^[/^7)>< M,$PPSY4@9&$@YWOVO L#TZZ1=V&H'RW%@>G81TMQ8*HXJ!=[4E(#*.>X8-Z% M:B11"K0NY5W88@%3+ZBG.EH1J-K. 7BJQ O=&P#_8*FM[J 7_!D5VU5 MM7OCX-#512H22;:^G81RP=+BZ,7JZW-:?25)6D!1]G& MG<'RPF2Y88]-620*TKG%3H#B02,7G6$WW1:S%79Q.[$Q3,UN/C8J+0'*+3J7 M'R"V4MX)O8SV^9D%+*)^6G/9F_- ),R5"VH3EW>GFSYEO:BD@JY+.^'IF9BQ MLLFMNI"Q4#N)7F?R%?!3FW[9QKFO&%7#@0?PU6\S&2_*W,S'&,(1>88(7-@(*-1@8R++8([HAF-70W''=VR MKEZ#_1C;HDU2>-W=,[?TB^R9MXTY5%J;+K0:[DU&F$%@FYHC]/.V\LZ2NDF( MB@]FB?+T]2-T$H?^(MG_R%9&HO-SFIF*U9.EIO!SMHJ[W-,[=C6)&/UZ1:

GT9"]/]8S'W#"]"G0-\LJB=)W_ MGBHS%C*+V/2'5]]P8VRZHY%CCH;&U&:Z077'<0=CID^'AC,F)<[HVUULU,@,G0%+\MR<-$DK"RFXDA>P3 M]H_+P!0%5U6AKD3,?%<%F(WVIIXKO;X.\V_S6+>@:8?F7E/Q+DMO3S1G5.BLI(YZ8'9 MZB_$T$E"_WE]?88HY:6?O[05A;ELU,MET]PC!7AK1&EX:N2R.2DVEU[O&G#1 M'O.TM&>+N4:>%@6O9;<4F^IY6DZ*C0)VH>JJ\<>]>43VIQ\1QB5,CUXD7!BF @-5P@F;\223[2!@[M7Z@JDKIF5#8_+7]G&'=<. M\ZPYJ)O(%S=<&[GA^MQAW?R\;7:Q_U+K*OVGL*J2:1@1^F)(6C@:=V'H/?)F MEJ]! ]WT6G] M+9FQ2+BG!$;.7%@Y83DM^K!T$CYLI'<'R5B_?(G)NZSG7L9K"N2IDP2S.3J%$ MF%UT0VYA,/2.;=P4!E=DD<0)#>0.VA7QN$@WXG7,%[$'5MW[>^B-G!Z<4>74 MS"KY)$U2$3^FXD_>?_I\R!F'EMHO#;)2=,U2ZIQS'5L9.4JEN0%'72*KHK(6 MW.4C0]Y:63&TG]TWB]/M M&=:'_E9#E@?ZG9N8 (7H';P+^O!B37K1/L[>?5#& - B,++^]!\'CZ(9\7PQ($N,7B7+N)U6X]/ MIRS*VZSZ%'?I N:G!)-W2GP_?!3-Y.DP,J4\2M\3\1C:/_)DEB;$NF: F@IMC'3S9Q!'X1#[I,7+L1A&(4!N&)C)NRN7@%M$BG MHC5,2#\\Q30]+"@9),JE-B5I!!SY"%07P48.W"S83L#O@HJE@/^3"TJB#XU\ M9M$#=]FF. E>7+WB/N) ")C8QLNVVV[+]20*OP);>HSZ@A4%-/E8TIR)KB^> M24$VXM0_B!:O3^*%E7NW5J3W2JN"97(ETQ.&A34Q7OA ]@P2J;]$\N)P MSMTX4V@Q([/0%Q:37.AHFMU0+#EB61(R+Y6]>#3-_2Q7)Z':!$!36":D[MX^ MP<#C=)E>+SYT#N9:(M[+:!3(-SX]YB":#8SOQ&3DH@>Z-.4)6*B9E,:FR8P% M,O/NPZ=K4'@,II4P8AA](E S]9MW0&6Q,RC534'C?HI"H%P2]V4[XR9;ACT& M.LR'IJ"0_:6 *5N4.+""P#?<:8W 6SQQ^=TC&^_[B0& 3^1QD.;.PQ#/0!.1QF0^' @-08)G50(K##A=1D:%R M5A7?I/R[6D7"A>]EWTL](LDD5'H83!>Q'%TD7W^?4FUUAEV8<9F--0D729$V M@B73T8AW1FM+T 6>Y:"D4@&"90\HE$^1"R%+N&T9"%H4)E.RE-9=CH?ZI?IQG1,JQ2 M@ 5]5PIW91G%]]ET3Z:^7S=N*;1!K,OG.[O>+3@ICF"?3Q=^ <(YBC0"?=Y MLLQE/1>,U+P6LUT9VL+?V'I,KCK2NTC)MI)"H6"$&,XH<&3, 5NPMJG[]X*G MH"T1:"!!+)&K62.-6^<&(! O9K9Z:BF"ORHT2?&Q/%%+CID0 M"P&NR J3W45")@^NGK)TT]AE".SR,4WI(YA 6CV OK<_ 9#/4ZH!C:[)N\R= M>Z8]?:21)YCE(?2!B,(8 ;D-+<$;ZPG_NPW@1R;5ZOCGS.%?YP/<; M_7X&QF39%V)2J?1T$$%Y;L1$?%# M&38!-!92ZH /P %WDUIUCPU- *B/:V%O!%&W+*;"Z'$;5.[S\\\JMXVX:V-]S M*GH_@3M9Z-'87^A1#)=[/[QZN?J?80U?87E(+ ]YVO*0JR2VJ=P(A<*GRPM5 MB/PW]:5%_7G&0*/]R&-W(;=%SW5T;]>H:A_=>UURT;E$@<[=PBE6]VF8GV!( MEY"(98%K!4RPCDPRU6*)6W#[('DVM-?JT$E@>.MC_?"%OW5;$76Y! MASYWEV(;#E:MK)M53$"8BK$\AK)(Q%REUS4-PR3=3,K?+J=Y_6+84& ^V)25 MU1ISYD*BCC8\Z3*6 M*);U_"5!H\FT^)&Y3/IQN3>\08Y&%U(K1X9_[S,HOI]$;S:J Y>J_UOYJKJ^ M?5M=;;Y9&68G)T?=$G+MH?6'HA6+]#Z'3LSC9)>LH=@>@J*R0&71?GI_*H06 MMFJ6(^7/IJ8;G71F7&[JGS^__[*52Z+*9$_#8V72J>#@<' XN%,.[DC^NKS. M.] &EU*%):\OOZ/Q++V]('YA?R_X _73C2U,M=/0!7(;O4+?OWV-J9L7T\Q'3ZRH)CCYW*BP."<\:U6\?" M>*K",S;&6M6T^@C.F< 9F$[EPDP(CM(N,,)SOG7''E[*9NO6*8#;-%%#>NSQ M^I+'=O%Y?+Y5SQ\SOB"E664]4@@OR$-%H->'I9?B@8E,.&E1L",\YP@[*>PM[[QX?2U,12"\" \"$_SX+'&EC9&<-0$!V5':7AZ4GAP\THY8%JS.Z+^H_E:\C=' 31*KFYLD9M\P!IJ%H2I%X;$Q-X*RV/0-6\=+"@K#8UF5+0*$ MYUP6VZCR>63$1FEG!^$YGV8;5#_XJM8VB=*;(U_"A/J9+U/5ERQ=Q*FE>4/+ MSU]Q(1OU=:=ZXKBJ5+A0. BYN!M<+%(0B"QAE8_A(P,KA6-G&=@8]<=V[:N+ MR,5*@=E9+@9C8FQ9R,7(Q4WFXI[@8E,ST9A !FXF U<\^(OLB^RKT,2-<7^H M.W4+U)V4BSM0V/N7#[?__O#+AR\?WA^KNK<%A/;"A3AVK6 U8QP=C@Y'5V=T MW;I)\@NG$^[SA#/,\8W/X_/'?KY3.;Y_9)-D3X*^@S?RE9ML>4=FUQ35]E6< MON7H#:Y.@]S6)&[K9>S6Q#O=R&E-XK2F'XU#;FL2MSE]PS0:?$X6N:U)W-;+ MV U74170:#.GX2J*W-81;NM4T87T$K"_%1'N6"HA>U"]:O(SL&.J@./F)1?H M8%YRY8#!%!M*PV./351JJH+3D^B@4E,.&%1J"(\JA^943!OTJ5!<@=S3)9WX M;'7G]J@#.FGZ(()%%IH9R4%X$!Z$!^'9"0\665 8')0=I>'!(@N* J/R;HC' MXWN?+J^#$(SJO6ABJW:VZM:]"7'4N6/[8D;?'#C: (-A:L*#L4JEX4'I41P> M>S1&>%2%!Y4;PH/P-%*YX3[9KI-US=LDZ]G=W".S^H;E-/@N9,OAP4#R_]_> MES\UCB0+_RL5O;TO()X1EGS3LQ/!]#&/W;ZVZ7[[O9\VRE(9:UJ6/"H)\/[U M7V96Z; M@PT&9+LF8FBPI3KRSJS,K%JCQW!/S='3<9H;6P8&/4:X&?08]-0< M/2\JW [GIHV26V.NVWBJ_=>;TVRGX3CMAUX?;3JTU@J9!TO%1[U&WQE8'=-B MV!#P3A)PN]$:M#?.>31$;(BX1ANW6XVFW3.W;1@JWF4J!ENB:YOK"@P![RP! MF]LV#/GN+OEVP(C8_'KWYR#B [ALX_T_?UQ\_S]SSX99G5F=6=V*U1U6O8@Z M*A%_IGXR8SQ)8G^8)M@N@241NPBOA70C]C'QK,>DY^VI3;)#9H?=;G0Z[8<& M+W; /C;D5J>]-7>XIY>AM%VB-"W8'GBV8,C-D-O&Y#;H65U#;K5!R3Z3F]&C M=<+&/E/:KE?*&6K;)6K3:O2!=T[O6J2[CI5_GZ/0A8?B*(#OKI@?)B(6,MG) M L#.818 V@UGT-_X*,ED^3_70;7&CVE65CO4F/J86J/';K3LOJG-K"MZCC1^ MC&"K'6J,8#/H,85_ZC3[,5T0'Y=M5S_"LSN-?L?9U]SU0\8L>1F]/4R(/62D M/NY0TV"VQICM- 9VMY;YOP:SV_"*6D80[Q%2'W4J9A!;7\0^[@#*U&%LNT$+ MXZ&WPF];,[U;[:V#Z!Z,[73;S1[/V!ZH>"9813#*&O: MJH.&[?0>$,$W/&)XY$!XQ.XW!NW!QB%3PRB&40Z+4<#J&K1:AE$,HQA&N=OJ M0D9Q+,=8789'#(]L]7Y7PR&&0PZ$0^Q!H]O.P53XF0L%FZ4 MQG*NX0@.@Q-X8ICH ;X");JS<10 >3*NEH&'!G.'"#"H^#/E 7T3C4;P5(+E M+?CGF%_C:ID_F7(W85&8S4:'?+TWDLDQ#*!FD/I#?29A[04=."OIX$LH$*> M!R;3H?0]G\< T$:.D*\BE$@&[*,_\1/A-1!YL ,_E&G,0U> !@2XAC- +4_8 M#9=,2"0L7XZ%AZ@=<1?1Q!,!&$_\6$P '$SR:X"59-, ]@6C(66P']8_+/8= M?H$GL"W-6 1>AG(U/%(/@(-?P=A(*SY\XP8^/"\1L?CGD >T+IA?P!M^,L;U M5E)'1D(S"_;+_L[#E,UO 8ZWW(Y)EB[^ O* MAVL>H+Q>VDF]MOFP38'AXL:"2Z &L(1>=WHMJ\-@ 0'R^RB.)NRUW6AW!Y:3 M?PIJ[1W(TLE0Q(K*6W8#=5 +*?%U?]"Q>N5G/_'8'<\]V+;8I1 ,#1>G^8:6 M]B&(;B1[YTO04ZB^Z3O[#4@;^()T(FE<4.6?2)FBQ,ZMH>(UVN(YF&XS"8^B MON6Y-8<:,7LL%E<\1C(F+3Z)KFE Q2"XG!$MQTOC[!'0%G[D+?/)6B2@,=%V MK!Z6!R_7#M_X7C+67E/Y1(5/@3N!9V^\I62B^,*9/P7(KB6LU#I7/HY MCHLB\RMQ,@3Z^WG"1[#8,Q[<\)E$#ZPLA$ "+;7$E= M8-XH)MU\!I:?B%69^2^\-FMAXUB,_O;J+[X]<-Q^O^?TN_:H+9HV;_9Z;F<@ MFJ.NW>L.^+][KW[]3MH+/3:84$E<_FL5&>V %B%W))GLNMXH;8-\5C0'8Q^U M!?P#Q@',B A#$:D[B<0=$XAC@H= MFQG>U8JZ !T;VE$9L$>@8XVX^AR3T=I '3'P<%7<1WU1A0K MFSD6^A5)88.$)@I%,D^CRD8NK16?G:=BME7?M6T[,K/5PUE MMT#=.QL-M?KS3JNSO47=/=1C*U@KD]\'CZJ 5=;@\QP0]-?J<4^B:^Y88*<+ M?]?;]!'($2U)Y=+AX29[7GG\L5M$0)J+94KK:0&R<5OV_0)U9@MDT&X]CO=V ML)BCRBC?[#CR'AK8[R/K^S9?[^/H0;?UT)NLUQ8 -4[(,)2[NY1K#S;NKOOD ME+O3MMJZK2<7G40ZZG],NY8=+$!M#S8O5-M2^]-G+AW>0>1TL#AJIWO3*C@W M*R3!W+GBH**OZDL"_J.0\HQ=5$2>/L?#RB3 -_M7FZ M%AGO;KNQHPZHN+YITU<_Q+0'3:OS[(AY;N/B)4X02^T%[HMZ[V"G:WM%I^LU M8RW5:;\'ZLML$S3U%C>E8ZB7@,X+V:B&)PQ/W,$3G<=V87MVGMBCZHGZ9IW: MQXR! T*)I5Z6D+[.^7)Q*,U7)0_@.?MK9S#(BG>RLW]X>FGLU]VVG04(2L\M M3'E4G8EPQEZW['86W;IWFL$]TQQOF*%7EVPAP.3O4>3=P+YTQDO"PRN?DJHI M_;R!"0NKLHQW.<%HC6V74E1U0FJ[T6D-K&Y51FI^N-6@;%1XM-UI6>U[$U(Q MK2.;IZ@P&D4Q+#9DXM8=P\J$+LDAMGG=:UN#8ES,?9]$(!#_H[Q]?,*VK5;V MA,4N5-E*+,#W3U6V/%8A\$0E:;O1!)-R0O@SI7R1(3SC@8P%FWJF)U99NCC* M^8]/,/(MPRJF<,2OHY@R0T"V_@2(P3 J[566LV\XD[ 9?P0R.R2H(CI0W5_.^"0EH<(5<3E/; CNO-!&>B\^_ /(S<2Z3.'61")!'KP3%OE394UZ=1UG8 M6DT!#9>2LJ]$B#R3"0/-043IXM:7Q$PP$7<1P)2(2N0-G T@9_PJ%B(O]QFE M,4V>+4QS#\?,-2J, .X9@0B"-4@>SQI,CJ,TP-S'Z-KW!$NE6K=,1\!46-2% MF6\:C<#!$RSHTLEG>D*B?=I."!INCCT+85 4SV!982E"& W!TE+;1>4-G\T8 MR0U/"Q1@;%C(5&=0ZLG4YF),T%3%;%OCNKK17C7#76J,@* J> _DZ/?95)@< M.Y-C9W+L=N7W3&?B>YZ39C6[+>:FL-),R>!]ZG :,_] 3Q9HD M#=9:9>J=< MT=J"B5[WQ)CY7),VFILO=$S/V)W9,B^8 7-' PQ,B,E272*5'_,D7L2:,'SM M6$TV5''I)UG'>F K3D>7SD2Q&>;K5K=7I%;4)9_FSO.][ B]: VVRQDQY9/R M2;XCS,R(8M4(D/K#*K_84P?02-H@Z&X2%7J5J8M'UEFCU&$J818I=78&Y;;@ MP3/VF)UR%%5IP&-&4@_?T5/-SL#[GB]_(X[2HS5@=9CJX8 )3@,"^@GW@P?;0#_-LFDGDP4HP%2:D M-!W53P;/X;'G*6T;Q\1V+V!YC\$-W].6/V4"F<818=J73-P*E[J]8A\EI)P0 M,QNB4/HR(>9&0D%R ##Z,64890C4N&N4BQVO8NZ)3$2HO 2 IY*V2 ;803(C M,&S:A*]G/7BI#>[\J_CH;[_]]M^GEXEJP7K>TK^JGGW9'Y34 ;^''H\]]E]\ M,GW#OD91G'=X.KJD#[\>LV]ZY$L17_LN#/DIBKRB%=2%;@*4?:]HY(.?N./L MU?E&17=0RT%V\&LM1*],!S_3P6\O._A56Q6J^_-%(B9/TL'OQ3/RWH*3@K*_ MHILZ4WJ4\L6\.44!C.Q/T@D+!$A,$NJQN +K >3L+%-*C2+@I:I;;Z+X9TG] M6^PR!1EC#%&=8DL: /-,P0$[P7^ISUO1QO4*AB8+PZ>:6]V[EGYB'BZ[ MQBTDU)9PQ%WL E=.LILW3[ ^5POF!B6K2IFEM,:^_(F)>!%VE5.ZXRH"QR[$ MUQO:L+GV 1>TX!P,DG*)I2AE[4D?T <&%J4-JN;T, &?3H$0B6$"?I.UJJ-1 MZ!$$"5EZU%QQ-,+&>11,G/B4)(CZW(OY#5=XR($/]@^?9;N@OG99I[\@PM;U M.$_IB<*$&L[08']@V7F&^QT5'(..U<^>JRC!V ^$43(O@K0$NF N ME7M!SLU+.. N='?4]ZN:<6L7ZWV*]Q/@+M/A"2J)*0H5DG?(2T*_Z<(30\Q" MUG=+J-3HH/#WP!$"^27N&#?[ACKY$T_>J M/$A2O0>1B)K'%WJ5Y!\OUMZP( M4%]80:_'@($1Y5MC=K=(;H0(:9/["]=STH]#MA,6ONGU6@#!K=]J H M0E&55+U&J]'7/M#R]U M@12S?O*++>&1GX*-$;]FL4G;>55!+G,5A6N+P8/T0-O& S4>Z--[H"LX\N5= MT,JK,?:T=&>U5EONMIWW\^9YZVT_UWFD>[)Z,3 (0.1/= .FO',X.8H_K$N+ MT?UQX#WZ,F\I7]2:E5\6MYD+22V^]=5LH\57M.)$/:-L12[)WTN3@ PW+(", MHB0D!99W!<=]G6T'L<]=OV1C,I&2H9L4,+7[5KN[6771REHHJ]/<7OU2]1S[ ML*:>U>SW:K:F.L*ICFL"W W:CRF'JT\*\.(I=74AS=MJ*?PDY^8=J[^8!ERU MJ-5IP/8C\X#MSCIXJE^UTW>PS/#ZK# 92Z9:!6Q<:W9G!NZN B:[L_9N\#RR M.,P49JYU]W.]*24W0I\<'%NOS-PY6%_D1CN8Z ;>SU%\?N[]D4KPN!X#;0-0 M(RR,L-AW>*\2%CM=,;2!KU-U'MA@0W'EAY0[J4--NA67*:8_O)+D0-1 MI[V)"#7-EYX-+X[5,GBI'U[L9M?J&<34#S&#OC4P>*D?7IRFU35XJ1]>;'NP MR86=IJ_?@\U,U2QC"V;F#E\/Z_1[F]@SYM[>Y^H9V.I:_8?YH@8Y3^\$O,2= MR@8O]^&EW;$ZAF?JB1NP:YKFAO@Z(J;;>0$+X!##FKH3RT&'->UVW\3/ZH@8 MI],R<9HZ(J;=="S'(*9^B+%[_1<(U!C$W(>83G;+N$%-W5 #/..\0-3Y$(*; M%ZJILC@]RFY!/Z;V=.O>YK>)E[-VTE+B@UJ%GC#,:P3 WQ8CL;5Y\8 MW#P;SVP2'S)H>2Z6L5^*978ZI/SHKC8"K\8I][-Y,N?@T"HFE_9?DW1'P81'S4<08/2$TTY%LK+!XL^?8'G:V7K1L2-B3\K&:$8[K,Z@Y@=3L=.MVD]&N=X_E--KVG"G27=.3#7>T=L.0,K=5I M;W3OLO/&4%MM,++/U&8D6[WPL=>T]G!/T]":H36C10VUU93:7E"RW>-59[>% MAU$H5I.F>:H^3QU"B 8]SX0> M.A4WR*DGFWMD)5B/4J.SA>Y3P8'5] M+18\ %!P[5(@>$)*=^")0+S /ZI"=Z1>I.Z/#TRG4$"H.E(U*3=; U"]I< V MRBNV *6:QKX,GQ@^V48%A^$0PR'[SB&/+Q(Q7&*X9-^Y9!MU*(9/#)_L.Y\\ MKM3%<(CAD'WGD,=7T[P0EU#L[S3A,.&S0\Y!R/V[]%\..L^__O47^)$M9L+C M*S_,2@ZR39\@@YS9_>E"A!$_>>I@8O5FCNQCQMCWL9""$4PE\T,W2#W!PB@\ M^?W\_"N;QO!MF/#$CT)I*9JA@_&Q"#PVG.%!./,EO) P?LW] ,=AHRAF*8P* MWU_@/89NI%\]!U#@4#P(9@ULT1(+]3:+A1NE,:XDRMZA87!\3PP3/0"LMA2\ MU"?Q0(.T 'A^PJ8\3K+^+VXT ;#.*%[=>R.+-QG CE^I<.@TCEPAI9 -&"3& ML>#5V?V#2:!-?P1T"F,$_I^I#UN;,7'-@U2!BT*TGG!]2[!J$!E7W);TT_7[Y>:+U]U&7S=VZU MV&>)2C.N0BH".A?^E(B*R#PA&BR1(Q+-%^0,-A*PKBL1XHC"4]#I(8ZFU ? HOC;%)PB2P/W#2;T#&%3%UX M2+)A%*:R^!CFPIE'?BP3]F<*O"=BV&T:EW91 JL"#4@2:CZ:O2WY1##/!S@C M$^(L.$ !*$!&-!'+W+A#1$8".$H3?7V71E@RC@7V80V3L<0F6$ RGWCLCI7@ M;-D-YC2==@-;M@(U(BCP+1^$FEN2<=F)$<).2=<&NP$@3F,?]!KLA7FQ?RU" MI(40B+!8!I*G6Q >8%7I%"0!HOIK];>7DI!/_ FN >;(\9\_.<4^7HIKB'+# M,,5C+Q# 0.-J;?E+R9@#%8(>F7!/5)(0SB$X4-Q,\#A'_'81YZR%./8TDZ]' M-8SMJ,#=4-M^YK">!Q,,OBFD/AD=+UN=:T.@\T& M^.;16HMIG;'7G8[EY*]-]?CRN$&&ED^RO%!N9)@)3TW8LYKYBR1J)"^$2Y+& MH53GVE.DD\45K[] IV_9Q0+U HXMT-6,:]NU4;8&V9A[^:RD@^&A%(QF6K1C MEU>]$>8V6'.KM&98ZA=0=Y4KBD5 A@2(\M#UIP1M$,1E0/FX3/#ZN#+262+< M<0AT?D78^ -T*A@,VQ4CFM;;CM7KH+<428+R&:T6-,V;&]]+QMIS+;^H?=!F M\0H? CFGR>I72IZF"XL4\0NQ=*LS#X[RSW%<^ 57XF08"_[SA*.-=L:#&SZ3 MZ B7O4UP-1=@N+C]%](W]RB[T>C))E<.%+A>44R4? 8D+6)\"@#":[,6!AP^ M^MNKO_CVP''[_9[3[]JCMFC:O-GKN9V!:(ZZ=J\[X/_NO?KU.WG6**1A0E6M MSW^M(J,=4-$?\LMF]T-%%_MQYY2UE\:9YGT&??UZT"QI5]2&T00F!&?HVO>P M*VYN,V>J*/M&8I@B "/:0PWP=P[F=CQ;7P,MS(,>G4\]>%_W.U8O5TT-T/^# M^15.@0%$C/-6+W)+"YR;]YB,!FH/K*92JKIIM?.5@5:<"#!"Q&0:1#-PPW70 MA]WXR7@Y8B[,[8.'=@4S$+173L86YK'8__@RB6(,!>MP8?]XK M52$1S-+,'%1P=F\$V6HNK7W"_3"!_P'(0QZ 9!$K@9F&B1_HU=&08QZ,<,%( M%=;67#[?^]NK^[64W>Z\6A+@3R>+EU)D21:_RT3&+BN4?XU%F(N\1AX0!X*4 M)9F(X:V,AL"6'W+I$ZUQD*@\)K(.P-:0&<\7TI8DE*2PB0 )YJ-ID40Z3%/6 M"QA;";, #,8A<:R.-?CK'<:=$$[/:;^@9?FDJ-'"0$7\=2R*X"J(3T$,V@U8 M :5B$Y@;#(0&:*#B$_H-83I1,KZ$ER1R?Q:ZT)=9&*V$9L(ZA5K32:I\)(WZ M&Z :L =&2D"7="8XTXC_WR(>DUY^1^'1*"Y+/G@-A-"87PLZ2\G?Y:2349^C MT@!RD+ V4LZ9>!RE05!:WQQ])A7;PW>Y\OA=V$!.3O:2C4$MOY"J.Y]TO#XM$LX A4 M >TBB%1(<)A*V+XDROW$9VHX.Q\/3674'>+V)%^$IQ5(\;@&T"'AO,+G(:W1 MMGH*RPM,AF).'\-G;J$2 2H.JDSGS \ VSI*K\8(XH=RW*2 M4TK#@*$5HI?7 %ZF( =5(5*W.DB+16+C04I)GW4I9@I@1TK*5E:JE8@>K6Q M\OMA98 [A"8!I'(W S K , MSG-9VS4AZ&_I#6.,[=LSGW/4J3C87XN@Y&_U4%P>@P17N"( K_6R/NY8],XPFPMNQPRI#S-@1.9S$,T M5<%+?!<&:QE MI],K'R:] R<$382EZ(C=:/<'Q9/'%KL4@GW%%)T+\)$2,4$Q^"%GP\NLXE&R M$_89O'8&0ADC.4[S#:*F0;_;;Y1!6E@HGB]1R>&9R9I).W=F=>T$ C_HB.#W M-<.450E1:@+4<2@OKO !23*6: "1W;8&S;^RH[4F 8RW+:?_U^.=M@T^E)0" M"%>.Q$@' -7A'!W!.V-'_C$]49C]%!3"$927"5LY]_Y()<(;X7OZ7BLB,.>! MGH7.<\$H90-5&1AQOE:$H,O ]?J/_@M'!4I/L@RBQIP9>#+DJI*XE'J1/YB& MX#0$ V/'5W!\N3Q*? -)B&195(Z6&Q@M%!E Z5A*C&8D'EC-[Y4^88QNF,4 M+Z>Q5**2&N[HK09>L>?WOUU\?W=^3.J(B(UT6$.YO:"*5:2X"LB8/T4.$WS M$\($ +-E.9TSVVHV&P!['V.4:TDQ MZFG@$QF1&8 K&RU3*0Q7*;25U3,/=>+MIM5ITT)62_"FU1W0(\>*%'"D54#& M(9VFU>O>,R;&[14 'BHH#O( NFL.H,T!]!X=0-]KG5;9GPLB!P2R2P%5RMT& M:WLF@9WCG1/$Z!:M)GLK]71YPA,,NW0RJ6: MQ0_L3ANGU35WVM05.5BS9W!C<&-P8W!C<&.N8-R#IP[A M%.0[O\W2'T^/AB(4(S]9?;!]%YNO>XML_=C\J-=\0 ?B&CC@>XZ7;G^'[Y'? M<]P<.=VNU39,4SO$=&VK99BFIKAY\ 5<)E1V/W3/2X4RI^4:FE/LR^3'6$UR M8!$SN]%N-3=N'F_\RV="3[MCV08W]<2-W7 &G8U5J4'/<['.YD=2!C?/A9O> MQB?>];IMN-9FSL5"U>J!!6NZ_8>F4QC_YLEU9N>A%]X9W#PY;C8_.S>X>2[< M]$S,IK:X>3%]Q'C7.S7,EH=DF9E-;W#1-?F!M<=,V M<>BZXJ;EO!1NGCM@\Q+=C0C$/S9KOO8T/=.[5F>-Q5;TU,+\_9.65='@!FTV MU2CIR"ZR 51[H<,(2!UU'E ?;/RV)T>+W33Y*77$2]OJ&+34#BUVWX2@ZHJ; MH[[5?7:6,1GH-7C*(*$&3SUW'/8E?!3;H6!L=:/D%W-&8%4/=4:<%<[(?4A; M6;"\UP7KFVV^WMK2;K3MP4/C@.M!X(6B4(9V]YUV6^T'GRX8RJT)#@^4.H0XNTD?C_.7\O'BPL!\\N@V='\M9$K0_0G;,)O_4DZ*:Y&?$PZSGUFXEJ: MOGX*#V\]W++!7!-OS[R_P^\_D\\T\3TO$"\I\2Y67!]:+?I67MRZ6 *+TL\/ M2?KE%ZP>9C(BW<&Z^WD\YOW=>Y^$V"E=GG3OQ9M@BV<#K'$E^]:8:' ?#SDJ M<_18<=#R3R6(U"7U>%ETZ4KMI5NPE_.ZYR^[ICNFERZ[GO 9XX&,LKO%Z:YM ME\OQ\@116!X>+ZS"FZ@!AG@U>3+F^$/,P.>A.ZAC;(@D\2N0J+[K3SD*U%&: MI+%@-$$L7.%/8238& E66!I\*9!S-KC^.%:H^?W\ M_&OI0NZ)X!)AIN"/#Z58TSC$"^%#T'?ZVGC@M# 4+I4XTK7>+DA5P*^*)6:W M>L]?<9O2/?155&,QO#*W]+"Z]G>%I\"'\ T[XHCO"%8=J"99BEZ+2]'NO WM MF/D%+B(1NDH.'\0OA6W+GZ!DD8"U%Q<++'K$?W$ M]= OL"C_F@%Y$M MH>*:]HQSU^?U%5>Z/[6)M'3?(4F"MQJE +B//L _IBQ;[[\^;#[Z.MS9S86 M3O,PDS22^4 )&;:!1V-Q[8L;0!AL/00")@@ >_TA"IH:!=$-*C8!?R5*V:#H MBD(?: =?5;3:8$$..7P&],!/X.X8@ AJ3J; E:#K_,Q*CY%]\3D<&8Q&YJ9Q M+$)WIMX 601\YTLWE5)QWE<>)^RBP2X2,=&7@#?8/U-47 D=<-!H\$&0_?T. M7@>U2*+W?!BE"3H3N"9$['$#F %LF*MQ)C]R5@90!3/I2XL]#/MS//"DZ*<1 MSQ"9OKL&06@JWW6ZUMM .LD4 _U.ZC4*!9L"J, ]2JFAY3 6 ;$?6G0QT"DL/Y[( MA060 2B+P8<\@"TB]X?T8703$CC E,/EHXD"8)ME+ O\[Z6N-DYO!, *_T6+ M))]U#.C0&SKYDUANM@!J/;9:&@(ZCGFH;!V);R+[$W!00 K7;'W2L7J;S&CB_ MPL/K=JM=?(&/*H@K.<5'(S*?X*\YJ([ 5@-H7 HQ)\H8[.-##KE+$%T:1B?L M9 *,D] (FHY_-'G0Y@L\85LO"+2]4/X.5&F#"AX'GLD MH5=:!>NO?,]DX?ZH^6(GU1(Q*8D&DGR@9<%W!TX&!0LH!],W0:%!@@VII1!L M0&521JZB"9( *#Y*$K.@/Y01Y%H.!9GS7BJ6Q&))& ;SBR[+PR5;&9:6X"WT M9(_/#\I=U/1!8=\LC N2$CQ813!AC([.0YF M"@+@+OM17'+=T#\'LP;^)SL*US;Q$S*?EKP?Z8Z%EY(FD6#T^ !]]$JN^%0" MX)(;(0 -_ \8GWP/8.0TUN!%'R.\XE?X;DGZ$RIP.)!K6L3K!0-V>1!= 1ZV MP[KSEOQST'NUK?Y^- +KE/3!13A2;MLN\V^^"2!0('8@;#G% ^!<8G%1_B'I7*B(A-8CN-%I% M+C) @PDYQ?;803"K"AP!25V)/+J.' A* G5(9MO/-6E"8T7M18#__ET-YPED MA5PLR6*X8FTJB)*0_X[G 1@.B%!EA_CI$&=0A.-Q$R]X"PQE%0U4BXR^\-FMAXUB,_O;J+[X] M<-Q^O^?TN_:H+9HV;_9Z;F<@FJ.NW>L.^+][>/42R3L,U88H>N4OI_S7*C*Z M5XVMTGV^][=7]R_%[K1?[9!-\&4T8K\IA< NQ^B@OR4K;*) ^$@+9R?,B$T= M2[O98/_UE[[CX&%'#BNR,Y'V "[@)Z#E><(^@NX*YC]MT*OV&S*@)QC*K_8\ M@0UB?A/F,4>WF&I3LW1=PNV]6AKR^-.9A40W1.;@8'7L!AFL'!4^'9XER%3G?P MP!$LD ] 2T"B)__( W(S 2Z-@#U[[!T\,QF*>"X2U++8V[NF0W,F&<-\RD#3 M1QTEJPLAQL/1=$1#%"S)0-RR/U+OJF"9&S*OBH.M(1J[ M,*Q7G%OEP,# 9*B.[F0"+Y///2(0*)./C+8(_-',"<

<[*:'^2);3:VMI( M([P,BWQ3>"XQR"7" L3&3O/$HA16)+I"%*LOE3S.'WQ5(3.R!\M?@>$/O[M: MJ"MP@IU^[D53=%2T?#8&>=D@[Z\VR#?0,-WF*V/&&S-^6V;\R\C?TC&J=0_N MGRPR7[VRB]NE>E7?$V!^LP^5*$[ ML!%5+@(,19;,@K6H-I/;8=EAGES8"0;V8AV>UU%[;1A6G _J5(0SK%9>3?$IW0 M@5?!. WR)?D]""+\&'4,D%T@<8@5-3E:,@U4D_9@4&/NYH&L7) M",S!2.I0KLI?R#<*E)S%?X="?0>+#:(;$:^ D8+$[&P+IT/MSG,D=:Y))63Y M=M\\L5*[RXB83X)K8\GUJU_?\E1F0JM,,'N*,C,-,VF]E SA1;!3M$Q@ M=]<5I^0&Q=M#<2ST>6UV2LK!.UXJAUC&49ZW&B;1W4_FV%2O&'0^+3IY$$0N MY? NXC-+'U0H$CP.*5U0Q(6Q0MBL>$Z9*]EC#\Q;J8>M^@,#!V5%@AF-RI33 MT6G)LEB;RG^D! 74/AEEZJ"A=)?PNI+RZ2JYD(Y=8T)'SYF]D2H MJ/*R'Q)JVC.>=T+F/95SE7FC @%9VE"8G1O @E0E%OH;85%F V\O@:@\O"QB M Y2WDFO3.*L@X6'F>*-/C*"]8[A[$T-VX*CBL@B)[$F J9Q".>9RVJ5 M_<9Y8:V^4$P#9.P+,+&0L% 5@)3#?Z6E*KBR8^6Y9*()]TCHP==\&/B8G,R2 MF+L_*>LKIK 2?!0*91*R:,Z'O19CWU5983#&6'B8EN9&833!X[4L )9E@>=% M=& ;QHM7"4[!)IG/GE^*/BV&T4C'5;OLNI#$8P"B$>9L*Q;@&'S(:C^3.6CO M1!PIKZS_ADIHUVG_8CF0J:H#\CCD?.IT"9$8/BK5QF(JL50"=769R2C [$J< MJA26*8EW35ISX=7%>HZYS.F*0&P1^BWG4>=)PI1*G&?_5Y4]E"ERXPJ%=IY' M\@XFFDL,\03P7B"S!,E%%E,+*Q6&W%GG06IN#DRH[GI-J__751,,0:%'F,F- M=2Q8(4H!.R5<%)$@LVH#04>28:B!U>V2C2#S>M62N(0WV.M6MV?IG@I9FGKF MX$2JR :H0ZEAPM-2>>XN,/X''=Q_GP7W]T( +"J_3$,L*,'L9*/(P\ Z+,P? M06N*%T4X*W(V8E'FVJ4J1U!WH=1YW\3$E RP0+@I#:(%3 =0F<\"\6,25H9)>05:Y8RU\*E^Q:**]^5#,X$*1JU> MM70@UM+G;@CY(-0$4XZ%C>(7T.,M5HL)U4H]964HU, MGI'),WKQ/*-VC?.,$'QQ%"BY^#6.7.%A,L@NF[E?TG*1*MI.*K8I?209]('R MZ(OJ_^'-U;$6*3%H; *>PG3V QJS+(0%U0T$2%B8J2@(5L)9V*0Z]D MB>!9_# 6& _-0DU@+OF!H 948&9-T+5278_PT=PS.7?U%C%\A'%@6B?V#L'\ M[0FZQWCNJ^QU'!Z_P'"KGC,!T&<5P(S*($=^D0-T^?YM[E/&::#U)VX.++IW M]T,JZ]NUZOMU %B&V%#,9\\O0:T,[0W QUTWG>@J/QW!GJ2A[V:]$ZI\['(A M=!$,QWFF8+!B3[$ S [AIGD.7_%Y$3:),-M>Q*KG1*G#4X.RY0,LVD84!3,, M-OM2UT=F528Y; JJW>G#HW_IM#GM%F2TJN+N/-:MVG0S**KD'?MB5 *S!J=" M(GVW!&H54!%43 VO8$YA-MH:O,]7Q6FRM#]EE(Z5^Q3X$S^K:LTJBQ7QN > (+@_:VH P:1:*)OY9 C=)XA0!],%?/RT\C M/C7L9SKHGA6;420Y5.54BL% %I3@J>A"\2$RA$M!'.\!81C$%BUG@<>H6(S= M<%D4SJDOQE2,KW*D 6.<^ LI%(_!9,%:,Y"K/X5JUK#T?&.S7:[;SW.Q2G;M M:&+9%3V("$"[N9T(0-=$ $P$8+L- U:P]+,R3;5/_O7\VW=V<6&Q+]__Y_TW M=O'YPY=OG\Z_7WSY_.!Z\.[@Y>O!2Y6@-0Z"J#)_BGX(M MV.OSQ@NT0JCLA M!/36M(#N$_4_Z#FUHO?S&A,\GF2S#RJ=#;4\-JMN'/&2)XU/ M)00Z=1("CL6>^CAW0RGP(P3![$M,)O+8)0]4VNM[5=I7RO=$\?]#Y6QIO;BA MH'BIYAK3%!Q1:H)7M:]=%W:C"$,:Y(>3^4OI'2"$L$%II?*= X=J?3@!QYW) M,8^I"A+#3:KW]ZS%DV@UE:.HKZ#2,^NO+?CJ=/GSEF,U M^[W*KYJ67?GYJJ'LEM6WG8V&6OUYIU4]R<:+@A>,;JVWX^_4C_ESBL84BM1+ M)4>_:G%9;?X]>FT=RUEC=:NNOG:L_IU77]OWW0ZWC,A[[LFZ ]\*>74BXG.= M!JU:17SEOL>^ G()LQO0]L-!LAT DH!WTUA:84+'4-J[/\<#NECI" M$IVHC&]UY^Q(IP'+ M*A)_ICM:7_3VT+_S,,4D>OLD\VQ6:H,UKD_=M\NC6W:SX?0[#[M=M1;W1]]Q M]>?3(K-VE/[ZR?"W-MY>9N-V#]SV_23A0Y9-E*+IO-E/Q!K9=!BRJ=5W+*>& M)+RQZ:>/NG;)]/L@AK&V_9S!VK;?#DI*N]'LM!L#NWLGH3V-U+M#N.V/F-HA M@6-WK)9=$SK8#^Y:QPXQO'4(O'6_,G]VM;R#$1DZ;-Y2/&8'Q4G+:73ZK8>9 MA#O@N.R/8%IOB_4F-K &V@^,[M6 UO9<$CPJP%$#]!A1L$NBX!&1"!-LN!^\ M=)Z^CBFCHCHZFZT%T/2B%'/CLB7N6QC7;K0&O4:OW[Z;]K8&EF=R:;?[V '3 MQUI:<(^H@X3A*:6VWIMZ?4M:U;EW(Q&0:1#.A>K!B M;UXYFK&$WU)1_C@*5$G\$.A*=Y'PJ1-B*-SYOMG8P5%W<\CNZ;G!*R77+6^N M-PJJ3P,^_EL$0,:2H+^GP8PY#DYO=Y\&Z(^MC.G7J3*F4[O*&-44 M\**HHJA7O4LU9_SBWYZ%4?@YG<#[+C4[ .KYAE74[HG]BH5\ JL1KG?V.0J_ MI8&PF\..?1['^K;4#P&_>L74EH&*;I,SZA0,BPVD>$6D-3KI.>U-9BI/\SV> MA,FZLW0>.LMFF^D^ FP;[:?WZE=X7?QR.C?;KYO^_:".R?=4-*TAATQWB^KN M%O96NEOT[2?K;I$]!SMT3P!J,7>3,]7\9_9"0*M]ZXLY6(G;L3_TDS*^)8KB2M%JUUZC'"]-J5!78!9':[RZ6: M@X'5:_8VK=3L69W.9K6!JT8:-"VG/7BB2K_J,BD _DO%@"U[98CRJ8I7_DC! MIQW=H;.>2BHWZZXV[EZ@5AOC))G*L]/3FYL;"]9I7477I^?@U6(KQ5/A7?'X MU.,)/QW8;:?9/\7U#CI-N]UN]IJVW6QU3Z_@']L1M]>M&]L:)X"I3V("\X5> MJF[2EC)R_;P?9Q;3^)AX%G7TB^)II*_D H,Z]%1GF71*O?E"K]3T;[X_11O= MZ&:O/(9RN6-!UQ*XU-UO3IH!?;+B1HB\1^M;BKTD"[T[U"O]DW\TJ*6B5X11 M%CH@Y'T5J3..E+31<&&UMJ.66Z%OURB5V2D9X&Q?!JCM& %0$P% OSHM^+5M M=T_]Z_\X?V*G&''; Q\$LXH.//_,._#HHD*UJK^GH6"MINIR\T F/T^O@/R8D[7* MV7OF;CVM@C=,_+Q,; _@5Z?;/ 7>/;&;'0<^M >*B?$V3VJ0I(MKPDVQL*= T#.L8E6QM;J *2!3;OU M'7*OP5QNXEOJN\:BD%A71FR@Y]G#53S6&3MDA]B#O>=][.YB-/L."070RS;J MY;:X!0M=\?0<+P'9-MGO030$]M1-L"Y")#OD7"R09T>7WX]5S^R2)H\S35ZT M-L]+89R^;NM\".Q@#-V=90>G@AW>97?@SC/!.O2O[GLX3"YX HO0<,'S<$$K M\]9BBM2@BQ;[KKK#+G)_LA\A&%/GF"+"SK.K6=D)-CZB8TVTNOY7IY2HY(A% M]=*]4[VLYJRC@I5@J<>'P$:KZU0,&]6@?QY2=V_D MC0LI4Q&3":>_$0A@S_92I<;K8^&FDUUP>,GC(0^%//ER&X@9 MW90'WSC P8? .<94VF7.<59PSD>+G0>!+S$G(?T)BS-,L\5N"T;=[#+3.%M4 M-\-CLL5LW2ORAW5IO;7FF<9N=9KKL=>@V37LA>QE=-(NL]=V=)+AK">(.-=0 M;SUM!X6YFY&*2WYE<=FAONJ-W&A8X6S#[+(_U5/:B:\N.57U8(FZ-^Z"DMO! M>T]$*'U,B_\ME3Y=^?XMOV#Y(SCV*5X]<>3_O]^^?3P^@U^.L7[#@Y<$W;]( M]>@JN4[7LUZ.A4AD QY=_6SIED?*LG&CB: WUGT%H12+,:[]6I0&N%[W?2[' M[ ,@!!>Z]DO%57TJ\JUN%3^ZAE7C5954([UBI*H;+ALLX5=7ZC**81"Y/VD6 MI-J%[&-/))R",/#\8L7TW@F')SB-JKUP<.GV;RROVZX@6%L.('NOHJNEC@[U M*KRLK!&K336FLP#5!U9CMLU=X^:N\4.Y:YQ=7OS^^?S[CV_O+]>O_WLA!O]: MLO51_L;8W20N;(8%3P'OD[([1]YQ[@<4IRGY28IV!NQ!"Z2U&A2O1,730;I% MV,->'BY/T$2AH(N%Q;4\P/O!AZ*,0]&63L0(B_U (T7 M;[^PC]_?67-6WR[<0+EV3^ 9NZ\=\)XU##R5I^S\\[MO[_]%0^&(%>!1U+ MZ6E?1B/?%7$5\!;<%ELKJ2<%Z'SC/"/N=I3F4-QA4/GCQXO++Y_9NQ__*-FM M#[J,3 M 0 :79Z+3(P,C0P,S,Q+GAS9.U=WW?:.!9^[U^AY:E[SKA 2-(FI^D< MDI I>PBP0#JS3W.$+4 [1F)D.0GSUZ]^V&!C8]F$M-YQ^M+8UOUT=;\KZ>K* M%I]_?EZZX!$Q#U-R56M^:-0 (C9U,)E?U1XF=]:GVL]?WKW[_ _+^NUZU .W MU/:7B'!PPQ#DR %/F"\ 7R#P*V5_X$<(AB[D,\J6EO5%B=W0U9KA^8*#D\;) M:5@L?,HNI^CTY.+<;EAGYR=3ZQ1^.K>F)TUHG=EVZ\)I-"^:YV<_S2_M::/I M-,Y;EGTF2IPV;&A-9Z>?K!/HS%JS9N/\XF-+@3Y[EYZ]0$L(1-.(=_GL7=46 MG*\NZ_6GIZ7C*?10 M6!P__A4KC)]N$3>"MK(;)@O[P"0;.'EBC(.2$)R!KVITMAC7(JU M:D SVZ,VY,IA94E/%%6-2Y2O(Y=[\LJ25Q^>/:=6SU^K[UES"%>%:H[*Z-J# M.T4TB+AI\^+BHOXL_2Y=@U174N4M^:?5/!&.4:#:?3Z9OVYQ985RQ]!AV^>* MZ1#*O5"'U,ZRSQ=,DNK:>ZD:F^Y>6(U LI :"LA#]H#>:H7)C.H;XI9T MW[=O!\)!D0S!'0/EEHOWIE2QX&9HR$SS$@<1(2S^\*B+';F6N8:NC%K&"X2X M]T"@[V N(]N:'SP?E/#/]^H3#/\$#+1 MS@7B6&A^?%[C\$:26R\E&;R/U5AYTC?&].BL2P2#Z"B=. O62/)I/I*W=0 Z M [J6M_ZB>?,.HRDGQU">JS*-Q?(I@=ZBSN7/AUGEC8@ M&^D^/XAN41%0-;V1O(>*!21SY&'2^=/'?'U\JO?A&PG_>!#ANCJ "= 5OO%> MC)>C16_%*S-ZQ*>C>T2%@[OVSSY"XV(* $*5"MK]K=T??VKV'SN"N/1YW)N-V_[;7;5]W>]U)?B),*"96 MFHU=5B0B4)!@< 2^TY_DI20J831_<]?\$>D*6?FV M$2,3PLC$Z2X3"@[$\( &K+^7D%6* M<$:=;YW^0R2%;(LL*?[@=]U>NOV^/.K?0WX6SM27?0S[MF MR((P MMB>=VVW(/1P-;A]NM(*P_:HP&IX1\A$ MP$EB\1L @ "A0O8>/UR/._]^$-XF(YG<72 A9K1Y8L6[A0 :HT)63^;1AM3% M-D;>P8FX#4 &$Q<79Z>G'Q-,I"3DP/L0KTJK!D-6;0*G;FZ&\F$9R4HD-/+D MZ6,G"1R(!&,*II>YM@*V3PB8#1V(LTAA:MHY6B>KI"U M4P2-5D\D.F)IOBJ:/RM95XB.'$!&>A(Y$&/NKXJ4!K+33 5[5 XH M$UV?$FD34]ZJBJRU;?4-'B;S< 5]BSC$;NZ5_5YY(S_)A?T&"X1@X'T 5R5. M#&OQ.XC9-^CZB,[N,('$QM#M$H\S]06/]Q6YSG0=?9]*9D@AGOH$;E?,6*0V8OU M#61L+?JLLO51_2M?548/2N0_/W8'@CUXDT5#R/;H%-=8)CH"L$ND8@J@*1.BM)?%:R M7*QN_:744$#S!6(IGY06<-([PNHVQ%H.=@'X)7D+BO7?V!H50C2 MR&0BJ6;:2*AZ_)5E_LUL1_7DVGZ"S"D8C!V.;^0ZD1HS<[V=OVDP?P-=:26Y M3]\.*L9O-H:1PT1R*F-/J8(,9;Q67KP;&H",7"4R2IFOJ5>4KZR=NX-GR$*@ M1AX3"23CQN#;))G%P&8?:),G5VES=3S2)O$F]UK$RK!/>;A&W;VB M28\?JJ+1Y5*^ C.Z7&0':Z,UT&KK0Z&V24VUD247X$KW<$6^?V<+A UX\^:$ MJURC.28$D[FP9T>E,C;.X7"&&J3-11_SJ(_!Y^&BJ#_&\JCEHBL5=SQ<*8>[+ MMO["J+^ZJNF"F*-E#>AC@O6=)27"$]BZ*YY([.U9XKO&&2';A9Z'9UB?4-YV M_NL'$<,]6DX1B]I!*Z[-D$/0W&+'9THX9^,VOU)QZ= EQ,3GG!W:8G#NXWQ8$.[R>O:I&T]-.OF"\> M")UZPMNEREVR\KDGUA&4V**]BC=QY3,9)UU##WMWE"$\)YUG6YUZN]=LKU1; MJ=VM3XG\51HH/X71+\ITGE?R^. #PZ>7@9;55/=BOKGWN0_=[#DZ6:X,\_.8 MBV71@KH.8IZ.C-K!3RY*S294G_9L6O<41?G!ZY\Q(I@RM4EQZZ-_0>(+IEL- M^?M*V1SF$"P#J?H$[RX1?4V,19Q1UU6]C2,FNI77)=&^UB%<3019$^GA@"6- M,3JS&;(YG84C\4@H3HE,N.TDW49(.I4MFB4?B! S?B-24JQ_]]KOM:HKJ77' M2*J[PMPT)J84+$7_$?XM&&+0Q7\A$3U",IBZ6+]ZN'UF6&X6 RGG8B2RN7MP MTJ001CG-$+CH9CV%G&O#CGQ&:K\X5%DCG\V.:SMS2_@NV!*>+!A"VM_;L6UA M];G[)A44FRTJEQ1_-,Q!WG>MP\(&Q)$R_#X!O]4.C@0:<82$E7 MN&&R?1!].^C@D>= M+(./A,JAM$)@\03396;@\21\>A.605A2MI?PV]4!S.5*!&#S82I&&6MKG-&/ 512A*Z M]$2IAY6 #.MDKAX;539C/4(KRF3*4E\*WZ.N_H3E M@^G9%)KD[#7?J?:2 M]+8'XC#X1)(^LM<^&1+EG/-C@YY^HTHL\GY=8'MQBQ^Q@XA\>_X;E9UHA.<+ M[MU206Q[M7(S-DU?!%K 4$6RV?I#^MQS[9V8)(?!^RD3NG5?'=[>(CMZ1TPB M0A/L8#$*9<3)1\$NZ:R\&1G2T@)!#L$9[.S@)?;[XMM]/4R0K-G;%ZJ]&/E.+ND"7?*2JV_9I5E7?M&>^48NL=*$+P,M:2]/)C8M,92]+9K"LP/'IUNT0PQ)G]T>2G?.-"S%V-R0R['V^AYI;]OUD!] MH.")E>$2?GGW/U!+ P04 " 7::%8EWT/BNP< "N$ $ % &EV>BTR M,#(T,#,S,5]C86PN>&ULW5U9[9 M-T8"2%C39U^Q MFX]GTU^>BY_X\VSXM!M_ M.5P\DUSJ\[>=_[;[.:*6P2;.C)61:?"612F F914R%P$86'3L;3?_U+Q?'/+U[\ M\<2G6??EA>1]D3Y6 MO/B?7]]]2H=X!&P\G2]@FNH"\_'/\^6+[V8)%DNJWXOKV9WOJ#^Q\[>Q^A(3 MDBGQT[=Y?OZWOSQ[MB)'-YO@1RS/ZO^_?=R_LN1X^A7G:?93FAV]J+]_\6HV MS3B=8Z9OYK/).%<^OX1)W<"G0\3%_+C=&.)X,EZ,<3Z**H8@@F;6 MR3!$CU B>+^?DKE=)J M2>5;EE]1<_N=O"'FSDZ1Y&A2:7CIDU^==!VIA+UI?C^;IM4/(^*W\@83D\8; MIK4US//L&')N>.0^"&D;;W8SA%?I<4F^]KKT;-9E[$@?/G_V!U;==:8:5W"A M2S<$[^IC>?:.%_.3HZ/E9S(2L*/SOR_=[*B-E"QF#\:CE9C0QG:5H[V49B?3 MQ?P#G$*<("&B5[J3^]&6H'4(SA%--&L&"H2\J<9,-9J)\:"Q1VV)=1[;D M$Y.M!^';SE)&]F;T;C;]\AF[H]<8%P?ELN+?K^9A4?V7#]TLGZ3%?*2S%<5& MP5!S3>B"(/1"OV$I*)7NC>S M1I_P&#H"=*[=SG=^.DHF^"(],NN1X%CKF$?A")TP/ B>D(O&YN9.,.O(AGDB MLM&6\LT$X;(2&Z&RZ(TLM'A,%),FQ7S1E@5>C$FN2.E]:T_]TOKKL-L^,79O M3=]F''Z-!%R.I=!%0$LM9 5DF :H L.8=7!:Q6Q- M8Z;? VD=.7!/3 Y:?^SM,3G"D(7CK!;+B7&0ZDWF-%.0Q M5R+Z)#BB:"WCUS$,*>[>D>_797LGU[W#Y .,Z3E[!4]%-:2@N;%@-&9),U'YW"',3[K3 M2R*;; 27P3 T(C/-/5EE+R3AT,$Z$&!C;"P:-U%L&"&SIR0+.]*\&>\_X@+& M4\QOH)N.IU_FY(>?')TL\X9DH\=IO!CI(%(4(%BRANR\IR_ /7GCSH(U7A83 M6UN+^U$-*4YN+!J-6=(R97N.8QG5D]XZ[O 0I_/Q5UPY@]AELDEY.36G3P M8=8MB;U8=.-XLJ@G#9]G]3!A-ET0[>@3O^Q/%]CA?#%2);HBDF/@/)E-DPU] M1[0@QSIEJ74V GH/T;9!WD.XJBU*Z3+%%^ %\3%(!LEY!J B*&O(+K3.6-T7 MK@XMM.M=QFYD.'=C4[/'[=?Q=-8M"7"V*>50-87F)P+&QQ:?DA%80T>/*W)6SS$K./F) 4#QGM>K)DO7)% MZ7J>9$FT:4#RH5"I23 M1MIJQ"4*$L W MW\X\^+_/9OF/\60R2MX%BK4$L]DA>=2&''4R,K3UD H&HB*T5O'KX!I2OJF! M5#1G11.G[UQ'=16YL&"FKU*KDE("D<(Q(P,"HQ3MN0 7,$ M&]?P!'?%,:2"D!W=PP=E2<.\]>P8N\7IAPDLRYQK9'-<856;1[N5B@=!,;MV MY.MPR8*/CDE3#I.W(FE#/^(B9!UY\ $$+TSYDBD0S;2+3 *F M?>1&^)R$;'WV?6GYM7)!_.GP=5O*-K'^MV>B[D]*Z.!!A9OM_I: O $LH$/1/]V9>#?JU$)\BTG.#*'HF5&)E(]+I<$ M+=0S\R1="LH((57K[/%]F!KN>21422'+P%119$BU2RQ:9YA07CN=HK>Z=9/= MG3VJ@^G)W%T2;E3#;TGR=I5_>'0\ZZ [76WF/"F_=U2=\FV.OV@?->2GC;,L M--$#+%+HKP)+Q2*@E,KHUE4_[7D?P!G2X42OXM2*)==DY*\OKA/N'?W< M*>E54Y9_-Q+#]:HJ^9+&MOJ]%@EO>X^%X,.S*Y_57 #3(2Y;Q8K45*Y0)3K!D"CT4'#*+PB0*H))1+I P MA]0^"WFV^I <^.TY?$OJ<1OJ-C,?5W:REI7#J'3=+L,B.-/*<@8Y%8;<%N0A M)BU;IZ(W!KFAJ]UODT\[8>F76>VZH<=?QZ2%\_QJ5?BHIE=-+=C@B5NF40!Y M2IQLG[+):1D3E-Q8M*Z&N@]@YH05QUI%7=S8&Z^QC1Q:,C:66(>E( M7Y#\?P\"F87BK MQS"DK$U;#; 3M9LF7$ZFX]6$U?G^M ZD77[_&=/A=#:9?3DEN3Q(Z>08INET M%%0LRQ ?D+YHR.2")1YK8L&!=@046A][; AQ2(F9MA+3)Z_:U7K@E/8\62JS MH_&TJCG"^!7/I=QX&U31P HY=;4 A70<)P?DN@.28[?7^YMM=C746&U)5:4,_HSF=V[4<'-4SB'\O@1R4ZU6P(Y$0E? $ M0J!B.@C+(AC%HC=9NVR8K3D_P+3&UGJ%T]&#^<[PX?'4R7] * MW47M=Z4^_#@G-4;"40=ZN)LZZMYKD$8U&GG<.5I>[:UG1M!FYM= M=;S.,6$G!,.T%>6'):A:1YRQC=!!;'Z#_&-&0,L=#%:R&/&UW:.YIG(G<:U*HCN48\JH.VQ M4UCD)Q8+A;8;:Z(=ZQQ:L(*YZ'0..=N46U^1W3HE[S8@M8'VWS(?1W%:H.*SWA#4]@,C(5Z-$F1I,S M7#A0-,9!"4"!O/VDD@=*3SQN@+ZE]/TXGGX\YC=.MA'0,P/T$J=(A!J%%+7" MVH#/;9W>5>K]%75$GT/G8RE"8>M,_1U0!I5R;2I&NU']4=M/;ADMWFLOR@_7 M>XC&E/4WW*A+Y98%SP>W;]7]YG.&Y3VO*0?/=+">!>EK9Q-D'>L,8FB=YVB\ MA88.B..JN! ]B\M99;XX%CG/3 IN-9?"&ME:NPVS4^8QI>P'O3:;\*=M=N>^ M.Q.45$69G,CW+G6#CC/OC6?+RYY\X!:;EW.TNM7BH5+20Y*IYCQ]6&GC/":O MN&0(RT!-&49^A69@@M8Y)B.Q]7'EYM+6=N]OR7L>?YFN[I-.IU=KOI8_G0EV M_M^357;D@EI2:T>!,H7)A2):[;%.3J?OE#-%)I&SM*W['_O9R9 L1',YW>01 M?2!AZ/VA7B7]SJ$)""I)*5F*F2('Z8 %KP*K1B\'YS(VGSBQ%K A&9%'$[OM M6=6RA>$N SHJM+R4T;$"]78(S1/SW"/STIABC8OI^J7U?;KQ/>YT*UC$L;ZWVGW9G?E_RUR_K>N_3EZ8$JR+9.ATDV22* M62!RPZSU,6'4(JG6Y>-/H4^_+VEIP8;'S=7"_/#M9/;'O-\,[\_F M6F5C:9EK4TP_8FUX3K3BV933JR]<>N<'[,:UX#+5^W_Q-:[^ORBUIV\.8?H% M/]*NWI2"J9X#D$PZ"631X.Q:8)_0,&6,$D$YE4OK<\"'W6$#ZULA?.AF]>', M+T]_F]>"B8O#[CT*$K^>#=FL@S3KZ8P12,\IU'/S)%QUYK$$])[;UE59ZZ,; ME+LW7!F_Q8+WP?Z6SN%M^%85/5?QE1JD82#+5:U@="X)'ECF6;),OJ?G8 MW?71#2DC\/3%;\=3F*:K^!(@9&\4LZ5$MARY"$%I)F46(G'.<_-A M^.NC&](LC:[262E6Z5F[SPJ,7<&((#1S!(M@ M\L"\T8GE$A(11R"_/@/PU@+RK18?5.ZI9\%Y& ZUK-U-B/D'380769*#[O(D M,+*!BY-N>D!Q^O%X 9-1D3%F1]9*^Z28=H L$*&8(Y_@Z22BP")J4=@R^" ^)*UA'$>X" M8DCM6P^A#Q^,8>WTXG6[?^=5=:.LDK BD,#G6M)6[ZGSJC9:DR>O0I+H2_.2 MP[71;=BT]:1-;\^\Z\7FKAZ'&TZE$";*K ,K4M0C""M8D))\@1#!I@0E6>S1 MF-Z.:DA-68]@)1NPJKGY^R[JWY7HJH;J-:;+KQR43R=Q/LYCZ,;+>6K!@4?% M7 #R-3&$.IX\U*%J!:5.Q1B]H1'<$LJ0AI8]L"E\".:U*UW:)0LV*B92 (.& M!5V;K>O8Z%C0,E!84BB*A^;C>7<"W():-Z]'W%N<7\GU.TQ.< 0^>TT>#+,2 MZR4!:MGO:YF !%P"J-S^FJ!U@/UISJXVDKL;Q4S->?B8-Y]R9[/26%BMK&0Z MUHL^D=P=)71("I0DE;*&QN_OYM,G<=JTE4 ]$-?ZSM+?=@8K@\H6,; +A,^ M,E10[$QM"YGV/8(?J>VL@3+*\<%P]J=KSEP!J;>2I9++A)#-J$' M?WR ;64]R<8/.L8V(7V["CT\[C"-EQ2A[R=XYIA='D0["5JAV0 MD$FR=2R2>1XTA0\E**-)V\?6_O#M2)Y YKNUL#1@2?.Y8XGV?74\E4Y.RF T M<[&.04O*LF@\>1LJ9ETH_#.A^2CIN\!LF*Y^E"1B:REIPYDF'O_?83RM%YI6 M<,IHFU=3MML&K#]DPA5?QQK M)DR;'1:/P%@>>J1A4TK MG.8P08H#OTM\/'VU_V%:U6AT*D4?F2E9GP^)39(I;ET1VI(A%FL8N'L76DS[LJ)W"&%=Y^Q.[JB% TO/@E%2K'>36?K)5$Q9B8TI!B\ M+:'Y ,L-X*TC4.%/(E!]UZ!].*ZY1*3FE$CTK M7E*D*&OVWIC C.+:\5PKXUK'\/>"6DMZ_F39Y+:<>HQF'2>LY,$EAJ*VJ2MP MY.1SP8@J.ELHD?S]ASEGN;=99W,Z?,3C,PMQ4-Z-I\M NL,\7HR,%UKX[!EZ M69DN:-M*%N(-<$.1-)>N=8;]3C!/H?MA5]&Y>:=8"\[T4CAW%0Y04")-24SZ M4+N9>,WM@V12<2$- BK36M/>">8)G+^TEI,VC&D>+AR4BYBV7D@\FZ[F.YB4 MN$/T3"XO18UQ<5^S MCBW"1T$N)BIDV@F9)7VJFJO39/:F M>?4"3A.N9-N#\=$",%,*R39%M,R3L+/HG3"@N?:R=6OK%C"?PEG. RBEIMQL MHJDN.V7W/!)0Z"D0@4(E62?9&W2K:[,Y2E/G&LGB[!I::OT5G\)934L5U1,O M&A6*+OOS+G+YE0+W8!1U,D6RIMX]9)EV@M#6:5HV4I ML6AU?3K1'46BFZZ\ MX2',DY>;GGG3S+Q=EN]/.!W/NFJ(1RBUD\$&QCT)M+:WUO1_(4SF?Z#,JWY$D?!S,$ZZ+M_;(G+\F-YR2Z#'*]8QPC,N])[TERYZVR MTG!H759P/ZJG< S3EW/3B%)#NN;J/47WO34Y2E+3/^J6?YS4N8#R97\6YUAS-)LLV M&*S9?ON-)FWNS>=(V@?&W6JI\3Q-9O.3#D3OY-8!\9U@=B_XON54V] S4$\HF7.1-FCK>"!=- L*()<44VY^V\>VQ0"BICY&P M:X$;TEE&/Q+3#Y_:]8^0L]^1P3T[L%[18%1")+E%$N$LR< 6X5DH$)FJ$RR$ M-5$T+RRX%(=MWOQ4=>6N97A/K1^:"6?IUT'?FL+V$^GA_$R?@+K$J5 MI1 R26,8\JJC30@L:*]9MA&XQQ2";5TPLB74(?EB#:7K^N/S$(SL,YC:C#(:+(NL@J(2T*^Z8CQ"821R3-27: MTGI:P Z]4P^E9;;E^WK=*YM1O6T#[V44DOR 4K)D8*&.Q%1 WV5-W@+MTD1- M&V_=?K#-G+:'"MI:,7TG.C?LYK\EO9 Y!85"Z'J'<:%M:0H+M'-,.*$C.(G1 MM7:^MDWN/%0LUHKK.].[3]?@TS_V/KYYM?=A__/>NU]G7U?W%NU/E^,%YOOS M^0EFF.:#D\5\0?^3D[.]E[#U4@TCM/A>;4: M;??W66V<^5@I/G\]>S];[!T?3TY'Y T%)X-@1B)1P$,A M);0KAD'= M!<7!Z40WV:M3=[']_OO__[IP]O/KXZ^/77@_=+ ["][?KQYS4P M4!L ;F2%_KD44M3UJZ;NOZXV"P"NQ7B7<38R_][LHH:1F@H^O<^4GPH%--9<.9= M*@RS=5$5;[UJ?9_2EE"'%+T_NO UYFROM_62X3EXM_]Z[_.;U]^3K!\^'KS^ M[=7G3Q=Y\(NZFV45SGQV^2J,?^"D.@CD$IQ[F?&>JN#MS?*CPFUQ?_!@R+VC M4U$=QTN@[NTC0)F3TKH6]L9Z351"YFM?/'A2'(NDRID.GKZSM&]E MO;566*VNUX_?T6EYZ\]7LOJ@43D(#&5-%B.) MGH^$3.ED0*; @VO=+' KD"$DTQ]"+-IQ8TW7ZNSU^B7"'/_VE_\'4$L#!!0 M ( !=IH5B,8ASJNC\ &V\ @ 4 :79Z+3(P,C0P,S,Q7V1E9BYX;6SM MO5MS6SFR)OJ^?T6=FM>#+MPO';OWA&RKNC5ARSZ6JWKF28%+0N)NBO20E*O4 MO_XD2.I*4B)%8)&2'5&AHBY>ZT/F!R SD9GXS__YYT7_IV\P&O>&@[_]S/Y" M?_X)!G&8>H.SO_W\VY=?B?WY?_[7?_S'?_X_A/SO-Y_?__1N&"\O8##YZ>T( M_ 323W_T)N<_3<[AIW\.1__J??,_?>K[21Z.+@CYK^D_>SO\>C7JG9U/?N*4 MR^L_N_[MZ*\!)'T^G_/_AH#98EJ0:+"OY T M>A*RM(3[E$5F5#LCI@_M]P;_^FOY$OP8?L+A#<;3;__V\_ED\O6OO_SRQQ]_ M_.7/,.K_93@Z^X53*GZY_NN?YW_^Y\+?_R&F?\V<<[],?WOSI^/>LC_$Q[)? M_O>']R?Q'"X\Z0W&$S^(MR_ UZ?)S3^\BT;],OLE_NFX]]?Q]-^_'T8_F2KH MR2'\M/(ORG?D^L](^1%AG CVES_'Z>?_^H^??II)SH_B:-B'SY!_FG_\[?/1 M(M+>8/)+ZEW\,O^;7WR_CXBG3YA05Z*_'G(!I0J< M_U&>]LO6F,X1R"A>!B#X4Q@4BE?$N.SIVV.^>19)D/UE?U(1\>*SJ^(=7OA> M30$O/+H"VNF#R 5F4_#E-"S%^!Q.#B%^A/QM<_*9(74ZFO1C&3;X5Q??&A#Z=!6Q%-BD3A MNXFT7A+/%!"1LQ>:A:@4:S6F*8+[X[EES,'H>F3SJ;C1CI)'PXNJ^IP,JXEQ MIBD$_?-/PU&"$1I1^*OI^O#7V!\B[__V\V1T";<_' XFR.K#_O2%.&_AK'QX M+A/&H\GII]$P7<;)Q]$)C+[U(AS\V1N?2N8C9<#08,J9R*08"5X:0CD'"=0D M[ODZ7, 7W.$!?G?+@57OKLB"1_;P1UCQ##4.*XIS&2>V5^_X8)#FB,;OIAO. M6J!.'Q@2V^MZ$4A%A:\T@&[574='BPJO).#.M)^0USX!)Z!S)-)X3JRFF:1L MN#79 17QY6G]GAFY$Z5O(M>*RKY>Q8Z*!34IR]A!*K ^3*W*4WR[RD)2PCR7 M.$XFB3,.ES2ADTQ2FAC6TO8&>_MR)#75OLP>7ZKS;=4TK"[C1> MC'KAY$(8ELB?(9O,+B$\4' !:U0QP/,72G\D:A@:V$VL!&F./Y%"$(8+K@(0(6U9R= D M=IXBL X:305RJC*C%D)YL4O(77$7%'_O6__/OURWANE3WXTN;IK[UX[UH-4 M_*+Q<'1U2B%HX4PDB3)*I$3_VN$&2I@%Y2%8SI5_XM1AD_=UK^U*ZADVEFV# M^?_>A^$(\7R&?CF4F8__5 MM*9*:2*4\?F&>! B,A!R]LE0*867ER;\&@ V*2)T=">@4$Y&358#@K':5B?,$I-="E)J27R2& MVLJ6'$Y\_\O(#\8XR%G4]&@P@;/1E,AOS_WH#,I!#8^&:4/0Y,E$!A:(U<8A M0&^S=1I4CNL8DNN\[*4KO8U4%]6NMUT/#BZ&HTGOWU-('S/B\X.S7NA#\7(G MX],DE++>H\?$<*&2RBGB7/ D*C1N4Y(I^]HG%8\C>NG$:"#W15:8ZH&%4Q># M2#$YPH.(B"IR@A9/1L='2!$":&UK[PL+(%Z+[K>3[J*Z;35USU+YW@_'R$"( M,9>4&RHC#M XA^L2BX@K\[)-I6QKGSPL@?%Z8D?/%&T#O_%X.!C>1S7GX0VY M@U=1!A6)MK%XMQ*(H\#Q4[ N.<<"V,JZ?Q+4BV="7;$W\#%O&5IBX(?_][(W MN?H D_-ANCT\'9\&JJ.10$E6'NT5#9($[0)A(+AU0EMTB*L?3:\!K'M^5%;H MPH%U;6TTS6&8P2WV[0A_@J;NN]ZW7H)!.A64Q1B8)!!I2;- 4]?JC%YOR-IH MKY,P[?*>5L)Z?72IJXD&^\XUI&N'%Y=0=&D13LQ3&Q=9'*32A :7<(-4C 51 MG1CW(+P^$CQ?P@TVE&EJQ,1);0R./([A8:W0AR.8_=T7_R>, M#_]$<>'[>P,_NII:]3CV4M.#VNA/1S];0T]#9IQ1[PAD=-5DL)9X%AFQ2@>: M.;!$Z]LMS8;SXMVG?5%U@S.9&\CS.?<&!JB?R6FB!HS6DN L0EC,H7$O@R8, MX5IC8O22-F'@ I17PI[M1-Q@_<)U%%%,@T+ #0_">F)DQI744$\"L^C))2T9 M2SFF5-L:NGW[B]?O,P79X$#E&":W2]7!9)8]5,H9OPQ7K#Z<@^>&1D(M-T1* MB1:9YY:8A.2+5-.0:Z?K; SRQ1.DK5H:',%<>^WC3ZAR&(U*S?TP_NL4-.<. M'77B'9KN4GO?*B>IE9"N@O'A.U!!Q@].8>U0]]4H8P9Q IYT7 M"SMQ8B,#DB10ETJ-I*ZM[WL 7KR6GR_.1=VZ;75[Z$<#7&3&GV TK4N[S5RG MFFF--J?AH(BDF9% N2(F1VUQ#^/"UCYR687EQ6N\BI"71,NWKOUX".R-'_?B MJ6/*4:O1Y_#6H;MN,G&L?-' /$O1"K%6HXZRCJ">UO+N0&!R4/ M0;WK]2\GD$ZEL58%2PE,LW_P,W&(BT@14M J@E>MI_T2 <7*_^U:I9U-MS/SB#<6\P._MKVC5JY;LZ:!^UWCC;]9&*T5$1M"$AEYU& M)DL1TL9XYDKRJ(D1Q^1+21HDHIBB+."6*G/M@L&] MZ2.UB3Z?Z".UB1AWW4=J80BSZ?1V>/%U."@S;=IL)4C&;-+%F#*"2,[0R1$\ MD!Q+H,1+FT/M_>910'O2:6HC1:_BS-8";V%WW,JV M_50#Q3TT0JI)O3-*Y""YE*")]0S!95&BID(2#5Z;E"2/OKHAVAT55O2DVA43 M-A%V P9\0KMX,)GWO-#.T8B^97^"Y9#25':^_\GWTM'@K?_:F_C^'!SN/U(H5[*VG"O-3BAQC''B M>61"<.-H]97[44 O6//U!-T@C?++"/SX:,HW-@@BF;09?X>$*W1456 M@ %1E,J@2UVAK)TSL!+,"]9^'0$W2 SZ#!,4!*3KH.8U*G V%F]5@T1H0N%8 M14IHD'H3!=4,M*FL]N5(7K#.*XBV03[008R7%Y?3)B/3M,QBI8[@O+@QW^:9 M;== K>'>"$&"#VBO GHFB%"3+'*T,AJ-7VHO_NN">\&T:*. %FE&2Y-6KOL8 MNJ ?PS/:_#QJLF[2156+#L8O(/9_X]F M-NRLY^UX)HO/"/S7X>@//TJG3)3^F>BMF$A+9A-/)' *)'(/I9M-UA#JYY5N M G$O4A"V.4AHJ9(&48-%<#B 6;O#3Z5/ 4I^G90Y)0TUR@!!XZCTMBDIU))F MW$)U\H[%2->[LF*CTX4:R+OG6U."+)Q0=*[=!JO*1I)R&R+![2:BLZD]89ER%H2ASM6VVM;!];IY5ETS%0- I3IOEAUS M-%C.:YP9=]-J#@<35 T4X*=9<2$H9>5&%<0,*!EGI"(V.<-ESLG#@ZJ"I562 MSWW_ZV1-9QII$$Q:D>W^UH_/3P-ZRHF+3)0N&>^F!#.*EWSBB L\<5IHPH1!4@?N(JO=]&45 MEN^$'-MHH$6;P/3?E_.>,U^&*TY+IOFVY7+B5/93W$RG9;F? 04T[DU@WC[[ M$XQZP_09XO!LIKC???\23J,HS6H,)3H5YX(:=+N]DX1)Q9A)+BI>NPBN]9A> M-U/WBA$5Z^_*%O\[;N0PNSAJ?$J#4EH*-/FR0B$I <1&7PZ"RYQ$$]"MU3__ M[C-?)S.VDER#.KJU&?IFD:&EZW^ZJ=QJT;'03'>"R71RGB MG0',AOD[>O@2^-"A%O'?J/5UR#R)"'I6AE9.-TFKN5-@2 M D>S0YA2!&VY)T$ )S1I[BTPJU3M*P76P?6ZB5A=,RUJ&2L%E9.CR0$PPF6I MRV**$>^5)3'08NZBM&CM1;/%D4&-0[LO6T^>/&3!Z? M B2=3)1$25ER&1PN5HX%DDT*+F>9>/5+'^J/8A_VA%JL>;@A[%;E[4E\<]IS M2IUPY49PXGEP1.:0B-6!$A6#C38@NH=AZ]I4O,'R_1#J>>)O<$[V -?L<&96 M'WS*LXHFHGVU_-]@0',18T4QS]7NS!^%W)F.V/ M[VMWK?8#JY^U?7N!-7%6:A\P/M#.IH;PU*;"'Z;LGA/>40N$*$K-S-6]K<@XXDTU+"(ZF* MJ78R7=>D>**I0=>6:.L)U3[:=M'1YQ1AN!W MN&@JR:UZRHI=ZT7=NX6U-#)L)2?0,N;'K_LM(@N+:4Q&@C^OO1D,#0Z;>>0S8:W7Y3 M>V/8^YNQ=\.DEIIK8&P\>7^S490;ZH@PI6NE*B>92>!DD![ B21 U8Y<[]W- MV;LA4DW-=-+[\]>#H\^_'[S_[?#CKP^P_SK[T!X MWO@^HH*3W[KY8AF(4\9(YH<3I&(,N20V4X"1Q2N<,G)Q-, M9*QV%=\ZN+J*,7;*JX?+;G4%[4OD\<[ /DPSL::/+WW$9PT!M0+(( V:N KW MDT0%"0$W+$9C9E*B9>)K5T,\ 6E7<N/" M641\W99D#:B-PI4;P-Q-_+*JFA^V[FNLHP:T6@*P+->S ^+Q/+I#F=4NF428 MYZ4B2"KBJ2]7+XID?&( MMG6]PBNG<0Z6_*GNC)VO YQ3V7FPI$D2T\S9B3Q M/@)13E@6&7=)U.$ M*J&8'^#I*)VF;0)OAVT(6LE:(?-I5NI:4&*],[&/6^3:,Q MMW[XY][X7]-E&0 786$$$<*45B%4V$QV\U(9:Z2*KS*#'\+Q:*[J:$AJD M?-YB*W?ZEOM_[IQ@K8.MD#DS_\U^O6 MG*F\7.52T4")E*"(TZ[T=!5<91"0ZV>*+P/2O0523UG=W9,KA.J9WT$1**0H^3$EHYU$DK*NHJ*&* 2:$Y>BMJ=B)#@<*@^]/J]R=6I#D9(#9)$PW-)D\K$D+07RG;%D>V6L;-K88>[0EU'O/7R#_C]Z,$(DYU?W[*MFV4'K MO;9Y_L\S1E\[PV>V#Z&E>X=%\S.I]''P&>+E:%2*/0=IVK=X_NWTJ.J6QTZ" M!C")&&J*JZ9Q%XO ";<)<*5BE.G:)D75 50[ -T"S"QL&M$TG%8HHT-!2_B[ M6(R!$A=#B,I"XE [-%0-?.=91)US=^59:Z=ZW\.\HYN/-RO9=%V;U>_0;)TO MC1&=+R9N%B2PTHS?@8.D)$,?J5WZT2/(=GY^TBUK5JR]22.WD2XT6\ MUW5^:X!M=/ZR$="=9RU5T_@J4C53U\XY)I-P.H,K9YH*;78 8BEN']QJ)P2- M+MC:O1^&30^A\9\\$Z$5&[ID[BKNU(X M)AWQ7CJ%<+W0O@."\.^3(,_10D M!RJI]/2[YO/Z#N*+H/,&ZFY XP_# 5S-.I?\>CE(UVUL4@";I!5$,E>V(F=Q M%TJ9@**1HTG*C:A]S+(W55-&U+*V03@#2_.J/.1B5E=$A M*1*21##>:^(\BR2KX&1.(D7V@#-+.TDM//@[I\#VPJ[<4^S=_'*^N_>\'(Q& MI0WRW4Y8:,AJ84L6+90:F^1M#=([XWE:@P[KO>T'1UJHI:TO>9-L M=+M#*P/,2^M(5&!PF_8964TI?IMBR9G.+-5.\'D4T ^?LHZN&F2(W8![7#+K M3<+[PYM/Q'4&V-K!;#6XG7N:VQ)J%57WB@TMWA!H><E?:<>7VW(^PAV[H_L,%5Q"UUT5PIYC8XGHR3^*Q*$T$1&7>Z59X8X MX3G71D?!:Q]P/HZH>^9LHZ_U2AF?(^P&N\IR=$L:A)PZ:IS((A*N5"0R@$ ? MW*,@+$T*<"9H4=L&6AM<]P2IJ=6U"+.M2AIPYTZMY M.,O1A'.:,@#-X6&$J\+=HPLP7O2"L:U8&T2H[C6^#1-DY^PRLI.R54YWTUOF M.V4YDXHXJG#DB96\C,"(<$F8')+7U3NFKX]N%_?P;:G,U>2HJ8D6Y<_+2K*% M]E(J'+7VV1$IF" ^!4%4]E3PH)D6U>M:]Z(ZOI7>UJF#WT3HG=7!9T6SCMP0 M,1^E)=8J2[C31B;)J M&+1>-/,J2%;[KH.'&%ZTEK<2Z,HRXVT#"\L,TL!#LM1H8G&PI?[9H4$J%/' M%'WJE84\NZ&Y96UQ@IT=J++Z.S04 (CFI3KGY,W M'F)H%8GZ53;LGP]Z;:FBG 6D^3LYA=!=/T F\3(*P,C6D<[BH"9X(LQ%Y MC(96\+4KBQ]B^)YILI4^5GJQ'?92.O:CV45RS=HF+;RA>8>DQ\>TE\V0*'I= MW#E):"C!#RK0/V+&$I>DS0(],B]_-$-:*TV2"RLH-XKDB$ZLS"6,)+DD,61I MI'<)C< ]E.0+;H:T"7?;-4/:1._[T@SIT7[F0J3D)/-$)\9+']A4;H%-1"7' M58Z4/+NEVB'3LVD'QGMTM(DRTNBYIPJ2-NZ3A: MKZ4A.NO,6^=HQB!=QN\0FNEKK=HE-!-T@I?(?D,YPDWP'X][98%9G-FVY M91G2F@-QL:#2/I-@RYT7RE(;K'<@:Q]]+D?R?1L=%;33( 2UB.JZ,]\:N!J9 M&JLP[<;,J*&W)ZFPA= ;;",K\7&>-?7!$01:.C4(3:RSE@CCC>_T2,R10ZHEQ.># M#850.\ZU!JSNS8PZ.ERP,^LJH('!<6M>'0_+J'U_=@?MJ;&444DS44QE'+=7 MQ(98+C;1/% )R;G:";BKL+ST\XQMXG%5]-.4-]?9@A$,=>6B/[2PRN$M^F,) M?+F6S4-427#6[@*1G=]%M$<\>88^FA1UQ!&.'][![/]'@X<([POKU#.&_CL( M K9Y-'3Q@ZM[6?7//77=[/G;G[EN,9Y*)ZXG\1S291\^YCLOO*6;8T@! M@ZXU4QPM)Z=*65F2)/E A4$?7*I<>48_CFCK"H1E3Y]%%50R2ADTV[0N*0M) M2.("LEW;4-)J$SH4M:VEU6BZ.K6LJ/^%BH0ZHMZ7<\7;093@Y=3AM B<2Q1, MEB!1.DD1)W&YS"$IK4(RNOIIXB**787S:JEW957;L\33"15"V=A!] M"8RN(LHU=+QX,KJ=5/TJ^CRUAI?W:Q_:\DW,"8_H9=3I#JYP;FDN/XZVV@-J(V" MS1O W'D+_>W5/.Q61RT[K]P"+(OQ+/WHIL]UN42%O: MY4T[6G\V3/2IIM\M%J!-E-.DK?AH=-4;G'V&KP@:TDP(J^&&["$S6KQZP'FE MK2R91HZ T$+AUJX.(8Q(!ZV"(E:6!JA?*6L6YTK5S>C;!]WI)U4Q+#0)[;T>0>BB0.+VQ8[K/ M)TZ!E2-%'60D4D8@/K&$R[20O"2PB%P[$WH1Q6OQO;:4;W.-S[?F=3 U\JN6 MX=F- [6MKAY5_1:";G'?Q3)L/IK$#)5$)^T06XBE4ZL@.BN;,K745[_9MSOE M/^'\=*'[3>3;I%_D +>D&;+YYI.%LTY)1M3T5*E4BX>@(]$X[,08]?BCRAI? M1+TNVULY"8\BM1-O "2D'')/Y <=->AFE7AF5<[G0BQ)IDD>K [VPS&,V M+D=#JS>578;CM>SM6\NX0=?YAYCFY%X'5:/]?3FBW>SPVVOL"0IL(>X6*_YR M=.AR*&>0Z18\;FP.W5G/,R= $X/$-.A8^TRN2Q(\L=-WQ8%-I-Q ][\-QJ6, M#E*!-=^3*!,I*\]Q@"4O,0@H222".)M$1!YLUF;+>^V@90B@CI,(@(JL)=5*5V$(*U9/M%U&\ENU^2_DN:GSK&TCN M(SKV%S=]I=; U:Q)WW),NVK0MYW.'J7 E@)OTC%E!3['?*;: 8DB"%SJ,NYO M-!BBA* !EZNHH6V246LB/-F*KQL>;"+GZA4V@]YP=#R

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

  •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end XML 80 ivz-20240331_htm.xml IDEA: XBRL DOCUMENT 0000914208 2024-01-01 2024-03-31 0000914208 2024-03-31 0000914208 2023-12-31 0000914208 us-gaap:InvestmentAdviceMember 2024-01-01 2024-03-31 0000914208 us-gaap:InvestmentAdviceMember 2023-01-01 2023-03-31 0000914208 us-gaap:DistributionAndShareholderServiceMember 2024-01-01 2024-03-31 0000914208 us-gaap:DistributionAndShareholderServiceMember 2023-01-01 2023-03-31 0000914208 us-gaap:InvestmentPerformanceMember 2024-01-01 2024-03-31 0000914208 us-gaap:InvestmentPerformanceMember 2023-01-01 2023-03-31 0000914208 us-gaap:FinancialServiceOtherMember 2024-01-01 2024-03-31 0000914208 us-gaap:FinancialServiceOtherMember 2023-01-01 2023-03-31 0000914208 2023-01-01 2023-03-31 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0000914208 2022-12-31 0000914208 2023-03-31 0000914208 us-gaap:PreferredStockMember 2023-12-31 0000914208 us-gaap:CommonStockMember 2023-12-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000914208 us-gaap:TreasuryStockCommonMember 2023-12-31 0000914208 us-gaap:RetainedEarningsMember 2023-12-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000914208 us-gaap:ParentMember 2023-12-31 0000914208 us-gaap:NoncontrollingInterestMember 2023-12-31 0000914208 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000914208 us-gaap:ParentMember 2024-01-01 2024-03-31 0000914208 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000914208 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000914208 us-gaap:PreferredStockMember 2024-03-31 0000914208 us-gaap:CommonStockMember 2024-03-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000914208 us-gaap:TreasuryStockCommonMember 2024-03-31 0000914208 us-gaap:RetainedEarningsMember 2024-03-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000914208 us-gaap:ParentMember 2024-03-31 0000914208 us-gaap:NoncontrollingInterestMember 2024-03-31 0000914208 us-gaap:PreferredStockMember 2022-12-31 0000914208 us-gaap:CommonStockMember 2022-12-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000914208 us-gaap:TreasuryStockCommonMember 2022-12-31 0000914208 us-gaap:RetainedEarningsMember 2022-12-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000914208 us-gaap:ParentMember 2022-12-31 0000914208 us-gaap:NoncontrollingInterestMember 2022-12-31 0000914208 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000914208 us-gaap:ParentMember 2023-01-01 2023-03-31 0000914208 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000914208 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000914208 us-gaap:PreferredStockMember 2023-03-31 0000914208 us-gaap:CommonStockMember 2023-03-31 0000914208 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000914208 us-gaap:TreasuryStockCommonMember 2023-03-31 0000914208 us-gaap:RetainedEarningsMember 2023-03-31 0000914208 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000914208 us-gaap:ParentMember 2023-03-31 0000914208 us-gaap:NoncontrollingInterestMember 2023-03-31 0000914208 ivz:ReclassificationAdjustmentsMember 2024-01-01 2024-03-31 0000914208 ivz:ReclassificationAdjustmentsMember 2023-01-01 2023-03-31 0000914208 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0000914208 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0000914208 us-gaap:MoneyMarketFundsMember 2024-03-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000914208 ivz:SeedCapitalMember 2024-03-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000914208 ivz:DeferredCompensationArrangementsMember 2024-03-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000914208 us-gaap:FairValueInputsLevel1Member 2024-03-31 0000914208 us-gaap:FairValueInputsLevel2Member 2024-03-31 0000914208 us-gaap:FairValueInputsLevel3Member 2024-03-31 0000914208 us-gaap:LiabilityMember 2024-03-31 0000914208 us-gaap:FairValueInputsLevel1Member us-gaap:LiabilityMember 2024-03-31 0000914208 us-gaap:FairValueInputsLevel2Member us-gaap:LiabilityMember 2024-03-31 0000914208 us-gaap:FairValueInputsLevel3Member us-gaap:LiabilityMember 2024-03-31 0000914208 us-gaap:MoneyMarketFundsMember 2023-12-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000914208 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000914208 ivz:SeedCapitalMember 2023-12-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000914208 ivz:SeedCapitalMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000914208 ivz:DeferredCompensationArrangementsMember 2023-12-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000914208 ivz:DeferredCompensationArrangementsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000914208 us-gaap:FairValueInputsLevel1Member 2023-12-31 0000914208 us-gaap:FairValueInputsLevel2Member 2023-12-31 0000914208 us-gaap:FairValueInputsLevel3Member 2023-12-31 0000914208 us-gaap:LiabilityMember 2023-12-31 0000914208 us-gaap:FairValueInputsLevel1Member us-gaap:LiabilityMember 2023-12-31 0000914208 us-gaap:FairValueInputsLevel2Member us-gaap:LiabilityMember 2023-12-31 0000914208 us-gaap:FairValueInputsLevel3Member us-gaap:LiabilityMember 2023-12-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000914208 us-gaap:TotalReturnSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000914208 ivz:SeedCapitalMember 2024-03-31 0000914208 ivz:SeedCapitalMember 2023-12-31 0000914208 ivz:DeferredCompensationArrangementsMember 2024-03-31 0000914208 ivz:DeferredCompensationArrangementsMember 2023-12-31 0000914208 us-gaap:LineOfCreditMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-03-31 0000914208 us-gaap:LineOfCreditMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0000914208 us-gaap:LineOfCreditMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0000914208 us-gaap:LineOfCreditMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 ivz:SeniorNotesDueJanuary152026MemberMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary152026MemberMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary152026MemberMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueJanuary152026MemberMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 ivz:SeniorNotesDueJanuary152026MemberMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 ivz:SeniorNotesDueNovember302043Member us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueNovember302043Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueNovember302043Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2024-03-31 0000914208 ivz:SeniorNotesDueNovember302043Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 ivz:SeniorNotesDueNovember302043Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2023-12-31 0000914208 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-03-31 0000914208 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0000914208 ivz:SeniorNotesDueJanuary302024Member us-gaap:UnsecuredDebtMember 2024-01-30 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0000914208 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000914208 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0000914208 country:BM 2024-01-01 2024-03-31 0000914208 country:BM 2023-01-01 2023-03-31 0000914208 srt:AmericasMember 2024-01-01 2024-03-31 0000914208 srt:AmericasMember 2023-01-01 2023-03-31 0000914208 srt:AsiaPacificMember 2024-01-01 2024-03-31 0000914208 srt:AsiaPacificMember 2023-01-01 2023-03-31 0000914208 us-gaap:EMEAMember 2024-01-01 2024-03-31 0000914208 us-gaap:EMEAMember 2023-01-01 2023-03-31 0000914208 ivz:TimeVestedNYSEMember 2023-12-31 0000914208 us-gaap:PerformanceSharesMember 2023-12-31 0000914208 ivz:TimeVestedNYSEMember 2022-12-31 0000914208 us-gaap:PerformanceSharesMember 2022-12-31 0000914208 ivz:TimeVestedNYSEMember 2024-01-01 2024-03-31 0000914208 us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0000914208 ivz:TimeVestedNYSEMember 2023-01-01 2023-03-31 0000914208 us-gaap:PerformanceSharesMember 2023-01-01 2023-03-31 0000914208 ivz:TimeVestedNYSEMember 2024-03-31 0000914208 us-gaap:PerformanceSharesMember 2024-03-31 0000914208 ivz:TimeVestedNYSEMember 2023-03-31 0000914208 us-gaap:PerformanceSharesMember 2023-03-31 0000914208 srt:MaximumMember ivz:EquityCommitmentMember 2024-03-31 0000914208 ivz:EquityCommitmentMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:BankLoanObligationsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:BankLoanObligationsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:BankLoanObligationsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:BankLoanObligationsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:BankLoanObligationsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:EquitySecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:PrivateEquityFundsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:PrivateEquityFundsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PrivateEquityFundsMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:BankLoanObligationsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:BankLoanObligationsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:BankLoanObligationsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:BankLoanObligationsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:BankLoanObligationsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:EquitySecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:PrivateEquityFundsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member us-gaap:PrivateEquityFundsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PrivateEquityFundsMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000914208 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2023-12-31 0000914208 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000914208 us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000914208 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000914208 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000914208 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2024-03-31 0000914208 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2023-12-31 0000914208 ivz:MassMutualMember ivz:InvescoMember ivz:MassMutualMember 2024-03-31 0000914208 us-gaap:SubsequentEventMember 2024-04-23 2024-04-23 shares iso4217:USD iso4217:USD shares pure 0000914208 --12-31 2024 Q1 false 10-Q true 2024-03-31 false 001-13908 Invesco Ltd. D0 98-0557567 1331 Spring Street, Suite 2500, Atlanta, GA 30309 404 892-0896 Common stock, $0.20 par value IVZ NYSE Yes Yes Large Accelerated Filer false false false 449831075 895700000 1469200000 708300000 701500000 963500000 919100000 529800000 462400000 217300000 250100000 8902200000 8765900000 0 393900000 823400000 832600000 583600000 599500000 5832400000 5848100000 8621000000 8691500000 28077200000 28933800000 452500000 900400000 1321200000 1294400000 7370400000 7121800000 459100000 492100000 0 393900000 1257500000 1489500000 1363700000 1325700000 12224400000 13017800000 667800000 745700000 0.20 0.20 1000 1000 4000000 4000000 4000000 4000000 4000000 4000000 4010500000 4010500000 0.20 0.20 1050000000 1050000000 566100000 566100000 113200000 113200000 7314600000 7451600000 2864400000 3002600000 6878000000 6826700000 -897100000 -801800000 14554800000 14597600000 630200000 572700000 15185000000 15170300000 28077200000 28933800000 1048700000 1027900000 377000000.0 334200000 800000 5600000 48800000 50500000 1475300000 1418200000 504000000.0 455100000 472700000 462800000 18100000 19600000 117600000 110500000 138500000 105000000.0 0 41600000 11300000 14100000 1262200000 1208700000 213100000 209500000 6900000 26100000 12400000 8600000 15900000 18000000.0 35900000 27400000 30500000 -17900000 282900000 235700000 68700000 69900000 214200000 165800000 13500000 -38400000 59200000 59200000 141500000 145000000.0 0.31 0.32 0.31 0.32 214200000 165800000 -96300000 55100000 1000000.0 4400000 -95300000 59500000 118900000 225300000 13500000 -38400000 59200000 59200000 46200000 204500000 214200000 165800000 45100000 46800000 21100000 37800000 35300000 27400000 -2400000 -63200000 6900000 26100000 15900000 2700000 3400000 -32700000 -16800000 -2900000 -365100000 70700000 -689400000 -326600000 -54400000 -98900000 21000000.0 38100000 472800000 562600000 237700000 669500000 36500000 40700000 100000 21000000.0 6900000 7000000.0 -1700000 -10600000 -287300000 45500000 20400000 27700000 59200000 59200000 90200000 85700000 98300000 27500000 42600000 67900000 274300000 39700000 76100000 5200000 1030400000 0 662800000 0 600000000.0 0 -148300000 -178500000 -490000000.0 -231900000 -14100000 11700000 -2000000.0 1000000.0 1931600000 1434100000 1425500000 1214900000 895700000 889000000.0 529800000 325900000 1425500000 1214900000 4010500000 113200000 7451600000 -3002600000 6826700000 -801800000 14597600000 572700000 15170300000 745700000 200700000 200700000 37900000 238600000 -24400000 -95300000 -95300000 -95300000 -19600000 -19600000 -53500000 14.75 59200000 59200000 59200000 0.20 90200000 90200000 90200000 21100000 21100000 21100000 158400000 -158400000 0 0 300000 200000 500000 500000 20400000 20400000 20400000 4010500000 113200000 7314600000 -2864400000 6878000000 -897100000 14554800000 630200000 15185000000 667800000 4010500000 113200000 7554900000 -3040900000 7518300000 -942400000 15213600000 629900000 15843500000 998700000 204200000 204200000 -24800000 179400000 -13600000 59500000 59500000 59500000 17900000 17900000 -105500000 14.75 59200000 59200000 59200000 0.1875 85700000 85700000 85700000 37800000 37800000 37800000 180600000 -180600000 0 0 500000 0 500000 500000 27700000 27700000 27700000 4010500000 113200000 7412600000 -2888000000 7577600000 -882900000 15343000000 587200000 15930200000 879600000 ACCOUNTING POLICIES<div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Information</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invesco Ltd. (the Parent) and its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of investment management capabilities. The company operates globally and its sole business is investment management.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2023 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report.</span></div><div><span><br/></span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Accounting and Consolidation</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the quarter ended March 31, 2024, expenses for client-related travel and entertainment and outsourced services were reclassified to General and administrative expenses. The impact of this reclassification on the Consolidated Statements of Income is as follows:</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• For the three months ended March 31, 2024: decreased Marketing and Property, office and technology expenses by $6.7 million and $23.6 million, respectively, and increased General and administrative by $30.3 million.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• For the three months ended March 31, 2023: decreased Marketing and Property, office and technology expenses by $5.4 million and $23.9 million, respectively, and increased General and administrative by $29.3 million.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to the most recent Form 10-K filed with the SEC.</span></div> <div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Accounting and Consolidation</span></div>The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the quarter ended March 31, 2024, expenses for client-related travel and entertainment and outsourced services were reclassified to General and administrative expenses. The impact of this reclassification on the Consolidated Statements of Income is as follows:</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• For the three months ended March 31, 2024: decreased Marketing and Property, office and technology expenses by $6.7 million and $23.6 million, respectively, and increased General and administrative by $30.3 million.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">• For the three months ended March 31, 2023: decreased Marketing and Property, office and technology expenses by $5.4 million and $23.9 million, respectively, and increased General and administrative by $29.3 million.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification had no impact on our reported Operating revenues, Operating income, Net income, or any internal performance measure on which management is compensated.</span></div> -6700000 -23600000 30300000 -5400000 -23900000 29300000 <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to the most recent Form 10-K filed with the SEC.</span></div> FAIR VALUE OF ASSETS AND LIABILITIES <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products."</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> (in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for policyholders </span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholder payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    These financial instruments are not measured at fair value on a recurring basis. Policyholder payables were indexed to the value of the assets held for policyholders and changes in fair value were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> recorded and offset to zero in other operating r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">evenues. In January 2024, all funds were distributed to customers. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:52.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:52.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for policyholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)    The balance primarily represents cash held in affiliated money market funds.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)    Equity method and other investments of $651.4 million and $14.9 million, respectively, are excluded from this table (December 31, 2023: $631.8 million and $14.9 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The majority of A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ssets held for policyholders were held in affiliated funds.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Return Swap (TRS)</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to holding equity investments, the company has a TRS to hedge economically certain deferred compensation liabilities. The notional value of the TRS at March 31, 2024 was $424.4 million, and the fair value of the TRS was an asset of $8.1 million (December 31, 2023 notional value was $393.0 million and the fair value was an asset of $4.9 million). During the three months ended March 31, 2024, market valuation gains related to the TRS were $18.0 million (three months ended March 31, 2023: $13.1 million net gain).</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the TRS was determined under the market approach using quoted prices of the underlying investments and, as such, is classified as level 2 of the valuation hierarchy. The TRS is not designated for hedge accounting.</span></div> <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products."</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> (in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for policyholders </span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholder payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    These financial instruments are not measured at fair value on a recurring basis. Policyholder payables were indexed to the value of the assets held for policyholders and changes in fair value were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> recorded and offset to zero in other operating r</span>evenues. In January 2024, all funds were distributed to customers. 895700000 1469200000 297200000 272400000 0 393900000 0 393900000 -8100000 -4900000 <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:52.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:52.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for policyholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1)    The balance primarily represents cash held in affiliated money market funds.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)    Equity method and other investments of $651.4 million and $14.9 million, respectively, are excluded from this table (December 31, 2023: $631.8 million and $14.9 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The majority of A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ssets held for policyholders were held in affiliated funds.</span></div> 434700000 434700000 0 0 86000000.0 86000000.0 0 0 211200000 211200000 0 0 8100000 0 8100000 0 740000000.0 731900000 8100000 0 1300000 0 0 1300000 1300000 0 0 1300000 927800000 927800000 0 0 75700000 75700000 0 0 196700000 196700000 0 0 393900000 393900000 0 0 4900000 0 4900000 0 1599000000 1594100000 4900000 0 1300000 0 0 1300000 1300000 0 0 1300000 651400000 14900000 631800000 14900000 424400000 8100000 393000000 4900000 18000000 13100000 INVESTMENTS<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosures below include details of the company’s investments. Investments held by CIP are detailed </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">te 11, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Consolidated Investment Products."</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity investments</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized gains and losses for the three months ended March 31, 2024 that relate to equity investments still held at March 31, 2024 were a $16.2 million net gain (three months ended March 31, 2023: $6.7 million net gain).</span></div> <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosures below include details of the company’s investments. Investments held by CIP are detailed </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">te 11, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Consolidated Investment Products."</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed capital</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments related to deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.</span></div> 86000000.0 75700000 211200000 196700000 651400000 631800000 14900000 14900000 963500000 919100000 16200000 6700000 DEBT <div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products."</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.0 billion floating rate credit agreement expiring April 26, 2028</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured Senior Notes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 4.000% - due January 30, 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 3.750% - due January 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400 million 5.375% - due November 30, 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)     On January 30, 2024, the outstanding balance of the $600.0 million senior notes was paid in full.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.</span></div> <div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products."</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.0 billion floating rate credit agreement expiring April 26, 2028</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured Senior Notes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 4.000% - due January 30, 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 3.750% - due January 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400 million 5.375% - due November 30, 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)     On January 30, 2024, the outstanding balance of the $600.0 million senior notes was paid in full.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)    The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.</span></div> 2000000000 367600000 367600000 0 0 600000000 0.04000 0 0 599900000 599100000 500000000 0.03750 498700000 488000000.0 498600000 489100000 400000000 0.05375 391200000 391700000 391000000.0 409600000 1257500000 1247300000 1489500000 1497800000 600000000 SHARE CAPITAL <div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of preferred shares issued and outstanding is represented in the table below:</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred shares issued </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred shares outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    Substantially all the preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares and common share equivalents issued are represented in the table below:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issued</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Treasury shares for which dividend and voting rights do not apply</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of preferred shares issued and outstanding is represented in the table below:</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred shares issued </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred shares outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)    Substantially all the preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares and common share equivalents issued are represented in the table below:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issued</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Treasury shares for which dividend and voting rights do not apply</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4000000.0 4000000.0 4000000.0 4000000.0 P5Y 566100000 566100000 116300000 116600000 449800000 449500000 OTHER COMPREHENSIVE INCOME/(LOSS) <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income/(loss) were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:39.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.330%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income/(loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences on investments in foreign subsidiaries</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(801.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(815.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(942.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(897.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income/(loss) were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:39.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.330%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee benefit plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income/(loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences on investments in foreign subsidiaries</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(801.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(815.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(942.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(897.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -96300000 0 -96300000 55100000 0 55100000 0 1000000.0 1000000.0 0 4400000 4400000 -96300000 1000000.0 -95300000 55100000 4400000 59500000 -670100000 -131700000 -801800000 -815000000.0 -127400000 -942400000 -96300000 1000000.0 -95300000 55100000 4400000 59500000 -766400000 -130700000 -897100000 -759900000 -123000000.0 -882900000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REVENUE </span><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic disaggregation of revenue for the three months ended March 31, 2024 and 2023 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific (APAC)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa (EMEA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.9</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic disaggregation of revenue for the three months ended March 31, 2024 and 2023 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific (APAC)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa (EMEA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.9</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 1140600000 1083400000 68700000 69900000 266000000.0 264900000 1475300000 1418200000 COMMON SHARE-BASED COMPENSATION <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognized total compensation expense of $21.1 million and $37.8 million related to equity-settled common share-based compensation in the three months ended March 31, 2024 and 2023, respectively. </span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements on employee common share awards during the periods ended March 31 are detailed below:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:33.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions of common shares, except fair values)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance- Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at the beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and distributed during the period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at the end of the period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.41 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of common shares that vested during the three months ended March 31, 2024 was $67.0 million (three months ended March 31, 2023: $87.3 million). The weighted average grant date fair value of the United States (U.S.) dollar share awards that were granted during the three months ended March 31, 2024 was $15.13 (three months ended March 31, 2023: $17.74).</span></div>At March 31, 2024, there was $182.5 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be recognized over a weighted average period of 2.94 years. 21100000 37800000 <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements on employee common share awards during the periods ended March 31 are detailed below:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:33.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions of common shares, except fair values)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time- Vested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance- Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at the beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and distributed during the period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at the end of the period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.41 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 10400000 1600000 18.84 10300000 2100000 4900000 900000 15.13 4300000 700000 200000 100000 18.21 0 200000 4400000 300000 18.29 4500000 500000 10700000 2100000 17.41 10100000 2100000 67000000 87300000 15.13 17.74 182500000 P2Y11M8D EARNINGS PER COMMON SHARE <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of earnings per common share (EPS) is as follows:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:75.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Invesco Ltd.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Invesco Ltd:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of non-participating common share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, "Common Share-Based Compensation," for a summary of common share awards outstanding under the company’s common share-based payment programs. These programs could result in the issuance of common shares that would affect the measurement of basic and diluted EPS.</span></div> <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of earnings per common share (EPS) is as follows:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:75.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Invesco Ltd.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Invesco Ltd:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of non-participating common share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 141500000 145000000.0 453200000 458100000 300000 800000 453500000 458900000 0.31 0.32 0.31 0.32 COMMITMENTS AND CONTINGENCIES <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies may arise in the ordinary course of business.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The company has committed to co-invest in certain investment products, which may be called in future periods. At March 31, 2024, the company’s undrawn co-invest capital commitments were $664.6 million (December 31, 2023: $623.3 million). </span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our managed investment products have entered into revolving credit facilities with financial institutions. The company provided equity commitments and guarantees to the financial institutions for certain of these revolving credit facilities that are temporary in nature. The revolving credit facilities look first to the respective investment products for repayment and servicing. The company’s equity commitment or guarantee would only be called in the event a particular investment product is unable to meet its obligation. The company believes the likelihood of being required to fund its equity commitments or guarantees under these arrangements to be remote. To date, the company has not been required to fund any equity commitments or guarantees under these arrangements. The maximum amount of future payments under the commitments is $274.6 million and under the guarantees is $30.0 million. The fair value of the guarantee liability is not significant to the consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company and some of its subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies </span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability.</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company and certain related entities have in recent years been subject to various regulatory inquiries, reviews and investigations and legal proceedings, including civil litigation, governmental investigations and enforcement actions. These actions can arise from normal business operations and/or matters that have been the subject of previous regulatory reviews. As a global company with investment products registered in numerous countries and subject to the jurisdiction of one or more regulators in each country, at any given time, our business operations may be subject to review, investigation, or disciplinary action.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the impact that a legal or regulatory matter will have on the company, management evaluates the need for an accrual on a case-by-case basis. If the likelihood of a loss is deemed probable and is reasonably estimable, the estimated loss is accrued. If the likelihood of a loss is assessed as less than probable, a loss is not accrued. If a loss is deemed probable but an amount or range of loss cannot be reasonably estimated, a loss is not accrued but the matter is disclosed. </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management’s opinion, adequate accrual has been made as of March 31, 2024 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount and are deemed probable. Management believes that the ultimate resolution of claims will not materially affect the company’s business, revenue, net income or liquidity.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is cooperating with requests from the SEC in connection with their investigation of investment advisers’ compliance with record retention requirements relating to certain types of electronic business communications. At this time a range of loss related to this matter cannot be reasonably estimated. </span></div>Further, the investment management industry also is generally subject to extensive levels of ongoing regulatory oversight and examination. In the U.S., United Kingdom (U.K.) and other jurisdictions in which the company operates, governmental authorities regularly make inquiries, hold investigations and administer market conduct examinations with respect to the company’s compliance with applicable laws and regulations. Additional lawsuits or regulatory enforcement actions arising out of these inquiries may in the future be filed against the company, related entities and individuals in the U.S., U.K. and other jurisdictions in which the company and its affiliates operate. Any material loss of investor and/or client confidence as a result of such inquiries and/or litigation could result in a significant decline in assets under management (AUM), which would have an adverse effect on the company’s future financial results and its ability to grow its business. 664600000 623300000 274600000 30000000 CONSOLIDATED INVESTMENT PRODUCTS <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances related to CIP are identified on the Consolidated Balance Sheets. At March 31, 2024, the company’s net investment in and net receivables from CIP were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$521.9 million (December 31, 2023: $546.2 million). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidation of CIP had no impact on net income attributable to the company during the three months ended March 31, 2024.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2024 and December 31, 2023:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets (Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at NAV as a practical expedient</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,133.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and fixed income mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other private equity funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,902.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,887.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:38.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets (Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at NAV as a practical expedient</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,837.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and fixed income mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other private equity funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,765.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,944.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March 31, 2024, CIP borrowings with a fair value of $565.0 million (December 31, 2023: $353.7 million) are classified as level 3 in the valuation hierarchy.</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3 Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3 Assets</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CIP Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CIP Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deconsolidation of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains and losses included in the Consolidated Statements of Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from Level 3 into Levels 1 or 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 from Levels 1 or 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance as of March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Non-consolidated Variable interest entities (VIEs)</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2024, the company's risk of loss with respect to VIEs in which the company is not the primary beneficiary included our investment carrying value of $141.4 million (December 31, 2023: $122.9 million) and unfunded capital commitments of $153.2 million (December 31, 2023: $142.5 million).</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.</span></div> 521900000 546200000 <div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of March 31, 2024 and December 31, 2023:</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.370%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets (Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at NAV as a practical expedient</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,133.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and fixed income mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other private equity funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,902.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,887.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:38.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets (Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at NAV as a practical expedient</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,837.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and fixed income mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other private equity funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,765.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,944.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 7133800000 0 6143300000 990500000 0 624500000 11900000 612300000 300000 0 172900000 30100000 19400000 123400000 0 112900000 200000 112700000 0 0 412600000 0 0 0 412600000 445500000 0 0 0 445500000 8902200000 42200000 6887700000 1114200000 858100000 6837200000 0 6140100000 697100000 0 669800000 13300000 656200000 300000 0 231900000 85200000 18300000 128400000 0 137900000 8000000.0 129900000 0 0 425500000 0 0 0 425500000 463600000 0 0 0 463600000 8765900000 106500000 6944500000 825800000 889100000 565000000 353700000 <div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:68.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3 Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3 Assets</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CIP Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CIP Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deconsolidation of CIP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains and losses included in the Consolidated Statements of Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers from Level 3 into Levels 1 or 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3 from Levels 1 or 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance as of March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 825800000 368600000 275000000.0 100000 2300000 13400000 0 600000 -1900000 -7600000 16200000 130200000 34000000.0 132200000 -200000 2200000 1114200000 351300000 141400000 122900000 153200000 142500000 RELATED PARTIES<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MassMutual owns approximately 18.1% in common stock of the company and owns substantially all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares as of March 31, 2024. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s Board of Directors, the company considers MassMutual a related party.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” The majority of the company's Operating revenues and receivables are from Invesco's managed funds. Related parties also include those defined in the company’s proxy statement. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2, "Fair Value of Assets and Liabilities" and Note 3, "Investments" for more information on balances invested in Invesco affiliated funds.</span></div> 0.181 4000000000 SUBSEQUENT EVENTS<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, the company declared a first quarter 2024 dividend of $0.205 per common share, payable on June 4, 2024, to common shareholders of record at the close of business on May 14, 2024 with an ex-dividend date of May 13, 2024.</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024, the company declared a preferred dividend of $14.75 per preferred share to the holders of preferred shares representing the period from March 1, 2024 through May 31, 2024. The preferred dividend is payable on June 3, 2024.</span></div> 0.205 14.75 false false false false